data_1zry_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zry _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 119.278 -0.391 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.7 p -60.07 92.36 0.02 OUTLIER 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.797 1.239 . . . . 0.0 110.946 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.98 -170.27 42.46 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.4 t -106.5 144.53 33.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.288 1.035 . . . . 0.0 108.221 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -141.58 126.84 18.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.691 0.796 . . . . 0.0 110.917 -171.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -126.45 115.89 20.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.701 0.8 . . . . 0.0 109.189 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.3 p -50.93 143.82 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.89 1.676 . . . . 0.0 110.4 170.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -146.1 -5.52 0.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -166.21 91.24 0.45 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -164.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.64 94.73 4.82 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.988 1.315 . . . . 0.0 107.639 174.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -55.52 -76.66 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.286 1.434 . . . . 0.0 112.133 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -85.2 59.39 5.6 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.066 0.946 . . . . 0.0 111.152 -172.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -67.14 0.43 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.541 0.737 . . . . 0.0 111.905 -173.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -53.01 -41.2 64.43 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.051 0.94 . . . . 0.0 112.541 -169.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -60.55 -53.72 54.08 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.308 0.643 . . . . 0.0 110.958 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -46.12 80.47 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.06 0.944 . . . . 0.0 109.883 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.6 -46.26 80.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.785 1.234 . . . . 0.0 110.835 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -27.77 69.43 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.308 0.643 . . . . 0.0 111.838 -171.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.21 -31.6 71.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.005 0.522 . . . . 0.0 111.627 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.45 163.93 23.42 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.654 0.781 . . . . 0.0 109.793 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.4 52.04 1.36 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 111.998 -172.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.17 137.54 22.14 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.68 162.73 29.81 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.276 2.65 . . . . 0.0 111.97 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.88 -42.69 72.4 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.246 1.418 . . . . 0.0 113.511 -172.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -61.43 -44.61 96.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.37 0.668 . . . . 0.0 110.622 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.78 -35.15 79.67 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.646 -0.692 . . . . 0.0 110.482 171.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.71 -31.25 52.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 119.245 0.93 . . . . 0.0 112.688 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.57 -48.7 10.31 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 168.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.4 mmt -75.71 -48.68 20.89 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.543 0.737 . . . . 0.0 111.048 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.42 78.9 0.1 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 125.793 1.637 . . . . 0.0 111.355 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 179.03 -42.14 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.301 2.24 . . . . 0.0 107.11 -171.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -107.14 -0.38 22.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.187 1.795 . . . . 0.0 112.118 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.7 mt -62.99 117.21 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 118.99 0.813 . . . . 0.0 109.554 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -108.53 98.59 28.97 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.761 1.225 . . . . 0.0 108.943 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.26 140.38 33.79 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.603 2.202 . . . . 0.0 113.83 175.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.75 137.66 37.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 166.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.24 145.65 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.743 1.217 . . . . 0.0 108.035 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 105.24 3.67 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.906 0.882 . . . . 0.0 109.214 -168.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.7 mt -107.71 131.06 58.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.742 1.217 . . . . 0.0 108.368 -173.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? -129.04 134.43 48.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.738 1.215 . . . . 0.0 108.715 -176.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -106.21 150.15 26.16 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.2 160.23 40.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 128.206 2.602 . . . . 0.0 107.755 173.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -19.67 -72.23 0.01 OUTLIER Glycine 0 C--N 1.343 0.963 0 C-N-CA 127.719 2.581 . . . . 0.0 114.231 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -123.19 18.81 9.92 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.99 1.316 . . . . 0.0 110.74 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -124.43 144.68 49.93 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.068 0.849 . . . . 0.0 109.404 -172.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -143.68 127.79 17.57 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 122.447 0.299 . . . . 0.0 110.811 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.91 138.82 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.946 1.298 . . . . 0.0 107.94 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.89 117.27 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.966 1.306 . . . . 0.0 107.895 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.5 m -107.61 143.3 36.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.625 1.57 . . . . 0.0 107.506 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -146.04 143.82 29.67 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.488 1.115 . . . . 0.0 108.222 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -138.07 120.66 16.17 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.3 p -136.11 159.5 70.71 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.02 1.728 . . . . 0.0 108.601 172.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.49 67.98 6.23 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.788 2.992 . . . . 0.0 108.899 168.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -157.88 -60.85 0.08 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.633 1.573 . . . . 0.0 107.994 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -171.04 162.94 7.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.555 1.942 . . . . 0.0 107.758 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.8 p -84.57 99.0 10.47 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.72 65.49 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.5 m -90.79 123.98 34.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.804 1.242 . . . . 0.0 108.121 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -142.45 178.86 7.3 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.224 1.41 . . . . 0.0 108.964 -176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -167.7 166.79 13.67 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 121.918 -0.489 . . . . 0.0 110.721 -177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -152.88 155.61 37.39 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.715 0.806 . . . . 0.0 110.419 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.6 m -119.45 136.42 54.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 169.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.8 mt -57.21 -64.11 0.99 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.968 0.507 . . . . 0.0 109.931 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.43 49.91 1.86 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.358 -0.69 . . . . 0.0 112.043 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -155.12 -95.67 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.049 0.925 . . . . 0.0 110.515 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -142.81 169.36 17.72 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.296 1.039 . . . . 0.0 110.502 -174.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.25 147.19 20.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.905 1.282 . . . . 0.0 109.61 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -153.83 100.46 2.37 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.4 mm -120.08 104.79 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.069 1.348 . . . . 0.0 107.521 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -109.48 173.46 6.31 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.441 0.696 . . . . 0.0 112.45 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.2 p -138.89 170.83 15.27 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.293 2.237 . . . . 0.0 108.333 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -154.78 73.78 0.9 Allowed 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.86 -61.55 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.204 1.002 . . . . 0.0 109.817 -176.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.8 -125.45 5.64 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -116.4 161.36 19.18 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.714 1.606 . . . . 0.0 110.061 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -61.16 143.12 56.09 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.906 0.883 . . . . 0.0 111.96 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.9 mt -132.88 102.83 5.79 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.665 1.586 . . . . 0.0 107.318 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.75 139.37 8.83 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.353 0.661 . . . . 0.0 110.161 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 41.2 t -145.37 -63.91 0.33 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.583 1.553 . . . . 0.0 107.349 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.0 t -161.11 159.11 28.68 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.11 0.964 . . . . 0.0 109.513 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.7 139.69 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 125.35 1.46 . . . . 0.0 107.468 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -164.06 -157.07 0.37 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.68 121.9 38.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.008 1.323 . . . . 0.0 107.589 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.11 -52.6 2.59 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.89 1.676 . . . . 0.0 110.43 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -149.92 -80.26 0.12 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.272 0.629 . . . . 0.0 109.575 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.97 -69.13 1.41 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 173.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -145.7 -115.68 0.08 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.228 1.411 . . . . 0.0 107.379 163.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.06 163.41 27.16 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.353 1.061 . . . . 0.0 112.529 -174.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.85 141.62 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.798 1.639 . . . . 0.0 106.708 172.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -166.64 139.65 3.8 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.415 0.552 . . . . 0.0 110.594 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -81.55 74.51 8.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.856 0.862 . . . . 0.0 108.952 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.4 p -82.46 -171.23 3.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.864 1.266 . . . . 0.0 109.577 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -58.49 -59.35 5.5 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.035 0.534 . . . . 0.0 110.679 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.61 -48.11 0.07 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.184 0.593 . . . . 0.0 110.971 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.0 t80 67.55 -75.5 0.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.895 1.678 . . . . 0.0 111.729 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.9 m -158.55 -53.88 0.07 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 127.065 2.146 . . . . 0.0 106.689 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -165.17 -126.4 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.558 2.343 . . . . 0.0 105.832 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -124.03 -71.28 0.72 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.671 1.188 . . . . 0.0 108.547 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -154.27 97.73 2.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -145.88 92.14 2.17 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.486 1.114 . . . . 0.0 108.945 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.6 t -139.59 138.42 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.011 1.324 . . . . 0.0 107.712 176.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -106.72 159.15 16.44 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.512 1.125 . . . . 0.0 108.498 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -25.23 -63.05 0.06 OUTLIER Glycine 0 C--N 1.342 0.881 0 C-N-CA 127.401 2.429 . . . . 0.0 114.254 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -130.71 34.55 4.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.012 0.925 . . . . 0.0 111.239 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -144.02 112.97 6.73 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.642 0.777 . . . . 0.0 109.44 173.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.2 ttm -100.18 82.29 2.51 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.38 71.1 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.618 1.167 . . . . 0.0 108.735 -173.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.4 84.14 0.8 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -105.59 26.0 10.06 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.936 1.294 . . . . 0.0 111.212 -168.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 mm -108.7 -124.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 117.9 -1.048 . . . . 0.0 108.184 -173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 t -132.86 125.32 29.7 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 120.198 1.363 . . . . 0.0 112.954 -165.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -41.28 78.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.75 -65.99 0.08 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.99 -43.81 4.95 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.513 1.054 . . . . 0.0 112.189 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.3 t -107.54 154.04 8.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 124.208 1.003 . . . . 0.0 109.541 -172.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.3 p -103.72 107.58 18.51 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.52 120.85 43.02 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.1 mp -76.19 75.3 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 171.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -93.88 106.16 18.14 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.675 1.19 . . . . 0.0 108.466 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -107.91 119.23 38.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.615 1.566 . . . . 0.0 109.907 -175.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.0 p -125.07 121.52 34.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 170.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -107.35 155.55 19.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.347 1.459 . . . . 0.0 109.049 -173.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -74.82 148.21 40.5 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.413 177.311 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.4 p -51.77 118.67 3.55 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.556 1.142 . . . . 0.0 110.84 -172.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.27 172.05 42.26 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -170.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.4 p -114.9 102.43 9.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.887 1.275 . . . . 0.0 108.249 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -115.57 147.37 40.82 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.325 1.05 . . . . 0.0 110.007 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -95.53 -131.7 0.17 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.625 0.77 . . . . 0.0 109.094 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 p 176.75 133.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 127.584 2.354 . . . . 0.0 105.099 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -146.17 -8.91 0.52 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -158.06 110.99 2.4 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -165.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.7 140.2 52.9 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 172.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -90.32 -77.96 0.39 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.413 0.551 . . . . 0.0 112.189 -170.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -83.31 57.42 3.98 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.158 0.983 . . . . 0.0 110.208 -176.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -69.13 -61.59 1.73 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -54.56 -43.31 71.94 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-O 118.983 -0.532 . . . . 0.0 111.801 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.52 -50.66 72.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.796 0.438 . . . . 0.0 110.709 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -58.22 -50.11 74.7 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.755 0.822 . . . . 0.0 110.675 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -16.94 62.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.398 0.679 . . . . 0.0 111.678 -175.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -95.74 -15.11 22.83 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.013 0.925 . . . . 0.0 111.811 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.07 -38.3 87.96 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 166.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.98 144.77 57.07 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.03 43.99 1.04 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.28 0.632 . . . . 0.0 111.941 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.19 145.06 29.58 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.95 1.3 . . . . 0.0 107.99 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.8 135.61 26.11 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.566 2.844 . . . . 0.0 111.869 -171.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -46.34 -41.53 13.53 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.56 1.544 . . . . 0.0 113.061 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -40.46 -56.04 2.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 126.977 2.111 . . . . 0.0 111.858 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.47 -41.66 84.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.888 0.875 . . . . 0.0 110.504 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.3 mp -60.79 -37.82 77.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 118.594 0.634 . . . . 0.0 110.4 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -53.06 -34.22 55.55 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.423 0.689 . . . . 0.0 111.065 177.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 81.2 mmm -108.14 19.71 19.6 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.961 1.704 . . . . 0.0 112.202 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.79 -36.06 4.96 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.554 1.542 . . . . 0.0 110.358 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -56.11 -28.66 58.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.141 0.977 . . . . 0.0 113.476 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.85 -17.46 40.84 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.087 0.955 . . . . 0.0 113.039 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.58 143.6 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.636 0.774 . . . . 0.0 110.09 -176.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -117.36 107.95 44.35 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.084 1.354 . . . . 0.0 109.005 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -57.43 -174.47 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.455 3.437 . . . . 0.0 115.187 173.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.5 tt -118.8 146.21 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 157.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.74 78.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.3 143.81 30.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.56 1.944 . . . . 0.0 107.687 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 tt -145.74 142.1 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 118.426 0.557 . . . . 0.0 109.721 169.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -133.75 155.12 50.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.291 1.836 . . . . 0.0 109.254 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -127.16 161.67 27.95 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.837 1.255 . . . . 0.0 112.364 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -149.31 163.4 37.81 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.301 2.641 . . . . 0.0 107.824 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -23.28 -66.8 0.03 OUTLIER Glycine 0 C--N 1.344 1.002 0 C-N-CA 127.453 2.454 . . . . 0.0 114.114 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -129.16 21.8 5.71 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.079 1.752 . . . . 0.0 110.137 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -126.58 150.28 48.95 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.601 0.76 . . . . 0.0 111.584 -171.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -139.14 140.31 37.86 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.173 0.989 . . . . 0.0 110.555 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.2 t -135.44 112.54 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -105.54 149.79 8.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.3 m -143.5 82.58 1.74 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.131 1.372 . . . . 0.0 108.129 -172.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.9 m -114.83 47.17 1.3 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.669 1.187 . . . . 0.0 109.812 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.73 168.47 9.16 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -166.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.2 p -124.94 158.06 64.33 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 126.025 1.73 . . . . 0.0 107.298 171.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.6 65.12 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.145 2.563 . . . . 0.0 108.381 168.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -174.84 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.691 1.596 . . . . 0.0 108.862 -172.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -128.18 122.91 33.02 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.869 1.267 . . . . 0.0 109.171 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.3 m -95.5 82.08 3.62 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.143 1.377 . . . . 0.0 110.303 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -91.29 96.18 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.5 m -139.28 74.76 1.48 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.341 1.057 . . . . 0.0 109.415 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.51 138.44 58.07 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 m -155.55 142.81 19.33 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -167.56 148.4 5.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -99.69 142.66 30.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 162.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 mp -56.03 -72.07 0.08 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.027 0.931 . . . . 0.0 110.093 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.14 72.62 2.46 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -167.79 174.3 7.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.565 0.746 . . . . 0.0 110.901 -173.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -81.63 166.09 20.48 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.513 0.725 . . . . 0.0 109.24 162.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.87 85.65 0.54 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.24 73.53 3.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.076 0.55 . . . . 0.0 110.479 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.2 mt -77.13 125.97 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.0 p -107.75 -163.48 0.9 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.013 1.325 . . . . 0.0 109.465 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -161.86 171.15 18.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.579 0.752 . . . . 0.0 110.238 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.38 -61.18 1.74 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.097 1.359 . . . . 0.0 110.209 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -135.33 21.02 3.4 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.785 1.234 . . . . 0.0 111.153 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.91 -121.21 1.62 Allowed Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -141.55 -77.06 0.28 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.154 1.382 . . . . 0.0 109.389 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.4 134.03 2.72 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.42 114.61 28.17 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.176 0.99 . . . . 0.0 110.602 -171.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.28 52.08 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.41 1.084 . . . . 0.0 108.335 174.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 79.7 m -115.23 -57.77 2.21 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.559 1.144 . . . . 0.0 110.348 -170.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.5 p -104.17 84.29 2.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 -170.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.2 m -123.62 -130.81 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.048 1.339 . . . . 0.0 109.039 -171.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -24.0 127.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.715 2.406 . . . . 0.0 114.014 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.3 tt -114.76 95.69 5.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.18 -61.86 1.46 Allowed 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 123.657 0.783 . . . . 0.0 108.923 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -67.92 -56.87 7.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.252 0.621 . . . . 0.0 111.233 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.27 -38.89 0.08 OUTLIER Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -110.88 171.44 7.46 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.286 1.434 . . . . 0.0 107.89 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.04 159.44 33.82 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.13 -86.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -76.99 87.65 3.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.612 1.165 . . . . 0.0 110.349 -171.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -104.13 41.45 1.3 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.508 1.123 . . . . 0.0 108.704 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.5 p -151.03 57.4 0.91 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.459 0.703 . . . . 0.0 110.106 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -156.4 -167.78 2.52 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -64.1 133.17 52.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.182 0.593 . . . . 0.0 109.625 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.8 t80 69.02 51.93 0.52 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.758 1.223 . . . . 0.0 110.944 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 73.9 m -112.45 134.61 53.88 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.234 1.014 . . . . 0.0 109.647 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -78.0 170.28 16.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.62 0.768 . . . . 0.0 110.231 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -57.29 -73.2 0.07 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.846 1.258 . . . . 0.0 112.316 -171.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -161.06 -55.28 0.05 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.495 1.118 . . . . 0.0 108.892 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -167.41 178.82 5.28 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.524 0.73 . . . . 0.0 112.152 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 63.7 t -108.69 145.94 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 126.818 2.047 . . . . 0.0 108.633 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -108.01 151.75 25.41 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.8 0.84 . . . . 0.0 109.734 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -13.34 -72.2 0.01 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 128.777 3.084 . . . . 0.0 115.81 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -128.56 28.4 5.42 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.502 1.121 . . . . 0.0 110.972 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -151.45 113.66 4.54 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.7 ttt -98.9 97.68 8.84 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.864 1.266 . . . . 0.0 107.751 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.3 t -105.79 102.81 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -115.68 129.36 56.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.665 0.786 . . . . 0.0 109.474 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.6 t -110.91 116.41 31.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 164.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.34 110.37 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -168.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.0 p -73.59 104.06 4.41 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.877 1.271 . . . . 0.0 110.311 -172.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -92.08 174.19 7.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.905 1.282 . . . . 0.0 110.226 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -41.87 -52.48 4.77 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.066 1.793 . . . . 0.0 113.836 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -136.36 19.86 3.58 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.279 -0.734 . . . . 0.0 114.469 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.7 t -149.43 162.98 4.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 171.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.0 t -118.3 125.37 49.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 159.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 28.2 tp -101.77 99.86 10.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.1 mt -55.55 128.6 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.335 166.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -146.57 124.03 11.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.315 1.446 . . . . 0.0 108.496 176.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -107.81 116.29 31.68 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.7 p -110.98 127.55 55.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.143 1.377 . . . . 0.0 107.839 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -105.87 145.77 30.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.517 1.127 . . . . 0.0 108.894 -170.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.5 tpt85 -69.8 121.99 18.34 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.616 0.766 . . . . 0.0 110.711 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.271 -1.347 . . . . 0.0 109.289 173.889 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 . . . . . 0 C--O 1.224 -0.246 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 p -57.56 100.2 0.05 OUTLIER 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.188 0.995 . . . . 0.0 111.768 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.84 -174.71 47.07 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.9 p -105.91 128.14 53.59 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -130.26 153.44 48.62 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.207 0.603 . . . . 0.0 111.548 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -142.22 119.72 11.69 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.39 1.076 . . . . 0.0 109.908 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.456 ' CG1' ' HD2' ' A' ' 36' ' ' PRO . 1.2 p -49.77 138.01 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.729 1.212 . . . . 0.0 109.293 163.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -138.77 -16.67 1.12 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 172.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.3 85.94 2.19 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.308 1.043 . . . . 0.0 110.709 -163.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -95.52 145.67 25.02 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 167.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -79.82 -106.67 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -85.99 75.41 9.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -46.23 75.84 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.948 0.899 . . . . 0.0 110.97 -176.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -62.6 -16.71 57.84 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -72.2 -54.06 10.77 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.378 0.99 . . . . 0.0 110.917 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -43.17 -63.37 0.82 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.102 1.761 . . . . 0.0 112.423 -172.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -12.37 59.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.415 1.086 . . . . 0.0 113.885 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.03 -32.21 64.96 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.012 0.823 . . . . 0.0 109.953 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.8 41.25 0.72 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.619 0.768 . . . . 0.0 111.686 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -138.34 168.71 19.18 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.356 1.462 . . . . 0.0 108.509 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.47 39.47 1.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.792 0.837 . . . . 0.0 111.384 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 mp -97.74 141.69 23.39 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.89 153.1 58.43 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.664 2.243 . . . . 0.0 109.732 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -57.01 -25.34 58.39 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.335 1.054 . . . . 0.0 113.091 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.92 -45.82 71.3 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.604 1.162 . . . . 0.0 111.166 171.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.5 mt -80.87 -4.91 56.46 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.644 -0.694 . . . . 0.0 112.214 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.96 -28.03 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.075 0.852 . . . . 0.0 109.945 166.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -53.65 -44.46 69.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 166.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 9.1 ttt -62.07 -63.57 1.21 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.311 1.044 . . . . 0.0 110.265 168.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.22 79.35 0.98 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.047 0.939 . . . . 0.0 112.58 -174.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.68 -44.81 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.744 2.017 . . . . 0.0 107.738 174.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -85.83 48.74 1.65 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.525 1.53 . . . . 0.0 108.578 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.8 mm -127.86 135.33 63.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 C-N-CA 124.881 1.272 . . . . 0.0 109.471 -175.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.12 82.24 4.46 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -176.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HD2' ' CG1' ' A' ' 8' ' ' VAL . 21.6 Cg_exo -70.27 173.1 11.92 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.711 2.274 . . . . 0.0 112.879 -173.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 pt -107.46 137.8 36.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 167.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.6 t -118.45 104.04 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -112.94 98.61 7.28 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.004 2.122 . . . . 0.0 107.267 -166.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.7 mt -106.29 133.41 50.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 123.318 0.647 . . . . 0.0 110.026 -173.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -126.56 121.71 33.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.009 1.724 . . . . 0.0 107.821 172.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -108.7 145.09 35.6 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.344 0.592 . . . . 0.0 110.92 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.65 161.36 30.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 129.75 3.22 . . . . 0.0 106.408 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -14.44 -68.57 0.01 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 127.868 2.651 . . . . 0.0 114.378 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -129.97 12.14 5.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.583 1.553 . . . . 0.0 110.802 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.13 139.22 47.84 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 118.785 0.72 . . . . 0.0 109.866 -172.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -135.14 119.31 17.65 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.15 0.58 . . . . 0.0 109.583 -172.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.8 t -113.63 110.32 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -108.38 118.95 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m -106.86 106.84 17.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.86 1.664 . . . . 0.0 107.205 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 p -108.17 82.08 1.58 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.053 1.741 . . . . 0.0 107.799 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -104.03 127.54 51.6 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.086 0.954 . . . . 0.0 109.883 -166.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.3 p -113.84 157.33 42.12 Favored Pre-proline 0 CA--C 1.53 0.21 0 C-N-CA 125.819 1.648 . . . . 0.0 109.754 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.41 60.11 5.64 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.54 2.827 . . . . 0.0 109.423 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -175.65 -53.7 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.411 1.484 . . . . 0.0 110.497 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -126.92 154.46 44.46 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.682 1.193 . . . . 0.0 110.742 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.1 p -110.17 53.6 0.69 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.021 1.328 . . . . 0.0 110.05 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -72.21 138.12 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.5 m -148.36 137.96 22.17 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.243 1.017 . . . . 0.0 108.346 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -132.26 102.04 5.61 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.134 1.374 . . . . 0.0 108.483 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.5 p -110.6 141.03 44.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.702 1.201 . . . . 0.0 109.379 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -156.05 176.9 12.05 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.661 0.784 . . . . 0.0 110.313 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.0 m -137.36 149.38 46.95 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 172.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.12 -65.39 0.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.647 0.779 . . . . 0.0 110.043 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.94 62.39 4.38 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -162.46 159.04 24.56 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.516 0.726 . . . . 0.0 110.594 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.76 136.47 37.4 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.518 1.127 . . . . 0.0 109.528 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.46 144.85 10.97 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.698 1.199 . . . . 0.0 109.426 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -110.32 130.67 55.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.762 1.225 . . . . 0.0 108.468 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 42.6 mm -108.37 141.35 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.429 1.091 . . . . 0.0 109.113 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.5 p -108.82 164.54 12.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.313 1.445 . . . . 0.0 110.631 -173.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 t -128.71 160.1 33.55 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.745 1.218 . . . . 0.0 108.183 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -71.34 -67.18 0.54 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -140.62 103.02 4.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.865 0.866 . . . . 0.0 108.731 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.54 -109.28 0.24 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -157.36 163.55 38.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.954 0.902 . . . . 0.0 109.784 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -70.36 87.17 0.62 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.182 0.993 . . . . 0.0 110.06 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 tt -151.74 78.08 1.24 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -141.27 86.42 2.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.0 1.32 . . . . 0.0 108.427 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.1 p -107.47 86.51 2.31 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -150.23 53.64 0.91 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.158 0.983 . . . . 0.0 110.815 -170.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.3 m -133.85 50.82 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -154.25 170.96 20.03 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.513 -0.742 . . . . 0.0 109.659 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.74 133.32 35.92 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.202 1.801 . . . . 0.0 106.299 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.05 -52.95 2.93 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.276 0.631 . . . . 0.0 109.775 -176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.0 -52.75 0.29 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.517 1.127 . . . . 0.0 108.741 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.05 41.21 0.54 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -142.19 125.01 16.01 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.242 1.017 . . . . 0.0 109.193 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 tt -73.26 79.15 1.31 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.593 1.557 . . . . 0.0 108.434 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.7 143.33 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.493 1.117 . . . . 0.0 110.021 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 t -118.4 -37.43 3.33 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.206 1.402 . . . . 0.0 109.249 169.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -160.79 167.16 27.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.304 1.042 . . . . 0.0 109.071 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.2 t -144.92 136.0 24.91 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -129.45 -135.49 0.22 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.975 0.91 . . . . 0.0 108.964 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -63.31 -47.03 83.97 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.74 0.816 . . . . 0.0 109.604 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -83.71 62.16 6.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.021 1.728 . . . . 0.0 109.829 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.5 m -66.28 127.06 30.73 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -101.42 -41.13 6.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.829 1.252 . . . . 0.0 111.954 -172.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -166.05 166.63 17.1 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.327 0.512 . . . . 0.0 111.285 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -149.31 -61.2 0.22 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.203 1.401 . . . . 0.0 108.829 169.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -85.31 89.41 7.66 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.005 0.922 . . . . 0.0 110.962 -171.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.5 t -106.9 134.42 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 125.194 1.398 . . . . 0.0 107.283 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -124.95 153.15 43.18 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.929 0.892 . . . . 0.0 109.987 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -30.67 -53.98 0.24 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 127.635 2.54 . . . . 0.0 115.219 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -122.97 11.95 9.64 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.725 1.21 . . . . 0.0 112.557 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -148.49 105.89 3.65 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.888 0.875 . . . . 0.0 108.848 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.1 ttt -101.56 115.35 30.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 t -106.67 86.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.2 111.52 3.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.2 m -107.11 81.97 1.62 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 tp -104.35 116.17 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.712 0.805 . . . . 0.0 109.463 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -98.97 157.99 15.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.125 0.97 . . . . 0.0 110.125 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -161.12 166.01 28.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.049 1.74 . . . . 0.0 107.172 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 2.08 -82.17 0.0 OUTLIER Glycine 0 C--N 1.344 1.001 0 C-N-CA 128.617 3.008 . . . . 0.0 115.355 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -141.15 52.3 0.68 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.1 p -160.88 145.06 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.599 1.159 . . . . 0.0 108.542 -173.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t -150.4 135.94 18.13 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.848 0.459 . . . . 0.0 110.655 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.86 139.2 49.97 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.88 1.272 . . . . 0.0 108.762 -173.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.61 -11.06 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.232 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 5.79 80.74 0.01 OUTLIER 'General case' 0 C--N 1.349 0.549 0 C-N-CA 129.593 3.157 . . . . 0.0 113.005 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -104.22 121.92 44.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.891 1.276 . . . . 0.0 108.127 -170.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.4 p -122.15 152.28 40.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.084 1.754 . . . . 0.0 109.944 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -124.17 148.4 47.26 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.294 1.038 . . . . 0.0 108.918 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.9 73.22 4.46 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 123.823 0.702 . . . . 0.0 109.643 -177.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 C--O 1.25 1.116 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.048 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 . . . . . 0 CA--C 1.532 0.288 0 CA-C-O 120.688 0.28 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 t -169.27 72.39 0.08 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.358 1.463 . . . . 0.0 108.14 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.22 -163.59 31.78 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 t -105.1 135.02 47.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -134.93 106.4 6.83 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -80.65 -122.26 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -171.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.445 HG13 ' CD ' ' A' ' 36' ' ' PRO . 3.2 p 175.76 125.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -175.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -134.88 -24.41 1.48 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.8 -67.99 0.83 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.831 -1.08 . . . . 0.0 112.585 -168.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . 0.272 1.1 pt20 3.9 83.61 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.373 2.269 . . . . 0.0 114.045 -162.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -75.13 -71.85 0.33 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.043 0.937 . . . . 0.0 111.629 -169.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -82.91 53.81 2.53 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.921 0.889 . . . . 0.0 110.406 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -67.71 -42.24 82.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.198 0.599 . . . . 0.0 111.263 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -53.99 -52.12 61.74 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.829 1.252 . . . . 0.0 112.147 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -55.29 -50.86 68.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.911 0.484 . . . . 0.0 110.703 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -65.52 -48.47 72.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.248 1.419 . . . . 0.0 112.111 -172.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.24 -50.96 63.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.371 0.668 . . . . 0.0 110.459 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.98 65.59 6.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.308 1.051 . . . . 0.0 109.512 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.13 -27.52 0.05 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.034 2.534 . . . . 0.0 109.487 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.2 mt -67.58 -120.56 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.485 1.514 . . . . 0.0 107.823 163.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.12 67.17 0.59 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.274 -0.891 . . . . 0.0 110.401 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 mp -124.42 143.64 43.66 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.816 1.246 . . . . 0.0 108.281 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 141.42 24.44 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.351 3.367 . . . . 0.0 111.765 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -47.66 -44.61 27.32 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 125.294 1.438 . . . . 0.0 113.336 -171.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.01 -48.95 32.45 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.542 1.137 . . . . 0.0 111.3 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.0 mt -74.61 -23.1 58.66 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.929 0.892 . . . . 0.0 112.017 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.0 mp -73.34 -41.29 57.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 CA-C-N 119.562 1.074 . . . . 0.0 109.344 170.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -42.99 86.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 46.3 ttm -56.43 -56.28 23.12 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.416 1.086 . . . . 0.0 110.589 167.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.42 -37.9 57.82 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 113.208 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -59.13 -30.73 68.36 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.286 1.434 . . . . 0.0 111.683 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -77.21 -26.88 53.24 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.146 0.978 . . . . 0.0 111.491 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mt -70.59 116.84 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.842 0.857 . . . . 0.0 111.65 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.1 106.49 16.18 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 168.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.445 ' CD ' HG13 ' A' ' 8' ' ' VAL . 66.5 Cg_endo -68.13 177.8 4.12 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.061 1.841 . . . . 0.0 112.982 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 pt -129.37 153.31 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 165.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.5 t -131.68 111.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -121.68 97.6 5.57 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.816 2.046 . . . . 0.0 107.575 -162.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.4 mt -108.63 140.38 27.45 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 C-N-CA 122.784 0.434 . . . . 0.0 110.21 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -142.11 150.05 40.65 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.929 1.292 . . . . 0.0 108.093 171.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -121.75 167.52 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.151 0.981 . . . . 0.0 112.531 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -151.56 159.61 44.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.746 2.818 . . . . 0.0 107.77 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.31 -59.67 0.22 Allowed Glycine 0 C--N 1.341 0.858 0 C-N-CA 126.625 2.06 . . . . 0.0 113.937 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -130.93 33.45 4.19 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.816 1.246 . . . . 0.0 110.429 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -144.31 154.49 43.1 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.913 0.779 . . . . 0.0 111.866 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -149.7 127.29 11.62 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.689 0.796 . . . . 0.0 110.194 -173.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.2 t -108.27 122.73 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.51 96.17 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.774 1.629 . . . . 0.0 109.024 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 m -102.88 98.84 8.76 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.42 1.088 . . . . 0.0 108.515 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -105.68 117.75 34.81 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -137.06 138.48 40.45 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.629 0.772 . . . . 0.0 111.128 -167.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -124.49 153.89 69.48 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.641 1.577 . . . . 0.0 108.172 167.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.66 56.01 5.74 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.105 3.203 . . . . 0.0 109.854 172.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -175.0 -51.54 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.121 1.769 . . . . 0.0 109.543 -171.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -125.44 162.32 25.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.436 1.095 . . . . 0.0 109.823 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.3 m -138.3 118.28 13.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.889 0.876 . . . . 0.0 108.78 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.17 43.26 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.8 p -79.79 126.94 31.6 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.63 1.172 . . . . 0.0 108.414 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -140.13 168.91 18.71 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.195 0.998 . . . . 0.0 110.737 -172.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.1 m -153.16 153.44 32.76 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.812 1.245 . . . . 0.0 109.443 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -148.44 151.99 36.18 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.376 1.07 . . . . 0.0 110.318 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 m -86.66 -117.64 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.8 mt -151.07 -78.45 0.13 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 171.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.8 41.75 2.91 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.28 144.99 25.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.032 1.333 . . . . 0.0 107.962 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 151.61 20.91 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.093 1.357 . . . . 0.0 113.701 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.61 138.19 9.46 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.631 1.172 . . . . 0.0 109.804 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.08 91.13 3.6 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.478 1.111 . . . . 0.0 111.446 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.8 mm -94.1 127.88 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.729 1.612 . . . . 0.0 108.749 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -155.7 152.83 29.07 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.264 0.626 . . . . 0.0 111.018 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.7 p -89.77 147.72 23.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.325 1.45 . . . . 0.0 109.266 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.1 -64.98 1.07 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -106.94 80.26 1.41 Allowed 'General case' 0 C--N 1.343 0.299 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.04 -112.93 0.29 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -164.26 135.35 4.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.526 1.13 . . . . 0.0 108.728 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -68.22 103.59 1.61 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.67 1.188 . . . . 0.0 110.045 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.4 mt -125.38 60.2 1.24 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.482 1.113 . . . . 0.0 109.311 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -97.29 139.48 33.18 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.793 1.237 . . . . 0.0 107.827 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 91.2 m -128.91 -74.37 0.57 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.0 p -146.73 163.97 34.23 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.679 1.592 . . . . 0.0 107.898 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.12 88.82 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.742 0.817 . . . . 0.0 109.382 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -132.72 -173.84 3.29 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.024 1.73 . . . . 0.0 109.24 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.35 142.25 37.44 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.681 1.592 . . . . 0.0 108.986 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.18 -176.83 5.08 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.609 1.164 . . . . 0.0 110.286 174.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -76.41 73.06 3.17 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.48 1.112 . . . . 0.0 110.954 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.79 -82.8 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 106.251 -2.74 . . . . 0.0 106.251 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -160.47 -54.28 0.05 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.722 0.809 . . . . 0.0 109.076 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.97 144.94 43.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.451 1.1 . . . . 0.0 108.514 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.5 -47.4 77.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 122.39 0.276 . . . . 0.0 110.508 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -103.11 148.82 25.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.789 1.635 . . . . 0.0 109.214 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.86 163.1 28.38 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 169.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.2 p -54.16 -76.49 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.593 0.757 . . . . 0.0 110.229 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -140.26 146.04 38.09 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -58.35 -40.86 83.32 Favored 'General case' 0 CA--C 1.526 0.052 0 C-N-CA 123.53 0.732 . . . . 0.0 109.463 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -87.3 40.04 0.9 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.143 0.977 . . . . 0.0 110.113 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.4 m -149.09 -94.2 0.07 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 125.786 1.634 . . . . 0.0 108.217 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -114.82 140.61 48.8 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.885 0.874 . . . . 0.0 110.121 -171.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.58 -54.58 2.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.058 0.943 . . . . 0.0 109.715 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.9 154.19 21.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.415 0.686 . . . . 0.0 111.41 -166.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -68.57 172.89 5.59 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.265 1.026 . . . . 0.0 111.615 175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.7 m -107.05 178.89 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.668 1.587 . . . . 0.0 110.962 -168.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.73 160.75 17.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.243 1.417 . . . . 0.0 110.033 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -32.58 -64.47 0.26 Allowed Glycine 0 C--N 1.342 0.905 0 C-N-CA 127.356 2.408 . . . . 0.0 114.373 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -121.3 33.72 5.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.737 0.815 . . . . 0.0 110.491 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -151.15 98.58 2.58 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 122.635 0.374 . . . . 0.0 111.738 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.1 ttt -92.41 80.81 4.9 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 166.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.68 27.22 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.448 1.099 . . . . 0.0 110.547 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -73.51 143.56 46.51 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.1 p -101.7 144.01 30.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -174.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 tt -103.17 114.21 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -169.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.3 t -103.49 164.19 11.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.009 0.924 . . . . 0.0 112.035 -173.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -147.94 172.63 13.9 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 128.206 2.602 . . . . 0.0 106.395 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.55 -39.8 85.78 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.89 -42.61 16.12 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.609 1.1 . . . . 0.0 113.532 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.32 154.64 39.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 CA-C-N 117.887 0.843 . . . . 0.0 112.495 -162.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 p -112.48 109.67 19.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 163.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.33 114.68 28.37 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -167.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.7 mm -66.88 80.32 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.723 1.609 . . . . 0.0 108.344 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -110.76 145.88 37.33 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.476 1.511 . . . . 0.0 108.846 171.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -143.13 119.29 10.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.404 1.882 . . . . 0.0 106.466 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.6 p -109.29 115.76 30.6 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -106.17 151.54 24.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -74.48 146.43 42.77 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--O 1.252 1.218 0 CA-C-O 117.69 -1.148 . . . . 0.0 110.437 -178.232 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.308 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 p -171.06 68.16 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.739 0.816 . . . . 0.0 109.782 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.67 -160.02 25.56 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 p -103.35 119.5 38.99 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -124.59 146.04 49.27 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.618 0.767 . . . . 0.0 109.318 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -141.9 135.25 29.27 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.19 0.596 . . . . 0.0 109.877 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.484 ' CG1' ' HD2' ' A' ' 36' ' ' PRO . 1.4 p -77.87 140.92 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 124.814 1.245 . . . . 0.0 110.449 176.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -135.72 -13.91 1.92 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.129 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.0 135.98 15.51 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -167.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.35 145.4 21.65 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -90.6 -107.97 0.09 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.459 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -76.97 60.17 1.76 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.537 1.062 . . . . 0.0 110.338 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -75.15 -30.49 60.78 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.233 0.613 . . . . 0.0 111.517 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -56.61 -47.3 79.94 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.093 0.406 . . . . 0.0 110.122 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.03 -31.15 71.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.657 1.183 . . . . 0.0 111.459 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -58.56 -38.9 78.82 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.219 0.463 . . . . 0.0 110.079 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -72.24 -55.51 7.08 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.116 0.416 . . . . 0.0 109.944 169.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -76.05 73.71 2.92 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 124.979 1.311 . . . . 0.0 109.7 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.23 -32.35 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.197 2.599 . . . . 0.0 108.817 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.7 mt -72.73 -117.37 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.529 1.532 . . . . 0.0 108.28 169.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.21 31.93 0.48 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.157 0.983 . . . . 0.0 110.754 172.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.88 121.98 69.37 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.23 161.85 39.78 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.033 2.488 . . . . 0.0 112.166 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -53.21 -45.57 68.68 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.776 1.63 . . . . 0.0 112.413 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -52.44 -50.42 62.63 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.841 0.856 . . . . 0.0 110.454 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -42.47 95.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.664 0.786 . . . . 0.0 109.879 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.3 mt -55.06 -36.78 40.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-N 119.181 0.9 . . . . 0.0 111.545 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -45.13 -45.46 11.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.38 1.072 . . . . 0.0 111.33 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.6 mmt -80.25 -57.41 3.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.317 1.447 . . . . 0.0 109.851 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.39 -45.32 6.12 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 127.725 2.41 . . . . 0.0 113.978 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -61.98 -39.9 93.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.058 0.543 . . . . 0.0 110.357 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -95.66 52.47 1.36 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.589 1.156 . . . . 0.0 109.693 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.0 mm -115.7 128.58 72.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.94 1.296 . . . . 0.0 107.864 170.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.37 91.11 49.99 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.484 ' HD2' ' CG1' ' A' ' 8' ' ' VAL . 11.2 Cg_exo -71.53 170.44 18.5 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 CA-C-N 120.758 1.306 . . . . 0.0 111.465 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.59 134.49 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 167.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.8 t -116.54 99.34 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.84 110.28 22.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.088 1.755 . . . . 0.0 107.695 -168.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.7 mt -121.46 134.19 65.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 C-N-CA 124.124 0.97 . . . . 0.0 110.553 -163.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -129.91 120.83 25.52 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -90.85 140.7 29.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.378 1.071 . . . . 0.0 109.877 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.69 157.45 33.86 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 128.582 2.753 . . . . 0.0 108.12 173.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -32.56 -59.76 0.4 Allowed Glycine 0 C--N 1.344 0.999 0 C-N-CA 126.822 2.153 . . . . 0.0 112.705 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -136.1 71.23 1.42 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 165.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -165.53 155.81 13.21 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.129 0.972 . . . . 0.0 109.13 164.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -141.2 127.11 19.29 Favored 'General case' 0 C--O 1.228 -0.054 0 C-N-CA 123.935 0.894 . . . . 0.0 109.649 174.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.4 t -108.6 133.38 53.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 173.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.32 117.44 24.64 Favored 'Isoleucine or valine' 0 C--N 1.341 0.21 0 C-N-CA 124.368 1.067 . . . . 0.0 108.914 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.8 m -108.35 107.2 17.67 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.383 1.473 . . . . 0.0 108.39 -173.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -103.72 93.49 4.93 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -107.95 122.62 47.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.359 1.463 . . . . 0.0 109.042 -170.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.2 p -108.63 156.63 38.48 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 123.818 0.847 . . . . 0.0 109.714 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.33 58.01 4.28 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.87 2.38 . . . . 0.0 108.979 166.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -167.64 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.055 1.342 . . . . 0.0 109.785 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -135.47 178.91 6.67 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.188 1.795 . . . . 0.0 109.284 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.0 m -138.26 137.41 37.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.254 1.022 . . . . 0.0 108.255 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.4 t -133.84 90.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.9 m -87.29 121.76 30.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -121.26 156.14 33.14 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.697 1.199 . . . . 0.0 110.115 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.1 p -149.02 141.02 23.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.388 1.075 . . . . 0.0 108.858 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.463 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -148.4 153.11 38.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.716 0.806 . . . . 0.0 109.879 174.714 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.0 m -125.26 165.18 18.78 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.639 1.176 . . . . 0.0 108.685 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -82.88 -64.31 1.2 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.91 1.684 . . . . 0.0 109.634 -172.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.61 38.82 2.97 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.021 0.82 . . . . 0.0 111.893 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -162.49 138.41 7.37 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -55.47 163.7 1.19 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.614 1.566 . . . . 0.0 113.288 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.463 ' CB ' ' HB3' ' A' ' 62' ' ' PHE . . . -150.45 86.83 1.42 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.543 0.737 . . . . 0.0 110.108 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -78.88 51.97 1.18 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.586 1.954 . . . . 0.0 111.882 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.04 128.37 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.039 0.935 . . . . 0.0 109.273 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.8 p -116.75 -172.93 2.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.118 1.767 . . . . 0.0 108.086 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.1 t -143.0 -174.05 4.08 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.934 0.493 . . . . 0.0 110.236 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 42.2 mtp -66.11 -63.24 1.12 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.166 1.386 . . . . 0.0 110.331 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -106.2 49.33 0.81 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.244 1.017 . . . . 0.0 108.326 -172.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.55 118.74 0.57 Allowed Glycine 0 C--N 1.344 0.975 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -104.7 -101.41 0.32 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.489 1.116 . . . . 0.0 108.936 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -98.84 82.64 2.81 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.049 1.295 . . . . 0.0 108.98 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tt -148.14 74.65 1.3 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -171.0 167.28 7.3 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.197 0.999 . . . . 0.0 110.112 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.63 -165.18 1.17 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.746 1.618 . . . . 0.0 108.064 170.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -106.69 135.13 48.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.52 1.128 . . . . 0.0 108.195 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.8 m -74.68 155.98 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.168 0.587 . . . . 0.0 110.617 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -162.46 159.82 25.5 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.46 0.704 . . . . 0.0 110.537 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.36 138.69 44.22 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.879 1.672 . . . . 0.0 108.168 -175.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.29 -61.65 1.45 Allowed 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.942 0.897 . . . . 0.0 108.824 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -145.97 -62.81 0.32 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.616 0.766 . . . . 0.0 110.107 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.62 -77.84 0.91 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.443 0.545 . . . . 0.0 112.001 -174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -135.89 -172.47 3.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.045 1.338 . . . . 0.0 109.869 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.2 134.41 39.07 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.245 1.418 . . . . 0.0 110.971 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.33 131.62 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.0 m -151.45 67.79 0.9 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -73.96 80.4 1.67 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.685 1.194 . . . . 0.0 109.904 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 55.9 p -166.86 -33.16 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.539 1.135 . . . . 0.0 111.569 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -75.97 71.26 2.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.199 1.4 . . . . 0.0 110.068 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -47.13 -62.95 1.18 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.261 1.824 . . . . 0.0 111.981 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -88.81 64.02 7.08 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.272 0.629 . . . . 0.0 109.803 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.8 t -153.13 -163.38 1.68 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.627 1.171 . . . . 0.0 108.986 174.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -78.38 135.47 37.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.471 0.708 . . . . 0.0 109.85 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -76.2 164.3 26.21 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -102.97 74.04 1.28 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.46 1.104 . . . . 0.0 108.601 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -125.14 132.2 53.12 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.054 1.742 . . . . 0.0 107.851 172.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -157.43 157.09 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.133 0.973 . . . . 0.0 109.462 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -126.72 147.55 49.95 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.253 1.021 . . . . 0.0 108.494 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -35.97 -51.3 1.18 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.425 1.964 . . . . 0.0 113.965 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -130.08 36.38 4.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.427 1.891 . . . . 0.0 111.064 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -161.76 125.11 3.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.748 0.819 . . . . 0.0 109.016 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 41.9 ttm -123.45 84.68 2.3 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.347 1.059 . . . . 0.0 109.281 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.8 t -105.13 82.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -80.49 154.48 27.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.702 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.5 p -108.14 116.4 31.9 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.065 1.746 . . . . 0.0 106.649 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 71.9 mt -103.72 96.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.7 m -75.57 125.4 28.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -142.65 166.57 24.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.923 1.289 . . . . 0.0 107.614 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -54.73 -40.22 70.46 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.326 0.489 . . . . 0.0 112.171 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.8 -38.5 6.5 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.597 1.094 . . . . 0.0 113.398 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.85 150.91 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 118.406 1.103 . . . . 0.0 111.887 -170.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.9 p -106.76 91.36 3.64 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 162.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.88 114.12 28.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.751 0.786 . . . . 0.0 112.249 -158.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.2 mm -68.13 118.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.297 1.839 . . . . 0.0 108.484 172.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -125.28 114.84 19.47 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -107.37 105.49 15.45 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.292 1.037 . . . . 0.0 109.519 -169.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.8 p -114.12 145.3 41.82 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.419 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -136.87 154.95 50.36 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.5 -171.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -73.23 74.67 1.31 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.862 1.665 . . . . 0.0 113.165 -165.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.271 -1.347 . . . . 0.0 109.822 175.197 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 . . . . . 0 C--O 1.226 -0.18 0 CA-C-O 119.878 -0.106 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.3 p -51.03 99.1 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.602 1.561 . . . . 0.0 111.886 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.71 -168.16 39.99 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.6 p -110.03 131.92 54.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -131.21 140.59 49.91 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.155 0.982 . . . . 0.0 110.775 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -119.19 106.51 12.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.744 1.217 . . . . 0.0 109.224 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 p -47.21 136.58 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 125.644 1.578 . . . . 0.0 109.638 165.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -147.81 -29.81 0.32 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.5 -7.78 46.4 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -154.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -54.61 104.78 0.12 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.869 1.213 . . . . 0.0 111.132 -173.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.19 -76.54 0.11 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.188 0.595 . . . . 0.0 110.058 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -83.09 58.31 4.36 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.052 0.941 . . . . 0.0 108.472 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -57.78 -30.54 65.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.151 -1.593 . . . . 0.0 111.364 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -36.25 76.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.552 0.741 . . . . 0.0 111.863 173.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -67.17 -40.58 86.63 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -55.48 -43.57 75.66 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.328 0.651 . . . . 0.0 111.682 -176.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -78.99 49.89 0.97 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.578 1.151 . . . . 0.0 111.474 -174.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 -40.99 1.31 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.049 0.94 . . . . 0.0 111.261 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.17 46.04 1.08 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.587 0.755 . . . . 0.0 110.32 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.3 mt -138.79 -128.85 0.12 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.231 2.212 . . . . 0.0 105.524 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.72 77.11 0.45 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.238 1.015 . . . . 0.0 109.4 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.48 139.51 35.75 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.851 0.86 . . . . 0.0 109.651 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.61 147.08 39.88 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.218 2.612 . . . . 0.0 109.771 175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.26 -38.6 68.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.771 1.228 . . . . 0.0 113.304 -168.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.91 -44.03 14.27 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.419 1.488 . . . . 0.0 112.073 170.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -76.8 -33.04 58.01 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 117.898 -1.049 . . . . 0.0 111.13 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -64.48 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 CA-C-N 120.012 1.278 . . . . 0.0 109.77 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -44.8 -37.46 3.84 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.519 1.127 . . . . 0.0 112.083 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.2 mmt -90.39 -42.03 11.15 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.599 1.16 . . . . 0.0 111.218 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.66 -39.49 68.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.928 0.891 . . . . 0.0 112.872 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -69.23 7.06 0.82 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -172.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -131.78 12.2 4.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.275 0.943 . . . . 0.0 111.935 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.4 mm -87.19 105.97 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -105.31 105.32 51.69 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 123.836 0.854 . . . . 0.0 108.758 -175.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.19 178.69 1.85 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.517 2.145 . . . . 0.0 115.14 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.32 114.96 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 169.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.6 t -107.28 92.34 2.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 124.542 1.137 . . . . 0.0 108.494 -169.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -97.4 138.36 34.97 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.762 2.025 . . . . 0.0 108.476 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.7 mt -136.02 136.09 49.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 C-N-CA 123.49 0.716 . . . . 0.0 109.847 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -128.26 142.62 51.1 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.963 2.105 . . . . 0.0 108.345 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -125.42 158.57 34.05 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.64 1.176 . . . . 0.0 111.463 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.12 161.18 42.06 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 127.389 2.276 . . . . 0.0 109.017 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.72 -66.29 0.14 Allowed Glycine 0 C--N 1.344 0.975 0 C-N-CA 127.144 2.307 . . . . 0.0 113.822 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -124.73 33.06 5.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.885 1.274 . . . . 0.0 109.831 171.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.258 16.4 t70 -140.26 147.62 40.24 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.089 0.859 . . . . 0.0 112.541 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -146.17 134.52 21.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.752 0.821 . . . . 0.0 109.851 -174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.3 t -133.1 127.91 55.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.46 153.25 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 124.027 0.931 . . . . 0.0 108.851 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.0 m -141.21 81.06 1.77 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.5 m -106.33 80.08 1.45 Allowed 'General case' 0 C--N 1.339 0.15 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -107.45 144.43 34.39 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.034 0.934 . . . . 0.0 111.098 -167.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.7 p -127.86 150.93 74.76 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 126.918 2.087 . . . . 0.0 106.457 171.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.61 59.79 4.96 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.596 2.198 . . . . 0.0 109.991 166.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.3 ttt-85 -168.31 -60.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.443 1.097 . . . . 0.0 110.89 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -120.04 173.45 7.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.736 2.014 . . . . 0.0 109.252 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.2 m -137.94 117.18 12.68 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.931 0.892 . . . . 0.0 111.017 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 t -128.31 80.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 170.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -109.27 65.99 0.63 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -69.29 153.4 43.68 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.178 0.591 . . . . 0.0 110.452 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.3 t -154.34 144.15 21.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.292 1.037 . . . . 0.0 108.616 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -161.65 152.48 17.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.948 0.404 . . . . 0.0 110.83 174.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.8 m -81.71 -106.5 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.7 mt -152.92 -75.97 0.13 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 171.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.61 48.48 0.93 Allowed Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.95 -80.33 0.44 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.447 1.099 . . . . 0.0 108.872 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -143.3 162.61 35.22 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.432 1.093 . . . . 0.0 110.329 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.85 123.13 7.73 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.702 0.801 . . . . 0.0 111.484 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -99.69 102.7 14.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.657 1.983 . . . . 0.0 108.079 174.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.5 mm -121.69 124.09 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 t -108.24 -179.14 3.8 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.514 0.725 . . . . 0.0 110.291 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 t -120.36 -177.38 3.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.077 1.351 . . . . 0.0 110.198 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 60.9 mmm -109.45 -91.21 0.45 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.476 1.51 . . . . 0.0 107.141 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -114.18 -35.59 4.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.434 1.494 . . . . 0.0 109.499 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.83 72.32 0.11 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.2 96.59 2.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.023 0.929 . . . . 0.0 109.579 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -115.12 147.54 40.11 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.217 1.007 . . . . 0.0 111.029 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.54 165.88 11.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.669 1.588 . . . . 0.0 109.703 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -155.58 78.12 0.99 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.5 p -159.38 169.62 23.58 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.567 1.147 . . . . 0.0 109.857 -174.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.8 m -115.75 92.11 3.81 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 m -60.07 146.03 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.341 1.056 . . . . 0.0 110.921 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -163.55 -164.22 0.9 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.788 0.835 . . . . 0.0 109.122 -169.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.4 160.4 31.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.641 1.976 . . . . 0.0 107.877 172.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.65 -64.51 1.18 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.249 1.02 . . . . 0.0 109.31 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -132.96 -66.37 0.67 Allowed 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.689 1.196 . . . . 0.0 108.149 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.28 29.1 0.79 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.217 0.913 . . . . 0.0 111.208 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -133.43 135.97 44.91 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.31 1.444 . . . . 0.0 107.212 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.5 mt -72.4 86.41 1.14 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.953 1.301 . . . . 0.0 110.072 -172.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.73 141.22 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 122.832 0.453 . . . . 0.0 111.266 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -131.71 154.3 49.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.798 1.639 . . . . 0.0 107.107 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -70.46 -164.18 0.08 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.005 0.922 . . . . 0.0 110.98 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 36.7 p -75.08 66.73 1.66 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.509 1.124 . . . . 0.0 112.641 -175.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -132.39 126.01 32.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.536 1.534 . . . . 0.0 108.053 172.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.79 52.56 2.06 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.872 0.869 . . . . 0.0 109.281 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.86 28.04 1.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.821 0.849 . . . . 0.0 111.965 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.9 p -170.84 -80.99 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.032 0.933 . . . . 0.0 109.084 -171.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -158.48 175.04 14.2 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.46 1.104 . . . . 0.0 108.35 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -84.71 -135.52 0.05 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -118.46 114.52 23.0 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -147.17 149.1 32.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.082 0.953 . . . . 0.0 108.943 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 p -168.62 165.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.423 1.089 . . . . 0.0 108.774 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.55 156.03 42.43 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.508 0.723 . . . . 0.0 110.148 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -31.34 -55.27 0.31 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 127.234 2.35 . . . . 0.0 114.676 -173.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -136.23 28.37 3.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.465 1.106 . . . . 0.0 110.759 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -145.93 149.71 34.72 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.81 1.244 . . . . 0.0 110.112 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 38.1 mtt -130.02 110.54 11.72 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 m -117.2 50.97 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.357 0.663 . . . . 0.0 110.875 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -86.38 116.55 24.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.835 0.854 . . . . 0.0 109.074 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.2 m -102.21 127.8 49.0 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.7 mt -103.99 88.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 123.519 0.728 . . . . 0.0 109.382 -160.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.5 t -80.35 100.32 8.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.501 1.52 . . . . 0.0 107.838 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -102.06 -136.84 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.914 1.286 . . . . 0.0 108.893 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.9 -72.72 0.9 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.827 0.727 . . . . 0.0 111.488 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -123.06 49.08 0.91 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.1 t -150.81 147.86 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.833 1.653 . . . . 0.0 108.509 -170.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 t -150.63 97.78 2.55 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.58 126.19 51.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.163 0.985 . . . . 0.0 110.335 -163.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mp -79.84 66.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -86.35 141.55 29.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -168.53 143.25 3.35 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.3 p -133.82 151.64 51.62 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.888 1.275 . . . . 0.0 109.083 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -117.46 141.94 47.74 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.192 0.997 . . . . 0.0 109.11 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.0 ttp85 -75.57 147.83 39.34 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.867 176.779 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 p -25.48 90.89 0.01 OUTLIER 'General case' 0 C--N 1.342 0.252 0 C-N-CA 128.179 2.591 . . . . 0.0 114.197 -163.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.08 -150.44 9.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.6 p -108.21 142.88 37.79 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.862 1.265 . . . . 0.0 107.891 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -145.7 133.62 21.31 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.838 0.855 . . . . 0.0 110.158 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -139.35 127.03 21.87 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.904 0.882 . . . . 0.0 109.106 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.427 ' CG1' ' HD2' ' A' ' 36' ' ' PRO . 1.9 m -72.76 135.89 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -125.5 -29.86 3.16 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.196 0.31 . . . . 0.0 111.746 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.3 112.77 7.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.495 0.718 . . . . 0.0 110.483 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.23 -160.81 0.77 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -135.8 -101.64 0.22 Allowed 'General case' 0 C--N 1.343 0.283 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.977 170.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -81.21 66.54 6.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.163 0.892 . . . . 0.0 110.66 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.99 -28.34 70.03 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.315 1.046 . . . . 0.0 110.681 -175.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -62.49 -55.59 26.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.212 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -59.67 -39.02 83.11 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -52.95 -52.97 56.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.145 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.12 -29.1 63.74 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.328 1.051 . . . . 0.0 112.696 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -37.76 75.59 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.994 0.816 . . . . 0.0 110.877 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.81 -33.9 76.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.482 0.713 . . . . 0.0 111.618 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.99 156.09 32.14 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.852 0.461 . . . . 0.0 110.485 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.78 35.49 0.84 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.281 1.033 . . . . 0.0 112.169 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 mp -88.58 139.29 29.71 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.61 157.83 54.98 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.587 2.192 . . . . 0.0 110.473 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -62.17 -36.86 83.16 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -166.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -61.16 -48.79 79.96 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.285 0.634 . . . . 0.0 110.206 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -20.18 64.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.701 1.2 . . . . 0.0 110.907 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.8 mt -78.22 -37.0 21.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.896 0.771 . . . . 0.0 110.845 171.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.56 -38.38 80.96 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.0 ttt -63.92 -51.98 61.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.915 1.286 . . . . 0.0 110.52 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.71 -39.89 62.46 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.245 1.418 . . . . 0.0 112.479 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.17 -16.23 19.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.053 1.341 . . . . 0.0 112.306 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -121.14 18.05 11.59 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 mm -79.37 123.52 36.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.09 101.48 30.48 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 168.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.427 ' HD2' ' CG1' ' A' ' 8' ' ' VAL . 92.8 Cg_endo -74.52 179.9 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.402 1.401 . . . . 0.0 111.302 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -131.02 158.63 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 168.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.6 t -132.39 121.8 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 165.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -125.48 95.57 4.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.265 2.226 . . . . 0.0 105.086 -170.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.8 tt -118.5 140.5 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.669 1.188 . . . . 0.0 111.227 -165.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -139.59 143.93 37.52 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.517 1.127 . . . . 0.0 109.742 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.48 147.36 31.79 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.908 1.283 . . . . 0.0 111.117 -175.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -135.49 163.47 30.01 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 129.05 2.94 . . . . 0.0 107.456 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -20.5 -72.24 0.01 OUTLIER Glycine 0 C--N 1.344 0.982 0 C-N-CA 127.618 2.533 . . . . 0.0 114.338 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -127.19 30.87 5.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.526 1.531 . . . . 0.0 109.32 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -131.43 152.32 50.77 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.523 0.601 . . . . 0.0 112.107 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -138.03 130.58 29.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.022 0.929 . . . . 0.0 109.837 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.14 127.46 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.2 t -127.8 109.37 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.243 1.417 . . . . 0.0 109.491 -173.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -107.43 102.15 11.45 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.496 1.118 . . . . 0.0 108.096 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 t -105.7 111.34 23.98 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -108.25 129.05 55.22 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.331 0.653 . . . . 0.0 109.909 -171.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 p -134.55 150.0 72.5 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 126.161 1.784 . . . . 0.0 107.957 171.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.52 73.93 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.768 2.979 . . . . 0.0 109.56 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -167.63 -52.16 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.786 1.634 . . . . 0.0 108.137 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.14 150.41 11.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.632 1.173 . . . . 0.0 107.878 176.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.4 p -80.1 94.84 6.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.6 72.57 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.5 m -97.65 128.76 44.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.29 1.436 . . . . 0.0 108.489 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -145.35 162.62 36.81 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.746 1.218 . . . . 0.0 107.997 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.3 m -150.68 141.53 22.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.36 137.44 27.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.917 0.487 . . . . 0.0 110.618 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.0 m -98.47 141.59 31.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.757 1.223 . . . . 0.0 107.856 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.6 mt -68.09 -57.71 5.66 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.804 0.842 . . . . 0.0 110.634 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.34 57.9 4.66 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -169.58 138.58 1.93 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.736 1.614 . . . . 0.0 107.172 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -58.5 129.08 40.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.047 0.539 . . . . 0.0 109.71 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.22 157.0 47.37 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.659 1.183 . . . . 0.0 110.628 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -144.99 158.98 43.64 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.222 1.409 . . . . 0.0 108.845 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.1 mm -105.95 148.9 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 125.457 1.503 . . . . 0.0 109.694 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.8 m -105.54 153.85 21.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.851 1.66 . . . . 0.0 109.891 -171.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 m -44.67 142.73 1.59 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.764 2.026 . . . . 0.0 112.727 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.16 176.82 8.14 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.835 1.254 . . . . 0.0 110.242 -172.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.64 -73.34 0.68 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.492 1.517 . . . . 0.0 107.78 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.01 95.59 0.16 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -157.99 -54.66 0.07 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -132.54 178.68 6.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.539 1.536 . . . . 0.0 109.907 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tp -150.01 149.08 29.84 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.713 1.205 . . . . 0.0 108.956 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -70.65 101.97 2.18 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.0 p -144.05 -170.47 3.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.351 1.46 . . . . 0.0 109.531 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.6 m -107.36 110.49 22.5 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.308 1.043 . . . . 0.0 108.805 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.4 m -78.34 136.78 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.287 0.635 . . . . 0.0 110.658 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -165.66 118.47 1.14 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.323 1.049 . . . . 0.0 109.257 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -109.32 131.42 55.09 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 172.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.96 -67.58 0.9 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.11 62.79 0.23 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.29 -87.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -128.94 159.27 36.37 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.259 1.423 . . . . 0.0 108.895 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 tt -74.16 81.79 1.79 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.112 0.965 . . . . 0.0 108.77 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.7 p -74.51 142.76 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.518 0.727 . . . . 0.0 110.235 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.0 t -165.36 174.23 10.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.322 1.449 . . . . 0.0 108.218 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -148.32 152.73 37.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.838 0.855 . . . . 0.0 110.658 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 99.4 p -164.24 -144.58 0.08 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.975 1.31 . . . . 0.0 108.625 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -82.52 -151.53 0.1 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.945 1.298 . . . . 0.0 110.153 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -77.75 65.47 3.22 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.031 1.332 . . . . 0.0 110.523 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -147.38 149.98 33.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.361 1.464 . . . . 0.0 108.746 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.0 t -152.93 103.32 2.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -59.65 -38.34 81.16 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.408 1.083 . . . . 0.0 110.913 173.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -155.66 150.48 26.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.588 1.155 . . . . 0.0 108.631 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -115.85 -55.14 2.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.369 1.068 . . . . 0.0 108.921 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.43 153.72 42.21 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.638 0.775 . . . . 0.0 111.094 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.7 t -139.86 142.18 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.897 1.679 . . . . 0.0 107.02 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -105.83 154.21 20.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -41.34 -38.33 1.95 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.554 1.549 . . . . 0.0 115.018 -172.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.28 40.15 1.92 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.91 0.884 . . . . 0.0 110.681 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -167.15 116.18 0.84 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.608 0.763 . . . . 0.0 110.496 173.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -99.69 127.05 45.81 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 169.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.11 173.58 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.871 0.869 . . . . 0.0 112.765 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -43.13 88.06 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.803 2.841 . . . . 0.0 115.826 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.8 t -165.43 131.0 2.57 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 tp -172.54 121.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.546 1.938 . . . . 0.0 106.802 167.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 m -112.0 125.81 54.47 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -129.35 161.96 29.08 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.936 1.294 . . . . 0.0 109.766 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -2.94 -74.93 0.01 OUTLIER Glycine 0 C--N 1.346 1.129 0 C-N-CA 129.249 3.309 . . . . 0.0 115.693 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -144.11 47.79 0.76 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.0 p -165.69 131.69 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -127.32 135.8 51.05 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.06 158.17 28.43 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.97 1.308 . . . . 0.0 110.46 -169.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 mp -97.71 113.97 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 172.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 tpt85 -123.26 114.02 19.68 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.235 1.414 . . . . 0.0 109.431 -174.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -111.11 110.95 21.71 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.902 0.881 . . . . 0.0 109.452 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.4 p -114.63 130.3 56.78 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 122.1 0.953 . . . . 0.0 109.504 169.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -113.91 143.82 44.07 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -173.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.25 165.67 11.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.162 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.033 -1.936 . . . . 0.0 108.352 178.813 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.457 -0.117 0 N-CA-C 110.761 -0.088 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 t -138.57 40.99 2.21 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.445 1.098 . . . . 0.0 108.753 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.98 172.55 53.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.257 0.932 . . . . 0.0 113.74 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 m -148.85 109.44 4.21 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -143.21 157.72 44.25 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.141 1.376 . . . . 0.0 111.121 -166.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -139.95 134.43 31.54 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 124.066 0.947 . . . . 0.0 111.073 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.5 150.81 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 127.029 2.132 . . . . 0.0 112.103 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -146.3 -6.85 0.55 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 163.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -152.64 76.65 1.15 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.776 0.43 . . . . 0.0 110.142 -164.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.75 103.2 15.1 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -77.89 0.06 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.54 1.136 . . . . 0.0 113.043 -171.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -85.48 51.1 2.1 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.866 0.866 . . . . 0.0 111.122 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -43.5 77.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.54 1.136 . . . . 0.0 111.777 -168.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.9 -38.8 92.41 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.874 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -61.88 -48.21 81.53 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.507 0.594 . . . . 0.0 110.783 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -55.92 -47.16 78.01 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.141 1.376 . . . . 0.0 111.406 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.25 -43.08 74.7 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.143 0.577 . . . . 0.0 112.301 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -78.92 67.99 4.76 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.111 0.964 . . . . 0.0 109.963 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.05 -44.88 0.06 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.176 1.79 . . . . 0.0 108.614 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.07 147.69 27.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.67 52.32 2.36 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.755 1.222 . . . . 0.0 112.674 -162.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mt -92.01 147.16 34.24 Favored Pre-proline 0 N--CA 1.453 -0.275 0 C-N-CA 124.518 1.127 . . . . 0.0 108.758 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.46 151.8 48.2 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.323 2.015 . . . . 0.0 109.559 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -62.24 -28.77 69.93 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -170.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -63.11 -44.97 94.18 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.345 0.52 . . . . 0.0 110.548 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.81 -41.78 99.44 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.24 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.53 -34.47 61.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 118.525 0.602 . . . . 0.0 111.377 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.91 -44.08 73.88 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.765 0.711 . . . . 0.0 110.469 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.56 -47.09 57.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.827 0.851 . . . . 0.0 110.643 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.41 -46.2 73.11 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 111.823 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -65.59 -30.56 71.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.186 2.194 . . . . 0.0 110.818 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -108.17 50.71 0.77 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.363 1.465 . . . . 0.0 108.984 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.39 150.91 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.068 1.347 . . . . 0.0 109.118 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -128.2 99.91 24.09 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.099 1.359 . . . . 0.0 109.756 -170.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.86 160.13 50.37 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.062 2.508 . . . . 0.0 113.78 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.3 pt -105.6 170.97 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.1 t -141.25 103.73 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -123.69 101.21 7.17 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.204 2.602 . . . . 0.0 106.053 -167.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.6 mt -108.87 150.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.526 0.731 . . . . 0.0 110.031 -171.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -134.25 119.74 19.12 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.051 1.34 . . . . 0.0 108.716 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -83.9 153.28 24.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.72 1.608 . . . . 0.0 109.425 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.34 152.99 10.99 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.984 1.714 . . . . 0.0 108.235 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -20.6 -69.77 0.01 OUTLIER Glycine 0 C--N 1.344 0.99 0 C-N-CA 127.733 2.587 . . . . 0.0 113.969 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -125.94 20.71 7.64 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.786 1.235 . . . . 0.0 110.568 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.35 134.26 55.03 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.409 1.004 . . . . 0.0 109.887 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -134.42 101.31 4.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.5 t -107.98 116.18 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -174.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 p -111.91 125.06 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.522 1.129 . . . . 0.0 109.72 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 m -107.52 95.11 5.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 t -107.82 63.15 0.62 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -102.14 162.55 12.83 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.343 0.657 . . . . 0.0 110.314 -170.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.54 162.36 55.26 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.476 1.111 . . . . 0.0 108.341 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.04 51.37 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.461 2.774 . . . . 0.0 111.433 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 178.57 -58.6 0.01 OUTLIER 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.19 1.796 . . . . 0.0 109.013 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -95.66 155.83 16.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.137 1.375 . . . . 0.0 109.571 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.6 p -132.44 109.61 9.94 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.819 0.848 . . . . 0.0 110.672 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -129.76 87.86 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.6 m -110.26 136.73 49.01 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 171.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -137.02 150.81 48.33 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.2 p -144.05 94.25 2.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.9 0.88 . . . . 0.0 108.781 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.76 104.32 14.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.1 m -76.68 126.77 31.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 164.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.7 mt -57.46 -56.43 21.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.774 0.829 . . . . 0.0 111.376 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.51 53.66 4.85 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -167.16 148.44 5.77 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.885 0.874 . . . . 0.0 109.387 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -53.67 107.08 0.22 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.345 1.458 . . . . 0.0 108.896 170.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.53 58.98 0.64 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.237 0.615 . . . . 0.0 110.951 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -100.3 101.12 12.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 171.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.52 143.22 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 125.227 1.411 . . . . 0.0 107.801 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.4 t -158.8 152.2 22.83 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.124 0.97 . . . . 0.0 109.322 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 t -167.84 -47.06 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.098 1.359 . . . . 0.0 108.988 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -75.6 165.44 25.07 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.382 1.073 . . . . 0.0 108.851 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.28 74.24 1.73 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.706 0.802 . . . . 0.0 109.025 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.21 58.54 0.1 OUTLIER Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.051 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.48 91.75 1.93 Allowed 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -124.93 58.2 1.26 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.353 1.061 . . . . 0.0 109.58 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.76 173.01 17.21 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.349 1.06 . . . . 0.0 110.369 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -116.72 143.06 46.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.323 1.449 . . . . 0.0 108.321 172.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.3 p -163.17 164.48 25.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.331 1.052 . . . . 0.0 109.314 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 88.2 m -135.37 108.01 7.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.2 137.5 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.83 169.87 21.19 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.734 0.413 . . . . 0.0 110.556 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -137.12 136.39 38.25 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.451 1.5 . . . . 0.0 107.609 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.57 -60.3 1.59 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.566 1.146 . . . . 0.0 108.972 -176.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -161.79 -57.42 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.602 0.761 . . . . 0.0 109.629 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.51 -59.47 8.76 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.896 0.76 . . . . 0.0 112.167 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -158.85 172.98 17.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.55 1.14 . . . . 0.0 109.068 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.84 162.35 20.59 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.999 0.52 . . . . 0.0 112.276 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.98 144.21 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.324 1.449 . . . . 0.0 108.901 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.7 m -114.45 -66.45 1.09 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.593 1.557 . . . . 0.0 109.224 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -165.59 159.43 16.58 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.22 1.408 . . . . 0.0 107.673 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.5 p -62.69 170.25 2.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.643 1.177 . . . . 0.0 112.751 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -50.84 106.42 0.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.373 1.469 . . . . 0.0 112.091 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.7 mttm 179.11 -55.9 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 126.62 1.968 . . . . 0.0 106.99 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -77.39 -55.09 5.69 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.942 1.297 . . . . 0.0 110.888 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.2 m -157.71 -37.63 0.07 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.274 -0.87 . . . . 0.0 113.229 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 9.16 80.63 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.294 2.237 . . . . 0.0 113.574 -159.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -128.05 93.97 3.81 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.721 2.008 . . . . 0.0 107.031 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -151.26 74.84 1.16 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.742 0.817 . . . . 0.0 111.472 -172.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -176.66 129.86 0.19 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.044 1.338 . . . . 0.0 109.023 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.53 155.81 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.9 0.88 . . . . 0.0 108.694 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -114.13 160.18 19.23 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.921 1.288 . . . . 0.0 109.282 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -31.05 -56.07 0.28 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 127.533 2.492 . . . . 0.0 115.056 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -128.58 29.56 5.27 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.976 0.911 . . . . 0.0 111.772 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.55 107.07 3.78 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.14 0.427 . . . . 0.0 110.598 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 40.1 ttm -84.46 86.79 7.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.6 m -123.78 122.96 65.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.122 1.369 . . . . 0.0 109.294 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.44 175.59 3.53 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.318 1.047 . . . . 0.0 109.029 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.2 p -106.43 152.68 23.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.361 1.065 . . . . 0.0 110.304 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.5 mt -104.2 106.9 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 m -89.81 99.71 12.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -123.86 -179.86 4.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.539 1.536 . . . . 0.0 109.552 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -46.96 117.25 2.94 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 125.063 1.316 . . . . 0.0 110.77 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 8.11 59.26 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 128.361 2.886 . . . . 0.0 114.875 -156.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.0 t -140.85 144.75 26.41 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 126.008 1.723 . . . . 0.0 108.759 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.0 m -136.31 101.55 4.71 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.02 102.85 12.32 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.97 98.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.243 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 168.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -98.96 105.32 17.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.7 ttt85 -108.26 111.7 23.8 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 -173.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.3 t -124.6 149.92 46.54 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.201 1.8 . . . . 0.0 108.716 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -125.23 146.16 49.65 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.825 1.25 . . . . 0.0 109.693 -170.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.75 148.57 42.46 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.061 0.944 . . . . 0.0 111.004 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--O 1.25 1.087 0 CA-C-O 117.46 -1.257 . . . . 0.0 110.501 175.313 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 119.531 -0.271 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.1 p -38.01 108.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.654 1.982 . . . . 0.0 113.367 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.01 -179.17 46.47 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.3 t -107.57 134.42 50.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.019 1.328 . . . . 0.0 107.639 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -133.66 118.76 18.54 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.432 0.693 . . . . 0.0 110.209 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -102.75 93.43 5.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.971 1.308 . . . . 0.0 109.539 -172.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.477 ' CG1' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -53.95 129.37 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.069 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -145.62 10.06 1.21 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.37 0.419 . . . . 0.0 111.784 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -161.33 105.76 1.31 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 122.7 0.4 . . . . 0.0 110.238 -161.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.66 -167.16 1.48 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.18 1.392 . . . . 0.0 108.591 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -135.52 -104.24 0.22 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.966 0.803 . . . . 0.0 111.141 -174.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -75.46 67.62 2.02 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.219 1.008 . . . . 0.0 109.356 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -81.52 -45.31 16.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.166 0.586 . . . . 0.0 112.412 -169.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.0 -43.38 91.5 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.383 0.538 . . . . 0.0 110.468 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -61.0 -50.93 71.37 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.527 1.131 . . . . 0.0 110.44 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -56.64 -49.06 76.11 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.097 0.959 . . . . 0.0 110.134 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -58.75 -46.38 87.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.269 1.028 . . . . 0.0 111.667 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -65.79 -24.42 66.92 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.287 0.635 . . . . 0.0 111.83 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.35 -23.99 60.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.613 0.765 . . . . 0.0 111.03 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.0 mt -84.14 -162.12 0.62 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.97 41.57 2.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.045 0.938 . . . . 0.0 111.381 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.0 127.8 31.16 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.3 164.86 33.17 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.582 2.854 . . . . 0.0 113.615 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -59.48 -44.95 92.92 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.11 1.764 . . . . 0.0 112.514 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -54.58 -46.63 73.76 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.486 0.714 . . . . 0.0 110.577 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.29 -43.43 86.34 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.501 -0.762 . . . . 0.0 109.986 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.35 -41.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 CA-C-N 118.747 0.703 . . . . 0.0 111.618 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -42.96 -43.35 4.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.129 1.372 . . . . 0.0 111.44 173.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 19.7 mmt -102.11 -1.88 30.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.938 1.695 . . . . 0.0 112.536 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.56 -51.04 6.13 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.766 1.226 . . . . 0.0 110.704 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -56.83 -39.83 74.94 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.402 0.681 . . . . 0.0 111.471 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.65 -37.28 79.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.11 1.364 . . . . 0.0 111.55 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -51.14 142.62 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.503 1.121 . . . . 0.0 111.74 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -119.08 98.39 50.85 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 125.43 1.492 . . . . 0.0 107.209 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HD2' ' CG1' ' A' ' 8' ' ' VAL . 17.0 Cg_exo -63.57 176.09 2.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.803 2.335 . . . . 0.0 112.396 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.67 131.36 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 169.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.2 t -113.08 96.58 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -103.88 101.31 11.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.869 2.067 . . . . 0.0 107.778 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.46 138.36 32.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -173.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -141.42 131.5 24.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.455 1.102 . . . . 0.0 108.994 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -104.15 150.66 24.15 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.441 1.497 . . . . 0.0 110.053 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -152.38 155.4 37.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.394 1.878 . . . . 0.0 108.863 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -21.1 -68.18 0.01 OUTLIER Glycine 0 C--N 1.345 1.035 0 C-N-CA 127.563 2.506 . . . . 0.0 114.115 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -123.81 12.96 9.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.946 1.298 . . . . 0.0 110.893 172.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -114.38 143.53 44.76 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.334 0.97 . . . . 0.0 110.09 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -141.55 110.17 6.06 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.0 t -108.25 122.21 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.883 1.273 . . . . 0.0 108.599 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.15 104.52 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.01 1.324 . . . . 0.0 107.786 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.8 m -101.3 82.8 2.38 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.8 p -102.93 98.96 8.85 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -137.37 140.02 41.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.314 -162.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 p -130.38 157.02 78.62 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 126.277 1.831 . . . . 0.0 106.873 167.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.26 60.67 6.41 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.167 2.578 . . . . 0.0 108.707 168.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -169.84 -67.57 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.639 1.176 . . . . 0.0 109.66 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -106.83 156.31 18.81 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.864 1.266 . . . . 0.0 110.07 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -123.15 70.17 1.02 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.219 1.408 . . . . 0.0 108.731 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.3 t -71.95 -46.75 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -6.48 106.11 0.01 OUTLIER 'General case' 0 C--N 1.345 0.408 0 C-N-CA 129.386 3.074 . . . . 0.0 114.244 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -104.81 156.74 17.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.728 1.211 . . . . 0.0 109.693 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.1 t -158.94 95.18 1.27 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.45 163.7 22.07 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.639 0.776 . . . . 0.0 111.297 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.8 m -133.46 150.77 51.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.89 1.676 . . . . 0.0 107.191 -176.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.3 mt -65.46 -60.15 3.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.474 0.31 . . . . 0.0 111.479 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.3 47.75 1.01 Allowed Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.317 0.96 . . . . 0.0 111.122 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -164.99 144.09 6.73 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -57.13 165.14 1.42 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.843 1.257 . . . . 0.0 112.591 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.22 98.79 2.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.504 0.721 . . . . 0.0 109.46 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -89.47 83.34 6.35 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.413 1.085 . . . . 0.0 109.899 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.93 167.02 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 125.345 1.458 . . . . 0.0 109.695 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.2 t -162.2 176.01 11.08 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.013 0.925 . . . . 0.0 110.053 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 t -113.49 121.28 43.78 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.241 1.416 . . . . 0.0 108.223 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.45 85.23 7.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -169.71 -70.03 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.099 0.959 . . . . 0.0 111.514 174.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.39 -119.19 3.24 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 124.748 1.166 . . . . 0.0 111.094 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -108.46 171.79 7.22 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.787 1.235 . . . . 0.0 109.158 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -154.69 131.07 10.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.924 0.89 . . . . 0.0 108.834 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.19 136.28 48.14 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.859 1.263 . . . . 0.0 109.399 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -147.81 124.32 11.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.2 t -106.98 -65.78 1.07 Allowed 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -150.7 127.61 11.06 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.1 m -104.26 49.75 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.275 1.43 . . . . 0.0 110.06 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -91.45 -179.28 5.34 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.399 1.079 . . . . 0.0 111.349 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -154.85 139.96 17.46 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.741 2.017 . . . . 0.0 106.796 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.45 -72.11 0.73 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.821 0.848 . . . . 0.0 110.093 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -95.39 -67.84 0.83 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.877 0.871 . . . . 0.0 110.248 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.64 48.49 0.22 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -158.96 128.92 5.74 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.379 1.072 . . . . 0.0 109.337 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.04 135.64 51.24 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.976 1.31 . . . . 0.0 109.872 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.5 p -158.7 154.56 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.05 1.34 . . . . 0.0 108.545 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.5 m -135.37 127.58 30.05 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.516 1.126 . . . . 0.0 108.253 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.6 88.63 2.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.922 0.889 . . . . 0.0 110.36 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.2 m -130.46 83.76 2.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.944 1.298 . . . . 0.0 109.235 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.04 76.67 2.9 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.0 -52.97 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 126.822 2.049 . . . . 0.0 106.897 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -98.95 91.81 5.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.546 1.539 . . . . 0.0 107.504 171.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -99.8 118.72 36.88 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.992 0.917 . . . . 0.0 109.441 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -126.21 103.76 7.86 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.394 1.077 . . . . 0.0 109.001 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -69.89 134.39 48.38 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -108.61 49.2 0.82 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.463 1.105 . . . . 0.0 110.767 -171.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -81.3 83.66 6.82 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.4 p -108.27 128.55 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.346 1.458 . . . . 0.0 108.971 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -122.06 156.5 33.41 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.11 1.364 . . . . 0.0 109.075 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -26.13 -60.39 0.08 OUTLIER Glycine 0 CA--C 1.53 1.013 0 C-N-CA 127.562 2.505 . . . . 0.0 115.487 -173.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -131.51 28.24 4.65 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.848 0.859 . . . . 0.0 111.571 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -155.35 119.5 4.61 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 41.8 ttm -106.12 115.22 29.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.03 61.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.844 1.258 . . . . 0.0 108.69 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -73.08 165.37 25.15 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.06 0.944 . . . . 0.0 110.952 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m -131.44 96.88 4.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 173.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 pp -106.65 134.91 46.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 94.2 m -129.83 137.76 50.63 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.039 1.336 . . . . 0.0 111.046 -167.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -108.34 179.45 4.2 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.199 2.2 . . . . 0.0 107.594 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -18.95 -56.55 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 128.139 2.78 . . . . 0.0 115.334 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -155.05 36.01 0.66 Allowed Glycine 0 CA--C 1.532 1.116 0 CA-C-O 118.689 -1.062 . . . . 0.0 114.072 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -146.26 151.61 14.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.32 0 CA-C-N 118.778 1.289 . . . . 0.0 109.037 170.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 87.3 m -128.53 142.95 50.91 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.423 1.489 . . . . 0.0 110.254 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -108.43 146.88 32.43 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.8 tp -80.17 63.35 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 170.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -52.23 97.3 0.02 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 126.19 1.796 . . . . 0.0 111.56 -170.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -125.32 113.68 17.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.919 0.887 . . . . 0.0 110.124 -169.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 56.4 p -126.36 144.68 50.73 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.505 1.522 . . . . 0.0 109.692 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -114.39 142.34 46.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.398 1.479 . . . . 0.0 108.952 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.66 98.59 6.26 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.7 t . . . . . 0 C--O 1.252 1.199 0 CA-C-O 116.494 -1.717 . . . . 0.0 107.144 175.394 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 . . . . . 0 CA--C 1.53 0.178 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 p -50.32 95.5 0.01 OUTLIER 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.303 1.841 . . . . 0.0 112.198 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.73 -171.38 44.45 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -106.83 142.38 36.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 168.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -142.41 124.47 15.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.178 0.991 . . . . 0.0 109.387 -169.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -119.78 112.11 18.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.096 0.958 . . . . 0.0 109.239 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.44 ' CG1' ' HD2' ' A' ' 36' ' ' PRO . 1.4 p -63.94 121.46 12.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 C-N-CA 124.109 0.964 . . . . 0.0 109.853 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -113.65 -24.22 9.32 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.538 0.735 . . . . 0.0 110.981 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.63 143.87 28.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.272 1.429 . . . . 0.0 108.113 -169.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.99 162.89 34.33 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.48 -100.93 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.283 0.633 . . . . 0.0 110.869 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -106.97 65.05 0.65 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.546 1.138 . . . . 0.0 110.532 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.0 -41.5 99.6 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.013 0.525 . . . . 0.0 111.16 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -58.35 -24.55 60.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 119.026 -0.511 . . . . 0.0 112.017 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -88.45 -38.78 14.75 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 123.093 0.557 . . . . 0.0 111.89 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -46.14 -41.53 12.63 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.073 0.949 . . . . 0.0 110.49 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.447 ' CD1' HG22 ' A' ' 28' ' ' ILE . 7.6 mt -78.61 40.16 0.37 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.107 1.763 . . . . 0.0 112.77 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.4 -33.31 1.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.188 0.904 . . . . 0.0 111.852 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.7 98.38 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.239 0.616 . . . . 0.0 110.579 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.53 168.26 20.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.126 0.97 . . . . 0.0 110.713 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.74 60.28 0.64 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.698 1.199 . . . . 0.0 111.183 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 mp -103.23 148.47 35.72 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.685 1.194 . . . . 0.0 108.583 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.88 158.01 59.23 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.385 2.723 . . . . 0.0 111.52 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.08 -35.21 69.1 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.53 -35.52 80.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.368 0.667 . . . . 0.0 111.677 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -24.55 64.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.562 0.745 . . . . 0.0 112.219 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.447 HG22 ' CD1' ' A' ' 18' ' ' LEU . 3.9 mp -70.54 -39.49 76.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -55.65 -52.33 64.18 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 16.4 mmt -83.77 47.18 1.26 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.331 1.052 . . . . 0.0 110.571 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -151.52 -58.67 0.16 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.757 1.623 . . . . 0.0 109.42 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.1 ptt85 -69.79 -37.31 76.27 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 122.244 -0.285 . . . . 0.0 111.31 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -83.79 37.27 0.58 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.767 0.827 . . . . 0.0 110.424 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.5 mm -130.62 117.31 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.1 96.7 39.84 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.818 1.247 . . . . 0.0 107.764 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.44 ' HD2' ' CG1' ' A' ' 8' ' ' VAL . 8.3 Cg_exo -72.52 164.85 34.39 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.743 2.295 . . . . 0.0 112.698 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.13 117.18 53.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 166.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.95 140.23 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -148.64 100.32 3.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.065 0.946 . . . . 0.0 109.161 -165.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 mt -108.87 135.7 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.593 0.757 . . . . 0.0 109.624 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -125.05 133.28 53.0 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.15 1.38 . . . . 0.0 108.286 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.1 150.66 21.8 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.448 1.099 . . . . 0.0 110.465 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -140.19 154.13 46.83 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 127.735 2.414 . . . . 0.0 106.729 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.93 -55.28 2.31 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.21 1.386 . . . . 0.0 112.499 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -129.84 61.57 1.57 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.739 1.615 . . . . 0.0 109.194 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.4 155.42 17.66 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.246 0.546 . . . . 0.0 110.789 163.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -139.54 111.85 7.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.841 1.656 . . . . 0.0 106.986 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 80.9 t -106.17 127.72 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -127.42 119.79 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.436 1.094 . . . . 0.0 109.207 -171.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.1 m -107.93 141.08 40.09 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.607 1.563 . . . . 0.0 107.522 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.4 t -148.54 87.43 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.146 1.378 . . . . 0.0 107.353 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 120.21 41.33 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.925 0.89 . . . . 0.0 108.844 -170.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 p -101.19 153.8 37.57 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 124.519 1.127 . . . . 0.0 110.041 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.85 51.29 3.33 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.232 2.621 . . . . 0.0 110.418 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -167.09 -48.41 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.694 1.197 . . . . 0.0 110.441 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -130.59 -166.16 1.65 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.647 1.579 . . . . 0.0 108.903 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.8 m -155.27 130.59 9.63 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.48 1.112 . . . . 0.0 108.222 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -133.12 136.03 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.1 m -152.93 141.87 21.21 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.779 1.232 . . . . 0.0 107.894 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -145.84 166.42 26.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.247 1.419 . . . . 0.0 109.473 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.0 p -157.13 141.87 16.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.845 0.858 . . . . 0.0 109.436 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -169.44 167.32 9.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.533 1.133 . . . . 0.0 108.826 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 m -133.02 164.76 26.28 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.842 0.857 . . . . 0.0 110.294 -167.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.48 -58.85 5.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.286 1.035 . . . . 0.0 110.62 175.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.46 36.18 4.39 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.84 1.21 . . . . 0.0 113.564 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -130.24 128.61 41.99 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.862 1.331 . . . . 0.0 109.236 167.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -66.77 133.17 49.61 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.41 0.684 . . . . 0.0 109.463 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -161.15 107.78 1.43 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.097 0.959 . . . . 0.0 109.575 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.86 150.03 44.64 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.22 0.464 . . . . 0.0 110.027 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.7 mm -108.37 111.59 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.277 1.031 . . . . 0.0 108.483 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.9 t -107.39 155.04 20.45 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.491 1.116 . . . . 0.0 111.032 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.6 p -138.12 137.25 37.51 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.8 1.24 . . . . 0.0 109.023 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.7 ptp -88.44 82.36 7.0 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.371 1.068 . . . . 0.0 110.412 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -155.51 -93.56 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.152 0.581 . . . . 0.0 110.934 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.34 -31.5 0.1 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.465 1.507 . . . . 0.0 111.904 -174.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.06 124.79 7.15 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.953 1.376 . . . . 0.0 111.406 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -94.55 131.38 40.34 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.27 0.628 . . . . 0.0 109.323 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.1 tt -157.51 73.42 0.71 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 171.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -141.9 149.77 40.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.688 1.195 . . . . 0.0 108.513 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -136.89 119.84 16.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.4 m -146.37 71.31 1.24 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.6 m -131.08 -65.24 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.141 0.576 . . . . 0.0 111.315 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -99.51 130.72 45.79 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.189 1.396 . . . . 0.0 110.817 -169.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -125.75 119.04 26.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.773 1.629 . . . . 0.0 107.481 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.98 -53.63 0.48 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.015 0.926 . . . . 0.0 109.901 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -66.86 -60.09 2.97 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.249 0.619 . . . . 0.0 110.58 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.2 -48.69 0.1 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.03 110.46 22.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.5 119.51 7.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.431 1.092 . . . . 0.0 111.216 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.0 p -160.11 162.14 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.875 0.87 . . . . 0.0 109.861 -173.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 m -145.86 -38.5 0.24 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.544 1.138 . . . . 0.0 110.028 173.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -139.68 141.19 37.0 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 125.745 1.618 . . . . 0.0 107.787 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.5 t -168.28 67.56 0.07 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.514 1.126 . . . . 0.0 108.463 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -89.35 -99.49 0.09 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.77 0.828 . . . . 0.0 111.085 -173.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -73.57 -48.97 28.8 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -76.43 74.74 3.19 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.0 m -72.93 93.88 1.78 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -90.43 -16.36 29.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.848 1.259 . . . . 0.0 111.672 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.72 136.84 58.15 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.232 0.613 . . . . 0.0 109.883 -172.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.87 169.07 18.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.149 0.98 . . . . 0.0 110.548 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -123.16 146.38 47.82 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.814 1.646 . . . . 0.0 107.915 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.6 t -139.25 124.94 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -121.51 -173.95 2.75 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.664 1.186 . . . . 0.0 109.506 -169.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -39.3 116.49 0.62 Allowed Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.845 1.688 . . . . 0.0 111.593 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 p30 8.19 56.77 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.835 2.854 . . . . 0.0 115.195 -163.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -158.6 133.74 8.49 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.47 0.708 . . . . 0.0 110.372 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.8 ttt -129.41 129.65 44.97 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.903 2.081 . . . . 0.0 106.032 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.55 -72.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -53.48 142.18 22.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.716 0.806 . . . . 0.0 109.635 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.5 m -139.05 -88.72 0.21 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.869 -175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.75 149.21 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.276 0.944 . . . . 0.0 110.353 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 t -123.02 142.54 50.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.133 0.973 . . . . 0.0 109.485 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -109.26 -164.98 0.98 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.848 1.659 . . . . 0.0 108.383 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.71 -58.93 12.0 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 123.87 0.748 . . . . 0.0 113.255 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -131.55 42.29 1.41 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 123.876 0.75 . . . . 0.0 112.014 -175.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.8 p -169.31 157.86 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 125.481 1.512 . . . . 0.0 107.461 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.9 t -151.5 152.28 32.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -149.07 79.65 1.41 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.294 0.569 . . . . 0.0 112.158 -168.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.22 126.47 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 161.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -112.16 124.83 53.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -102.32 98.69 8.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 82.9 p -106.93 135.59 48.23 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.64 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -108.12 138.59 44.13 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -98.7 131.9 44.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.11 1.364 . . . . 0.0 108.971 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 C--O 1.25 1.094 0 C-N-CA 125.145 1.378 . . . . 0.0 107.914 -176.7 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -43.85 -54.6 5.12 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 124.629 1.172 . . . . 0.0 111.291 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.7 p -60.07 92.36 0.02 OUTLIER 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.797 1.239 . . . . 0.0 110.946 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.98 -170.27 42.46 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.4 t -106.5 144.53 33.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.288 1.035 . . . . 0.0 108.221 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -141.58 126.84 18.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.691 0.796 . . . . 0.0 110.917 -171.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -126.45 115.89 20.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.701 0.8 . . . . 0.0 109.189 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.3 p -50.93 143.82 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.89 1.676 . . . . 0.0 110.4 170.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -146.1 -5.52 0.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -166.21 91.24 0.45 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -164.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.64 94.73 4.82 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.988 1.315 . . . . 0.0 107.639 174.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -55.52 -76.66 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.286 1.434 . . . . 0.0 112.133 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -85.2 59.39 5.6 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.066 0.946 . . . . 0.0 111.152 -172.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -67.14 0.43 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.541 0.737 . . . . 0.0 111.905 -173.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -53.01 -41.2 64.43 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.051 0.94 . . . . 0.0 112.541 -169.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -60.55 -53.72 54.08 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.308 0.643 . . . . 0.0 110.958 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -46.12 80.47 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.06 0.944 . . . . 0.0 109.883 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.6 -46.26 80.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.785 1.234 . . . . 0.0 110.835 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -27.77 69.43 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.308 0.643 . . . . 0.0 111.838 -171.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.21 -31.6 71.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.005 0.522 . . . . 0.0 111.627 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.45 163.93 23.42 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.654 0.781 . . . . 0.0 109.793 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.4 52.04 1.36 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 111.998 -172.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.17 137.54 22.14 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.68 162.73 29.81 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.276 2.65 . . . . 0.0 111.97 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.88 -42.69 72.4 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.246 1.418 . . . . 0.0 113.511 -172.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -61.43 -44.61 96.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.37 0.668 . . . . 0.0 110.622 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.78 -35.15 79.67 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.646 -0.692 . . . . 0.0 110.482 171.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.71 -31.25 52.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 119.245 0.93 . . . . 0.0 112.688 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.57 -48.7 10.31 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 168.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.4 mmt -75.71 -48.68 20.89 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.543 0.737 . . . . 0.0 111.048 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.42 78.9 0.1 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 125.793 1.637 . . . . 0.0 111.355 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 179.03 -42.14 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.301 2.24 . . . . 0.0 107.11 -171.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -107.14 -0.38 22.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.187 1.795 . . . . 0.0 112.118 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.7 mt -62.99 117.21 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 118.99 0.813 . . . . 0.0 109.554 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -108.53 98.59 28.97 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.761 1.225 . . . . 0.0 108.943 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.26 140.38 33.79 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.603 2.202 . . . . 0.0 113.83 175.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.75 137.66 37.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 166.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.24 145.65 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.743 1.217 . . . . 0.0 108.035 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 105.24 3.67 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.906 0.882 . . . . 0.0 109.214 -168.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.7 mt -107.71 131.06 58.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.742 1.217 . . . . 0.0 108.368 -173.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? -129.04 134.43 48.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.738 1.215 . . . . 0.0 108.715 -176.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -106.21 150.15 26.16 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.2 160.23 40.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 128.206 2.602 . . . . 0.0 107.755 173.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -19.67 -72.23 0.01 OUTLIER Glycine 0 C--N 1.343 0.963 0 C-N-CA 127.719 2.581 . . . . 0.0 114.231 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -123.19 18.81 9.92 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.99 1.316 . . . . 0.0 110.74 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -124.43 144.68 49.93 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.068 0.849 . . . . 0.0 109.404 -172.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -143.68 127.79 17.57 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 122.447 0.299 . . . . 0.0 110.811 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.91 138.82 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.946 1.298 . . . . 0.0 107.94 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.89 117.27 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.966 1.306 . . . . 0.0 107.895 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.5 m -107.61 143.3 36.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.625 1.57 . . . . 0.0 107.506 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -146.04 143.82 29.67 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.488 1.115 . . . . 0.0 108.222 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -138.07 120.66 16.17 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.3 p -136.11 159.5 70.71 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.02 1.728 . . . . 0.0 108.601 172.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.49 67.98 6.23 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.788 2.992 . . . . 0.0 108.899 168.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -157.88 -60.85 0.08 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.633 1.573 . . . . 0.0 107.994 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -171.04 162.94 7.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.555 1.942 . . . . 0.0 107.758 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.8 p -84.57 99.0 10.47 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.72 65.49 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.5 m -90.79 123.98 34.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.804 1.242 . . . . 0.0 108.121 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -142.45 178.86 7.3 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.224 1.41 . . . . 0.0 108.964 -176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -167.7 166.79 13.67 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 121.918 -0.489 . . . . 0.0 110.721 -177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -152.88 155.61 37.39 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.715 0.806 . . . . 0.0 110.419 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.6 m -119.45 136.42 54.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 169.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.8 mt -57.21 -64.11 0.99 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.968 0.507 . . . . 0.0 109.931 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.43 49.91 1.86 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.358 -0.69 . . . . 0.0 112.043 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -155.12 -95.67 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.049 0.925 . . . . 0.0 110.515 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -142.81 169.36 17.72 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.296 1.039 . . . . 0.0 110.502 -174.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.25 147.19 20.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.905 1.282 . . . . 0.0 109.61 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -153.83 100.46 2.37 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.4 mm -120.08 104.79 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.069 1.348 . . . . 0.0 107.521 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -109.48 173.46 6.31 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.441 0.696 . . . . 0.0 112.45 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.2 p -138.89 170.83 15.27 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.293 2.237 . . . . 0.0 108.333 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -154.78 73.78 0.9 Allowed 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.86 -61.55 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.204 1.002 . . . . 0.0 109.817 -176.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.8 -125.45 5.64 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -116.4 161.36 19.18 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.714 1.606 . . . . 0.0 110.061 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -61.16 143.12 56.09 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.906 0.883 . . . . 0.0 111.96 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.9 mt -132.88 102.83 5.79 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.665 1.586 . . . . 0.0 107.318 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.75 139.37 8.83 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.353 0.661 . . . . 0.0 110.161 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 41.2 t -145.37 -63.91 0.33 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.583 1.553 . . . . 0.0 107.349 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.0 t -161.11 159.11 28.68 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.11 0.964 . . . . 0.0 109.513 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.7 139.69 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 125.35 1.46 . . . . 0.0 107.468 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -164.06 -157.07 0.37 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.68 121.9 38.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.008 1.323 . . . . 0.0 107.589 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.11 -52.6 2.59 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.89 1.676 . . . . 0.0 110.43 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -149.92 -80.26 0.12 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.272 0.629 . . . . 0.0 109.575 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.97 -69.13 1.41 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 173.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -145.7 -115.68 0.08 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.228 1.411 . . . . 0.0 107.379 163.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.06 163.41 27.16 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.353 1.061 . . . . 0.0 112.529 -174.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.85 141.62 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.798 1.639 . . . . 0.0 106.708 172.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -166.64 139.65 3.8 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.415 0.552 . . . . 0.0 110.594 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -81.55 74.51 8.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.856 0.862 . . . . 0.0 108.952 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.4 p -82.46 -171.23 3.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.864 1.266 . . . . 0.0 109.577 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -58.49 -59.35 5.5 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.035 0.534 . . . . 0.0 110.679 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.61 -48.11 0.07 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.184 0.593 . . . . 0.0 110.971 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.0 t80 67.55 -75.5 0.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.895 1.678 . . . . 0.0 111.729 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.9 m -158.55 -53.88 0.07 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 127.065 2.146 . . . . 0.0 106.689 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -165.17 -126.4 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.558 2.343 . . . . 0.0 105.832 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -124.03 -71.28 0.72 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.671 1.188 . . . . 0.0 108.547 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -154.27 97.73 2.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -145.88 92.14 2.17 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.486 1.114 . . . . 0.0 108.945 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.6 t -139.59 138.42 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.011 1.324 . . . . 0.0 107.712 176.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -106.72 159.15 16.44 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.512 1.125 . . . . 0.0 108.498 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -25.23 -63.05 0.06 OUTLIER Glycine 0 C--N 1.342 0.881 0 C-N-CA 127.401 2.429 . . . . 0.0 114.254 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -130.71 34.55 4.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.012 0.925 . . . . 0.0 111.239 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -144.02 112.97 6.73 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.642 0.777 . . . . 0.0 109.44 173.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.2 ttm -100.18 82.29 2.51 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.38 71.1 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.618 1.167 . . . . 0.0 108.735 -173.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.4 84.14 0.8 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -105.59 26.0 10.06 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.936 1.294 . . . . 0.0 111.212 -168.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 mm -108.7 -124.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 117.9 -1.048 . . . . 0.0 108.184 -173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 t -132.86 125.32 29.7 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 120.198 1.363 . . . . 0.0 112.954 -165.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -41.28 78.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.75 -65.99 0.08 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.99 -43.81 4.95 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.513 1.054 . . . . 0.0 112.189 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.3 t -107.54 154.04 8.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 124.208 1.003 . . . . 0.0 109.541 -172.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.3 p -103.72 107.58 18.51 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.52 120.85 43.02 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.1 mp -76.19 75.3 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 171.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -93.88 106.16 18.14 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.675 1.19 . . . . 0.0 108.466 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -107.91 119.23 38.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.615 1.566 . . . . 0.0 109.907 -175.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.0 p -125.07 121.52 34.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 170.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -107.35 155.55 19.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.347 1.459 . . . . 0.0 109.049 -173.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -74.82 148.21 40.5 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.413 177.311 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 119.46 -0.305 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -95.25 14.57 21.83 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.609 171.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.4 p -51.77 118.67 3.55 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.556 1.142 . . . . 0.0 110.84 -172.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.27 172.05 42.26 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -170.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.4 p -114.9 102.43 9.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.887 1.275 . . . . 0.0 108.249 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -115.57 147.37 40.82 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.325 1.05 . . . . 0.0 110.007 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -95.53 -131.7 0.17 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.625 0.77 . . . . 0.0 109.094 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 p 176.75 133.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 127.584 2.354 . . . . 0.0 105.099 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -146.17 -8.91 0.52 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -158.06 110.99 2.4 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -165.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.7 140.2 52.9 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 172.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -90.32 -77.96 0.39 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.413 0.551 . . . . 0.0 112.189 -170.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -83.31 57.42 3.98 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.158 0.983 . . . . 0.0 110.208 -176.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -69.13 -61.59 1.73 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -54.56 -43.31 71.94 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-O 118.983 -0.532 . . . . 0.0 111.801 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.52 -50.66 72.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.796 0.438 . . . . 0.0 110.709 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -58.22 -50.11 74.7 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.755 0.822 . . . . 0.0 110.675 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -16.94 62.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.398 0.679 . . . . 0.0 111.678 -175.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -95.74 -15.11 22.83 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.013 0.925 . . . . 0.0 111.811 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.07 -38.3 87.96 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 166.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.98 144.77 57.07 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.03 43.99 1.04 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.28 0.632 . . . . 0.0 111.941 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.19 145.06 29.58 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.95 1.3 . . . . 0.0 107.99 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.8 135.61 26.11 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.566 2.844 . . . . 0.0 111.869 -171.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -46.34 -41.53 13.53 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.56 1.544 . . . . 0.0 113.061 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -40.46 -56.04 2.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 126.977 2.111 . . . . 0.0 111.858 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.47 -41.66 84.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.888 0.875 . . . . 0.0 110.504 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.3 mp -60.79 -37.82 77.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 118.594 0.634 . . . . 0.0 110.4 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -53.06 -34.22 55.55 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.423 0.689 . . . . 0.0 111.065 177.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 81.2 mmm -108.14 19.71 19.6 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.961 1.704 . . . . 0.0 112.202 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.79 -36.06 4.96 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.554 1.542 . . . . 0.0 110.358 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -56.11 -28.66 58.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.141 0.977 . . . . 0.0 113.476 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.85 -17.46 40.84 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.087 0.955 . . . . 0.0 113.039 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.58 143.6 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.636 0.774 . . . . 0.0 110.09 -176.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -117.36 107.95 44.35 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.084 1.354 . . . . 0.0 109.005 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -57.43 -174.47 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.455 3.437 . . . . 0.0 115.187 173.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.5 tt -118.8 146.21 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 157.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.74 78.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.3 143.81 30.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.56 1.944 . . . . 0.0 107.687 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 tt -145.74 142.1 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 118.426 0.557 . . . . 0.0 109.721 169.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -133.75 155.12 50.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.291 1.836 . . . . 0.0 109.254 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -127.16 161.67 27.95 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.837 1.255 . . . . 0.0 112.364 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -149.31 163.4 37.81 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.301 2.641 . . . . 0.0 107.824 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -23.28 -66.8 0.03 OUTLIER Glycine 0 C--N 1.344 1.002 0 C-N-CA 127.453 2.454 . . . . 0.0 114.114 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -129.16 21.8 5.71 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.079 1.752 . . . . 0.0 110.137 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -126.58 150.28 48.95 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.601 0.76 . . . . 0.0 111.584 -171.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -139.14 140.31 37.86 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.173 0.989 . . . . 0.0 110.555 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.2 t -135.44 112.54 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -105.54 149.79 8.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.3 m -143.5 82.58 1.74 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.131 1.372 . . . . 0.0 108.129 -172.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.9 m -114.83 47.17 1.3 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.669 1.187 . . . . 0.0 109.812 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.73 168.47 9.16 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -166.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.2 p -124.94 158.06 64.33 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 126.025 1.73 . . . . 0.0 107.298 171.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.6 65.12 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.145 2.563 . . . . 0.0 108.381 168.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -174.84 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.691 1.596 . . . . 0.0 108.862 -172.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -128.18 122.91 33.02 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.869 1.267 . . . . 0.0 109.171 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.3 m -95.5 82.08 3.62 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.143 1.377 . . . . 0.0 110.303 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -91.29 96.18 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.5 m -139.28 74.76 1.48 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.341 1.057 . . . . 0.0 109.415 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.51 138.44 58.07 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 m -155.55 142.81 19.33 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -167.56 148.4 5.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -99.69 142.66 30.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 162.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 mp -56.03 -72.07 0.08 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.027 0.931 . . . . 0.0 110.093 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.14 72.62 2.46 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -167.79 174.3 7.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.565 0.746 . . . . 0.0 110.901 -173.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -81.63 166.09 20.48 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.513 0.725 . . . . 0.0 109.24 162.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.87 85.65 0.54 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.24 73.53 3.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.076 0.55 . . . . 0.0 110.479 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.2 mt -77.13 125.97 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.0 p -107.75 -163.48 0.9 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.013 1.325 . . . . 0.0 109.465 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -161.86 171.15 18.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.579 0.752 . . . . 0.0 110.238 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.38 -61.18 1.74 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.097 1.359 . . . . 0.0 110.209 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -135.33 21.02 3.4 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.785 1.234 . . . . 0.0 111.153 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.91 -121.21 1.62 Allowed Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -141.55 -77.06 0.28 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.154 1.382 . . . . 0.0 109.389 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.4 134.03 2.72 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.42 114.61 28.17 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.176 0.99 . . . . 0.0 110.602 -171.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.28 52.08 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.41 1.084 . . . . 0.0 108.335 174.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 79.7 m -115.23 -57.77 2.21 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.559 1.144 . . . . 0.0 110.348 -170.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.5 p -104.17 84.29 2.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 -170.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.2 m -123.62 -130.81 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.048 1.339 . . . . 0.0 109.039 -171.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -24.0 127.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.715 2.406 . . . . 0.0 114.014 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.3 tt -114.76 95.69 5.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.18 -61.86 1.46 Allowed 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 123.657 0.783 . . . . 0.0 108.923 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -67.92 -56.87 7.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.252 0.621 . . . . 0.0 111.233 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.27 -38.89 0.08 OUTLIER Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -110.88 171.44 7.46 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.286 1.434 . . . . 0.0 107.89 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.04 159.44 33.82 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.13 -86.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -76.99 87.65 3.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.612 1.165 . . . . 0.0 110.349 -171.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -104.13 41.45 1.3 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.508 1.123 . . . . 0.0 108.704 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.5 p -151.03 57.4 0.91 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.459 0.703 . . . . 0.0 110.106 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -156.4 -167.78 2.52 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -64.1 133.17 52.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.182 0.593 . . . . 0.0 109.625 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.8 t80 69.02 51.93 0.52 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.758 1.223 . . . . 0.0 110.944 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 73.9 m -112.45 134.61 53.88 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.234 1.014 . . . . 0.0 109.647 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -78.0 170.28 16.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.62 0.768 . . . . 0.0 110.231 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -57.29 -73.2 0.07 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.846 1.258 . . . . 0.0 112.316 -171.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -161.06 -55.28 0.05 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.495 1.118 . . . . 0.0 108.892 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -167.41 178.82 5.28 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.524 0.73 . . . . 0.0 112.152 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 63.7 t -108.69 145.94 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 126.818 2.047 . . . . 0.0 108.633 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -108.01 151.75 25.41 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.8 0.84 . . . . 0.0 109.734 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -13.34 -72.2 0.01 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 128.777 3.084 . . . . 0.0 115.81 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -128.56 28.4 5.42 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.502 1.121 . . . . 0.0 110.972 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -151.45 113.66 4.54 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.7 ttt -98.9 97.68 8.84 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.864 1.266 . . . . 0.0 107.751 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.3 t -105.79 102.81 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -115.68 129.36 56.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.665 0.786 . . . . 0.0 109.474 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.6 t -110.91 116.41 31.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 164.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.34 110.37 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -168.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.0 p -73.59 104.06 4.41 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.877 1.271 . . . . 0.0 110.311 -172.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -92.08 174.19 7.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.905 1.282 . . . . 0.0 110.226 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -41.87 -52.48 4.77 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.066 1.793 . . . . 0.0 113.836 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -136.36 19.86 3.58 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.279 -0.734 . . . . 0.0 114.469 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.7 t -149.43 162.98 4.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 171.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.0 t -118.3 125.37 49.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 159.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 28.2 tp -101.77 99.86 10.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.1 mt -55.55 128.6 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.335 166.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -146.57 124.03 11.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.315 1.446 . . . . 0.0 108.496 176.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -107.81 116.29 31.68 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.7 p -110.98 127.55 55.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.143 1.377 . . . . 0.0 107.839 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -105.87 145.77 30.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.517 1.127 . . . . 0.0 108.894 -170.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.5 tpt85 -69.8 121.99 18.34 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.616 0.766 . . . . 0.0 110.711 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.271 -1.347 . . . . 0.0 109.289 173.889 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 119.362 -0.352 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -132.21 -59.12 0.94 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 123.695 0.798 . . . . 0.0 110.163 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 p -57.56 100.2 0.05 OUTLIER 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.188 0.995 . . . . 0.0 111.768 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.84 -174.71 47.07 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.9 p -105.91 128.14 53.59 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -130.26 153.44 48.62 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.207 0.603 . . . . 0.0 111.548 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -142.22 119.72 11.69 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.39 1.076 . . . . 0.0 109.908 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.456 ' CG1' ' HD2' ' A' ' 36' ' ' PRO . 1.2 p -49.77 138.01 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.729 1.212 . . . . 0.0 109.293 163.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -138.77 -16.67 1.12 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 172.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.3 85.94 2.19 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.308 1.043 . . . . 0.0 110.709 -163.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -95.52 145.67 25.02 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 167.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -79.82 -106.67 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -85.99 75.41 9.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -46.23 75.84 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.948 0.899 . . . . 0.0 110.97 -176.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -62.6 -16.71 57.84 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -72.2 -54.06 10.77 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.378 0.99 . . . . 0.0 110.917 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -43.17 -63.37 0.82 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.102 1.761 . . . . 0.0 112.423 -172.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -12.37 59.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.415 1.086 . . . . 0.0 113.885 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.03 -32.21 64.96 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.012 0.823 . . . . 0.0 109.953 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.8 41.25 0.72 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.619 0.768 . . . . 0.0 111.686 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -138.34 168.71 19.18 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.356 1.462 . . . . 0.0 108.509 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.47 39.47 1.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.792 0.837 . . . . 0.0 111.384 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 mp -97.74 141.69 23.39 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.89 153.1 58.43 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.664 2.243 . . . . 0.0 109.732 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -57.01 -25.34 58.39 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.335 1.054 . . . . 0.0 113.091 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.92 -45.82 71.3 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.604 1.162 . . . . 0.0 111.166 171.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.5 mt -80.87 -4.91 56.46 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.644 -0.694 . . . . 0.0 112.214 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.96 -28.03 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.075 0.852 . . . . 0.0 109.945 166.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -53.65 -44.46 69.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 166.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 9.1 ttt -62.07 -63.57 1.21 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.311 1.044 . . . . 0.0 110.265 168.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.22 79.35 0.98 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.047 0.939 . . . . 0.0 112.58 -174.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.68 -44.81 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.744 2.017 . . . . 0.0 107.738 174.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -85.83 48.74 1.65 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.525 1.53 . . . . 0.0 108.578 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.8 mm -127.86 135.33 63.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 C-N-CA 124.881 1.272 . . . . 0.0 109.471 -175.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.12 82.24 4.46 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -176.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HD2' ' CG1' ' A' ' 8' ' ' VAL . 21.6 Cg_exo -70.27 173.1 11.92 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.711 2.274 . . . . 0.0 112.879 -173.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 pt -107.46 137.8 36.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 167.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.6 t -118.45 104.04 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -112.94 98.61 7.28 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.004 2.122 . . . . 0.0 107.267 -166.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.7 mt -106.29 133.41 50.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 123.318 0.647 . . . . 0.0 110.026 -173.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -126.56 121.71 33.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.009 1.724 . . . . 0.0 107.821 172.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -108.7 145.09 35.6 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.344 0.592 . . . . 0.0 110.92 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.65 161.36 30.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 129.75 3.22 . . . . 0.0 106.408 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -14.44 -68.57 0.01 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 127.868 2.651 . . . . 0.0 114.378 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -129.97 12.14 5.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.583 1.553 . . . . 0.0 110.802 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.13 139.22 47.84 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 118.785 0.72 . . . . 0.0 109.866 -172.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -135.14 119.31 17.65 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.15 0.58 . . . . 0.0 109.583 -172.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.8 t -113.63 110.32 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -108.38 118.95 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m -106.86 106.84 17.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.86 1.664 . . . . 0.0 107.205 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 p -108.17 82.08 1.58 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.053 1.741 . . . . 0.0 107.799 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -104.03 127.54 51.6 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.086 0.954 . . . . 0.0 109.883 -166.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.3 p -113.84 157.33 42.12 Favored Pre-proline 0 CA--C 1.53 0.21 0 C-N-CA 125.819 1.648 . . . . 0.0 109.754 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.41 60.11 5.64 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.54 2.827 . . . . 0.0 109.423 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -175.65 -53.7 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.411 1.484 . . . . 0.0 110.497 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -126.92 154.46 44.46 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.682 1.193 . . . . 0.0 110.742 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.1 p -110.17 53.6 0.69 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.021 1.328 . . . . 0.0 110.05 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -72.21 138.12 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.5 m -148.36 137.96 22.17 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.243 1.017 . . . . 0.0 108.346 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -132.26 102.04 5.61 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.134 1.374 . . . . 0.0 108.483 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.5 p -110.6 141.03 44.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.702 1.201 . . . . 0.0 109.379 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -156.05 176.9 12.05 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.661 0.784 . . . . 0.0 110.313 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.0 m -137.36 149.38 46.95 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 172.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.12 -65.39 0.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.647 0.779 . . . . 0.0 110.043 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.94 62.39 4.38 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -162.46 159.04 24.56 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.516 0.726 . . . . 0.0 110.594 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.76 136.47 37.4 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.518 1.127 . . . . 0.0 109.528 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.46 144.85 10.97 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.698 1.199 . . . . 0.0 109.426 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -110.32 130.67 55.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.762 1.225 . . . . 0.0 108.468 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 42.6 mm -108.37 141.35 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.429 1.091 . . . . 0.0 109.113 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.5 p -108.82 164.54 12.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.313 1.445 . . . . 0.0 110.631 -173.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 t -128.71 160.1 33.55 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.745 1.218 . . . . 0.0 108.183 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -71.34 -67.18 0.54 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -140.62 103.02 4.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.865 0.866 . . . . 0.0 108.731 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.54 -109.28 0.24 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -157.36 163.55 38.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.954 0.902 . . . . 0.0 109.784 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -70.36 87.17 0.62 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.182 0.993 . . . . 0.0 110.06 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 tt -151.74 78.08 1.24 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -141.27 86.42 2.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.0 1.32 . . . . 0.0 108.427 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.1 p -107.47 86.51 2.31 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -150.23 53.64 0.91 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.158 0.983 . . . . 0.0 110.815 -170.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.3 m -133.85 50.82 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -154.25 170.96 20.03 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.513 -0.742 . . . . 0.0 109.659 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.74 133.32 35.92 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.202 1.801 . . . . 0.0 106.299 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.05 -52.95 2.93 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.276 0.631 . . . . 0.0 109.775 -176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.0 -52.75 0.29 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.517 1.127 . . . . 0.0 108.741 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.05 41.21 0.54 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -142.19 125.01 16.01 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.242 1.017 . . . . 0.0 109.193 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 tt -73.26 79.15 1.31 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.593 1.557 . . . . 0.0 108.434 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.7 143.33 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.493 1.117 . . . . 0.0 110.021 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 t -118.4 -37.43 3.33 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.206 1.402 . . . . 0.0 109.249 169.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -160.79 167.16 27.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.304 1.042 . . . . 0.0 109.071 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.2 t -144.92 136.0 24.91 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -129.45 -135.49 0.22 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.975 0.91 . . . . 0.0 108.964 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -63.31 -47.03 83.97 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.74 0.816 . . . . 0.0 109.604 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -83.71 62.16 6.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.021 1.728 . . . . 0.0 109.829 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.5 m -66.28 127.06 30.73 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -101.42 -41.13 6.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.829 1.252 . . . . 0.0 111.954 -172.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -166.05 166.63 17.1 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.327 0.512 . . . . 0.0 111.285 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -149.31 -61.2 0.22 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.203 1.401 . . . . 0.0 108.829 169.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -85.31 89.41 7.66 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.005 0.922 . . . . 0.0 110.962 -171.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.5 t -106.9 134.42 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 125.194 1.398 . . . . 0.0 107.283 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -124.95 153.15 43.18 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.929 0.892 . . . . 0.0 109.987 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -30.67 -53.98 0.24 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 127.635 2.54 . . . . 0.0 115.219 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -122.97 11.95 9.64 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.725 1.21 . . . . 0.0 112.557 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -148.49 105.89 3.65 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.888 0.875 . . . . 0.0 108.848 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.1 ttt -101.56 115.35 30.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 t -106.67 86.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.2 111.52 3.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.2 m -107.11 81.97 1.62 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 tp -104.35 116.17 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.712 0.805 . . . . 0.0 109.463 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -98.97 157.99 15.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.125 0.97 . . . . 0.0 110.125 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -161.12 166.01 28.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.049 1.74 . . . . 0.0 107.172 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 2.08 -82.17 0.0 OUTLIER Glycine 0 C--N 1.344 1.001 0 C-N-CA 128.617 3.008 . . . . 0.0 115.355 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -141.15 52.3 0.68 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.1 p -160.88 145.06 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.599 1.159 . . . . 0.0 108.542 -173.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t -150.4 135.94 18.13 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.848 0.459 . . . . 0.0 110.655 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.86 139.2 49.97 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.88 1.272 . . . . 0.0 108.762 -173.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.61 -11.06 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.232 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 5.79 80.74 0.01 OUTLIER 'General case' 0 C--N 1.349 0.549 0 C-N-CA 129.593 3.157 . . . . 0.0 113.005 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -104.22 121.92 44.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.891 1.276 . . . . 0.0 108.127 -170.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.4 p -122.15 152.28 40.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.084 1.754 . . . . 0.0 109.944 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -124.17 148.4 47.26 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.294 1.038 . . . . 0.0 108.918 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.9 73.22 4.46 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 123.823 0.702 . . . . 0.0 109.643 -177.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 C--O 1.25 1.116 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.048 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -84.34 69.11 10.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.174 0.59 . . . . 0.0 110.359 -170.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 t -169.27 72.39 0.08 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.358 1.463 . . . . 0.0 108.14 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.22 -163.59 31.78 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 t -105.1 135.02 47.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -134.93 106.4 6.83 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -80.65 -122.26 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -171.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.445 HG13 ' CD ' ' A' ' 36' ' ' PRO . 3.2 p 175.76 125.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -175.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -134.88 -24.41 1.48 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.8 -67.99 0.83 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.831 -1.08 . . . . 0.0 112.585 -168.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . 0.272 1.1 pt20 3.9 83.61 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.373 2.269 . . . . 0.0 114.045 -162.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -75.13 -71.85 0.33 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.043 0.937 . . . . 0.0 111.629 -169.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -82.91 53.81 2.53 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.921 0.889 . . . . 0.0 110.406 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -67.71 -42.24 82.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.198 0.599 . . . . 0.0 111.263 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -53.99 -52.12 61.74 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.829 1.252 . . . . 0.0 112.147 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -55.29 -50.86 68.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.911 0.484 . . . . 0.0 110.703 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -65.52 -48.47 72.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.248 1.419 . . . . 0.0 112.111 -172.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.24 -50.96 63.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.371 0.668 . . . . 0.0 110.459 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.98 65.59 6.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.308 1.051 . . . . 0.0 109.512 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.13 -27.52 0.05 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.034 2.534 . . . . 0.0 109.487 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.2 mt -67.58 -120.56 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.485 1.514 . . . . 0.0 107.823 163.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.12 67.17 0.59 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.274 -0.891 . . . . 0.0 110.401 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 mp -124.42 143.64 43.66 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.816 1.246 . . . . 0.0 108.281 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 141.42 24.44 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.351 3.367 . . . . 0.0 111.765 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -47.66 -44.61 27.32 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 125.294 1.438 . . . . 0.0 113.336 -171.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.01 -48.95 32.45 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.542 1.137 . . . . 0.0 111.3 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.0 mt -74.61 -23.1 58.66 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.929 0.892 . . . . 0.0 112.017 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.0 mp -73.34 -41.29 57.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 CA-C-N 119.562 1.074 . . . . 0.0 109.344 170.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -42.99 86.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 46.3 ttm -56.43 -56.28 23.12 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.416 1.086 . . . . 0.0 110.589 167.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.42 -37.9 57.82 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 113.208 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -59.13 -30.73 68.36 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.286 1.434 . . . . 0.0 111.683 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -77.21 -26.88 53.24 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.146 0.978 . . . . 0.0 111.491 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mt -70.59 116.84 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.842 0.857 . . . . 0.0 111.65 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.1 106.49 16.18 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 168.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.445 ' CD ' HG13 ' A' ' 8' ' ' VAL . 66.5 Cg_endo -68.13 177.8 4.12 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.061 1.841 . . . . 0.0 112.982 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 pt -129.37 153.31 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 165.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.5 t -131.68 111.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -121.68 97.6 5.57 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.816 2.046 . . . . 0.0 107.575 -162.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.4 mt -108.63 140.38 27.45 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 C-N-CA 122.784 0.434 . . . . 0.0 110.21 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -142.11 150.05 40.65 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.929 1.292 . . . . 0.0 108.093 171.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -121.75 167.52 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.151 0.981 . . . . 0.0 112.531 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -151.56 159.61 44.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.746 2.818 . . . . 0.0 107.77 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.31 -59.67 0.22 Allowed Glycine 0 C--N 1.341 0.858 0 C-N-CA 126.625 2.06 . . . . 0.0 113.937 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -130.93 33.45 4.19 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.816 1.246 . . . . 0.0 110.429 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -144.31 154.49 43.1 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.913 0.779 . . . . 0.0 111.866 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -149.7 127.29 11.62 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.689 0.796 . . . . 0.0 110.194 -173.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.2 t -108.27 122.73 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.51 96.17 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.774 1.629 . . . . 0.0 109.024 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 m -102.88 98.84 8.76 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.42 1.088 . . . . 0.0 108.515 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -105.68 117.75 34.81 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -137.06 138.48 40.45 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.629 0.772 . . . . 0.0 111.128 -167.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -124.49 153.89 69.48 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.641 1.577 . . . . 0.0 108.172 167.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.66 56.01 5.74 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.105 3.203 . . . . 0.0 109.854 172.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -175.0 -51.54 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.121 1.769 . . . . 0.0 109.543 -171.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -125.44 162.32 25.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.436 1.095 . . . . 0.0 109.823 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.3 m -138.3 118.28 13.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.889 0.876 . . . . 0.0 108.78 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.17 43.26 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.8 p -79.79 126.94 31.6 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.63 1.172 . . . . 0.0 108.414 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -140.13 168.91 18.71 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.195 0.998 . . . . 0.0 110.737 -172.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.1 m -153.16 153.44 32.76 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.812 1.245 . . . . 0.0 109.443 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -148.44 151.99 36.18 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.376 1.07 . . . . 0.0 110.318 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 m -86.66 -117.64 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.8 mt -151.07 -78.45 0.13 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 171.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.8 41.75 2.91 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.28 144.99 25.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.032 1.333 . . . . 0.0 107.962 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 151.61 20.91 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.093 1.357 . . . . 0.0 113.701 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.61 138.19 9.46 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.631 1.172 . . . . 0.0 109.804 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.08 91.13 3.6 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.478 1.111 . . . . 0.0 111.446 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.8 mm -94.1 127.88 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.729 1.612 . . . . 0.0 108.749 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -155.7 152.83 29.07 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.264 0.626 . . . . 0.0 111.018 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.7 p -89.77 147.72 23.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.325 1.45 . . . . 0.0 109.266 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.1 -64.98 1.07 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -106.94 80.26 1.41 Allowed 'General case' 0 C--N 1.343 0.299 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.04 -112.93 0.29 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -164.26 135.35 4.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.526 1.13 . . . . 0.0 108.728 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -68.22 103.59 1.61 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.67 1.188 . . . . 0.0 110.045 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.4 mt -125.38 60.2 1.24 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.482 1.113 . . . . 0.0 109.311 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -97.29 139.48 33.18 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.793 1.237 . . . . 0.0 107.827 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 91.2 m -128.91 -74.37 0.57 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.0 p -146.73 163.97 34.23 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.679 1.592 . . . . 0.0 107.898 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.12 88.82 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.742 0.817 . . . . 0.0 109.382 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -132.72 -173.84 3.29 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.024 1.73 . . . . 0.0 109.24 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.35 142.25 37.44 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.681 1.592 . . . . 0.0 108.986 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.18 -176.83 5.08 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.609 1.164 . . . . 0.0 110.286 174.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -76.41 73.06 3.17 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.48 1.112 . . . . 0.0 110.954 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.79 -82.8 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 106.251 -2.74 . . . . 0.0 106.251 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -160.47 -54.28 0.05 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.722 0.809 . . . . 0.0 109.076 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.97 144.94 43.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.451 1.1 . . . . 0.0 108.514 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.5 -47.4 77.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 122.39 0.276 . . . . 0.0 110.508 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -103.11 148.82 25.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.789 1.635 . . . . 0.0 109.214 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.86 163.1 28.38 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 169.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.2 p -54.16 -76.49 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.593 0.757 . . . . 0.0 110.229 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -140.26 146.04 38.09 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -58.35 -40.86 83.32 Favored 'General case' 0 CA--C 1.526 0.052 0 C-N-CA 123.53 0.732 . . . . 0.0 109.463 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -87.3 40.04 0.9 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.143 0.977 . . . . 0.0 110.113 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.4 m -149.09 -94.2 0.07 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 125.786 1.634 . . . . 0.0 108.217 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -114.82 140.61 48.8 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.885 0.874 . . . . 0.0 110.121 -171.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.58 -54.58 2.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.058 0.943 . . . . 0.0 109.715 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.9 154.19 21.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.415 0.686 . . . . 0.0 111.41 -166.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -68.57 172.89 5.59 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.265 1.026 . . . . 0.0 111.615 175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.7 m -107.05 178.89 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.668 1.587 . . . . 0.0 110.962 -168.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.73 160.75 17.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.243 1.417 . . . . 0.0 110.033 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -32.58 -64.47 0.26 Allowed Glycine 0 C--N 1.342 0.905 0 C-N-CA 127.356 2.408 . . . . 0.0 114.373 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -121.3 33.72 5.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.737 0.815 . . . . 0.0 110.491 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -151.15 98.58 2.58 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 122.635 0.374 . . . . 0.0 111.738 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.1 ttt -92.41 80.81 4.9 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 166.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.68 27.22 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.448 1.099 . . . . 0.0 110.547 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -73.51 143.56 46.51 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.1 p -101.7 144.01 30.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -174.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 tt -103.17 114.21 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -169.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.3 t -103.49 164.19 11.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.009 0.924 . . . . 0.0 112.035 -173.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -147.94 172.63 13.9 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 128.206 2.602 . . . . 0.0 106.395 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.55 -39.8 85.78 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.89 -42.61 16.12 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.609 1.1 . . . . 0.0 113.532 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.32 154.64 39.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 CA-C-N 117.887 0.843 . . . . 0.0 112.495 -162.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 p -112.48 109.67 19.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 163.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.33 114.68 28.37 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -167.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.7 mm -66.88 80.32 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.723 1.609 . . . . 0.0 108.344 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -110.76 145.88 37.33 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.476 1.511 . . . . 0.0 108.846 171.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -143.13 119.29 10.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.404 1.882 . . . . 0.0 106.466 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.6 p -109.29 115.76 30.6 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -106.17 151.54 24.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -74.48 146.43 42.77 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--O 1.252 1.218 0 CA-C-O 117.69 -1.148 . . . . 0.0 110.437 -178.232 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.31 78.66 1.83 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 p -171.06 68.16 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.739 0.816 . . . . 0.0 109.782 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.67 -160.02 25.56 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 p -103.35 119.5 38.99 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -124.59 146.04 49.27 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.618 0.767 . . . . 0.0 109.318 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -141.9 135.25 29.27 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.19 0.596 . . . . 0.0 109.877 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.484 ' CG1' ' HD2' ' A' ' 36' ' ' PRO . 1.4 p -77.87 140.92 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 124.814 1.245 . . . . 0.0 110.449 176.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -135.72 -13.91 1.92 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.129 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.0 135.98 15.51 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -167.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.35 145.4 21.65 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -90.6 -107.97 0.09 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.459 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -76.97 60.17 1.76 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.537 1.062 . . . . 0.0 110.338 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -75.15 -30.49 60.78 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.233 0.613 . . . . 0.0 111.517 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -56.61 -47.3 79.94 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.093 0.406 . . . . 0.0 110.122 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.03 -31.15 71.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.657 1.183 . . . . 0.0 111.459 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -58.56 -38.9 78.82 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.219 0.463 . . . . 0.0 110.079 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -72.24 -55.51 7.08 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.116 0.416 . . . . 0.0 109.944 169.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -76.05 73.71 2.92 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 124.979 1.311 . . . . 0.0 109.7 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.23 -32.35 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.197 2.599 . . . . 0.0 108.817 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.7 mt -72.73 -117.37 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.529 1.532 . . . . 0.0 108.28 169.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.21 31.93 0.48 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.157 0.983 . . . . 0.0 110.754 172.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.88 121.98 69.37 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.23 161.85 39.78 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.033 2.488 . . . . 0.0 112.166 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -53.21 -45.57 68.68 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.776 1.63 . . . . 0.0 112.413 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -52.44 -50.42 62.63 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.841 0.856 . . . . 0.0 110.454 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -42.47 95.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.664 0.786 . . . . 0.0 109.879 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.3 mt -55.06 -36.78 40.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-N 119.181 0.9 . . . . 0.0 111.545 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -45.13 -45.46 11.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.38 1.072 . . . . 0.0 111.33 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.6 mmt -80.25 -57.41 3.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.317 1.447 . . . . 0.0 109.851 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.39 -45.32 6.12 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 127.725 2.41 . . . . 0.0 113.978 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -61.98 -39.9 93.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.058 0.543 . . . . 0.0 110.357 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -95.66 52.47 1.36 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.589 1.156 . . . . 0.0 109.693 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.0 mm -115.7 128.58 72.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.94 1.296 . . . . 0.0 107.864 170.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.37 91.11 49.99 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.484 ' HD2' ' CG1' ' A' ' 8' ' ' VAL . 11.2 Cg_exo -71.53 170.44 18.5 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 CA-C-N 120.758 1.306 . . . . 0.0 111.465 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.59 134.49 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 167.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.8 t -116.54 99.34 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.84 110.28 22.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.088 1.755 . . . . 0.0 107.695 -168.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.7 mt -121.46 134.19 65.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 C-N-CA 124.124 0.97 . . . . 0.0 110.553 -163.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -129.91 120.83 25.52 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -90.85 140.7 29.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.378 1.071 . . . . 0.0 109.877 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.69 157.45 33.86 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 128.582 2.753 . . . . 0.0 108.12 173.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -32.56 -59.76 0.4 Allowed Glycine 0 C--N 1.344 0.999 0 C-N-CA 126.822 2.153 . . . . 0.0 112.705 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -136.1 71.23 1.42 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 165.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -165.53 155.81 13.21 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.129 0.972 . . . . 0.0 109.13 164.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -141.2 127.11 19.29 Favored 'General case' 0 C--O 1.228 -0.054 0 C-N-CA 123.935 0.894 . . . . 0.0 109.649 174.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.4 t -108.6 133.38 53.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 173.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.32 117.44 24.64 Favored 'Isoleucine or valine' 0 C--N 1.341 0.21 0 C-N-CA 124.368 1.067 . . . . 0.0 108.914 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.8 m -108.35 107.2 17.67 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.383 1.473 . . . . 0.0 108.39 -173.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -103.72 93.49 4.93 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -107.95 122.62 47.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.359 1.463 . . . . 0.0 109.042 -170.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.2 p -108.63 156.63 38.48 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 123.818 0.847 . . . . 0.0 109.714 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.33 58.01 4.28 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.87 2.38 . . . . 0.0 108.979 166.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -167.64 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.055 1.342 . . . . 0.0 109.785 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -135.47 178.91 6.67 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.188 1.795 . . . . 0.0 109.284 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.0 m -138.26 137.41 37.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.254 1.022 . . . . 0.0 108.255 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.4 t -133.84 90.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.9 m -87.29 121.76 30.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -121.26 156.14 33.14 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.697 1.199 . . . . 0.0 110.115 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.1 p -149.02 141.02 23.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.388 1.075 . . . . 0.0 108.858 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.463 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -148.4 153.11 38.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.716 0.806 . . . . 0.0 109.879 174.714 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.0 m -125.26 165.18 18.78 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.639 1.176 . . . . 0.0 108.685 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -82.88 -64.31 1.2 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.91 1.684 . . . . 0.0 109.634 -172.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.61 38.82 2.97 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.021 0.82 . . . . 0.0 111.893 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -162.49 138.41 7.37 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -55.47 163.7 1.19 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.614 1.566 . . . . 0.0 113.288 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.463 ' CB ' ' HB3' ' A' ' 62' ' ' PHE . . . -150.45 86.83 1.42 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.543 0.737 . . . . 0.0 110.108 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -78.88 51.97 1.18 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.586 1.954 . . . . 0.0 111.882 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.04 128.37 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.039 0.935 . . . . 0.0 109.273 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.8 p -116.75 -172.93 2.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.118 1.767 . . . . 0.0 108.086 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.1 t -143.0 -174.05 4.08 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.934 0.493 . . . . 0.0 110.236 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 42.2 mtp -66.11 -63.24 1.12 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.166 1.386 . . . . 0.0 110.331 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -106.2 49.33 0.81 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.244 1.017 . . . . 0.0 108.326 -172.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.55 118.74 0.57 Allowed Glycine 0 C--N 1.344 0.975 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -104.7 -101.41 0.32 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.489 1.116 . . . . 0.0 108.936 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -98.84 82.64 2.81 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.049 1.295 . . . . 0.0 108.98 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tt -148.14 74.65 1.3 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -171.0 167.28 7.3 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.197 0.999 . . . . 0.0 110.112 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.63 -165.18 1.17 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.746 1.618 . . . . 0.0 108.064 170.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -106.69 135.13 48.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.52 1.128 . . . . 0.0 108.195 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.8 m -74.68 155.98 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.168 0.587 . . . . 0.0 110.617 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -162.46 159.82 25.5 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.46 0.704 . . . . 0.0 110.537 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.36 138.69 44.22 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.879 1.672 . . . . 0.0 108.168 -175.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.29 -61.65 1.45 Allowed 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.942 0.897 . . . . 0.0 108.824 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -145.97 -62.81 0.32 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.616 0.766 . . . . 0.0 110.107 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.62 -77.84 0.91 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.443 0.545 . . . . 0.0 112.001 -174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -135.89 -172.47 3.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.045 1.338 . . . . 0.0 109.869 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.2 134.41 39.07 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.245 1.418 . . . . 0.0 110.971 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.33 131.62 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.0 m -151.45 67.79 0.9 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -73.96 80.4 1.67 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.685 1.194 . . . . 0.0 109.904 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 55.9 p -166.86 -33.16 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.539 1.135 . . . . 0.0 111.569 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -75.97 71.26 2.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.199 1.4 . . . . 0.0 110.068 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -47.13 -62.95 1.18 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.261 1.824 . . . . 0.0 111.981 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -88.81 64.02 7.08 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.272 0.629 . . . . 0.0 109.803 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.8 t -153.13 -163.38 1.68 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.627 1.171 . . . . 0.0 108.986 174.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -78.38 135.47 37.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.471 0.708 . . . . 0.0 109.85 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -76.2 164.3 26.21 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -102.97 74.04 1.28 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.46 1.104 . . . . 0.0 108.601 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -125.14 132.2 53.12 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.054 1.742 . . . . 0.0 107.851 172.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -157.43 157.09 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.133 0.973 . . . . 0.0 109.462 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -126.72 147.55 49.95 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.253 1.021 . . . . 0.0 108.494 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -35.97 -51.3 1.18 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.425 1.964 . . . . 0.0 113.965 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -130.08 36.38 4.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.427 1.891 . . . . 0.0 111.064 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -161.76 125.11 3.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.748 0.819 . . . . 0.0 109.016 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 41.9 ttm -123.45 84.68 2.3 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.347 1.059 . . . . 0.0 109.281 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.8 t -105.13 82.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -80.49 154.48 27.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.702 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.5 p -108.14 116.4 31.9 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.065 1.746 . . . . 0.0 106.649 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 71.9 mt -103.72 96.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.7 m -75.57 125.4 28.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -142.65 166.57 24.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.923 1.289 . . . . 0.0 107.614 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -54.73 -40.22 70.46 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.326 0.489 . . . . 0.0 112.171 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.8 -38.5 6.5 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.597 1.094 . . . . 0.0 113.398 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.85 150.91 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 118.406 1.103 . . . . 0.0 111.887 -170.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.9 p -106.76 91.36 3.64 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 162.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.88 114.12 28.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.751 0.786 . . . . 0.0 112.249 -158.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.2 mm -68.13 118.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.297 1.839 . . . . 0.0 108.484 172.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -125.28 114.84 19.47 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -107.37 105.49 15.45 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.292 1.037 . . . . 0.0 109.519 -169.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.8 p -114.12 145.3 41.82 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.419 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -136.87 154.95 50.36 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.5 -171.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -73.23 74.67 1.31 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.862 1.665 . . . . 0.0 113.165 -165.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.271 -1.347 . . . . 0.0 109.822 175.197 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -84.12 -45.16 13.29 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 122.618 0.367 . . . . 0.0 110.982 -175.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.3 p -51.03 99.1 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.602 1.561 . . . . 0.0 111.886 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.71 -168.16 39.99 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.6 p -110.03 131.92 54.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -131.21 140.59 49.91 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.155 0.982 . . . . 0.0 110.775 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -119.19 106.51 12.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.744 1.217 . . . . 0.0 109.224 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 p -47.21 136.58 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 125.644 1.578 . . . . 0.0 109.638 165.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -147.81 -29.81 0.32 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.5 -7.78 46.4 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -154.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -54.61 104.78 0.12 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.869 1.213 . . . . 0.0 111.132 -173.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.19 -76.54 0.11 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.188 0.595 . . . . 0.0 110.058 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -83.09 58.31 4.36 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.052 0.941 . . . . 0.0 108.472 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -57.78 -30.54 65.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.151 -1.593 . . . . 0.0 111.364 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -36.25 76.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.552 0.741 . . . . 0.0 111.863 173.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -67.17 -40.58 86.63 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -55.48 -43.57 75.66 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.328 0.651 . . . . 0.0 111.682 -176.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -78.99 49.89 0.97 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.578 1.151 . . . . 0.0 111.474 -174.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 -40.99 1.31 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.049 0.94 . . . . 0.0 111.261 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.17 46.04 1.08 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.587 0.755 . . . . 0.0 110.32 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.3 mt -138.79 -128.85 0.12 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.231 2.212 . . . . 0.0 105.524 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.72 77.11 0.45 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.238 1.015 . . . . 0.0 109.4 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.48 139.51 35.75 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.851 0.86 . . . . 0.0 109.651 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.61 147.08 39.88 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.218 2.612 . . . . 0.0 109.771 175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.26 -38.6 68.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.771 1.228 . . . . 0.0 113.304 -168.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.91 -44.03 14.27 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.419 1.488 . . . . 0.0 112.073 170.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -76.8 -33.04 58.01 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 117.898 -1.049 . . . . 0.0 111.13 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -64.48 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 CA-C-N 120.012 1.278 . . . . 0.0 109.77 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -44.8 -37.46 3.84 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.519 1.127 . . . . 0.0 112.083 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.2 mmt -90.39 -42.03 11.15 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.599 1.16 . . . . 0.0 111.218 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.66 -39.49 68.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.928 0.891 . . . . 0.0 112.872 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -69.23 7.06 0.82 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -172.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -131.78 12.2 4.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.275 0.943 . . . . 0.0 111.935 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.4 mm -87.19 105.97 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -105.31 105.32 51.69 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 123.836 0.854 . . . . 0.0 108.758 -175.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.19 178.69 1.85 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.517 2.145 . . . . 0.0 115.14 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.32 114.96 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 169.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.6 t -107.28 92.34 2.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 124.542 1.137 . . . . 0.0 108.494 -169.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -97.4 138.36 34.97 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.762 2.025 . . . . 0.0 108.476 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.7 mt -136.02 136.09 49.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 C-N-CA 123.49 0.716 . . . . 0.0 109.847 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -128.26 142.62 51.1 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.963 2.105 . . . . 0.0 108.345 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -125.42 158.57 34.05 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.64 1.176 . . . . 0.0 111.463 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.12 161.18 42.06 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 127.389 2.276 . . . . 0.0 109.017 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.72 -66.29 0.14 Allowed Glycine 0 C--N 1.344 0.975 0 C-N-CA 127.144 2.307 . . . . 0.0 113.822 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -124.73 33.06 5.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.885 1.274 . . . . 0.0 109.831 171.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.258 16.4 t70 -140.26 147.62 40.24 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.089 0.859 . . . . 0.0 112.541 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -146.17 134.52 21.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.752 0.821 . . . . 0.0 109.851 -174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.3 t -133.1 127.91 55.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.46 153.25 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 124.027 0.931 . . . . 0.0 108.851 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.0 m -141.21 81.06 1.77 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.5 m -106.33 80.08 1.45 Allowed 'General case' 0 C--N 1.339 0.15 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -107.45 144.43 34.39 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.034 0.934 . . . . 0.0 111.098 -167.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.7 p -127.86 150.93 74.76 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 126.918 2.087 . . . . 0.0 106.457 171.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.61 59.79 4.96 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.596 2.198 . . . . 0.0 109.991 166.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.3 ttt-85 -168.31 -60.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.443 1.097 . . . . 0.0 110.89 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -120.04 173.45 7.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.736 2.014 . . . . 0.0 109.252 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.2 m -137.94 117.18 12.68 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.931 0.892 . . . . 0.0 111.017 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 t -128.31 80.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 170.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -109.27 65.99 0.63 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -69.29 153.4 43.68 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.178 0.591 . . . . 0.0 110.452 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.3 t -154.34 144.15 21.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.292 1.037 . . . . 0.0 108.616 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -161.65 152.48 17.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.948 0.404 . . . . 0.0 110.83 174.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.8 m -81.71 -106.5 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.7 mt -152.92 -75.97 0.13 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 171.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.61 48.48 0.93 Allowed Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.95 -80.33 0.44 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.447 1.099 . . . . 0.0 108.872 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -143.3 162.61 35.22 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.432 1.093 . . . . 0.0 110.329 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.85 123.13 7.73 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.702 0.801 . . . . 0.0 111.484 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -99.69 102.7 14.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.657 1.983 . . . . 0.0 108.079 174.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.5 mm -121.69 124.09 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 t -108.24 -179.14 3.8 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.514 0.725 . . . . 0.0 110.291 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 t -120.36 -177.38 3.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.077 1.351 . . . . 0.0 110.198 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 60.9 mmm -109.45 -91.21 0.45 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.476 1.51 . . . . 0.0 107.141 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -114.18 -35.59 4.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.434 1.494 . . . . 0.0 109.499 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.83 72.32 0.11 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.2 96.59 2.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.023 0.929 . . . . 0.0 109.579 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -115.12 147.54 40.11 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.217 1.007 . . . . 0.0 111.029 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.54 165.88 11.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.669 1.588 . . . . 0.0 109.703 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -155.58 78.12 0.99 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.5 p -159.38 169.62 23.58 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.567 1.147 . . . . 0.0 109.857 -174.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.8 m -115.75 92.11 3.81 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 m -60.07 146.03 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.341 1.056 . . . . 0.0 110.921 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -163.55 -164.22 0.9 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.788 0.835 . . . . 0.0 109.122 -169.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.4 160.4 31.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.641 1.976 . . . . 0.0 107.877 172.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.65 -64.51 1.18 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.249 1.02 . . . . 0.0 109.31 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -132.96 -66.37 0.67 Allowed 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.689 1.196 . . . . 0.0 108.149 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.28 29.1 0.79 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.217 0.913 . . . . 0.0 111.208 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -133.43 135.97 44.91 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.31 1.444 . . . . 0.0 107.212 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.5 mt -72.4 86.41 1.14 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.953 1.301 . . . . 0.0 110.072 -172.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.73 141.22 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 122.832 0.453 . . . . 0.0 111.266 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -131.71 154.3 49.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.798 1.639 . . . . 0.0 107.107 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -70.46 -164.18 0.08 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.005 0.922 . . . . 0.0 110.98 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 36.7 p -75.08 66.73 1.66 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.509 1.124 . . . . 0.0 112.641 -175.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -132.39 126.01 32.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.536 1.534 . . . . 0.0 108.053 172.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.79 52.56 2.06 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.872 0.869 . . . . 0.0 109.281 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.86 28.04 1.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.821 0.849 . . . . 0.0 111.965 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.9 p -170.84 -80.99 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.032 0.933 . . . . 0.0 109.084 -171.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -158.48 175.04 14.2 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.46 1.104 . . . . 0.0 108.35 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -84.71 -135.52 0.05 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -118.46 114.52 23.0 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -147.17 149.1 32.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.082 0.953 . . . . 0.0 108.943 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 p -168.62 165.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.423 1.089 . . . . 0.0 108.774 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.55 156.03 42.43 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.508 0.723 . . . . 0.0 110.148 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -31.34 -55.27 0.31 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 127.234 2.35 . . . . 0.0 114.676 -173.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -136.23 28.37 3.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.465 1.106 . . . . 0.0 110.759 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -145.93 149.71 34.72 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.81 1.244 . . . . 0.0 110.112 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 38.1 mtt -130.02 110.54 11.72 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 m -117.2 50.97 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.357 0.663 . . . . 0.0 110.875 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -86.38 116.55 24.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.835 0.854 . . . . 0.0 109.074 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.2 m -102.21 127.8 49.0 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.7 mt -103.99 88.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 123.519 0.728 . . . . 0.0 109.382 -160.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.5 t -80.35 100.32 8.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.501 1.52 . . . . 0.0 107.838 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -102.06 -136.84 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.914 1.286 . . . . 0.0 108.893 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.9 -72.72 0.9 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.827 0.727 . . . . 0.0 111.488 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -123.06 49.08 0.91 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.1 t -150.81 147.86 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.833 1.653 . . . . 0.0 108.509 -170.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 t -150.63 97.78 2.55 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.58 126.19 51.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.163 0.985 . . . . 0.0 110.335 -163.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mp -79.84 66.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -86.35 141.55 29.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -168.53 143.25 3.35 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.3 p -133.82 151.64 51.62 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.888 1.275 . . . . 0.0 109.083 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -117.46 141.94 47.74 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.192 0.997 . . . . 0.0 109.11 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.0 ttp85 -75.57 147.83 39.34 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.867 176.779 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -81.6 -76.74 0.24 Allowed 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 p -25.48 90.89 0.01 OUTLIER 'General case' 0 C--N 1.342 0.252 0 C-N-CA 128.179 2.591 . . . . 0.0 114.197 -163.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.08 -150.44 9.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.6 p -108.21 142.88 37.79 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.862 1.265 . . . . 0.0 107.891 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -145.7 133.62 21.31 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.838 0.855 . . . . 0.0 110.158 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -139.35 127.03 21.87 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.904 0.882 . . . . 0.0 109.106 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.427 ' CG1' ' HD2' ' A' ' 36' ' ' PRO . 1.9 m -72.76 135.89 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -125.5 -29.86 3.16 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.196 0.31 . . . . 0.0 111.746 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.3 112.77 7.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.495 0.718 . . . . 0.0 110.483 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.23 -160.81 0.77 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -135.8 -101.64 0.22 Allowed 'General case' 0 C--N 1.343 0.283 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.977 170.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -81.21 66.54 6.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.163 0.892 . . . . 0.0 110.66 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.99 -28.34 70.03 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.315 1.046 . . . . 0.0 110.681 -175.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -62.49 -55.59 26.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.212 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -59.67 -39.02 83.11 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -52.95 -52.97 56.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.145 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.12 -29.1 63.74 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.328 1.051 . . . . 0.0 112.696 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -37.76 75.59 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.994 0.816 . . . . 0.0 110.877 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.81 -33.9 76.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.482 0.713 . . . . 0.0 111.618 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.99 156.09 32.14 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.852 0.461 . . . . 0.0 110.485 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.78 35.49 0.84 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.281 1.033 . . . . 0.0 112.169 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 mp -88.58 139.29 29.71 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.61 157.83 54.98 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.587 2.192 . . . . 0.0 110.473 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -62.17 -36.86 83.16 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -166.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -61.16 -48.79 79.96 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.285 0.634 . . . . 0.0 110.206 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -20.18 64.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.701 1.2 . . . . 0.0 110.907 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.8 mt -78.22 -37.0 21.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.896 0.771 . . . . 0.0 110.845 171.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.56 -38.38 80.96 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.0 ttt -63.92 -51.98 61.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.915 1.286 . . . . 0.0 110.52 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.71 -39.89 62.46 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.245 1.418 . . . . 0.0 112.479 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.17 -16.23 19.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.053 1.341 . . . . 0.0 112.306 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -121.14 18.05 11.59 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 mm -79.37 123.52 36.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.09 101.48 30.48 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 168.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.427 ' HD2' ' CG1' ' A' ' 8' ' ' VAL . 92.8 Cg_endo -74.52 179.9 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.402 1.401 . . . . 0.0 111.302 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -131.02 158.63 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 168.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.6 t -132.39 121.8 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 165.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -125.48 95.57 4.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.265 2.226 . . . . 0.0 105.086 -170.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.8 tt -118.5 140.5 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.669 1.188 . . . . 0.0 111.227 -165.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -139.59 143.93 37.52 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.517 1.127 . . . . 0.0 109.742 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.48 147.36 31.79 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.908 1.283 . . . . 0.0 111.117 -175.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -135.49 163.47 30.01 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 129.05 2.94 . . . . 0.0 107.456 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -20.5 -72.24 0.01 OUTLIER Glycine 0 C--N 1.344 0.982 0 C-N-CA 127.618 2.533 . . . . 0.0 114.338 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -127.19 30.87 5.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.526 1.531 . . . . 0.0 109.32 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -131.43 152.32 50.77 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.523 0.601 . . . . 0.0 112.107 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -138.03 130.58 29.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.022 0.929 . . . . 0.0 109.837 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.14 127.46 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.2 t -127.8 109.37 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.243 1.417 . . . . 0.0 109.491 -173.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -107.43 102.15 11.45 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.496 1.118 . . . . 0.0 108.096 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 t -105.7 111.34 23.98 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -108.25 129.05 55.22 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.331 0.653 . . . . 0.0 109.909 -171.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 p -134.55 150.0 72.5 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 126.161 1.784 . . . . 0.0 107.957 171.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.52 73.93 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.768 2.979 . . . . 0.0 109.56 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -167.63 -52.16 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.786 1.634 . . . . 0.0 108.137 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.14 150.41 11.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.632 1.173 . . . . 0.0 107.878 176.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.4 p -80.1 94.84 6.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.6 72.57 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.5 m -97.65 128.76 44.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.29 1.436 . . . . 0.0 108.489 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -145.35 162.62 36.81 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.746 1.218 . . . . 0.0 107.997 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.3 m -150.68 141.53 22.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.36 137.44 27.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.917 0.487 . . . . 0.0 110.618 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.0 m -98.47 141.59 31.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.757 1.223 . . . . 0.0 107.856 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.6 mt -68.09 -57.71 5.66 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.804 0.842 . . . . 0.0 110.634 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.34 57.9 4.66 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -169.58 138.58 1.93 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.736 1.614 . . . . 0.0 107.172 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -58.5 129.08 40.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.047 0.539 . . . . 0.0 109.71 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.22 157.0 47.37 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.659 1.183 . . . . 0.0 110.628 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -144.99 158.98 43.64 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.222 1.409 . . . . 0.0 108.845 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.1 mm -105.95 148.9 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 125.457 1.503 . . . . 0.0 109.694 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.8 m -105.54 153.85 21.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.851 1.66 . . . . 0.0 109.891 -171.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 m -44.67 142.73 1.59 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.764 2.026 . . . . 0.0 112.727 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.16 176.82 8.14 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.835 1.254 . . . . 0.0 110.242 -172.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.64 -73.34 0.68 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.492 1.517 . . . . 0.0 107.78 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.01 95.59 0.16 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -157.99 -54.66 0.07 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -132.54 178.68 6.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.539 1.536 . . . . 0.0 109.907 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tp -150.01 149.08 29.84 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.713 1.205 . . . . 0.0 108.956 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -70.65 101.97 2.18 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.0 p -144.05 -170.47 3.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.351 1.46 . . . . 0.0 109.531 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.6 m -107.36 110.49 22.5 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.308 1.043 . . . . 0.0 108.805 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.4 m -78.34 136.78 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.287 0.635 . . . . 0.0 110.658 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -165.66 118.47 1.14 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.323 1.049 . . . . 0.0 109.257 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -109.32 131.42 55.09 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 172.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.96 -67.58 0.9 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.11 62.79 0.23 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.29 -87.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -128.94 159.27 36.37 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.259 1.423 . . . . 0.0 108.895 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 tt -74.16 81.79 1.79 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.112 0.965 . . . . 0.0 108.77 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.7 p -74.51 142.76 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.518 0.727 . . . . 0.0 110.235 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.0 t -165.36 174.23 10.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.322 1.449 . . . . 0.0 108.218 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -148.32 152.73 37.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.838 0.855 . . . . 0.0 110.658 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 99.4 p -164.24 -144.58 0.08 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.975 1.31 . . . . 0.0 108.625 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -82.52 -151.53 0.1 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.945 1.298 . . . . 0.0 110.153 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -77.75 65.47 3.22 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.031 1.332 . . . . 0.0 110.523 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -147.38 149.98 33.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.361 1.464 . . . . 0.0 108.746 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.0 t -152.93 103.32 2.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -59.65 -38.34 81.16 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.408 1.083 . . . . 0.0 110.913 173.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -155.66 150.48 26.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.588 1.155 . . . . 0.0 108.631 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -115.85 -55.14 2.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.369 1.068 . . . . 0.0 108.921 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.43 153.72 42.21 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.638 0.775 . . . . 0.0 111.094 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.7 t -139.86 142.18 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.897 1.679 . . . . 0.0 107.02 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -105.83 154.21 20.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -41.34 -38.33 1.95 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.554 1.549 . . . . 0.0 115.018 -172.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.28 40.15 1.92 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.91 0.884 . . . . 0.0 110.681 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -167.15 116.18 0.84 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.608 0.763 . . . . 0.0 110.496 173.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -99.69 127.05 45.81 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 169.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.11 173.58 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.871 0.869 . . . . 0.0 112.765 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -43.13 88.06 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.803 2.841 . . . . 0.0 115.826 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.8 t -165.43 131.0 2.57 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 tp -172.54 121.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.546 1.938 . . . . 0.0 106.802 167.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 m -112.0 125.81 54.47 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -129.35 161.96 29.08 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.936 1.294 . . . . 0.0 109.766 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -2.94 -74.93 0.01 OUTLIER Glycine 0 C--N 1.346 1.129 0 C-N-CA 129.249 3.309 . . . . 0.0 115.693 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -144.11 47.79 0.76 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.0 p -165.69 131.69 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -127.32 135.8 51.05 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.06 158.17 28.43 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.97 1.308 . . . . 0.0 110.46 -169.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 mp -97.71 113.97 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 172.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 tpt85 -123.26 114.02 19.68 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.235 1.414 . . . . 0.0 109.431 -174.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -111.11 110.95 21.71 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.902 0.881 . . . . 0.0 109.452 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.4 p -114.63 130.3 56.78 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 122.1 0.953 . . . . 0.0 109.504 169.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -113.91 143.82 44.07 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -173.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.25 165.67 11.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.162 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.033 -1.936 . . . . 0.0 108.352 178.813 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.44 113.83 26.2 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.87 0.468 . . . . 0.0 110.761 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 t -138.57 40.99 2.21 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.445 1.098 . . . . 0.0 108.753 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.98 172.55 53.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.257 0.932 . . . . 0.0 113.74 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 m -148.85 109.44 4.21 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -143.21 157.72 44.25 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.141 1.376 . . . . 0.0 111.121 -166.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -139.95 134.43 31.54 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 124.066 0.947 . . . . 0.0 111.073 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.5 150.81 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 127.029 2.132 . . . . 0.0 112.103 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -146.3 -6.85 0.55 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 163.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -152.64 76.65 1.15 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.776 0.43 . . . . 0.0 110.142 -164.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.75 103.2 15.1 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -77.89 0.06 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.54 1.136 . . . . 0.0 113.043 -171.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -85.48 51.1 2.1 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.866 0.866 . . . . 0.0 111.122 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -43.5 77.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.54 1.136 . . . . 0.0 111.777 -168.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.9 -38.8 92.41 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.874 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -61.88 -48.21 81.53 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.507 0.594 . . . . 0.0 110.783 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -55.92 -47.16 78.01 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.141 1.376 . . . . 0.0 111.406 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.25 -43.08 74.7 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.143 0.577 . . . . 0.0 112.301 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -78.92 67.99 4.76 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.111 0.964 . . . . 0.0 109.963 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.05 -44.88 0.06 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.176 1.79 . . . . 0.0 108.614 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.07 147.69 27.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.67 52.32 2.36 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.755 1.222 . . . . 0.0 112.674 -162.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mt -92.01 147.16 34.24 Favored Pre-proline 0 N--CA 1.453 -0.275 0 C-N-CA 124.518 1.127 . . . . 0.0 108.758 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.46 151.8 48.2 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.323 2.015 . . . . 0.0 109.559 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -62.24 -28.77 69.93 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -170.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -63.11 -44.97 94.18 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.345 0.52 . . . . 0.0 110.548 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.81 -41.78 99.44 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.24 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.53 -34.47 61.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 118.525 0.602 . . . . 0.0 111.377 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.91 -44.08 73.88 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.765 0.711 . . . . 0.0 110.469 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.56 -47.09 57.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.827 0.851 . . . . 0.0 110.643 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.41 -46.2 73.11 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 111.823 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -65.59 -30.56 71.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.186 2.194 . . . . 0.0 110.818 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -108.17 50.71 0.77 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.363 1.465 . . . . 0.0 108.984 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.39 150.91 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.068 1.347 . . . . 0.0 109.118 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -128.2 99.91 24.09 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.099 1.359 . . . . 0.0 109.756 -170.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.86 160.13 50.37 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.062 2.508 . . . . 0.0 113.78 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.3 pt -105.6 170.97 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.1 t -141.25 103.73 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -123.69 101.21 7.17 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.204 2.602 . . . . 0.0 106.053 -167.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.6 mt -108.87 150.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.526 0.731 . . . . 0.0 110.031 -171.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -134.25 119.74 19.12 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.051 1.34 . . . . 0.0 108.716 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -83.9 153.28 24.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.72 1.608 . . . . 0.0 109.425 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.34 152.99 10.99 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.984 1.714 . . . . 0.0 108.235 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -20.6 -69.77 0.01 OUTLIER Glycine 0 C--N 1.344 0.99 0 C-N-CA 127.733 2.587 . . . . 0.0 113.969 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -125.94 20.71 7.64 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.786 1.235 . . . . 0.0 110.568 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.35 134.26 55.03 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.409 1.004 . . . . 0.0 109.887 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -134.42 101.31 4.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.5 t -107.98 116.18 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -174.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 p -111.91 125.06 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.522 1.129 . . . . 0.0 109.72 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 m -107.52 95.11 5.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 t -107.82 63.15 0.62 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -102.14 162.55 12.83 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.343 0.657 . . . . 0.0 110.314 -170.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.54 162.36 55.26 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.476 1.111 . . . . 0.0 108.341 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.04 51.37 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.461 2.774 . . . . 0.0 111.433 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 178.57 -58.6 0.01 OUTLIER 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.19 1.796 . . . . 0.0 109.013 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -95.66 155.83 16.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.137 1.375 . . . . 0.0 109.571 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.6 p -132.44 109.61 9.94 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.819 0.848 . . . . 0.0 110.672 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -129.76 87.86 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.6 m -110.26 136.73 49.01 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 171.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -137.02 150.81 48.33 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.2 p -144.05 94.25 2.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.9 0.88 . . . . 0.0 108.781 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.76 104.32 14.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.1 m -76.68 126.77 31.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 164.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.7 mt -57.46 -56.43 21.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.774 0.829 . . . . 0.0 111.376 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.51 53.66 4.85 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -167.16 148.44 5.77 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.885 0.874 . . . . 0.0 109.387 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -53.67 107.08 0.22 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.345 1.458 . . . . 0.0 108.896 170.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.53 58.98 0.64 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.237 0.615 . . . . 0.0 110.951 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -100.3 101.12 12.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 171.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.52 143.22 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 125.227 1.411 . . . . 0.0 107.801 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.4 t -158.8 152.2 22.83 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.124 0.97 . . . . 0.0 109.322 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 t -167.84 -47.06 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.098 1.359 . . . . 0.0 108.988 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -75.6 165.44 25.07 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.382 1.073 . . . . 0.0 108.851 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.28 74.24 1.73 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.706 0.802 . . . . 0.0 109.025 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.21 58.54 0.1 OUTLIER Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.051 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.48 91.75 1.93 Allowed 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -124.93 58.2 1.26 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.353 1.061 . . . . 0.0 109.58 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.76 173.01 17.21 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.349 1.06 . . . . 0.0 110.369 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -116.72 143.06 46.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.323 1.449 . . . . 0.0 108.321 172.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.3 p -163.17 164.48 25.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.331 1.052 . . . . 0.0 109.314 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 88.2 m -135.37 108.01 7.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.2 137.5 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.83 169.87 21.19 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.734 0.413 . . . . 0.0 110.556 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -137.12 136.39 38.25 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.451 1.5 . . . . 0.0 107.609 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.57 -60.3 1.59 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.566 1.146 . . . . 0.0 108.972 -176.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -161.79 -57.42 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.602 0.761 . . . . 0.0 109.629 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.51 -59.47 8.76 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.896 0.76 . . . . 0.0 112.167 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -158.85 172.98 17.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.55 1.14 . . . . 0.0 109.068 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.84 162.35 20.59 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.999 0.52 . . . . 0.0 112.276 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.98 144.21 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.324 1.449 . . . . 0.0 108.901 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.7 m -114.45 -66.45 1.09 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.593 1.557 . . . . 0.0 109.224 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -165.59 159.43 16.58 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.22 1.408 . . . . 0.0 107.673 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.5 p -62.69 170.25 2.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.643 1.177 . . . . 0.0 112.751 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -50.84 106.42 0.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.373 1.469 . . . . 0.0 112.091 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.7 mttm 179.11 -55.9 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 126.62 1.968 . . . . 0.0 106.99 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -77.39 -55.09 5.69 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.942 1.297 . . . . 0.0 110.888 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.2 m -157.71 -37.63 0.07 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.274 -0.87 . . . . 0.0 113.229 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 9.16 80.63 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.294 2.237 . . . . 0.0 113.574 -159.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -128.05 93.97 3.81 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.721 2.008 . . . . 0.0 107.031 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -151.26 74.84 1.16 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.742 0.817 . . . . 0.0 111.472 -172.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -176.66 129.86 0.19 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.044 1.338 . . . . 0.0 109.023 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.53 155.81 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.9 0.88 . . . . 0.0 108.694 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -114.13 160.18 19.23 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.921 1.288 . . . . 0.0 109.282 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -31.05 -56.07 0.28 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 127.533 2.492 . . . . 0.0 115.056 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -128.58 29.56 5.27 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.976 0.911 . . . . 0.0 111.772 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.55 107.07 3.78 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.14 0.427 . . . . 0.0 110.598 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 40.1 ttm -84.46 86.79 7.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.6 m -123.78 122.96 65.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.122 1.369 . . . . 0.0 109.294 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.44 175.59 3.53 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.318 1.047 . . . . 0.0 109.029 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.2 p -106.43 152.68 23.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.361 1.065 . . . . 0.0 110.304 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.5 mt -104.2 106.9 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 m -89.81 99.71 12.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -123.86 -179.86 4.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.539 1.536 . . . . 0.0 109.552 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -46.96 117.25 2.94 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 125.063 1.316 . . . . 0.0 110.77 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 8.11 59.26 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 128.361 2.886 . . . . 0.0 114.875 -156.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.0 t -140.85 144.75 26.41 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 126.008 1.723 . . . . 0.0 108.759 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.0 m -136.31 101.55 4.71 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.02 102.85 12.32 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.97 98.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.243 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 168.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -98.96 105.32 17.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.7 ttt85 -108.26 111.7 23.8 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 -173.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.3 t -124.6 149.92 46.54 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.201 1.8 . . . . 0.0 108.716 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -125.23 146.16 49.65 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.825 1.25 . . . . 0.0 109.693 -170.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.75 148.57 42.46 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.061 0.944 . . . . 0.0 111.004 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--O 1.25 1.087 0 CA-C-O 117.46 -1.257 . . . . 0.0 110.501 175.313 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 111.077 0.028 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -49.49 53.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.043 0.537 . . . . 0.0 110.942 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.1 p -38.01 108.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.654 1.982 . . . . 0.0 113.367 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.01 -179.17 46.47 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.3 t -107.57 134.42 50.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.019 1.328 . . . . 0.0 107.639 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -133.66 118.76 18.54 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.432 0.693 . . . . 0.0 110.209 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -102.75 93.43 5.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.971 1.308 . . . . 0.0 109.539 -172.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.477 ' CG1' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -53.95 129.37 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.069 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -145.62 10.06 1.21 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.37 0.419 . . . . 0.0 111.784 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -161.33 105.76 1.31 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 122.7 0.4 . . . . 0.0 110.238 -161.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.66 -167.16 1.48 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.18 1.392 . . . . 0.0 108.591 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -135.52 -104.24 0.22 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.966 0.803 . . . . 0.0 111.141 -174.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -75.46 67.62 2.02 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.219 1.008 . . . . 0.0 109.356 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -81.52 -45.31 16.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.166 0.586 . . . . 0.0 112.412 -169.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.0 -43.38 91.5 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.383 0.538 . . . . 0.0 110.468 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -61.0 -50.93 71.37 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.527 1.131 . . . . 0.0 110.44 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -56.64 -49.06 76.11 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.097 0.959 . . . . 0.0 110.134 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -58.75 -46.38 87.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.269 1.028 . . . . 0.0 111.667 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -65.79 -24.42 66.92 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.287 0.635 . . . . 0.0 111.83 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.35 -23.99 60.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.613 0.765 . . . . 0.0 111.03 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.0 mt -84.14 -162.12 0.62 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.97 41.57 2.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.045 0.938 . . . . 0.0 111.381 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.0 127.8 31.16 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.3 164.86 33.17 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.582 2.854 . . . . 0.0 113.615 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -59.48 -44.95 92.92 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.11 1.764 . . . . 0.0 112.514 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -54.58 -46.63 73.76 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.486 0.714 . . . . 0.0 110.577 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.29 -43.43 86.34 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.501 -0.762 . . . . 0.0 109.986 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.35 -41.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 CA-C-N 118.747 0.703 . . . . 0.0 111.618 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -42.96 -43.35 4.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.129 1.372 . . . . 0.0 111.44 173.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 19.7 mmt -102.11 -1.88 30.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.938 1.695 . . . . 0.0 112.536 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.56 -51.04 6.13 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.766 1.226 . . . . 0.0 110.704 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -56.83 -39.83 74.94 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.402 0.681 . . . . 0.0 111.471 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.65 -37.28 79.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.11 1.364 . . . . 0.0 111.55 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -51.14 142.62 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.503 1.121 . . . . 0.0 111.74 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -119.08 98.39 50.85 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 125.43 1.492 . . . . 0.0 107.209 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HD2' ' CG1' ' A' ' 8' ' ' VAL . 17.0 Cg_exo -63.57 176.09 2.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.803 2.335 . . . . 0.0 112.396 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.67 131.36 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 169.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.2 t -113.08 96.58 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -103.88 101.31 11.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.869 2.067 . . . . 0.0 107.778 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.46 138.36 32.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -173.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -141.42 131.5 24.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.455 1.102 . . . . 0.0 108.994 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -104.15 150.66 24.15 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.441 1.497 . . . . 0.0 110.053 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -152.38 155.4 37.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.394 1.878 . . . . 0.0 108.863 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -21.1 -68.18 0.01 OUTLIER Glycine 0 C--N 1.345 1.035 0 C-N-CA 127.563 2.506 . . . . 0.0 114.115 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -123.81 12.96 9.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.946 1.298 . . . . 0.0 110.893 172.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -114.38 143.53 44.76 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.334 0.97 . . . . 0.0 110.09 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -141.55 110.17 6.06 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.0 t -108.25 122.21 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.883 1.273 . . . . 0.0 108.599 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.15 104.52 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.01 1.324 . . . . 0.0 107.786 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.8 m -101.3 82.8 2.38 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.8 p -102.93 98.96 8.85 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -137.37 140.02 41.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.314 -162.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 p -130.38 157.02 78.62 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 126.277 1.831 . . . . 0.0 106.873 167.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.26 60.67 6.41 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.167 2.578 . . . . 0.0 108.707 168.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -169.84 -67.57 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.639 1.176 . . . . 0.0 109.66 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -106.83 156.31 18.81 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.864 1.266 . . . . 0.0 110.07 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -123.15 70.17 1.02 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.219 1.408 . . . . 0.0 108.731 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.3 t -71.95 -46.75 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -6.48 106.11 0.01 OUTLIER 'General case' 0 C--N 1.345 0.408 0 C-N-CA 129.386 3.074 . . . . 0.0 114.244 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -104.81 156.74 17.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.728 1.211 . . . . 0.0 109.693 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.1 t -158.94 95.18 1.27 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.45 163.7 22.07 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.639 0.776 . . . . 0.0 111.297 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.8 m -133.46 150.77 51.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.89 1.676 . . . . 0.0 107.191 -176.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.3 mt -65.46 -60.15 3.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.474 0.31 . . . . 0.0 111.479 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.3 47.75 1.01 Allowed Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.317 0.96 . . . . 0.0 111.122 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -164.99 144.09 6.73 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -57.13 165.14 1.42 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.843 1.257 . . . . 0.0 112.591 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.22 98.79 2.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.504 0.721 . . . . 0.0 109.46 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -89.47 83.34 6.35 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.413 1.085 . . . . 0.0 109.899 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.93 167.02 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 125.345 1.458 . . . . 0.0 109.695 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.2 t -162.2 176.01 11.08 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.013 0.925 . . . . 0.0 110.053 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 t -113.49 121.28 43.78 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.241 1.416 . . . . 0.0 108.223 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.45 85.23 7.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -169.71 -70.03 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.099 0.959 . . . . 0.0 111.514 174.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.39 -119.19 3.24 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 124.748 1.166 . . . . 0.0 111.094 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -108.46 171.79 7.22 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.787 1.235 . . . . 0.0 109.158 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -154.69 131.07 10.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.924 0.89 . . . . 0.0 108.834 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.19 136.28 48.14 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.859 1.263 . . . . 0.0 109.399 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -147.81 124.32 11.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.2 t -106.98 -65.78 1.07 Allowed 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -150.7 127.61 11.06 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.1 m -104.26 49.75 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.275 1.43 . . . . 0.0 110.06 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -91.45 -179.28 5.34 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.399 1.079 . . . . 0.0 111.349 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -154.85 139.96 17.46 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.741 2.017 . . . . 0.0 106.796 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.45 -72.11 0.73 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.821 0.848 . . . . 0.0 110.093 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -95.39 -67.84 0.83 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.877 0.871 . . . . 0.0 110.248 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.64 48.49 0.22 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -158.96 128.92 5.74 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.379 1.072 . . . . 0.0 109.337 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.04 135.64 51.24 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.976 1.31 . . . . 0.0 109.872 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.5 p -158.7 154.56 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.05 1.34 . . . . 0.0 108.545 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.5 m -135.37 127.58 30.05 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.516 1.126 . . . . 0.0 108.253 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.6 88.63 2.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.922 0.889 . . . . 0.0 110.36 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.2 m -130.46 83.76 2.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.944 1.298 . . . . 0.0 109.235 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.04 76.67 2.9 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.0 -52.97 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 126.822 2.049 . . . . 0.0 106.897 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -98.95 91.81 5.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.546 1.539 . . . . 0.0 107.504 171.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -99.8 118.72 36.88 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.992 0.917 . . . . 0.0 109.441 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -126.21 103.76 7.86 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.394 1.077 . . . . 0.0 109.001 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -69.89 134.39 48.38 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -108.61 49.2 0.82 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.463 1.105 . . . . 0.0 110.767 -171.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -81.3 83.66 6.82 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.4 p -108.27 128.55 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.346 1.458 . . . . 0.0 108.971 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -122.06 156.5 33.41 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.11 1.364 . . . . 0.0 109.075 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -26.13 -60.39 0.08 OUTLIER Glycine 0 CA--C 1.53 1.013 0 C-N-CA 127.562 2.505 . . . . 0.0 115.487 -173.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -131.51 28.24 4.65 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.848 0.859 . . . . 0.0 111.571 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -155.35 119.5 4.61 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 41.8 ttm -106.12 115.22 29.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.03 61.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.844 1.258 . . . . 0.0 108.69 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -73.08 165.37 25.15 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.06 0.944 . . . . 0.0 110.952 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m -131.44 96.88 4.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 173.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 pp -106.65 134.91 46.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 94.2 m -129.83 137.76 50.63 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.039 1.336 . . . . 0.0 111.046 -167.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -108.34 179.45 4.2 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.199 2.2 . . . . 0.0 107.594 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -18.95 -56.55 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 128.139 2.78 . . . . 0.0 115.334 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -155.05 36.01 0.66 Allowed Glycine 0 CA--C 1.532 1.116 0 CA-C-O 118.689 -1.062 . . . . 0.0 114.072 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -146.26 151.61 14.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.32 0 CA-C-N 118.778 1.289 . . . . 0.0 109.037 170.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 87.3 m -128.53 142.95 50.91 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.423 1.489 . . . . 0.0 110.254 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -108.43 146.88 32.43 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.8 tp -80.17 63.35 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 170.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -52.23 97.3 0.02 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 126.19 1.796 . . . . 0.0 111.56 -170.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -125.32 113.68 17.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.919 0.887 . . . . 0.0 110.124 -169.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 56.4 p -126.36 144.68 50.73 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.505 1.522 . . . . 0.0 109.692 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -114.39 142.34 46.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.398 1.479 . . . . 0.0 108.952 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.66 98.59 6.26 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.7 t . . . . . 0 C--O 1.252 1.199 0 CA-C-O 116.494 -1.717 . . . . 0.0 107.144 175.394 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 111.213 0.079 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -77.24 -37.22 53.65 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.017 0.527 . . . . 0.0 110.376 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 p -50.32 95.5 0.01 OUTLIER 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.303 1.841 . . . . 0.0 112.198 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.73 -171.38 44.45 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -106.83 142.38 36.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 168.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -142.41 124.47 15.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.178 0.991 . . . . 0.0 109.387 -169.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -119.78 112.11 18.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.096 0.958 . . . . 0.0 109.239 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.44 ' CG1' ' HD2' ' A' ' 36' ' ' PRO . 1.4 p -63.94 121.46 12.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 C-N-CA 124.109 0.964 . . . . 0.0 109.853 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -113.65 -24.22 9.32 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.538 0.735 . . . . 0.0 110.981 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.63 143.87 28.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.272 1.429 . . . . 0.0 108.113 -169.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.99 162.89 34.33 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.48 -100.93 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.283 0.633 . . . . 0.0 110.869 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -106.97 65.05 0.65 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.546 1.138 . . . . 0.0 110.532 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.0 -41.5 99.6 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.013 0.525 . . . . 0.0 111.16 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -58.35 -24.55 60.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 119.026 -0.511 . . . . 0.0 112.017 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -88.45 -38.78 14.75 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 123.093 0.557 . . . . 0.0 111.89 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -46.14 -41.53 12.63 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.073 0.949 . . . . 0.0 110.49 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.447 ' CD1' HG22 ' A' ' 28' ' ' ILE . 7.6 mt -78.61 40.16 0.37 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.107 1.763 . . . . 0.0 112.77 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.4 -33.31 1.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.188 0.904 . . . . 0.0 111.852 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.7 98.38 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.239 0.616 . . . . 0.0 110.579 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.53 168.26 20.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.126 0.97 . . . . 0.0 110.713 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.74 60.28 0.64 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.698 1.199 . . . . 0.0 111.183 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 mp -103.23 148.47 35.72 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.685 1.194 . . . . 0.0 108.583 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.88 158.01 59.23 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.385 2.723 . . . . 0.0 111.52 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.08 -35.21 69.1 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.53 -35.52 80.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.368 0.667 . . . . 0.0 111.677 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -24.55 64.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.562 0.745 . . . . 0.0 112.219 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.447 HG22 ' CD1' ' A' ' 18' ' ' LEU . 3.9 mp -70.54 -39.49 76.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -55.65 -52.33 64.18 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 16.4 mmt -83.77 47.18 1.26 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.331 1.052 . . . . 0.0 110.571 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -151.52 -58.67 0.16 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.757 1.623 . . . . 0.0 109.42 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.1 ptt85 -69.79 -37.31 76.27 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 122.244 -0.285 . . . . 0.0 111.31 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -83.79 37.27 0.58 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.767 0.827 . . . . 0.0 110.424 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.5 mm -130.62 117.31 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.1 96.7 39.84 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.818 1.247 . . . . 0.0 107.764 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.44 ' HD2' ' CG1' ' A' ' 8' ' ' VAL . 8.3 Cg_exo -72.52 164.85 34.39 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.743 2.295 . . . . 0.0 112.698 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.13 117.18 53.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 166.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.95 140.23 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -148.64 100.32 3.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.065 0.946 . . . . 0.0 109.161 -165.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 mt -108.87 135.7 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.593 0.757 . . . . 0.0 109.624 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -125.05 133.28 53.0 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.15 1.38 . . . . 0.0 108.286 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.1 150.66 21.8 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.448 1.099 . . . . 0.0 110.465 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -140.19 154.13 46.83 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 127.735 2.414 . . . . 0.0 106.729 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.93 -55.28 2.31 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.21 1.386 . . . . 0.0 112.499 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -129.84 61.57 1.57 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.739 1.615 . . . . 0.0 109.194 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.4 155.42 17.66 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.246 0.546 . . . . 0.0 110.789 163.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -139.54 111.85 7.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.841 1.656 . . . . 0.0 106.986 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 80.9 t -106.17 127.72 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -127.42 119.79 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.436 1.094 . . . . 0.0 109.207 -171.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.1 m -107.93 141.08 40.09 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.607 1.563 . . . . 0.0 107.522 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.4 t -148.54 87.43 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.146 1.378 . . . . 0.0 107.353 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 120.21 41.33 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.925 0.89 . . . . 0.0 108.844 -170.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 p -101.19 153.8 37.57 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 124.519 1.127 . . . . 0.0 110.041 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.85 51.29 3.33 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.232 2.621 . . . . 0.0 110.418 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -167.09 -48.41 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.694 1.197 . . . . 0.0 110.441 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -130.59 -166.16 1.65 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.647 1.579 . . . . 0.0 108.903 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.8 m -155.27 130.59 9.63 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.48 1.112 . . . . 0.0 108.222 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -133.12 136.03 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.1 m -152.93 141.87 21.21 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.779 1.232 . . . . 0.0 107.894 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -145.84 166.42 26.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.247 1.419 . . . . 0.0 109.473 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.0 p -157.13 141.87 16.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.845 0.858 . . . . 0.0 109.436 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -169.44 167.32 9.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.533 1.133 . . . . 0.0 108.826 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 m -133.02 164.76 26.28 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.842 0.857 . . . . 0.0 110.294 -167.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.48 -58.85 5.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.286 1.035 . . . . 0.0 110.62 175.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.46 36.18 4.39 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.84 1.21 . . . . 0.0 113.564 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -130.24 128.61 41.99 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.862 1.331 . . . . 0.0 109.236 167.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -66.77 133.17 49.61 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.41 0.684 . . . . 0.0 109.463 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -161.15 107.78 1.43 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.097 0.959 . . . . 0.0 109.575 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.86 150.03 44.64 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.22 0.464 . . . . 0.0 110.027 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.7 mm -108.37 111.59 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.277 1.031 . . . . 0.0 108.483 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.9 t -107.39 155.04 20.45 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.491 1.116 . . . . 0.0 111.032 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.6 p -138.12 137.25 37.51 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.8 1.24 . . . . 0.0 109.023 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.7 ptp -88.44 82.36 7.0 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.371 1.068 . . . . 0.0 110.412 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -155.51 -93.56 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.152 0.581 . . . . 0.0 110.934 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.34 -31.5 0.1 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.465 1.507 . . . . 0.0 111.904 -174.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.06 124.79 7.15 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.953 1.376 . . . . 0.0 111.406 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -94.55 131.38 40.34 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.27 0.628 . . . . 0.0 109.323 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.1 tt -157.51 73.42 0.71 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 171.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -141.9 149.77 40.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.688 1.195 . . . . 0.0 108.513 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -136.89 119.84 16.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.4 m -146.37 71.31 1.24 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.6 m -131.08 -65.24 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.141 0.576 . . . . 0.0 111.315 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -99.51 130.72 45.79 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.189 1.396 . . . . 0.0 110.817 -169.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -125.75 119.04 26.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.773 1.629 . . . . 0.0 107.481 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.98 -53.63 0.48 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.015 0.926 . . . . 0.0 109.901 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -66.86 -60.09 2.97 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.249 0.619 . . . . 0.0 110.58 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.2 -48.69 0.1 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.03 110.46 22.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.5 119.51 7.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.431 1.092 . . . . 0.0 111.216 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.0 p -160.11 162.14 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.875 0.87 . . . . 0.0 109.861 -173.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 m -145.86 -38.5 0.24 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.544 1.138 . . . . 0.0 110.028 173.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -139.68 141.19 37.0 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 125.745 1.618 . . . . 0.0 107.787 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.5 t -168.28 67.56 0.07 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.514 1.126 . . . . 0.0 108.463 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -89.35 -99.49 0.09 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.77 0.828 . . . . 0.0 111.085 -173.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -73.57 -48.97 28.8 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -76.43 74.74 3.19 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.0 m -72.93 93.88 1.78 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -90.43 -16.36 29.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.848 1.259 . . . . 0.0 111.672 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.72 136.84 58.15 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.232 0.613 . . . . 0.0 109.883 -172.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.87 169.07 18.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.149 0.98 . . . . 0.0 110.548 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -123.16 146.38 47.82 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.814 1.646 . . . . 0.0 107.915 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.6 t -139.25 124.94 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -121.51 -173.95 2.75 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.664 1.186 . . . . 0.0 109.506 -169.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -39.3 116.49 0.62 Allowed Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.845 1.688 . . . . 0.0 111.593 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 p30 8.19 56.77 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.835 2.854 . . . . 0.0 115.195 -163.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -158.6 133.74 8.49 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.47 0.708 . . . . 0.0 110.372 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.8 ttt -129.41 129.65 44.97 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.903 2.081 . . . . 0.0 106.032 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.55 -72.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -53.48 142.18 22.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.716 0.806 . . . . 0.0 109.635 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.5 m -139.05 -88.72 0.21 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.869 -175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.75 149.21 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.276 0.944 . . . . 0.0 110.353 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 t -123.02 142.54 50.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.133 0.973 . . . . 0.0 109.485 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -109.26 -164.98 0.98 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.848 1.659 . . . . 0.0 108.383 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.71 -58.93 12.0 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 123.87 0.748 . . . . 0.0 113.255 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -131.55 42.29 1.41 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 123.876 0.75 . . . . 0.0 112.014 -175.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.8 p -169.31 157.86 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 125.481 1.512 . . . . 0.0 107.461 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.9 t -151.5 152.28 32.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -149.07 79.65 1.41 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.294 0.569 . . . . 0.0 112.158 -168.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.22 126.47 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 161.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -112.16 124.83 53.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -102.32 98.69 8.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 82.9 p -106.93 135.59 48.23 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.64 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -108.12 138.59 44.13 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -98.7 131.9 44.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.11 1.364 . . . . 0.0 108.971 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 C--O 1.25 1.094 0 C-N-CA 125.145 1.378 . . . . 0.0 107.914 -176.7 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 119.278 -0.391 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.7 p -60.07 92.36 0.02 OUTLIER 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.797 1.239 . . . . 0.0 110.946 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.98 -170.27 42.46 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.4 t -106.5 144.53 33.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.288 1.035 . . . . 0.0 108.221 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -141.58 126.84 18.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.691 0.796 . . . . 0.0 110.917 -171.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -126.45 115.89 20.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.701 0.8 . . . . 0.0 109.189 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.484 HG11 ' HD2' ' A' ' 36' ' ' PRO . 8.3 p -50.93 143.82 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.89 1.676 . . . . 0.0 110.4 170.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -146.1 -5.52 0.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 121' ' ' ARG . . . -166.21 91.24 0.45 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -164.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.64 94.73 4.82 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.988 1.315 . . . . 0.0 107.639 174.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -55.52 -76.66 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.286 1.434 . . . . 0.0 112.133 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -85.2 59.39 5.6 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.066 0.946 . . . . 0.0 111.152 -172.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -67.14 0.43 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.541 0.737 . . . . 0.0 111.905 -173.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -53.01 -41.2 64.43 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.051 0.94 . . . . 0.0 112.541 -169.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -60.55 -53.72 54.08 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.308 0.643 . . . . 0.0 110.958 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -46.12 80.47 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.06 0.944 . . . . 0.0 109.883 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.608 HD21 HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -56.6 -46.26 80.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.785 1.234 . . . . 0.0 110.835 176.426 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -27.77 69.43 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.308 0.643 . . . . 0.0 111.838 -171.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.21 -31.6 71.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.005 0.522 . . . . 0.0 111.627 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.45 163.93 23.42 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.654 0.781 . . . . 0.0 109.793 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.4 52.04 1.36 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 111.998 -172.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.17 137.54 22.14 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.68 162.73 29.81 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.276 2.65 . . . . 0.0 111.97 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.88 -42.69 72.4 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.246 1.418 . . . . 0.0 113.511 -172.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -61.43 -44.61 96.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.37 0.668 . . . . 0.0 110.622 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.78 -35.15 79.67 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.646 -0.692 . . . . 0.0 110.482 171.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.608 HG12 HD21 ' A' ' 18' ' ' LEU . 78.5 mt -63.71 -31.25 52.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 119.245 0.93 . . . . 0.0 112.688 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.57 -48.7 10.31 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 168.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.4 mmt -75.71 -48.68 20.89 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.543 0.737 . . . . 0.0 111.048 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB3' ' HA ' ' A' ' 28' ' ' ILE . . . -66.42 78.9 0.1 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 125.793 1.637 . . . . 0.0 111.355 -173.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 179.03 -42.14 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.301 2.24 . . . . 0.0 107.11 -171.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -107.14 -0.38 22.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.187 1.795 . . . . 0.0 112.118 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.7 mt -62.99 117.21 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 118.99 0.813 . . . . 0.0 109.554 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -108.53 98.59 28.97 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.761 1.225 . . . . 0.0 108.943 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.484 ' HD2' HG11 ' A' ' 8' ' ' VAL . 91.8 Cg_endo -72.26 140.38 33.79 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.603 2.202 . . . . 0.0 113.83 175.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.75 137.66 37.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 166.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.24 145.65 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.743 1.217 . . . . 0.0 108.035 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 105.24 3.67 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.906 0.882 . . . . 0.0 109.214 -168.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.7 mt -107.71 131.06 58.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.742 1.217 . . . . 0.0 108.368 -173.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? -129.04 134.43 48.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.738 1.215 . . . . 0.0 108.715 -176.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -106.21 150.15 26.16 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.2 160.23 40.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 128.206 2.602 . . . . 0.0 107.755 173.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -19.67 -72.23 0.01 OUTLIER Glycine 0 C--N 1.343 0.963 0 C-N-CA 127.719 2.581 . . . . 0.0 114.231 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -123.19 18.81 9.92 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.99 1.316 . . . . 0.0 110.74 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -124.43 144.68 49.93 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.068 0.849 . . . . 0.0 109.404 -172.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -143.68 127.79 17.57 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 122.447 0.299 . . . . 0.0 110.811 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.91 138.82 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.946 1.298 . . . . 0.0 107.94 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.89 117.27 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.966 1.306 . . . . 0.0 107.895 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.5 m -107.61 143.3 36.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.625 1.57 . . . . 0.0 107.506 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -146.04 143.82 29.67 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.488 1.115 . . . . 0.0 108.222 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -138.07 120.66 16.17 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.3 p -136.11 159.5 70.71 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.02 1.728 . . . . 0.0 108.601 172.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.49 67.98 6.23 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.788 2.992 . . . . 0.0 108.899 168.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -157.88 -60.85 0.08 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.633 1.573 . . . . 0.0 107.994 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -171.04 162.94 7.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.555 1.942 . . . . 0.0 107.758 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.8 p -84.57 99.0 10.47 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.72 65.49 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.5 m -90.79 123.98 34.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.804 1.242 . . . . 0.0 108.121 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -142.45 178.86 7.3 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.224 1.41 . . . . 0.0 108.964 -176.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -167.7 166.79 13.67 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 121.918 -0.489 . . . . 0.0 110.721 -177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -152.88 155.61 37.39 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.715 0.806 . . . . 0.0 110.419 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.6 m -119.45 136.42 54.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 169.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.8 mt -57.21 -64.11 0.99 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.968 0.507 . . . . 0.0 109.931 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.43 49.91 1.86 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.358 -0.69 . . . . 0.0 112.043 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -155.12 -95.67 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.049 0.925 . . . . 0.0 110.515 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -142.81 169.36 17.72 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.296 1.039 . . . . 0.0 110.502 -174.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.25 147.19 20.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.905 1.282 . . . . 0.0 109.61 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -153.83 100.46 2.37 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.4 mm -120.08 104.79 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.069 1.348 . . . . 0.0 107.521 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -109.48 173.46 6.31 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.441 0.696 . . . . 0.0 112.45 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.2 p -138.89 170.83 15.27 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.293 2.237 . . . . 0.0 108.333 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -154.78 73.78 0.9 Allowed 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.86 -61.55 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.204 1.002 . . . . 0.0 109.817 -176.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.8 -125.45 5.64 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -116.4 161.36 19.18 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.714 1.606 . . . . 0.0 110.061 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -61.16 143.12 56.09 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.906 0.883 . . . . 0.0 111.96 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.9 mt -132.88 102.83 5.79 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.665 1.586 . . . . 0.0 107.318 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.75 139.37 8.83 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.353 0.661 . . . . 0.0 110.161 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 41.2 t -145.37 -63.91 0.33 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.583 1.553 . . . . 0.0 107.349 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.0 t -161.11 159.11 28.68 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.11 0.964 . . . . 0.0 109.513 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.7 139.69 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 125.35 1.46 . . . . 0.0 107.468 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -164.06 -157.07 0.37 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.68 121.9 38.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.008 1.323 . . . . 0.0 107.589 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.11 -52.6 2.59 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.89 1.676 . . . . 0.0 110.43 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -149.92 -80.26 0.12 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.272 0.629 . . . . 0.0 109.575 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.97 -69.13 1.41 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 173.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -145.7 -115.68 0.08 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.228 1.411 . . . . 0.0 107.379 163.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.06 163.41 27.16 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.353 1.061 . . . . 0.0 112.529 -174.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.85 141.62 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.798 1.639 . . . . 0.0 106.708 172.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -166.64 139.65 3.8 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.415 0.552 . . . . 0.0 110.594 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -81.55 74.51 8.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.856 0.862 . . . . 0.0 108.952 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.4 p -82.46 -171.23 3.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.864 1.266 . . . . 0.0 109.577 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -58.49 -59.35 5.5 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.035 0.534 . . . . 0.0 110.679 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.61 -48.11 0.07 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.184 0.593 . . . . 0.0 110.971 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.0 t80 67.55 -75.5 0.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.895 1.678 . . . . 0.0 111.729 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.9 m -158.55 -53.88 0.07 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 127.065 2.146 . . . . 0.0 106.689 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -165.17 -126.4 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.558 2.343 . . . . 0.0 105.832 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -124.03 -71.28 0.72 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.671 1.188 . . . . 0.0 108.547 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -154.27 97.73 2.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -145.88 92.14 2.17 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.486 1.114 . . . . 0.0 108.945 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.6 t -139.59 138.42 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.011 1.324 . . . . 0.0 107.712 176.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -106.72 159.15 16.44 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.512 1.125 . . . . 0.0 108.498 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -25.23 -63.05 0.06 OUTLIER Glycine 0 C--N 1.342 0.881 0 C-N-CA 127.401 2.429 . . . . 0.0 114.254 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -130.71 34.55 4.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.012 0.925 . . . . 0.0 111.239 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -144.02 112.97 6.73 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.642 0.777 . . . . 0.0 109.44 173.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.2 ttm -100.18 82.29 2.51 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.38 71.1 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.618 1.167 . . . . 0.0 108.735 -173.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.4 84.14 0.8 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -105.59 26.0 10.06 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.936 1.294 . . . . 0.0 111.212 -168.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 mm -108.7 -124.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 117.9 -1.048 . . . . 0.0 108.184 -173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 t -132.86 125.32 29.7 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 120.198 1.363 . . . . 0.0 112.954 -165.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -41.28 78.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.75 -65.99 0.08 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.99 -43.81 4.95 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.513 1.054 . . . . 0.0 112.189 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.3 t -107.54 154.04 8.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 124.208 1.003 . . . . 0.0 109.541 -172.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.3 p -103.72 107.58 18.51 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.52 120.85 43.02 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.1 mp -76.19 75.3 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 171.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -93.88 106.16 18.14 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.675 1.19 . . . . 0.0 108.466 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 6.0 mtt-85 -107.91 119.23 38.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.615 1.566 . . . . 0.0 109.907 -175.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.0 p -125.07 121.52 34.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 170.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -107.35 155.55 19.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.347 1.459 . . . . 0.0 109.049 -173.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -74.82 148.21 40.5 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.413 177.311 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.4 p -51.77 118.67 3.55 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.556 1.142 . . . . 0.0 110.84 -172.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.27 172.05 42.26 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -170.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.4 p -114.9 102.43 9.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.887 1.275 . . . . 0.0 108.249 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -115.57 147.37 40.82 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.325 1.05 . . . . 0.0 110.007 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -95.53 -131.7 0.17 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.625 0.77 . . . . 0.0 109.094 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.625 HG11 ' CD ' ' A' ' 36' ' ' PRO . 1.4 p 176.75 133.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 127.584 2.354 . . . . 0.0 105.099 -178.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -146.17 -8.91 0.52 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -158.06 110.99 2.4 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -165.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.7 140.2 52.9 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 172.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -90.32 -77.96 0.39 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.413 0.551 . . . . 0.0 112.189 -170.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -83.31 57.42 3.98 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.158 0.983 . . . . 0.0 110.208 -176.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -69.13 -61.59 1.73 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -54.56 -43.31 71.94 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-O 118.983 -0.532 . . . . 0.0 111.801 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.52 -50.66 72.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.796 0.438 . . . . 0.0 110.709 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -58.22 -50.11 74.7 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.755 0.822 . . . . 0.0 110.675 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -16.94 62.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.398 0.679 . . . . 0.0 111.678 -175.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -95.74 -15.11 22.83 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.013 0.925 . . . . 0.0 111.811 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.07 -38.3 87.96 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 166.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.98 144.77 57.07 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.03 43.99 1.04 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.28 0.632 . . . . 0.0 111.941 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.19 145.06 29.58 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.95 1.3 . . . . 0.0 107.99 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.8 135.61 26.11 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.566 2.844 . . . . 0.0 111.869 -171.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -46.34 -41.53 13.53 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.56 1.544 . . . . 0.0 113.061 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -40.46 -56.04 2.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 126.977 2.111 . . . . 0.0 111.858 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.47 -41.66 84.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.888 0.875 . . . . 0.0 110.504 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.3 mp -60.79 -37.82 77.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 118.594 0.634 . . . . 0.0 110.4 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -53.06 -34.22 55.55 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.423 0.689 . . . . 0.0 111.065 177.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 81.2 mmm -108.14 19.71 19.6 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.961 1.704 . . . . 0.0 112.202 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.79 -36.06 4.96 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.554 1.542 . . . . 0.0 110.358 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -56.11 -28.66 58.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.141 0.977 . . . . 0.0 113.476 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.85 -17.46 40.84 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.087 0.955 . . . . 0.0 113.039 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.58 143.6 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.636 0.774 . . . . 0.0 110.09 -176.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -117.36 107.95 44.35 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.084 1.354 . . . . 0.0 109.005 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.625 ' CD ' HG11 ' A' ' 8' ' ' VAL . 16.3 Cg_exo -57.43 -174.47 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.455 3.437 . . . . 0.0 115.187 173.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.5 tt -118.8 146.21 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 157.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.74 78.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.3 143.81 30.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.56 1.944 . . . . 0.0 107.687 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 tt -145.74 142.1 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 118.426 0.557 . . . . 0.0 109.721 169.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -133.75 155.12 50.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.291 1.836 . . . . 0.0 109.254 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -127.16 161.67 27.95 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.837 1.255 . . . . 0.0 112.364 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -149.31 163.4 37.81 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.301 2.641 . . . . 0.0 107.824 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -23.28 -66.8 0.03 OUTLIER Glycine 0 C--N 1.344 1.002 0 C-N-CA 127.453 2.454 . . . . 0.0 114.114 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -129.16 21.8 5.71 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.079 1.752 . . . . 0.0 110.137 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -126.58 150.28 48.95 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.601 0.76 . . . . 0.0 111.584 -171.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -139.14 140.31 37.86 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.173 0.989 . . . . 0.0 110.555 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.2 t -135.44 112.54 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -105.54 149.79 8.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.3 m -143.5 82.58 1.74 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.131 1.372 . . . . 0.0 108.129 -172.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.9 m -114.83 47.17 1.3 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.669 1.187 . . . . 0.0 109.812 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.73 168.47 9.16 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -166.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.2 p -124.94 158.06 64.33 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 126.025 1.73 . . . . 0.0 107.298 171.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.6 65.12 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.145 2.563 . . . . 0.0 108.381 168.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -174.84 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.691 1.596 . . . . 0.0 108.862 -172.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -128.18 122.91 33.02 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.869 1.267 . . . . 0.0 109.171 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.3 m -95.5 82.08 3.62 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.143 1.377 . . . . 0.0 110.303 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -91.29 96.18 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.5 m -139.28 74.76 1.48 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.341 1.057 . . . . 0.0 109.415 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.51 138.44 58.07 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 m -155.55 142.81 19.33 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -167.56 148.4 5.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -99.69 142.66 30.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 162.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 mp -56.03 -72.07 0.08 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.027 0.931 . . . . 0.0 110.093 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.14 72.62 2.46 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -167.79 174.3 7.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.565 0.746 . . . . 0.0 110.901 -173.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -81.63 166.09 20.48 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.513 0.725 . . . . 0.0 109.24 162.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.87 85.65 0.54 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.24 73.53 3.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.076 0.55 . . . . 0.0 110.479 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.2 mt -77.13 125.97 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.0 p -107.75 -163.48 0.9 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.013 1.325 . . . . 0.0 109.465 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -161.86 171.15 18.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.579 0.752 . . . . 0.0 110.238 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.38 -61.18 1.74 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.097 1.359 . . . . 0.0 110.209 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -135.33 21.02 3.4 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.785 1.234 . . . . 0.0 111.153 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.91 -121.21 1.62 Allowed Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -141.55 -77.06 0.28 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.154 1.382 . . . . 0.0 109.389 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.4 134.03 2.72 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.42 114.61 28.17 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.176 0.99 . . . . 0.0 110.602 -171.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.28 52.08 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.41 1.084 . . . . 0.0 108.335 174.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 79.7 m -115.23 -57.77 2.21 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.559 1.144 . . . . 0.0 110.348 -170.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.5 p -104.17 84.29 2.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 -170.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.2 m -123.62 -130.81 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.048 1.339 . . . . 0.0 109.039 -171.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -24.0 127.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.715 2.406 . . . . 0.0 114.014 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.3 tt -114.76 95.69 5.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.18 -61.86 1.46 Allowed 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 123.657 0.783 . . . . 0.0 108.923 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -67.92 -56.87 7.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.252 0.621 . . . . 0.0 111.233 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.27 -38.89 0.08 OUTLIER Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -110.88 171.44 7.46 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.286 1.434 . . . . 0.0 107.89 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.04 159.44 33.82 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.13 -86.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -76.99 87.65 3.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.612 1.165 . . . . 0.0 110.349 -171.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -104.13 41.45 1.3 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.508 1.123 . . . . 0.0 108.704 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.5 p -151.03 57.4 0.91 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.459 0.703 . . . . 0.0 110.106 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -156.4 -167.78 2.52 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -64.1 133.17 52.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.182 0.593 . . . . 0.0 109.625 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.8 t80 69.02 51.93 0.52 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.758 1.223 . . . . 0.0 110.944 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 73.9 m -112.45 134.61 53.88 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.234 1.014 . . . . 0.0 109.647 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -78.0 170.28 16.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.62 0.768 . . . . 0.0 110.231 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -57.29 -73.2 0.07 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.846 1.258 . . . . 0.0 112.316 -171.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -161.06 -55.28 0.05 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.495 1.118 . . . . 0.0 108.892 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -167.41 178.82 5.28 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.524 0.73 . . . . 0.0 112.152 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 63.7 t -108.69 145.94 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 126.818 2.047 . . . . 0.0 108.633 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -108.01 151.75 25.41 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.8 0.84 . . . . 0.0 109.734 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -13.34 -72.2 0.01 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 128.777 3.084 . . . . 0.0 115.81 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -128.56 28.4 5.42 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.502 1.121 . . . . 0.0 110.972 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -151.45 113.66 4.54 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.7 ttt -98.9 97.68 8.84 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.864 1.266 . . . . 0.0 107.751 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.3 t -105.79 102.81 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -115.68 129.36 56.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.665 0.786 . . . . 0.0 109.474 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.6 t -110.91 116.41 31.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 164.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.34 110.37 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -168.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.0 p -73.59 104.06 4.41 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.877 1.271 . . . . 0.0 110.311 -172.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -92.08 174.19 7.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.905 1.282 . . . . 0.0 110.226 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -41.87 -52.48 4.77 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.066 1.793 . . . . 0.0 113.836 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -136.36 19.86 3.58 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.279 -0.734 . . . . 0.0 114.469 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.7 t -149.43 162.98 4.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 171.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.0 t -118.3 125.37 49.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 159.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 28.2 tp -101.77 99.86 10.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.1 mt -55.55 128.6 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.335 166.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -146.57 124.03 11.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.315 1.446 . . . . 0.0 108.496 176.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -107.81 116.29 31.68 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.7 p -110.98 127.55 55.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.143 1.377 . . . . 0.0 107.839 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -105.87 145.77 30.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.517 1.127 . . . . 0.0 108.894 -170.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.5 tpt85 -69.8 121.99 18.34 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.616 0.766 . . . . 0.0 110.711 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.271 -1.347 . . . . 0.0 109.289 173.889 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 . . . . . 0 C--O 1.224 -0.246 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 p -57.56 100.2 0.05 OUTLIER 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.188 0.995 . . . . 0.0 111.768 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.84 -174.71 47.07 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.9 p -105.91 128.14 53.59 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -130.26 153.44 48.62 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.207 0.603 . . . . 0.0 111.548 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -142.22 119.72 11.69 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.39 1.076 . . . . 0.0 109.908 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.946 HG11 ' HD2' ' A' ' 36' ' ' PRO . 1.2 p -49.77 138.01 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.729 1.212 . . . . 0.0 109.293 163.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -138.77 -16.67 1.12 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 172.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . . . -136.3 85.94 2.19 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.308 1.043 . . . . 0.0 110.709 -163.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -95.52 145.67 25.02 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 167.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -79.82 -106.67 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -85.99 75.41 9.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -46.23 75.84 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.948 0.899 . . . . 0.0 110.97 -176.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -62.6 -16.71 57.84 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -72.2 -54.06 10.77 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.378 0.99 . . . . 0.0 110.917 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -43.17 -63.37 0.82 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.102 1.761 . . . . 0.0 112.423 -172.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -12.37 59.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.415 1.086 . . . . 0.0 113.885 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.03 -32.21 64.96 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.012 0.823 . . . . 0.0 109.953 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.8 41.25 0.72 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.619 0.768 . . . . 0.0 111.686 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -138.34 168.71 19.18 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.356 1.462 . . . . 0.0 108.509 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.47 39.47 1.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.792 0.837 . . . . 0.0 111.384 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 mp -97.74 141.69 23.39 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.89 153.1 58.43 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.664 2.243 . . . . 0.0 109.732 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -57.01 -25.34 58.39 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.335 1.054 . . . . 0.0 113.091 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.92 -45.82 71.3 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.604 1.162 . . . . 0.0 111.166 171.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.5 mt -80.87 -4.91 56.46 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.644 -0.694 . . . . 0.0 112.214 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.96 -28.03 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.075 0.852 . . . . 0.0 109.945 166.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -53.65 -44.46 69.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 166.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 9.1 ttt -62.07 -63.57 1.21 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.311 1.044 . . . . 0.0 110.265 168.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.22 79.35 0.98 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.047 0.939 . . . . 0.0 112.58 -174.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.68 -44.81 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.744 2.017 . . . . 0.0 107.738 174.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -85.83 48.74 1.65 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.525 1.53 . . . . 0.0 108.578 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.8 mm -127.86 135.33 63.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 C-N-CA 124.881 1.272 . . . . 0.0 109.471 -175.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HG2' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -154.12 82.24 4.46 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -176.02 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.946 ' HD2' HG11 ' A' ' 8' ' ' VAL . 21.6 Cg_exo -70.27 173.1 11.92 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.711 2.274 . . . . 0.0 112.879 -173.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.59 HD12 ' HG3' ' A' ' 39' ' ' GLU . 21.0 pt -107.46 137.8 36.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 167.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.6 t -118.45 104.04 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.59 ' HG3' HD12 ' A' ' 37' ' ' ILE . 25.7 mm-40 -112.94 98.61 7.28 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.004 2.122 . . . . 0.0 107.267 -166.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.7 mt -106.29 133.41 50.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 123.318 0.647 . . . . 0.0 110.026 -173.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -126.56 121.71 33.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.009 1.724 . . . . 0.0 107.821 172.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -108.7 145.09 35.6 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.344 0.592 . . . . 0.0 110.92 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.65 161.36 30.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 129.75 3.22 . . . . 0.0 106.408 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -14.44 -68.57 0.01 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 127.868 2.651 . . . . 0.0 114.378 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -129.97 12.14 5.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.583 1.553 . . . . 0.0 110.802 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.13 139.22 47.84 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 118.785 0.72 . . . . 0.0 109.866 -172.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -135.14 119.31 17.65 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.15 0.58 . . . . 0.0 109.583 -172.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.8 t -113.63 110.32 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -108.38 118.95 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m -106.86 106.84 17.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.86 1.664 . . . . 0.0 107.205 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 p -108.17 82.08 1.58 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.053 1.741 . . . . 0.0 107.799 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -104.03 127.54 51.6 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.086 0.954 . . . . 0.0 109.883 -166.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.3 p -113.84 157.33 42.12 Favored Pre-proline 0 CA--C 1.53 0.21 0 C-N-CA 125.819 1.648 . . . . 0.0 109.754 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.41 60.11 5.64 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.54 2.827 . . . . 0.0 109.423 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -175.65 -53.7 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.411 1.484 . . . . 0.0 110.497 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -126.92 154.46 44.46 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.682 1.193 . . . . 0.0 110.742 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.1 p -110.17 53.6 0.69 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.021 1.328 . . . . 0.0 110.05 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -72.21 138.12 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.5 m -148.36 137.96 22.17 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.243 1.017 . . . . 0.0 108.346 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -132.26 102.04 5.61 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.134 1.374 . . . . 0.0 108.483 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.5 p -110.6 141.03 44.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.702 1.201 . . . . 0.0 109.379 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -156.05 176.9 12.05 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.661 0.784 . . . . 0.0 110.313 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.0 m -137.36 149.38 46.95 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 172.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.12 -65.39 0.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.647 0.779 . . . . 0.0 110.043 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.94 62.39 4.38 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -162.46 159.04 24.56 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.516 0.726 . . . . 0.0 110.594 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.76 136.47 37.4 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.518 1.127 . . . . 0.0 109.528 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.46 144.85 10.97 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.698 1.199 . . . . 0.0 109.426 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -110.32 130.67 55.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.762 1.225 . . . . 0.0 108.468 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 42.6 mm -108.37 141.35 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.429 1.091 . . . . 0.0 109.113 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.5 p -108.82 164.54 12.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.313 1.445 . . . . 0.0 110.631 -173.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 t -128.71 160.1 33.55 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.745 1.218 . . . . 0.0 108.183 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -71.34 -67.18 0.54 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -140.62 103.02 4.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.865 0.866 . . . . 0.0 108.731 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.54 -109.28 0.24 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -157.36 163.55 38.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.954 0.902 . . . . 0.0 109.784 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -70.36 87.17 0.62 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.182 0.993 . . . . 0.0 110.06 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 tt -151.74 78.08 1.24 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -141.27 86.42 2.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.0 1.32 . . . . 0.0 108.427 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.1 p -107.47 86.51 2.31 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -150.23 53.64 0.91 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.158 0.983 . . . . 0.0 110.815 -170.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.3 m -133.85 50.82 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -154.25 170.96 20.03 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.513 -0.742 . . . . 0.0 109.659 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.74 133.32 35.92 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.202 1.801 . . . . 0.0 106.299 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.05 -52.95 2.93 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.276 0.631 . . . . 0.0 109.775 -176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.0 -52.75 0.29 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.517 1.127 . . . . 0.0 108.741 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.05 41.21 0.54 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -142.19 125.01 16.01 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.242 1.017 . . . . 0.0 109.193 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 tt -73.26 79.15 1.31 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.593 1.557 . . . . 0.0 108.434 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.7 143.33 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.493 1.117 . . . . 0.0 110.021 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 t -118.4 -37.43 3.33 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.206 1.402 . . . . 0.0 109.249 169.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -160.79 167.16 27.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.304 1.042 . . . . 0.0 109.071 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.2 t -144.92 136.0 24.91 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -129.45 -135.49 0.22 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.975 0.91 . . . . 0.0 108.964 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -63.31 -47.03 83.97 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.74 0.816 . . . . 0.0 109.604 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -83.71 62.16 6.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.021 1.728 . . . . 0.0 109.829 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.5 m -66.28 127.06 30.73 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -101.42 -41.13 6.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.829 1.252 . . . . 0.0 111.954 -172.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -166.05 166.63 17.1 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.327 0.512 . . . . 0.0 111.285 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -149.31 -61.2 0.22 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.203 1.401 . . . . 0.0 108.829 169.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -85.31 89.41 7.66 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.005 0.922 . . . . 0.0 110.962 -171.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.5 t -106.9 134.42 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 125.194 1.398 . . . . 0.0 107.283 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -124.95 153.15 43.18 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.929 0.892 . . . . 0.0 109.987 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -30.67 -53.98 0.24 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 127.635 2.54 . . . . 0.0 115.219 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -122.97 11.95 9.64 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.725 1.21 . . . . 0.0 112.557 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -148.49 105.89 3.65 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.888 0.875 . . . . 0.0 108.848 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.1 ttt -101.56 115.35 30.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 t -106.67 86.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -176.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.2 111.52 3.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.2 m -107.11 81.97 1.62 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -174.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 tp -104.35 116.17 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.712 0.805 . . . . 0.0 109.463 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -98.97 157.99 15.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.125 0.97 . . . . 0.0 110.125 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -161.12 166.01 28.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.049 1.74 . . . . 0.0 107.172 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 2.08 -82.17 0.0 OUTLIER Glycine 0 C--N 1.344 1.001 0 C-N-CA 128.617 3.008 . . . . 0.0 115.355 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -141.15 52.3 0.68 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.1 p -160.88 145.06 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.599 1.159 . . . . 0.0 108.542 -173.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t -150.4 135.94 18.13 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.848 0.459 . . . . 0.0 110.655 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.86 139.2 49.97 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.88 1.272 . . . . 0.0 108.762 -173.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.61 -11.06 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.232 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 5.79 80.74 0.01 OUTLIER 'General case' 0 C--N 1.349 0.549 0 C-N-CA 129.593 3.157 . . . . 0.0 113.005 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 30.4 ttt180 -104.22 121.92 44.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.891 1.276 . . . . 0.0 108.127 -170.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.4 p -122.15 152.28 40.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.084 1.754 . . . . 0.0 109.944 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -124.17 148.4 47.26 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.294 1.038 . . . . 0.0 108.918 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.9 73.22 4.46 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 123.823 0.702 . . . . 0.0 109.643 -177.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 C--O 1.25 1.116 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.048 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 . . . . . 0 CA--C 1.532 0.288 0 CA-C-O 120.688 0.28 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 t -169.27 72.39 0.08 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.358 1.463 . . . . 0.0 108.14 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.22 -163.59 31.78 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 t -105.1 135.02 47.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -134.93 106.4 6.83 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -80.65 -122.26 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -171.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.758 HG11 ' HD2' ' A' ' 36' ' ' PRO . 3.2 p 175.76 125.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -175.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -134.88 -24.41 1.48 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.8 -67.99 0.83 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.831 -1.08 . . . . 0.0 112.585 -168.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . 0.272 1.1 pt20 3.9 83.61 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.373 2.269 . . . . 0.0 114.045 -162.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -75.13 -71.85 0.33 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.043 0.937 . . . . 0.0 111.629 -169.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -82.91 53.81 2.53 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.921 0.889 . . . . 0.0 110.406 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -67.71 -42.24 82.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.198 0.599 . . . . 0.0 111.263 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -53.99 -52.12 61.74 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.829 1.252 . . . . 0.0 112.147 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -55.29 -50.86 68.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.911 0.484 . . . . 0.0 110.703 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.549 ' CG ' HD12 ' A' ' 118' ' ' LEU . 26.7 t80 -65.52 -48.47 72.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.248 1.419 . . . . 0.0 112.111 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.24 -50.96 63.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.371 0.668 . . . . 0.0 110.459 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.98 65.59 6.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.308 1.051 . . . . 0.0 109.512 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.13 -27.52 0.05 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.034 2.534 . . . . 0.0 109.487 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.2 mt -67.58 -120.56 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.485 1.514 . . . . 0.0 107.823 163.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.12 67.17 0.59 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.274 -0.891 . . . . 0.0 110.401 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HB2' HD11 ' A' ' 28' ' ' ILE . 5.1 mp -124.42 143.64 43.66 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.816 1.246 . . . . 0.0 108.281 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 141.42 24.44 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.351 3.367 . . . . 0.0 111.765 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -47.66 -44.61 27.32 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 125.294 1.438 . . . . 0.0 113.336 -171.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.01 -48.95 32.45 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.542 1.137 . . . . 0.0 111.3 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.0 mt -74.61 -23.1 58.66 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.929 0.892 . . . . 0.0 112.017 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.426 HD11 ' HB2' ' A' ' 23' ' ' LEU . 3.0 mp -73.34 -41.29 57.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 CA-C-N 119.562 1.074 . . . . 0.0 109.344 170.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -42.99 86.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 46.3 ttm -56.43 -56.28 23.12 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.416 1.086 . . . . 0.0 110.589 167.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.42 -37.9 57.82 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 113.208 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -59.13 -30.73 68.36 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.286 1.434 . . . . 0.0 111.683 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -77.21 -26.88 53.24 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.146 0.978 . . . . 0.0 111.491 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mt -70.59 116.84 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.842 0.857 . . . . 0.0 111.65 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.1 106.49 16.18 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 168.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.758 ' HD2' HG11 ' A' ' 8' ' ' VAL . 66.5 Cg_endo -68.13 177.8 4.12 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.061 1.841 . . . . 0.0 112.982 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.621 HD12 ' HG3' ' A' ' 39' ' ' GLU . 22.9 pt -129.37 153.31 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 165.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.5 t -131.68 111.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.621 ' HG3' HD12 ' A' ' 37' ' ' ILE . 59.4 mm-40 -121.68 97.6 5.57 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.816 2.046 . . . . 0.0 107.575 -162.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.4 mt -108.63 140.38 27.45 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 C-N-CA 122.784 0.434 . . . . 0.0 110.21 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -142.11 150.05 40.65 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.929 1.292 . . . . 0.0 108.093 171.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -121.75 167.52 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.151 0.981 . . . . 0.0 112.531 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -151.56 159.61 44.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.746 2.818 . . . . 0.0 107.77 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.31 -59.67 0.22 Allowed Glycine 0 C--N 1.341 0.858 0 C-N-CA 126.625 2.06 . . . . 0.0 113.937 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -130.93 33.45 4.19 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.816 1.246 . . . . 0.0 110.429 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -144.31 154.49 43.1 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.913 0.779 . . . . 0.0 111.866 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -149.7 127.29 11.62 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.689 0.796 . . . . 0.0 110.194 -173.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.2 t -108.27 122.73 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.51 96.17 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.774 1.629 . . . . 0.0 109.024 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 m -102.88 98.84 8.76 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.42 1.088 . . . . 0.0 108.515 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -105.68 117.75 34.81 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -137.06 138.48 40.45 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.629 0.772 . . . . 0.0 111.128 -167.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -124.49 153.89 69.48 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.641 1.577 . . . . 0.0 108.172 167.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.66 56.01 5.74 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.105 3.203 . . . . 0.0 109.854 172.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -175.0 -51.54 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.121 1.769 . . . . 0.0 109.543 -171.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -125.44 162.32 25.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.436 1.095 . . . . 0.0 109.823 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.3 m -138.3 118.28 13.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.889 0.876 . . . . 0.0 108.78 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.17 43.26 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.8 p -79.79 126.94 31.6 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.63 1.172 . . . . 0.0 108.414 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -140.13 168.91 18.71 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.195 0.998 . . . . 0.0 110.737 -172.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.1 m -153.16 153.44 32.76 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.812 1.245 . . . . 0.0 109.443 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -148.44 151.99 36.18 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.376 1.07 . . . . 0.0 110.318 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 m -86.66 -117.64 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.8 mt -151.07 -78.45 0.13 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 171.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.8 41.75 2.91 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.28 144.99 25.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.032 1.333 . . . . 0.0 107.962 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 151.61 20.91 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.093 1.357 . . . . 0.0 113.701 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.61 138.19 9.46 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.631 1.172 . . . . 0.0 109.804 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.08 91.13 3.6 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.478 1.111 . . . . 0.0 111.446 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.8 mm -94.1 127.88 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.729 1.612 . . . . 0.0 108.749 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -155.7 152.83 29.07 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.264 0.626 . . . . 0.0 111.018 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.7 p -89.77 147.72 23.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.325 1.45 . . . . 0.0 109.266 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.1 -64.98 1.07 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -106.94 80.26 1.41 Allowed 'General case' 0 C--N 1.343 0.299 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.04 -112.93 0.29 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -164.26 135.35 4.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.526 1.13 . . . . 0.0 108.728 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -68.22 103.59 1.61 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.67 1.188 . . . . 0.0 110.045 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.4 mt -125.38 60.2 1.24 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.482 1.113 . . . . 0.0 109.311 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -97.29 139.48 33.18 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.793 1.237 . . . . 0.0 107.827 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 91.2 m -128.91 -74.37 0.57 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.0 p -146.73 163.97 34.23 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.679 1.592 . . . . 0.0 107.898 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.12 88.82 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.742 0.817 . . . . 0.0 109.382 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -132.72 -173.84 3.29 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.024 1.73 . . . . 0.0 109.24 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.35 142.25 37.44 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.681 1.592 . . . . 0.0 108.986 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.18 -176.83 5.08 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.609 1.164 . . . . 0.0 110.286 174.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -76.41 73.06 3.17 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.48 1.112 . . . . 0.0 110.954 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.79 -82.8 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 106.251 -2.74 . . . . 0.0 106.251 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -160.47 -54.28 0.05 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.722 0.809 . . . . 0.0 109.076 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.97 144.94 43.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.451 1.1 . . . . 0.0 108.514 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.5 -47.4 77.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 122.39 0.276 . . . . 0.0 110.508 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -103.11 148.82 25.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.789 1.635 . . . . 0.0 109.214 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.86 163.1 28.38 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 169.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.2 p -54.16 -76.49 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.593 0.757 . . . . 0.0 110.229 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -140.26 146.04 38.09 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -58.35 -40.86 83.32 Favored 'General case' 0 CA--C 1.526 0.052 0 C-N-CA 123.53 0.732 . . . . 0.0 109.463 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -87.3 40.04 0.9 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.143 0.977 . . . . 0.0 110.113 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.4 m -149.09 -94.2 0.07 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 125.786 1.634 . . . . 0.0 108.217 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -114.82 140.61 48.8 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.885 0.874 . . . . 0.0 110.121 -171.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.58 -54.58 2.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.058 0.943 . . . . 0.0 109.715 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.9 154.19 21.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.415 0.686 . . . . 0.0 111.41 -166.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -68.57 172.89 5.59 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.265 1.026 . . . . 0.0 111.615 175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.7 m -107.05 178.89 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.668 1.587 . . . . 0.0 110.962 -168.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.73 160.75 17.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.243 1.417 . . . . 0.0 110.033 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -32.58 -64.47 0.26 Allowed Glycine 0 C--N 1.342 0.905 0 C-N-CA 127.356 2.408 . . . . 0.0 114.373 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -121.3 33.72 5.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.737 0.815 . . . . 0.0 110.491 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -151.15 98.58 2.58 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 122.635 0.374 . . . . 0.0 111.738 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.1 ttt -92.41 80.81 4.9 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 166.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.68 27.22 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.448 1.099 . . . . 0.0 110.547 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -73.51 143.56 46.51 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.1 p -101.7 144.01 30.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -174.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 tt -103.17 114.21 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -169.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.3 t -103.49 164.19 11.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.009 0.924 . . . . 0.0 112.035 -173.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -147.94 172.63 13.9 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 128.206 2.602 . . . . 0.0 106.395 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.55 -39.8 85.78 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.89 -42.61 16.12 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.609 1.1 . . . . 0.0 113.532 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.32 154.64 39.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 CA-C-N 117.887 0.843 . . . . 0.0 112.495 -162.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 p -112.48 109.67 19.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 163.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.549 HD12 ' CG ' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -100.33 114.68 28.37 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -167.52 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.7 mm -66.88 80.32 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.723 1.609 . . . . 0.0 108.344 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -110.76 145.88 37.33 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.476 1.511 . . . . 0.0 108.846 171.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -143.13 119.29 10.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.404 1.882 . . . . 0.0 106.466 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.6 p -109.29 115.76 30.6 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -106.17 151.54 24.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -74.48 146.43 42.77 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--O 1.252 1.218 0 CA-C-O 117.69 -1.148 . . . . 0.0 110.437 -178.232 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.308 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 p -171.06 68.16 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.739 0.816 . . . . 0.0 109.782 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.67 -160.02 25.56 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 p -103.35 119.5 38.99 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -124.59 146.04 49.27 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.618 0.767 . . . . 0.0 109.318 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -141.9 135.25 29.27 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.19 0.596 . . . . 0.0 109.877 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.796 HG11 ' HD2' ' A' ' 36' ' ' PRO . 1.4 p -77.87 140.92 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 124.814 1.245 . . . . 0.0 110.449 176.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -135.72 -13.91 1.92 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.129 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.0 135.98 15.51 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -167.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.35 145.4 21.65 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -90.6 -107.97 0.09 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.459 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -76.97 60.17 1.76 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.537 1.062 . . . . 0.0 110.338 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -75.15 -30.49 60.78 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.233 0.613 . . . . 0.0 111.517 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -56.61 -47.3 79.94 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.093 0.406 . . . . 0.0 110.122 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.03 -31.15 71.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.657 1.183 . . . . 0.0 111.459 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -58.56 -38.9 78.82 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.219 0.463 . . . . 0.0 110.079 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -72.24 -55.51 7.08 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.116 0.416 . . . . 0.0 109.944 169.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -76.05 73.71 2.92 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 124.979 1.311 . . . . 0.0 109.7 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.23 -32.35 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.197 2.599 . . . . 0.0 108.817 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.7 mt -72.73 -117.37 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.529 1.532 . . . . 0.0 108.28 169.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.21 31.93 0.48 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.157 0.983 . . . . 0.0 110.754 172.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.88 121.98 69.37 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.23 161.85 39.78 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.033 2.488 . . . . 0.0 112.166 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -53.21 -45.57 68.68 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.776 1.63 . . . . 0.0 112.413 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -52.44 -50.42 62.63 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.841 0.856 . . . . 0.0 110.454 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -42.47 95.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.664 0.786 . . . . 0.0 109.879 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.597 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 58.3 mt -55.06 -36.78 40.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-N 119.181 0.9 . . . . 0.0 111.545 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -45.13 -45.46 11.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.38 1.072 . . . . 0.0 111.33 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.6 mmt -80.25 -57.41 3.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.317 1.447 . . . . 0.0 109.851 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.597 ' HB3' ' HA ' ' A' ' 28' ' ' ILE . . . -43.39 -45.32 6.12 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 127.725 2.41 . . . . 0.0 113.978 -175.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -61.98 -39.9 93.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.058 0.543 . . . . 0.0 110.357 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -95.66 52.47 1.36 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.589 1.156 . . . . 0.0 109.693 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.0 mm -115.7 128.58 72.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.94 1.296 . . . . 0.0 107.864 170.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.37 91.11 49.99 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.796 ' HD2' HG11 ' A' ' 8' ' ' VAL . 11.2 Cg_exo -71.53 170.44 18.5 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 CA-C-N 120.758 1.306 . . . . 0.0 111.465 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.59 134.49 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 167.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.8 t -116.54 99.34 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.84 110.28 22.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.088 1.755 . . . . 0.0 107.695 -168.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.7 mt -121.46 134.19 65.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 C-N-CA 124.124 0.97 . . . . 0.0 110.553 -163.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -129.91 120.83 25.52 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -90.85 140.7 29.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.378 1.071 . . . . 0.0 109.877 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.69 157.45 33.86 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 128.582 2.753 . . . . 0.0 108.12 173.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -32.56 -59.76 0.4 Allowed Glycine 0 C--N 1.344 0.999 0 C-N-CA 126.822 2.153 . . . . 0.0 112.705 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' HA ' HD23 ' A' ' 64' ' ' LEU . 1.9 m-20 -136.1 71.23 1.42 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 165.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -165.53 155.81 13.21 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.129 0.972 . . . . 0.0 109.13 164.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -141.2 127.11 19.29 Favored 'General case' 0 C--O 1.228 -0.054 0 C-N-CA 123.935 0.894 . . . . 0.0 109.649 174.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.4 t -108.6 133.38 53.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 173.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 60' ' ' ASN . 12.5 p -134.32 117.44 24.64 Favored 'Isoleucine or valine' 0 C--N 1.341 0.21 0 C-N-CA 124.368 1.067 . . . . 0.0 108.914 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.8 m -108.35 107.2 17.67 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.383 1.473 . . . . 0.0 108.39 -173.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -103.72 93.49 4.93 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -107.95 122.62 47.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.359 1.463 . . . . 0.0 109.042 -170.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.2 p -108.63 156.63 38.48 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 123.818 0.847 . . . . 0.0 109.714 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.33 58.01 4.28 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.87 2.38 . . . . 0.0 108.979 166.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -167.64 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.055 1.342 . . . . 0.0 109.785 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -135.47 178.91 6.67 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.188 1.795 . . . . 0.0 109.284 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.0 m -138.26 137.41 37.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.254 1.022 . . . . 0.0 108.255 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.4 t -133.84 90.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.9 m -87.29 121.76 30.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HB2' HG13 ' A' ' 49' ' ' VAL . 82.9 m-20 -121.26 156.14 33.14 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.697 1.199 . . . . 0.0 110.115 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.1 p -149.02 141.02 23.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.388 1.075 . . . . 0.0 108.858 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.525 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -148.4 153.11 38.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.716 0.806 . . . . 0.0 109.879 174.714 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 45' ' ' ASP . 87.0 m -125.26 165.18 18.78 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.639 1.176 . . . . 0.0 108.685 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -82.88 -64.31 1.2 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.91 1.684 . . . . 0.0 109.634 -172.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.61 38.82 2.97 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.021 0.82 . . . . 0.0 111.893 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -162.49 138.41 7.37 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -55.47 163.7 1.19 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.614 1.566 . . . . 0.0 113.288 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 62' ' ' PHE . . . -150.45 86.83 1.42 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.543 0.737 . . . . 0.0 110.108 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -78.88 51.97 1.18 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.586 1.954 . . . . 0.0 111.882 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.04 128.37 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.039 0.935 . . . . 0.0 109.273 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.8 p -116.75 -172.93 2.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.118 1.767 . . . . 0.0 108.086 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.1 t -143.0 -174.05 4.08 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.934 0.493 . . . . 0.0 110.236 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 42.2 mtp -66.11 -63.24 1.12 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.166 1.386 . . . . 0.0 110.331 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -106.2 49.33 0.81 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.244 1.017 . . . . 0.0 108.326 -172.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.55 118.74 0.57 Allowed Glycine 0 C--N 1.344 0.975 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -104.7 -101.41 0.32 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.489 1.116 . . . . 0.0 108.936 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -98.84 82.64 2.81 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.049 1.295 . . . . 0.0 108.98 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tt -148.14 74.65 1.3 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -171.0 167.28 7.3 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.197 0.999 . . . . 0.0 110.112 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.63 -165.18 1.17 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.746 1.618 . . . . 0.0 108.064 170.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -106.69 135.13 48.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.52 1.128 . . . . 0.0 108.195 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.8 m -74.68 155.98 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.168 0.587 . . . . 0.0 110.617 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -162.46 159.82 25.5 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.46 0.704 . . . . 0.0 110.537 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.36 138.69 44.22 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.879 1.672 . . . . 0.0 108.168 -175.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.29 -61.65 1.45 Allowed 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.942 0.897 . . . . 0.0 108.824 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -145.97 -62.81 0.32 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.616 0.766 . . . . 0.0 110.107 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.62 -77.84 0.91 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.443 0.545 . . . . 0.0 112.001 -174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -135.89 -172.47 3.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.045 1.338 . . . . 0.0 109.869 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.2 134.41 39.07 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.245 1.418 . . . . 0.0 110.971 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.33 131.62 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.0 m -151.45 67.79 0.9 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -73.96 80.4 1.67 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.685 1.194 . . . . 0.0 109.904 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 55.9 p -166.86 -33.16 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.539 1.135 . . . . 0.0 111.569 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -75.97 71.26 2.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.199 1.4 . . . . 0.0 110.068 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -47.13 -62.95 1.18 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.261 1.824 . . . . 0.0 111.981 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -88.81 64.02 7.08 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.272 0.629 . . . . 0.0 109.803 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.8 t -153.13 -163.38 1.68 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.627 1.171 . . . . 0.0 108.986 174.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -78.38 135.47 37.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.471 0.708 . . . . 0.0 109.85 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -76.2 164.3 26.21 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -102.97 74.04 1.28 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.46 1.104 . . . . 0.0 108.601 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -125.14 132.2 53.12 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.054 1.742 . . . . 0.0 107.851 172.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -157.43 157.09 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.133 0.973 . . . . 0.0 109.462 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -126.72 147.55 49.95 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.253 1.021 . . . . 0.0 108.494 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -35.97 -51.3 1.18 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.425 1.964 . . . . 0.0 113.965 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -130.08 36.38 4.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.427 1.891 . . . . 0.0 111.064 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -161.76 125.11 3.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.748 0.819 . . . . 0.0 109.016 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 41.9 ttm -123.45 84.68 2.3 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.347 1.059 . . . . 0.0 109.281 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.8 t -105.13 82.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -80.49 154.48 27.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.702 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.5 p -108.14 116.4 31.9 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.065 1.746 . . . . 0.0 106.649 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 71.9 mt -103.72 96.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.7 m -75.57 125.4 28.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -142.65 166.57 24.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.923 1.289 . . . . 0.0 107.614 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -54.73 -40.22 70.46 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.326 0.489 . . . . 0.0 112.171 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.8 -38.5 6.5 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.597 1.094 . . . . 0.0 113.398 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.85 150.91 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 118.406 1.103 . . . . 0.0 111.887 -170.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.9 p -106.76 91.36 3.64 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 162.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.88 114.12 28.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.751 0.786 . . . . 0.0 112.249 -158.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.2 mm -68.13 118.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.297 1.839 . . . . 0.0 108.484 172.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -125.28 114.84 19.47 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -107.37 105.49 15.45 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.292 1.037 . . . . 0.0 109.519 -169.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.8 p -114.12 145.3 41.82 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.419 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -136.87 154.95 50.36 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.5 -171.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -73.23 74.67 1.31 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.862 1.665 . . . . 0.0 113.165 -165.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.271 -1.347 . . . . 0.0 109.822 175.197 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 . . . . . 0 C--O 1.226 -0.18 0 CA-C-O 119.878 -0.106 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.3 p -51.03 99.1 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.602 1.561 . . . . 0.0 111.886 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.71 -168.16 39.99 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.6 p -110.03 131.92 54.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -131.21 140.59 49.91 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.155 0.982 . . . . 0.0 110.775 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -119.19 106.51 12.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.744 1.217 . . . . 0.0 109.224 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.851 HG11 ' HD2' ' A' ' 36' ' ' PRO . 3.6 p -47.21 136.58 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 125.644 1.578 . . . . 0.0 109.638 165.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -147.81 -29.81 0.32 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.5 -7.78 46.4 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -154.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -54.61 104.78 0.12 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.869 1.213 . . . . 0.0 111.132 -173.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.19 -76.54 0.11 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.188 0.595 . . . . 0.0 110.058 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -83.09 58.31 4.36 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.052 0.941 . . . . 0.0 108.472 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -57.78 -30.54 65.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.151 -1.593 . . . . 0.0 111.364 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -36.25 76.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.552 0.741 . . . . 0.0 111.863 173.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -67.17 -40.58 86.63 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.624 ' HA ' HG21 ' A' ' 116' ' ' VAL . 1.7 t80 -55.48 -43.57 75.66 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.328 0.651 . . . . 0.0 111.682 -176.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -78.99 49.89 0.97 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.578 1.151 . . . . 0.0 111.474 -174.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 -40.99 1.31 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.049 0.94 . . . . 0.0 111.261 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.17 46.04 1.08 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.587 0.755 . . . . 0.0 110.32 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.3 mt -138.79 -128.85 0.12 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.231 2.212 . . . . 0.0 105.524 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.72 77.11 0.45 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.238 1.015 . . . . 0.0 109.4 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.48 139.51 35.75 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.851 0.86 . . . . 0.0 109.651 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.61 147.08 39.88 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.218 2.612 . . . . 0.0 109.771 175.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.26 -38.6 68.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.771 1.228 . . . . 0.0 113.304 -168.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.91 -44.03 14.27 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.419 1.488 . . . . 0.0 112.073 170.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -76.8 -33.04 58.01 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 117.898 -1.049 . . . . 0.0 111.13 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -64.48 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 CA-C-N 120.012 1.278 . . . . 0.0 109.77 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -44.8 -37.46 3.84 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.519 1.127 . . . . 0.0 112.083 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.2 mmt -90.39 -42.03 11.15 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.599 1.16 . . . . 0.0 111.218 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.66 -39.49 68.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.928 0.891 . . . . 0.0 112.872 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -69.23 7.06 0.82 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -172.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -131.78 12.2 4.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.275 0.943 . . . . 0.0 111.935 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.4 mm -87.19 105.97 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -105.31 105.32 51.69 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 123.836 0.854 . . . . 0.0 108.758 -175.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.851 ' HD2' HG11 ' A' ' 8' ' ' VAL . 11.3 Cg_endo -65.19 178.69 1.85 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.517 2.145 . . . . 0.0 115.14 -177.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.32 114.96 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 169.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.6 t -107.28 92.34 2.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 124.542 1.137 . . . . 0.0 108.494 -169.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -97.4 138.36 34.97 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.762 2.025 . . . . 0.0 108.476 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.7 mt -136.02 136.09 49.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 C-N-CA 123.49 0.716 . . . . 0.0 109.847 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -128.26 142.62 51.1 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.963 2.105 . . . . 0.0 108.345 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -125.42 158.57 34.05 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.64 1.176 . . . . 0.0 111.463 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.12 161.18 42.06 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 127.389 2.276 . . . . 0.0 109.017 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.72 -66.29 0.14 Allowed Glycine 0 C--N 1.344 0.975 0 C-N-CA 127.144 2.307 . . . . 0.0 113.822 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -124.73 33.06 5.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.885 1.274 . . . . 0.0 109.831 171.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.258 16.4 t70 -140.26 147.62 40.24 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.089 0.859 . . . . 0.0 112.541 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -146.17 134.52 21.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.752 0.821 . . . . 0.0 109.851 -174.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.3 t -133.1 127.91 55.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.46 153.25 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 124.027 0.931 . . . . 0.0 108.851 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.0 m -141.21 81.06 1.77 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.5 m -106.33 80.08 1.45 Allowed 'General case' 0 C--N 1.339 0.15 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -107.45 144.43 34.39 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.034 0.934 . . . . 0.0 111.098 -167.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.7 p -127.86 150.93 74.76 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 126.918 2.087 . . . . 0.0 106.457 171.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.61 59.79 4.96 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.596 2.198 . . . . 0.0 109.991 166.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.3 ttt-85 -168.31 -60.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.443 1.097 . . . . 0.0 110.89 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -120.04 173.45 7.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.736 2.014 . . . . 0.0 109.252 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.2 m -137.94 117.18 12.68 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.931 0.892 . . . . 0.0 111.017 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 t -128.31 80.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 170.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -109.27 65.99 0.63 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -69.29 153.4 43.68 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.178 0.591 . . . . 0.0 110.452 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.3 t -154.34 144.15 21.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.292 1.037 . . . . 0.0 108.616 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -161.65 152.48 17.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.948 0.404 . . . . 0.0 110.83 174.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.8 m -81.71 -106.5 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.7 mt -152.92 -75.97 0.13 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 171.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.61 48.48 0.93 Allowed Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.95 -80.33 0.44 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.447 1.099 . . . . 0.0 108.872 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -143.3 162.61 35.22 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.432 1.093 . . . . 0.0 110.329 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.85 123.13 7.73 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.702 0.801 . . . . 0.0 111.484 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -99.69 102.7 14.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.657 1.983 . . . . 0.0 108.079 174.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.5 mm -121.69 124.09 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 t -108.24 -179.14 3.8 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.514 0.725 . . . . 0.0 110.291 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 t -120.36 -177.38 3.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.077 1.351 . . . . 0.0 110.198 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 60.9 mmm -109.45 -91.21 0.45 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.476 1.51 . . . . 0.0 107.141 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -114.18 -35.59 4.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.434 1.494 . . . . 0.0 109.499 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.83 72.32 0.11 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.2 96.59 2.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.023 0.929 . . . . 0.0 109.579 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -115.12 147.54 40.11 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.217 1.007 . . . . 0.0 111.029 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.54 165.88 11.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.669 1.588 . . . . 0.0 109.703 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -155.58 78.12 0.99 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.5 p -159.38 169.62 23.58 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.567 1.147 . . . . 0.0 109.857 -174.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.8 m -115.75 92.11 3.81 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 m -60.07 146.03 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.341 1.056 . . . . 0.0 110.921 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -163.55 -164.22 0.9 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.788 0.835 . . . . 0.0 109.122 -169.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.4 160.4 31.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.641 1.976 . . . . 0.0 107.877 172.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.65 -64.51 1.18 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.249 1.02 . . . . 0.0 109.31 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -132.96 -66.37 0.67 Allowed 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.689 1.196 . . . . 0.0 108.149 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.28 29.1 0.79 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.217 0.913 . . . . 0.0 111.208 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -133.43 135.97 44.91 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.31 1.444 . . . . 0.0 107.212 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.5 mt -72.4 86.41 1.14 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.953 1.301 . . . . 0.0 110.072 -172.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.73 141.22 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 122.832 0.453 . . . . 0.0 111.266 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -131.71 154.3 49.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.798 1.639 . . . . 0.0 107.107 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -70.46 -164.18 0.08 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.005 0.922 . . . . 0.0 110.98 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 36.7 p -75.08 66.73 1.66 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.509 1.124 . . . . 0.0 112.641 -175.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -132.39 126.01 32.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.536 1.534 . . . . 0.0 108.053 172.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.79 52.56 2.06 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.872 0.869 . . . . 0.0 109.281 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.86 28.04 1.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.821 0.849 . . . . 0.0 111.965 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.9 p -170.84 -80.99 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.032 0.933 . . . . 0.0 109.084 -171.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -158.48 175.04 14.2 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.46 1.104 . . . . 0.0 108.35 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -84.71 -135.52 0.05 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -118.46 114.52 23.0 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -147.17 149.1 32.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.082 0.953 . . . . 0.0 108.943 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 p -168.62 165.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.423 1.089 . . . . 0.0 108.774 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.55 156.03 42.43 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.508 0.723 . . . . 0.0 110.148 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -31.34 -55.27 0.31 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 127.234 2.35 . . . . 0.0 114.676 -173.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -136.23 28.37 3.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.465 1.106 . . . . 0.0 110.759 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -145.93 149.71 34.72 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.81 1.244 . . . . 0.0 110.112 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 38.1 mtt -130.02 110.54 11.72 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 m -117.2 50.97 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.357 0.663 . . . . 0.0 110.875 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -86.38 116.55 24.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.835 0.854 . . . . 0.0 109.074 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.2 m -102.21 127.8 49.0 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.7 mt -103.99 88.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 123.519 0.728 . . . . 0.0 109.382 -160.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.5 t -80.35 100.32 8.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.501 1.52 . . . . 0.0 107.838 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -102.06 -136.84 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.914 1.286 . . . . 0.0 108.893 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.9 -72.72 0.9 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.827 0.727 . . . . 0.0 111.488 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -123.06 49.08 0.91 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 17' ' ' PHE . 1.1 t -150.81 147.86 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.833 1.653 . . . . 0.0 108.509 -170.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 t -150.63 97.78 2.55 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.58 126.19 51.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.163 0.985 . . . . 0.0 110.335 -163.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.8 mp -79.84 66.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -86.35 141.55 29.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -168.53 143.25 3.35 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.3 p -133.82 151.64 51.62 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.888 1.275 . . . . 0.0 109.083 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -117.46 141.94 47.74 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.192 0.997 . . . . 0.0 109.11 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.0 ttp85 -75.57 147.83 39.34 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.867 176.779 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.782 ' HB3' HD13 ' A' ' 40' ' ' ILE . 19.7 m-85 . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 p -25.48 90.89 0.01 OUTLIER 'General case' 0 C--N 1.342 0.252 0 C-N-CA 128.179 2.591 . . . . 0.0 114.197 -163.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.4 ' H ' HG23 ' A' ' 40' ' ' ILE . . . 178.08 -150.44 9.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.6 p -108.21 142.88 37.79 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.862 1.265 . . . . 0.0 107.891 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -145.7 133.62 21.31 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.838 0.855 . . . . 0.0 110.158 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -139.35 127.03 21.87 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.904 0.882 . . . . 0.0 109.106 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.485 HG11 ' HG2' ' A' ' 36' ' ' PRO . 1.9 m -72.76 135.89 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -125.5 -29.86 3.16 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.196 0.31 . . . . 0.0 111.746 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.3 112.77 7.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.495 0.718 . . . . 0.0 110.483 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -105.23 -160.81 0.77 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -135.8 -101.64 0.22 Allowed 'General case' 0 C--N 1.343 0.283 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.977 170.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -81.21 66.54 6.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.163 0.892 . . . . 0.0 110.66 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.99 -28.34 70.03 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.315 1.046 . . . . 0.0 110.681 -175.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -62.49 -55.59 26.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.212 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -59.67 -39.02 83.11 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.413 ' HA ' HG21 ' A' ' 116' ' ' VAL . 5.0 t80 -52.95 -52.97 56.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.145 176.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.12 -29.1 63.74 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.328 1.051 . . . . 0.0 112.696 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -37.76 75.59 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.994 0.816 . . . . 0.0 110.877 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.81 -33.9 76.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.482 0.713 . . . . 0.0 111.618 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.99 156.09 32.14 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.852 0.461 . . . . 0.0 110.485 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.78 35.49 0.84 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.281 1.033 . . . . 0.0 112.169 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 mp -88.58 139.29 29.71 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.61 157.83 54.98 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.587 2.192 . . . . 0.0 110.473 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -62.17 -36.86 83.16 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -166.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -61.16 -48.79 79.96 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.285 0.634 . . . . 0.0 110.206 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -20.18 64.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.701 1.2 . . . . 0.0 110.907 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.42 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 46.8 mt -78.22 -37.0 21.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.896 0.771 . . . . 0.0 110.845 171.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.56 -38.38 80.96 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.0 ttt -63.92 -51.98 61.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.915 1.286 . . . . 0.0 110.52 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 28' ' ' ILE . . . -52.71 -39.89 62.46 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.245 1.418 . . . . 0.0 112.479 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.17 -16.23 19.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.053 1.341 . . . . 0.0 112.306 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -121.14 18.05 11.59 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 mm -79.37 123.52 36.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.09 101.48 30.48 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 168.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.485 ' HG2' HG11 ' A' ' 8' ' ' VAL . 92.8 Cg_endo -74.52 179.9 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.402 1.401 . . . . 0.0 111.302 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -131.02 158.63 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 168.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.6 t -132.39 121.8 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 165.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -125.48 95.57 4.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.265 2.226 . . . . 0.0 105.086 -170.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.782 HD13 ' HB3' ' A' ' 2' ' ' PHE . 13.8 tt -118.5 140.5 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.669 1.188 . . . . 0.0 111.227 -165.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -139.59 143.93 37.52 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.517 1.127 . . . . 0.0 109.742 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.48 147.36 31.79 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.908 1.283 . . . . 0.0 111.117 -175.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -135.49 163.47 30.01 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 129.05 2.94 . . . . 0.0 107.456 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -20.5 -72.24 0.01 OUTLIER Glycine 0 C--N 1.344 0.982 0 C-N-CA 127.618 2.533 . . . . 0.0 114.338 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -127.19 30.87 5.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.526 1.531 . . . . 0.0 109.32 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -131.43 152.32 50.77 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.523 0.601 . . . . 0.0 112.107 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -138.03 130.58 29.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.022 0.929 . . . . 0.0 109.837 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.14 127.46 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.2 t -127.8 109.37 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.243 1.417 . . . . 0.0 109.491 -173.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -107.43 102.15 11.45 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.496 1.118 . . . . 0.0 108.096 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 t -105.7 111.34 23.98 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -108.25 129.05 55.22 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.331 0.653 . . . . 0.0 109.909 -171.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 p -134.55 150.0 72.5 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 126.161 1.784 . . . . 0.0 107.957 171.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.52 73.93 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.768 2.979 . . . . 0.0 109.56 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -167.63 -52.16 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.786 1.634 . . . . 0.0 108.137 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.14 150.41 11.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.632 1.173 . . . . 0.0 107.878 176.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.4 p -80.1 94.84 6.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.6 72.57 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.5 m -97.65 128.76 44.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.29 1.436 . . . . 0.0 108.489 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -145.35 162.62 36.81 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.746 1.218 . . . . 0.0 107.997 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.3 m -150.68 141.53 22.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.36 137.44 27.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.917 0.487 . . . . 0.0 110.618 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.0 m -98.47 141.59 31.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.757 1.223 . . . . 0.0 107.856 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.6 mt -68.09 -57.71 5.66 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.804 0.842 . . . . 0.0 110.634 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.34 57.9 4.66 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -169.58 138.58 1.93 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.736 1.614 . . . . 0.0 107.172 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -58.5 129.08 40.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.047 0.539 . . . . 0.0 109.71 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.22 157.0 47.37 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.659 1.183 . . . . 0.0 110.628 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -144.99 158.98 43.64 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.222 1.409 . . . . 0.0 108.845 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.1 mm -105.95 148.9 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 125.457 1.503 . . . . 0.0 109.694 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.8 m -105.54 153.85 21.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.851 1.66 . . . . 0.0 109.891 -171.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 m -44.67 142.73 1.59 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.764 2.026 . . . . 0.0 112.727 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.16 176.82 8.14 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.835 1.254 . . . . 0.0 110.242 -172.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.64 -73.34 0.68 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.492 1.517 . . . . 0.0 107.78 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.01 95.59 0.16 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -157.99 -54.66 0.07 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -132.54 178.68 6.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.539 1.536 . . . . 0.0 109.907 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tp -150.01 149.08 29.84 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.713 1.205 . . . . 0.0 108.956 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -70.65 101.97 2.18 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.0 p -144.05 -170.47 3.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.351 1.46 . . . . 0.0 109.531 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.6 m -107.36 110.49 22.5 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.308 1.043 . . . . 0.0 108.805 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.4 m -78.34 136.78 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.287 0.635 . . . . 0.0 110.658 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -165.66 118.47 1.14 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.323 1.049 . . . . 0.0 109.257 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -109.32 131.42 55.09 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 172.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.96 -67.58 0.9 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.11 62.79 0.23 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.29 -87.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -128.94 159.27 36.37 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.259 1.423 . . . . 0.0 108.895 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 tt -74.16 81.79 1.79 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.112 0.965 . . . . 0.0 108.77 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.7 p -74.51 142.76 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.518 0.727 . . . . 0.0 110.235 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.0 t -165.36 174.23 10.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.322 1.449 . . . . 0.0 108.218 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -148.32 152.73 37.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.838 0.855 . . . . 0.0 110.658 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 99.4 p -164.24 -144.58 0.08 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.975 1.31 . . . . 0.0 108.625 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -82.52 -151.53 0.1 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.945 1.298 . . . . 0.0 110.153 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -77.75 65.47 3.22 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.031 1.332 . . . . 0.0 110.523 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -147.38 149.98 33.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.361 1.464 . . . . 0.0 108.746 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.0 t -152.93 103.32 2.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -59.65 -38.34 81.16 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.408 1.083 . . . . 0.0 110.913 173.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -155.66 150.48 26.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.588 1.155 . . . . 0.0 108.631 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -115.85 -55.14 2.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.369 1.068 . . . . 0.0 108.921 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.43 153.72 42.21 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.638 0.775 . . . . 0.0 111.094 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.7 t -139.86 142.18 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.897 1.679 . . . . 0.0 107.02 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -105.83 154.21 20.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -41.34 -38.33 1.95 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.554 1.549 . . . . 0.0 115.018 -172.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.28 40.15 1.92 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.91 0.884 . . . . 0.0 110.681 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -167.15 116.18 0.84 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.608 0.763 . . . . 0.0 110.496 173.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -99.69 127.05 45.81 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 169.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.11 173.58 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.871 0.869 . . . . 0.0 112.765 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -43.13 88.06 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.803 2.841 . . . . 0.0 115.826 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.8 t -165.43 131.0 2.57 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 tp -172.54 121.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.546 1.938 . . . . 0.0 106.802 167.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 m -112.0 125.81 54.47 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -129.35 161.96 29.08 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.936 1.294 . . . . 0.0 109.766 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -2.94 -74.93 0.01 OUTLIER Glycine 0 C--N 1.346 1.129 0 C-N-CA 129.249 3.309 . . . . 0.0 115.693 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -144.11 47.79 0.76 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' A' ' 17' ' ' PHE . 2.0 p -165.69 131.69 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -127.32 135.8 51.05 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.06 158.17 28.43 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.97 1.308 . . . . 0.0 110.46 -169.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 mp -97.71 113.97 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 172.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 tpt85 -123.26 114.02 19.68 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.235 1.414 . . . . 0.0 109.431 -174.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -111.11 110.95 21.71 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.902 0.881 . . . . 0.0 109.452 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.4 p -114.63 130.3 56.78 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 122.1 0.953 . . . . 0.0 109.504 169.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -113.91 143.82 44.07 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -173.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.25 165.67 11.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.162 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.033 -1.936 . . . . 0.0 108.352 178.813 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.457 -0.117 0 N-CA-C 110.761 -0.088 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 t -138.57 40.99 2.21 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.445 1.098 . . . . 0.0 108.753 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.98 172.55 53.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.257 0.932 . . . . 0.0 113.74 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 m -148.85 109.44 4.21 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -143.21 157.72 44.25 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.141 1.376 . . . . 0.0 111.121 -166.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -139.95 134.43 31.54 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 124.066 0.947 . . . . 0.0 111.073 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.59 HG11 ' HD2' ' A' ' 36' ' ' PRO . 8.1 p -62.5 150.81 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 127.029 2.132 . . . . 0.0 112.103 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -146.3 -6.85 0.55 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 163.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . . . -152.64 76.65 1.15 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.776 0.43 . . . . 0.0 110.142 -164.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.75 103.2 15.1 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -77.89 0.06 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.54 1.136 . . . . 0.0 113.043 -171.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -85.48 51.1 2.1 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.866 0.866 . . . . 0.0 111.122 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -43.5 77.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.54 1.136 . . . . 0.0 111.777 -168.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.9 -38.8 92.41 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.874 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -61.88 -48.21 81.53 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.507 0.594 . . . . 0.0 110.783 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.612 ' HA ' HG21 ' A' ' 116' ' ' VAL . 30.5 t80 -55.92 -47.16 78.01 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.141 1.376 . . . . 0.0 111.406 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.25 -43.08 74.7 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.143 0.577 . . . . 0.0 112.301 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -78.92 67.99 4.76 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.111 0.964 . . . . 0.0 109.963 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.05 -44.88 0.06 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.176 1.79 . . . . 0.0 108.614 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -83.07 147.69 27.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.579 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.67 52.32 2.36 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.755 1.222 . . . . 0.0 112.674 -162.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mt -92.01 147.16 34.24 Favored Pre-proline 0 N--CA 1.453 -0.275 0 C-N-CA 124.518 1.127 . . . . 0.0 108.758 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.46 151.8 48.2 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.323 2.015 . . . . 0.0 109.559 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -62.24 -28.77 69.93 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -170.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -63.11 -44.97 94.18 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.345 0.52 . . . . 0.0 110.548 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.81 -41.78 99.44 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.24 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.53 -34.47 61.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 118.525 0.602 . . . . 0.0 111.377 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.91 -44.08 73.88 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.765 0.711 . . . . 0.0 110.469 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.56 -47.09 57.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.827 0.851 . . . . 0.0 110.643 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.41 -46.2 73.11 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 111.823 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -65.59 -30.56 71.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.186 2.194 . . . . 0.0 110.818 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -108.17 50.71 0.77 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.363 1.465 . . . . 0.0 108.984 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.39 150.91 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.068 1.347 . . . . 0.0 109.118 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -128.2 99.91 24.09 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.099 1.359 . . . . 0.0 109.756 -170.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.59 ' HD2' HG11 ' A' ' 8' ' ' VAL . 83.8 Cg_endo -70.86 160.13 50.37 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.062 2.508 . . . . 0.0 113.78 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.494 HD12 ' HG3' ' A' ' 39' ' ' GLU . 8.3 pt -105.6 170.97 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 168.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.1 t -141.25 103.73 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HG3' HD12 ' A' ' 37' ' ' ILE . 67.0 mm-40 -123.69 101.21 7.17 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.204 2.602 . . . . 0.0 106.053 -167.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.6 mt -108.87 150.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.526 0.731 . . . . 0.0 110.031 -171.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -134.25 119.74 19.12 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.051 1.34 . . . . 0.0 108.716 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -83.9 153.28 24.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.72 1.608 . . . . 0.0 109.425 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.34 152.99 10.99 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.984 1.714 . . . . 0.0 108.235 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -20.6 -69.77 0.01 OUTLIER Glycine 0 C--N 1.344 0.99 0 C-N-CA 127.733 2.587 . . . . 0.0 113.969 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -125.94 20.71 7.64 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.786 1.235 . . . . 0.0 110.568 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.35 134.26 55.03 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.409 1.004 . . . . 0.0 109.887 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -134.42 101.31 4.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.5 t -107.98 116.18 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -174.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 p -111.91 125.06 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.522 1.129 . . . . 0.0 109.72 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 m -107.52 95.11 5.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 t -107.82 63.15 0.62 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -102.14 162.55 12.83 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.343 0.657 . . . . 0.0 110.314 -170.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.54 162.36 55.26 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.476 1.111 . . . . 0.0 108.341 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.04 51.37 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.461 2.774 . . . . 0.0 111.433 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 178.57 -58.6 0.01 OUTLIER 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.19 1.796 . . . . 0.0 109.013 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -95.66 155.83 16.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.137 1.375 . . . . 0.0 109.571 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.6 p -132.44 109.61 9.94 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.819 0.848 . . . . 0.0 110.672 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -129.76 87.86 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.6 m -110.26 136.73 49.01 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 171.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -137.02 150.81 48.33 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.2 p -144.05 94.25 2.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.9 0.88 . . . . 0.0 108.781 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.426 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -105.76 104.32 14.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.07 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.1 m -76.68 126.77 31.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 164.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.7 mt -57.46 -56.43 21.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.774 0.829 . . . . 0.0 111.376 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.51 53.66 4.85 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -167.16 148.44 5.77 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.885 0.874 . . . . 0.0 109.387 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 67' ' ' GLU . 3.1 mp0 -53.67 107.08 0.22 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.345 1.458 . . . . 0.0 108.896 170.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.426 ' CB ' ' HB3' ' A' ' 62' ' ' PHE . . . -112.53 58.98 0.64 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.237 0.615 . . . . 0.0 110.951 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -100.3 101.12 12.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 171.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.52 143.22 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 125.227 1.411 . . . . 0.0 107.801 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.4 t -158.8 152.2 22.83 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.124 0.97 . . . . 0.0 109.322 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 t -167.84 -47.06 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.098 1.359 . . . . 0.0 108.988 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -75.6 165.44 25.07 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.382 1.073 . . . . 0.0 108.851 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.28 74.24 1.73 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.706 0.802 . . . . 0.0 109.025 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.21 58.54 0.1 OUTLIER Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.051 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.48 91.75 1.93 Allowed 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -124.93 58.2 1.26 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.353 1.061 . . . . 0.0 109.58 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.76 173.01 17.21 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.349 1.06 . . . . 0.0 110.369 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -116.72 143.06 46.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.323 1.449 . . . . 0.0 108.321 172.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.3 p -163.17 164.48 25.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.331 1.052 . . . . 0.0 109.314 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 88.2 m -135.37 108.01 7.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.2 137.5 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.83 169.87 21.19 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.734 0.413 . . . . 0.0 110.556 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -137.12 136.39 38.25 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.451 1.5 . . . . 0.0 107.609 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.57 -60.3 1.59 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.566 1.146 . . . . 0.0 108.972 -176.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -161.79 -57.42 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.602 0.761 . . . . 0.0 109.629 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.51 -59.47 8.76 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.896 0.76 . . . . 0.0 112.167 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -158.85 172.98 17.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.55 1.14 . . . . 0.0 109.068 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.84 162.35 20.59 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.999 0.52 . . . . 0.0 112.276 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.98 144.21 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.324 1.449 . . . . 0.0 108.901 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.7 m -114.45 -66.45 1.09 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.593 1.557 . . . . 0.0 109.224 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -165.59 159.43 16.58 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.22 1.408 . . . . 0.0 107.673 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.5 p -62.69 170.25 2.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.643 1.177 . . . . 0.0 112.751 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -50.84 106.42 0.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.373 1.469 . . . . 0.0 112.091 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.7 mttm 179.11 -55.9 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 126.62 1.968 . . . . 0.0 106.99 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -77.39 -55.09 5.69 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.942 1.297 . . . . 0.0 110.888 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.2 m -157.71 -37.63 0.07 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.274 -0.87 . . . . 0.0 113.229 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 9.16 80.63 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.294 2.237 . . . . 0.0 113.574 -159.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -128.05 93.97 3.81 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.721 2.008 . . . . 0.0 107.031 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -151.26 74.84 1.16 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.742 0.817 . . . . 0.0 111.472 -172.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -176.66 129.86 0.19 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.044 1.338 . . . . 0.0 109.023 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.53 155.81 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.9 0.88 . . . . 0.0 108.694 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -114.13 160.18 19.23 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.921 1.288 . . . . 0.0 109.282 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -31.05 -56.07 0.28 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 127.533 2.492 . . . . 0.0 115.056 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -128.58 29.56 5.27 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.976 0.911 . . . . 0.0 111.772 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.55 107.07 3.78 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.14 0.427 . . . . 0.0 110.598 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 40.1 ttm -84.46 86.79 7.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.6 m -123.78 122.96 65.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.122 1.369 . . . . 0.0 109.294 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.44 175.59 3.53 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.318 1.047 . . . . 0.0 109.029 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.2 p -106.43 152.68 23.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.361 1.065 . . . . 0.0 110.304 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.5 mt -104.2 106.9 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 m -89.81 99.71 12.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -123.86 -179.86 4.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.539 1.536 . . . . 0.0 109.552 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -46.96 117.25 2.94 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 125.063 1.316 . . . . 0.0 110.77 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 8.11 59.26 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 128.361 2.886 . . . . 0.0 114.875 -156.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.612 HG21 ' HA ' ' A' ' 17' ' ' PHE . 2.0 t -140.85 144.75 26.41 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 126.008 1.723 . . . . 0.0 108.759 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.0 m -136.31 101.55 4.71 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.02 102.85 12.32 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.97 98.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.243 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 168.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -98.96 105.32 17.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.561 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 45.7 ttt85 -108.26 111.7 23.8 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 -173.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.3 t -124.6 149.92 46.54 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.201 1.8 . . . . 0.0 108.716 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -125.23 146.16 49.65 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.825 1.25 . . . . 0.0 109.693 -170.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.75 148.57 42.46 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.061 0.944 . . . . 0.0 111.004 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--O 1.25 1.087 0 CA-C-O 117.46 -1.257 . . . . 0.0 110.501 175.313 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 119.531 -0.271 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.1 p -38.01 108.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.654 1.982 . . . . 0.0 113.367 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.01 -179.17 46.47 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.3 t -107.57 134.42 50.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.019 1.328 . . . . 0.0 107.639 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -133.66 118.76 18.54 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.432 0.693 . . . . 0.0 110.209 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -102.75 93.43 5.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.971 1.308 . . . . 0.0 109.539 -172.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.463 ' CG1' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -53.95 129.37 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.069 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -145.62 10.06 1.21 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.37 0.419 . . . . 0.0 111.784 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . . . -161.33 105.76 1.31 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 122.7 0.4 . . . . 0.0 110.238 -161.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.66 -167.16 1.48 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.18 1.392 . . . . 0.0 108.591 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.536 ' HB2' HG22 ' A' ' 119' ' ' ILE . 31.0 tt0 -135.52 -104.24 0.22 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.966 0.803 . . . . 0.0 111.141 -174.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -75.46 67.62 2.02 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.219 1.008 . . . . 0.0 109.356 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -81.52 -45.31 16.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.166 0.586 . . . . 0.0 112.412 -169.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.0 -43.38 91.5 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.383 0.538 . . . . 0.0 110.468 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -61.0 -50.93 71.37 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.527 1.131 . . . . 0.0 110.44 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.412 ' CD2' HD21 ' A' ' 118' ' ' LEU . 10.2 t80 -56.64 -49.06 76.11 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.097 0.959 . . . . 0.0 110.134 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -58.75 -46.38 87.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.269 1.028 . . . . 0.0 111.667 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -65.79 -24.42 66.92 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.287 0.635 . . . . 0.0 111.83 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.35 -23.99 60.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.613 0.765 . . . . 0.0 111.03 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.0 mt -84.14 -162.12 0.62 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.97 41.57 2.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.045 0.938 . . . . 0.0 111.381 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.0 127.8 31.16 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.3 164.86 33.17 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.582 2.854 . . . . 0.0 113.615 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -59.48 -44.95 92.92 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.11 1.764 . . . . 0.0 112.514 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -54.58 -46.63 73.76 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.486 0.714 . . . . 0.0 110.577 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.29 -43.43 86.34 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.501 -0.762 . . . . 0.0 109.986 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.35 -41.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 CA-C-N 118.747 0.703 . . . . 0.0 111.618 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -42.96 -43.35 4.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.129 1.372 . . . . 0.0 111.44 173.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 19.7 mmt -102.11 -1.88 30.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.938 1.695 . . . . 0.0 112.536 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.56 -51.04 6.13 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.766 1.226 . . . . 0.0 110.704 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -56.83 -39.83 74.94 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.402 0.681 . . . . 0.0 111.471 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.65 -37.28 79.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.11 1.364 . . . . 0.0 111.55 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -51.14 142.62 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.503 1.121 . . . . 0.0 111.74 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -119.08 98.39 50.85 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 125.43 1.492 . . . . 0.0 107.209 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.463 ' HD2' ' CG1' ' A' ' 8' ' ' VAL . 17.0 Cg_exo -63.57 176.09 2.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.803 2.335 . . . . 0.0 112.396 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.67 131.36 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 169.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.2 t -113.08 96.58 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -103.88 101.31 11.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.869 2.067 . . . . 0.0 107.778 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.46 138.36 32.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -173.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -141.42 131.5 24.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.455 1.102 . . . . 0.0 108.994 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -104.15 150.66 24.15 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.441 1.497 . . . . 0.0 110.053 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -152.38 155.4 37.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.394 1.878 . . . . 0.0 108.863 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -21.1 -68.18 0.01 OUTLIER Glycine 0 C--N 1.345 1.035 0 C-N-CA 127.563 2.506 . . . . 0.0 114.115 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -123.81 12.96 9.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.946 1.298 . . . . 0.0 110.893 172.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -114.38 143.53 44.76 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.334 0.97 . . . . 0.0 110.09 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -141.55 110.17 6.06 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.0 t -108.25 122.21 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.883 1.273 . . . . 0.0 108.599 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.15 104.52 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.01 1.324 . . . . 0.0 107.786 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.8 m -101.3 82.8 2.38 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.8 p -102.93 98.96 8.85 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -137.37 140.02 41.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.314 -162.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 p -130.38 157.02 78.62 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 126.277 1.831 . . . . 0.0 106.873 167.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.26 60.67 6.41 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.167 2.578 . . . . 0.0 108.707 168.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -169.84 -67.57 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.639 1.176 . . . . 0.0 109.66 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -106.83 156.31 18.81 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.864 1.266 . . . . 0.0 110.07 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -123.15 70.17 1.02 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.219 1.408 . . . . 0.0 108.731 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.3 t -71.95 -46.75 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -6.48 106.11 0.01 OUTLIER 'General case' 0 C--N 1.345 0.408 0 C-N-CA 129.386 3.074 . . . . 0.0 114.244 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -104.81 156.74 17.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.728 1.211 . . . . 0.0 109.693 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.1 t -158.94 95.18 1.27 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.45 163.7 22.07 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.639 0.776 . . . . 0.0 111.297 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.8 m -133.46 150.77 51.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.89 1.676 . . . . 0.0 107.191 -176.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.3 mt -65.46 -60.15 3.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.474 0.31 . . . . 0.0 111.479 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.3 47.75 1.01 Allowed Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.317 0.96 . . . . 0.0 111.122 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -164.99 144.09 6.73 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -57.13 165.14 1.42 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.843 1.257 . . . . 0.0 112.591 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.22 98.79 2.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.504 0.721 . . . . 0.0 109.46 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -89.47 83.34 6.35 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.413 1.085 . . . . 0.0 109.899 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.93 167.02 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 125.345 1.458 . . . . 0.0 109.695 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.2 t -162.2 176.01 11.08 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.013 0.925 . . . . 0.0 110.053 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 t -113.49 121.28 43.78 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.241 1.416 . . . . 0.0 108.223 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.45 85.23 7.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -169.71 -70.03 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.099 0.959 . . . . 0.0 111.514 174.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.39 -119.19 3.24 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 124.748 1.166 . . . . 0.0 111.094 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -108.46 171.79 7.22 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.787 1.235 . . . . 0.0 109.158 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -154.69 131.07 10.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.924 0.89 . . . . 0.0 108.834 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.19 136.28 48.14 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.859 1.263 . . . . 0.0 109.399 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -147.81 124.32 11.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.2 t -106.98 -65.78 1.07 Allowed 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -150.7 127.61 11.06 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.1 m -104.26 49.75 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.275 1.43 . . . . 0.0 110.06 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -91.45 -179.28 5.34 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.399 1.079 . . . . 0.0 111.349 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -154.85 139.96 17.46 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.741 2.017 . . . . 0.0 106.796 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.45 -72.11 0.73 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.821 0.848 . . . . 0.0 110.093 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -95.39 -67.84 0.83 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.877 0.871 . . . . 0.0 110.248 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.64 48.49 0.22 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -158.96 128.92 5.74 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.379 1.072 . . . . 0.0 109.337 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.04 135.64 51.24 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.976 1.31 . . . . 0.0 109.872 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.5 p -158.7 154.56 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.05 1.34 . . . . 0.0 108.545 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.5 m -135.37 127.58 30.05 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.516 1.126 . . . . 0.0 108.253 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.6 88.63 2.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.922 0.889 . . . . 0.0 110.36 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.2 m -130.46 83.76 2.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.944 1.298 . . . . 0.0 109.235 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.04 76.67 2.9 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.0 -52.97 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 126.822 2.049 . . . . 0.0 106.897 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -98.95 91.81 5.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.546 1.539 . . . . 0.0 107.504 171.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -99.8 118.72 36.88 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.992 0.917 . . . . 0.0 109.441 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -126.21 103.76 7.86 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.394 1.077 . . . . 0.0 109.001 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -69.89 134.39 48.38 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -108.61 49.2 0.82 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.463 1.105 . . . . 0.0 110.767 -171.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -81.3 83.66 6.82 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.4 p -108.27 128.55 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.346 1.458 . . . . 0.0 108.971 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -122.06 156.5 33.41 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.11 1.364 . . . . 0.0 109.075 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -26.13 -60.39 0.08 OUTLIER Glycine 0 CA--C 1.53 1.013 0 C-N-CA 127.562 2.505 . . . . 0.0 115.487 -173.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -131.51 28.24 4.65 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.848 0.859 . . . . 0.0 111.571 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -155.35 119.5 4.61 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 41.8 ttm -106.12 115.22 29.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.03 61.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.844 1.258 . . . . 0.0 108.69 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -73.08 165.37 25.15 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.06 0.944 . . . . 0.0 110.952 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m -131.44 96.88 4.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 173.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 pp -106.65 134.91 46.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 94.2 m -129.83 137.76 50.63 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.039 1.336 . . . . 0.0 111.046 -167.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -108.34 179.45 4.2 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.199 2.2 . . . . 0.0 107.594 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -18.95 -56.55 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 128.139 2.78 . . . . 0.0 115.334 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -155.05 36.01 0.66 Allowed Glycine 0 CA--C 1.532 1.116 0 CA-C-O 118.689 -1.062 . . . . 0.0 114.072 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -146.26 151.61 14.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.32 0 CA-C-N 118.778 1.289 . . . . 0.0 109.037 170.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 87.3 m -128.53 142.95 50.91 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.423 1.489 . . . . 0.0 110.254 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.412 HD21 ' CD2' ' A' ' 17' ' ' PHE . 1.6 mm? -108.43 146.88 32.43 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.536 HG22 ' HB2' ' A' ' 12' ' ' GLU . 8.8 tp -80.17 63.35 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 170.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -52.23 97.3 0.02 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 126.19 1.796 . . . . 0.0 111.56 -170.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.461 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 64.3 ttt180 -125.32 113.68 17.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.919 0.887 . . . . 0.0 110.124 -169.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 56.4 p -126.36 144.68 50.73 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.505 1.522 . . . . 0.0 109.692 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -114.39 142.34 46.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.398 1.479 . . . . 0.0 108.952 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.66 98.59 6.26 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.7 t . . . . . 0 C--O 1.252 1.199 0 CA-C-O 116.494 -1.717 . . . . 0.0 107.144 175.394 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 . . . . . 0 CA--C 1.53 0.178 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 p -50.32 95.5 0.01 OUTLIER 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.303 1.841 . . . . 0.0 112.198 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.73 -171.38 44.45 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -106.83 142.38 36.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 168.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -142.41 124.47 15.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.178 0.991 . . . . 0.0 109.387 -169.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -119.78 112.11 18.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.096 0.958 . . . . 0.0 109.239 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.811 HG11 ' HD2' ' A' ' 36' ' ' PRO . 1.4 p -63.94 121.46 12.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 C-N-CA 124.109 0.964 . . . . 0.0 109.853 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -113.65 -24.22 9.32 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.538 0.735 . . . . 0.0 110.981 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.63 143.87 28.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.272 1.429 . . . . 0.0 108.113 -169.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.99 162.89 34.33 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.48 -100.93 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.283 0.633 . . . . 0.0 110.869 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -106.97 65.05 0.65 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.546 1.138 . . . . 0.0 110.532 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.0 -41.5 99.6 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.013 0.525 . . . . 0.0 111.16 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -58.35 -24.55 60.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 119.026 -0.511 . . . . 0.0 112.017 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -88.45 -38.78 14.75 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 123.093 0.557 . . . . 0.0 111.89 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.489 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 67.1 t80 -46.14 -41.53 12.63 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.073 0.949 . . . . 0.0 110.49 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.762 HD13 HG23 ' A' ' 28' ' ' ILE . 7.6 mt -78.61 40.16 0.37 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.107 1.763 . . . . 0.0 112.77 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.4 -33.31 1.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.188 0.904 . . . . 0.0 111.852 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.7 98.38 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.239 0.616 . . . . 0.0 110.579 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.419 HD22 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -74.53 168.26 20.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.126 0.97 . . . . 0.0 110.713 175.148 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.74 60.28 0.64 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.698 1.199 . . . . 0.0 111.183 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.419 HD13 HD22 ' A' ' 21' ' ' LEU . 9.4 mp -103.23 148.47 35.72 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.685 1.194 . . . . 0.0 108.583 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.88 158.01 59.23 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.385 2.723 . . . . 0.0 111.52 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . 13.1 pt-20 -57.08 -35.21 69.1 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.53 -35.52 80.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.368 0.667 . . . . 0.0 111.677 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -24.55 64.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.562 0.745 . . . . 0.0 112.219 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.762 HG23 HD13 ' A' ' 18' ' ' LEU . 3.9 mp -70.54 -39.49 76.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -55.65 -52.33 64.18 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 16.4 mmt -83.77 47.18 1.26 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.331 1.052 . . . . 0.0 110.571 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 18' ' ' LEU . . . -151.52 -58.67 0.16 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.757 1.623 . . . . 0.0 109.42 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.1 ptt85 -69.79 -37.31 76.27 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 122.244 -0.285 . . . . 0.0 111.31 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -83.79 37.27 0.58 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.767 0.827 . . . . 0.0 110.424 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.5 mm -130.62 117.31 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.1 96.7 39.84 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.818 1.247 . . . . 0.0 107.764 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.811 ' HD2' HG11 ' A' ' 8' ' ' VAL . 8.3 Cg_exo -72.52 164.85 34.39 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.743 2.295 . . . . 0.0 112.698 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.13 117.18 53.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 166.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.95 140.23 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -148.64 100.32 3.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.065 0.946 . . . . 0.0 109.161 -165.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 mt -108.87 135.7 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.593 0.757 . . . . 0.0 109.624 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -125.05 133.28 53.0 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.15 1.38 . . . . 0.0 108.286 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.1 150.66 21.8 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.448 1.099 . . . . 0.0 110.465 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -140.19 154.13 46.83 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 127.735 2.414 . . . . 0.0 106.729 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.93 -55.28 2.31 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.21 1.386 . . . . 0.0 112.499 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -129.84 61.57 1.57 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.739 1.615 . . . . 0.0 109.194 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.4 155.42 17.66 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.246 0.546 . . . . 0.0 110.789 163.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -139.54 111.85 7.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.841 1.656 . . . . 0.0 106.986 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 80.9 t -106.17 127.72 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -127.42 119.79 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.436 1.094 . . . . 0.0 109.207 -171.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.1 m -107.93 141.08 40.09 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.607 1.563 . . . . 0.0 107.522 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.4 t -148.54 87.43 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.146 1.378 . . . . 0.0 107.353 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 120.21 41.33 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.925 0.89 . . . . 0.0 108.844 -170.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 p -101.19 153.8 37.57 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 124.519 1.127 . . . . 0.0 110.041 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.85 51.29 3.33 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.232 2.621 . . . . 0.0 110.418 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -167.09 -48.41 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.694 1.197 . . . . 0.0 110.441 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -130.59 -166.16 1.65 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.647 1.579 . . . . 0.0 108.903 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.8 m -155.27 130.59 9.63 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.48 1.112 . . . . 0.0 108.222 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -133.12 136.03 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.1 m -152.93 141.87 21.21 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.779 1.232 . . . . 0.0 107.894 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -145.84 166.42 26.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.247 1.419 . . . . 0.0 109.473 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.0 p -157.13 141.87 16.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.845 0.858 . . . . 0.0 109.436 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -169.44 167.32 9.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.533 1.133 . . . . 0.0 108.826 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 m -133.02 164.76 26.28 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.842 0.857 . . . . 0.0 110.294 -167.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.48 -58.85 5.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.286 1.035 . . . . 0.0 110.62 175.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.46 36.18 4.39 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.84 1.21 . . . . 0.0 113.564 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -130.24 128.61 41.99 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.862 1.331 . . . . 0.0 109.236 167.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -66.77 133.17 49.61 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.41 0.684 . . . . 0.0 109.463 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -161.15 107.78 1.43 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.097 0.959 . . . . 0.0 109.575 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.86 150.03 44.64 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.22 0.464 . . . . 0.0 110.027 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.7 mm -108.37 111.59 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.277 1.031 . . . . 0.0 108.483 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.9 t -107.39 155.04 20.45 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.491 1.116 . . . . 0.0 111.032 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.6 p -138.12 137.25 37.51 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.8 1.24 . . . . 0.0 109.023 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.7 ptp -88.44 82.36 7.0 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.371 1.068 . . . . 0.0 110.412 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -155.51 -93.56 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.152 0.581 . . . . 0.0 110.934 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.34 -31.5 0.1 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.465 1.507 . . . . 0.0 111.904 -174.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.06 124.79 7.15 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.953 1.376 . . . . 0.0 111.406 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -94.55 131.38 40.34 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.27 0.628 . . . . 0.0 109.323 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.1 tt -157.51 73.42 0.71 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 171.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -141.9 149.77 40.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.688 1.195 . . . . 0.0 108.513 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -136.89 119.84 16.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.4 m -146.37 71.31 1.24 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 83' ' ' HIS . 9.6 m -131.08 -65.24 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.141 0.576 . . . . 0.0 111.315 -175.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.42 ' N ' HG23 ' A' ' 82' ' ' VAL . 46.3 t-80 -99.51 130.72 45.79 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.189 1.396 . . . . 0.0 110.817 -169.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -125.75 119.04 26.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.773 1.629 . . . . 0.0 107.481 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.98 -53.63 0.48 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.015 0.926 . . . . 0.0 109.901 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -66.86 -60.09 2.97 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.249 0.619 . . . . 0.0 110.58 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.2 -48.69 0.1 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.03 110.46 22.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.5 119.51 7.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.431 1.092 . . . . 0.0 111.216 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.0 p -160.11 162.14 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.875 0.87 . . . . 0.0 109.861 -173.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 m -145.86 -38.5 0.24 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.544 1.138 . . . . 0.0 110.028 173.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -139.68 141.19 37.0 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 125.745 1.618 . . . . 0.0 107.787 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.5 t -168.28 67.56 0.07 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.514 1.126 . . . . 0.0 108.463 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -89.35 -99.49 0.09 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.77 0.828 . . . . 0.0 111.085 -173.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -73.57 -48.97 28.8 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -76.43 74.74 3.19 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.0 m -72.93 93.88 1.78 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -90.43 -16.36 29.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.848 1.259 . . . . 0.0 111.672 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.72 136.84 58.15 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.232 0.613 . . . . 0.0 109.883 -172.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.87 169.07 18.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.149 0.98 . . . . 0.0 110.548 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -123.16 146.38 47.82 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.814 1.646 . . . . 0.0 107.915 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.6 t -139.25 124.94 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -121.51 -173.95 2.75 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.664 1.186 . . . . 0.0 109.506 -169.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -39.3 116.49 0.62 Allowed Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.845 1.688 . . . . 0.0 111.593 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 p30 8.19 56.77 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.835 2.854 . . . . 0.0 115.195 -163.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -158.6 133.74 8.49 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.47 0.708 . . . . 0.0 110.372 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.8 ttt -129.41 129.65 44.97 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.903 2.081 . . . . 0.0 106.032 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.55 -72.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -53.48 142.18 22.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.716 0.806 . . . . 0.0 109.635 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.5 m -139.05 -88.72 0.21 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.869 -175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.75 149.21 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.276 0.944 . . . . 0.0 110.353 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 t -123.02 142.54 50.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.133 0.973 . . . . 0.0 109.485 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -109.26 -164.98 0.98 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.848 1.659 . . . . 0.0 108.383 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.71 -58.93 12.0 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 123.87 0.748 . . . . 0.0 113.255 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -131.55 42.29 1.41 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 123.876 0.75 . . . . 0.0 112.014 -175.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.8 p -169.31 157.86 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 125.481 1.512 . . . . 0.0 107.461 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.9 t -151.5 152.28 32.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.489 ' HG ' ' HB2' ' A' ' 17' ' ' PHE . 1.2 tm? -149.07 79.65 1.41 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.294 0.569 . . . . 0.0 112.158 -168.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.22 126.47 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 161.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -112.16 124.83 53.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -102.32 98.69 8.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 82.9 p -106.93 135.59 48.23 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.64 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -108.12 138.59 44.13 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -98.7 131.9 44.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.11 1.364 . . . . 0.0 108.971 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 C--O 1.25 1.094 0 C-N-CA 125.145 1.378 . . . . 0.0 107.914 -176.7 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -43.85 -54.6 5.12 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 124.629 1.172 . . . . 0.0 111.291 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.7 p -60.07 92.36 0.02 OUTLIER 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.797 1.239 . . . . 0.0 110.946 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.98 -170.27 42.46 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.4 t -106.5 144.53 33.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.288 1.035 . . . . 0.0 108.221 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -141.58 126.84 18.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.691 0.796 . . . . 0.0 110.917 -171.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -126.45 115.89 20.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.701 0.8 . . . . 0.0 109.189 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.484 HG11 ' HD2' ' A' ' 36' ' ' PRO . 8.3 p -50.93 143.82 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.89 1.676 . . . . 0.0 110.4 170.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -146.1 -5.52 0.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 121' ' ' ARG . . . -166.21 91.24 0.45 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -164.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.64 94.73 4.82 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.988 1.315 . . . . 0.0 107.639 174.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -55.52 -76.66 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.286 1.434 . . . . 0.0 112.133 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -85.2 59.39 5.6 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.066 0.946 . . . . 0.0 111.152 -172.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -67.14 0.43 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.541 0.737 . . . . 0.0 111.905 -173.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -53.01 -41.2 64.43 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.051 0.94 . . . . 0.0 112.541 -169.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -60.55 -53.72 54.08 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.308 0.643 . . . . 0.0 110.958 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -46.12 80.47 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.06 0.944 . . . . 0.0 109.883 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.608 HD21 HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -56.6 -46.26 80.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.785 1.234 . . . . 0.0 110.835 176.426 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -27.77 69.43 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.308 0.643 . . . . 0.0 111.838 -171.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.21 -31.6 71.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.005 0.522 . . . . 0.0 111.627 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.45 163.93 23.42 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.654 0.781 . . . . 0.0 109.793 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.4 52.04 1.36 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 111.998 -172.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.17 137.54 22.14 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.68 162.73 29.81 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.276 2.65 . . . . 0.0 111.97 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.88 -42.69 72.4 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.246 1.418 . . . . 0.0 113.511 -172.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -61.43 -44.61 96.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.37 0.668 . . . . 0.0 110.622 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.78 -35.15 79.67 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.646 -0.692 . . . . 0.0 110.482 171.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.608 HG12 HD21 ' A' ' 18' ' ' LEU . 78.5 mt -63.71 -31.25 52.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 119.245 0.93 . . . . 0.0 112.688 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.57 -48.7 10.31 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 168.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.4 mmt -75.71 -48.68 20.89 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.543 0.737 . . . . 0.0 111.048 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB3' ' HA ' ' A' ' 28' ' ' ILE . . . -66.42 78.9 0.1 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 125.793 1.637 . . . . 0.0 111.355 -173.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 179.03 -42.14 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.301 2.24 . . . . 0.0 107.11 -171.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -107.14 -0.38 22.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.187 1.795 . . . . 0.0 112.118 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.7 mt -62.99 117.21 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 118.99 0.813 . . . . 0.0 109.554 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -108.53 98.59 28.97 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.761 1.225 . . . . 0.0 108.943 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.484 ' HD2' HG11 ' A' ' 8' ' ' VAL . 91.8 Cg_endo -72.26 140.38 33.79 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.603 2.202 . . . . 0.0 113.83 175.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.75 137.66 37.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 166.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.24 145.65 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.743 1.217 . . . . 0.0 108.035 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 105.24 3.67 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.906 0.882 . . . . 0.0 109.214 -168.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.7 mt -107.71 131.06 58.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.742 1.217 . . . . 0.0 108.368 -173.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? -129.04 134.43 48.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.738 1.215 . . . . 0.0 108.715 -176.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -106.21 150.15 26.16 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.2 160.23 40.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 128.206 2.602 . . . . 0.0 107.755 173.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -19.67 -72.23 0.01 OUTLIER Glycine 0 C--N 1.343 0.963 0 C-N-CA 127.719 2.581 . . . . 0.0 114.231 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -123.19 18.81 9.92 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.99 1.316 . . . . 0.0 110.74 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -124.43 144.68 49.93 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.068 0.849 . . . . 0.0 109.404 -172.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -143.68 127.79 17.57 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 122.447 0.299 . . . . 0.0 110.811 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.91 138.82 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.946 1.298 . . . . 0.0 107.94 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.89 117.27 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.966 1.306 . . . . 0.0 107.895 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.5 m -107.61 143.3 36.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.625 1.57 . . . . 0.0 107.506 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -146.04 143.82 29.67 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.488 1.115 . . . . 0.0 108.222 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -138.07 120.66 16.17 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.3 p -136.11 159.5 70.71 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.02 1.728 . . . . 0.0 108.601 172.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.49 67.98 6.23 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.788 2.992 . . . . 0.0 108.899 168.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -157.88 -60.85 0.08 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.633 1.573 . . . . 0.0 107.994 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -171.04 162.94 7.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.555 1.942 . . . . 0.0 107.758 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.8 p -84.57 99.0 10.47 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.72 65.49 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.5 m -90.79 123.98 34.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.804 1.242 . . . . 0.0 108.121 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -142.45 178.86 7.3 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.224 1.41 . . . . 0.0 108.964 -176.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -167.7 166.79 13.67 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 121.918 -0.489 . . . . 0.0 110.721 -177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -152.88 155.61 37.39 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.715 0.806 . . . . 0.0 110.419 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.6 m -119.45 136.42 54.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 169.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.8 mt -57.21 -64.11 0.99 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.968 0.507 . . . . 0.0 109.931 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.43 49.91 1.86 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.358 -0.69 . . . . 0.0 112.043 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -155.12 -95.67 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.049 0.925 . . . . 0.0 110.515 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -142.81 169.36 17.72 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.296 1.039 . . . . 0.0 110.502 -174.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.25 147.19 20.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.905 1.282 . . . . 0.0 109.61 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -153.83 100.46 2.37 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.4 mm -120.08 104.79 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.069 1.348 . . . . 0.0 107.521 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -109.48 173.46 6.31 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.441 0.696 . . . . 0.0 112.45 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.2 p -138.89 170.83 15.27 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.293 2.237 . . . . 0.0 108.333 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -154.78 73.78 0.9 Allowed 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.86 -61.55 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.204 1.002 . . . . 0.0 109.817 -176.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.8 -125.45 5.64 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -116.4 161.36 19.18 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.714 1.606 . . . . 0.0 110.061 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -61.16 143.12 56.09 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.906 0.883 . . . . 0.0 111.96 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.9 mt -132.88 102.83 5.79 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.665 1.586 . . . . 0.0 107.318 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.75 139.37 8.83 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.353 0.661 . . . . 0.0 110.161 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 41.2 t -145.37 -63.91 0.33 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.583 1.553 . . . . 0.0 107.349 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.0 t -161.11 159.11 28.68 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.11 0.964 . . . . 0.0 109.513 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.7 139.69 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 125.35 1.46 . . . . 0.0 107.468 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -164.06 -157.07 0.37 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.68 121.9 38.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.008 1.323 . . . . 0.0 107.589 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.11 -52.6 2.59 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.89 1.676 . . . . 0.0 110.43 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -149.92 -80.26 0.12 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.272 0.629 . . . . 0.0 109.575 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.97 -69.13 1.41 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 173.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -145.7 -115.68 0.08 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.228 1.411 . . . . 0.0 107.379 163.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.06 163.41 27.16 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.353 1.061 . . . . 0.0 112.529 -174.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.85 141.62 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.798 1.639 . . . . 0.0 106.708 172.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -166.64 139.65 3.8 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.415 0.552 . . . . 0.0 110.594 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -81.55 74.51 8.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.856 0.862 . . . . 0.0 108.952 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.4 p -82.46 -171.23 3.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.864 1.266 . . . . 0.0 109.577 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -58.49 -59.35 5.5 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.035 0.534 . . . . 0.0 110.679 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.61 -48.11 0.07 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.184 0.593 . . . . 0.0 110.971 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.0 t80 67.55 -75.5 0.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.895 1.678 . . . . 0.0 111.729 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.9 m -158.55 -53.88 0.07 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 127.065 2.146 . . . . 0.0 106.689 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -165.17 -126.4 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.558 2.343 . . . . 0.0 105.832 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -124.03 -71.28 0.72 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.671 1.188 . . . . 0.0 108.547 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -154.27 97.73 2.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -145.88 92.14 2.17 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.486 1.114 . . . . 0.0 108.945 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.6 t -139.59 138.42 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.011 1.324 . . . . 0.0 107.712 176.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -106.72 159.15 16.44 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.512 1.125 . . . . 0.0 108.498 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -25.23 -63.05 0.06 OUTLIER Glycine 0 C--N 1.342 0.881 0 C-N-CA 127.401 2.429 . . . . 0.0 114.254 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -130.71 34.55 4.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.012 0.925 . . . . 0.0 111.239 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -144.02 112.97 6.73 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.642 0.777 . . . . 0.0 109.44 173.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.2 ttm -100.18 82.29 2.51 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.38 71.1 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.618 1.167 . . . . 0.0 108.735 -173.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.4 84.14 0.8 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -105.59 26.0 10.06 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.936 1.294 . . . . 0.0 111.212 -168.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 mm -108.7 -124.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 117.9 -1.048 . . . . 0.0 108.184 -173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 t -132.86 125.32 29.7 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 120.198 1.363 . . . . 0.0 112.954 -165.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -41.28 78.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.75 -65.99 0.08 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.99 -43.81 4.95 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.513 1.054 . . . . 0.0 112.189 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.3 t -107.54 154.04 8.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 124.208 1.003 . . . . 0.0 109.541 -172.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.3 p -103.72 107.58 18.51 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.52 120.85 43.02 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.1 mp -76.19 75.3 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 171.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -93.88 106.16 18.14 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.675 1.19 . . . . 0.0 108.466 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 6.0 mtt-85 -107.91 119.23 38.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.615 1.566 . . . . 0.0 109.907 -175.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.0 p -125.07 121.52 34.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 170.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -107.35 155.55 19.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.347 1.459 . . . . 0.0 109.049 -173.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -74.82 148.21 40.5 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.413 177.311 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 119.46 -0.305 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -95.25 14.57 21.83 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.609 171.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.4 p -51.77 118.67 3.55 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.556 1.142 . . . . 0.0 110.84 -172.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.27 172.05 42.26 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -170.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.4 p -114.9 102.43 9.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.887 1.275 . . . . 0.0 108.249 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -115.57 147.37 40.82 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.325 1.05 . . . . 0.0 110.007 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -95.53 -131.7 0.17 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.625 0.77 . . . . 0.0 109.094 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.625 HG11 ' CD ' ' A' ' 36' ' ' PRO . 1.4 p 176.75 133.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 127.584 2.354 . . . . 0.0 105.099 -178.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -146.17 -8.91 0.52 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -158.06 110.99 2.4 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -165.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.7 140.2 52.9 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 172.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -90.32 -77.96 0.39 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.413 0.551 . . . . 0.0 112.189 -170.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -83.31 57.42 3.98 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.158 0.983 . . . . 0.0 110.208 -176.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -69.13 -61.59 1.73 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -54.56 -43.31 71.94 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-O 118.983 -0.532 . . . . 0.0 111.801 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.52 -50.66 72.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.796 0.438 . . . . 0.0 110.709 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -58.22 -50.11 74.7 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.755 0.822 . . . . 0.0 110.675 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -16.94 62.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.398 0.679 . . . . 0.0 111.678 -175.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -95.74 -15.11 22.83 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.013 0.925 . . . . 0.0 111.811 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.07 -38.3 87.96 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 166.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.98 144.77 57.07 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.03 43.99 1.04 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.28 0.632 . . . . 0.0 111.941 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.19 145.06 29.58 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.95 1.3 . . . . 0.0 107.99 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.8 135.61 26.11 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.566 2.844 . . . . 0.0 111.869 -171.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -46.34 -41.53 13.53 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.56 1.544 . . . . 0.0 113.061 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -40.46 -56.04 2.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 126.977 2.111 . . . . 0.0 111.858 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.47 -41.66 84.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.888 0.875 . . . . 0.0 110.504 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.3 mp -60.79 -37.82 77.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 118.594 0.634 . . . . 0.0 110.4 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -53.06 -34.22 55.55 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.423 0.689 . . . . 0.0 111.065 177.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 81.2 mmm -108.14 19.71 19.6 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.961 1.704 . . . . 0.0 112.202 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.79 -36.06 4.96 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.554 1.542 . . . . 0.0 110.358 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -56.11 -28.66 58.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.141 0.977 . . . . 0.0 113.476 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.85 -17.46 40.84 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.087 0.955 . . . . 0.0 113.039 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.58 143.6 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.636 0.774 . . . . 0.0 110.09 -176.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -117.36 107.95 44.35 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.084 1.354 . . . . 0.0 109.005 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.625 ' CD ' HG11 ' A' ' 8' ' ' VAL . 16.3 Cg_exo -57.43 -174.47 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.455 3.437 . . . . 0.0 115.187 173.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.5 tt -118.8 146.21 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 157.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.74 78.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.3 143.81 30.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.56 1.944 . . . . 0.0 107.687 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 tt -145.74 142.1 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 118.426 0.557 . . . . 0.0 109.721 169.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -133.75 155.12 50.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.291 1.836 . . . . 0.0 109.254 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -127.16 161.67 27.95 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.837 1.255 . . . . 0.0 112.364 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -149.31 163.4 37.81 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.301 2.641 . . . . 0.0 107.824 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -23.28 -66.8 0.03 OUTLIER Glycine 0 C--N 1.344 1.002 0 C-N-CA 127.453 2.454 . . . . 0.0 114.114 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -129.16 21.8 5.71 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.079 1.752 . . . . 0.0 110.137 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -126.58 150.28 48.95 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.601 0.76 . . . . 0.0 111.584 -171.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -139.14 140.31 37.86 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.173 0.989 . . . . 0.0 110.555 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.2 t -135.44 112.54 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -105.54 149.79 8.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.3 m -143.5 82.58 1.74 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.131 1.372 . . . . 0.0 108.129 -172.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.9 m -114.83 47.17 1.3 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.669 1.187 . . . . 0.0 109.812 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.73 168.47 9.16 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -166.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.2 p -124.94 158.06 64.33 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 126.025 1.73 . . . . 0.0 107.298 171.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.6 65.12 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.145 2.563 . . . . 0.0 108.381 168.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -174.84 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.691 1.596 . . . . 0.0 108.862 -172.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -128.18 122.91 33.02 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.869 1.267 . . . . 0.0 109.171 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.3 m -95.5 82.08 3.62 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.143 1.377 . . . . 0.0 110.303 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -91.29 96.18 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.5 m -139.28 74.76 1.48 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.341 1.057 . . . . 0.0 109.415 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.51 138.44 58.07 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 m -155.55 142.81 19.33 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -167.56 148.4 5.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -99.69 142.66 30.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 162.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 mp -56.03 -72.07 0.08 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.027 0.931 . . . . 0.0 110.093 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.14 72.62 2.46 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -167.79 174.3 7.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.565 0.746 . . . . 0.0 110.901 -173.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -81.63 166.09 20.48 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.513 0.725 . . . . 0.0 109.24 162.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.87 85.65 0.54 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.24 73.53 3.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.076 0.55 . . . . 0.0 110.479 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.2 mt -77.13 125.97 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.0 p -107.75 -163.48 0.9 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.013 1.325 . . . . 0.0 109.465 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -161.86 171.15 18.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.579 0.752 . . . . 0.0 110.238 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.38 -61.18 1.74 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.097 1.359 . . . . 0.0 110.209 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -135.33 21.02 3.4 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.785 1.234 . . . . 0.0 111.153 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.91 -121.21 1.62 Allowed Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -141.55 -77.06 0.28 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.154 1.382 . . . . 0.0 109.389 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.4 134.03 2.72 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.42 114.61 28.17 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.176 0.99 . . . . 0.0 110.602 -171.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.28 52.08 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.41 1.084 . . . . 0.0 108.335 174.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 79.7 m -115.23 -57.77 2.21 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.559 1.144 . . . . 0.0 110.348 -170.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.5 p -104.17 84.29 2.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 -170.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.2 m -123.62 -130.81 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.048 1.339 . . . . 0.0 109.039 -171.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -24.0 127.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.715 2.406 . . . . 0.0 114.014 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.3 tt -114.76 95.69 5.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.18 -61.86 1.46 Allowed 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 123.657 0.783 . . . . 0.0 108.923 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -67.92 -56.87 7.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.252 0.621 . . . . 0.0 111.233 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.27 -38.89 0.08 OUTLIER Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -110.88 171.44 7.46 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.286 1.434 . . . . 0.0 107.89 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.04 159.44 33.82 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.13 -86.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -76.99 87.65 3.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.612 1.165 . . . . 0.0 110.349 -171.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -104.13 41.45 1.3 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.508 1.123 . . . . 0.0 108.704 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.5 p -151.03 57.4 0.91 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.459 0.703 . . . . 0.0 110.106 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -156.4 -167.78 2.52 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -64.1 133.17 52.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.182 0.593 . . . . 0.0 109.625 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.8 t80 69.02 51.93 0.52 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.758 1.223 . . . . 0.0 110.944 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 73.9 m -112.45 134.61 53.88 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.234 1.014 . . . . 0.0 109.647 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -78.0 170.28 16.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.62 0.768 . . . . 0.0 110.231 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -57.29 -73.2 0.07 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.846 1.258 . . . . 0.0 112.316 -171.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -161.06 -55.28 0.05 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.495 1.118 . . . . 0.0 108.892 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -167.41 178.82 5.28 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.524 0.73 . . . . 0.0 112.152 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 63.7 t -108.69 145.94 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 126.818 2.047 . . . . 0.0 108.633 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -108.01 151.75 25.41 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.8 0.84 . . . . 0.0 109.734 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -13.34 -72.2 0.01 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 128.777 3.084 . . . . 0.0 115.81 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -128.56 28.4 5.42 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.502 1.121 . . . . 0.0 110.972 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -151.45 113.66 4.54 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.7 ttt -98.9 97.68 8.84 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.864 1.266 . . . . 0.0 107.751 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.3 t -105.79 102.81 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -115.68 129.36 56.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.665 0.786 . . . . 0.0 109.474 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.6 t -110.91 116.41 31.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 164.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.34 110.37 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -168.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.0 p -73.59 104.06 4.41 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.877 1.271 . . . . 0.0 110.311 -172.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -92.08 174.19 7.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.905 1.282 . . . . 0.0 110.226 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -41.87 -52.48 4.77 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.066 1.793 . . . . 0.0 113.836 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -136.36 19.86 3.58 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.279 -0.734 . . . . 0.0 114.469 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.7 t -149.43 162.98 4.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 171.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.0 t -118.3 125.37 49.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 159.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 28.2 tp -101.77 99.86 10.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.1 mt -55.55 128.6 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.335 166.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -146.57 124.03 11.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.315 1.446 . . . . 0.0 108.496 176.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -107.81 116.29 31.68 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.7 p -110.98 127.55 55.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.143 1.377 . . . . 0.0 107.839 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -105.87 145.77 30.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.517 1.127 . . . . 0.0 108.894 -170.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.5 tpt85 -69.8 121.99 18.34 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.616 0.766 . . . . 0.0 110.711 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.271 -1.347 . . . . 0.0 109.289 173.889 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 119.362 -0.352 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -132.21 -59.12 0.94 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 123.695 0.798 . . . . 0.0 110.163 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 p -57.56 100.2 0.05 OUTLIER 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.188 0.995 . . . . 0.0 111.768 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.84 -174.71 47.07 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.9 p -105.91 128.14 53.59 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -130.26 153.44 48.62 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.207 0.603 . . . . 0.0 111.548 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -142.22 119.72 11.69 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.39 1.076 . . . . 0.0 109.908 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.946 HG11 ' HD2' ' A' ' 36' ' ' PRO . 1.2 p -49.77 138.01 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.729 1.212 . . . . 0.0 109.293 163.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -138.77 -16.67 1.12 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 172.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . . . -136.3 85.94 2.19 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.308 1.043 . . . . 0.0 110.709 -163.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -95.52 145.67 25.02 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 167.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -79.82 -106.67 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -85.99 75.41 9.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -46.23 75.84 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.948 0.899 . . . . 0.0 110.97 -176.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -62.6 -16.71 57.84 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -72.2 -54.06 10.77 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.378 0.99 . . . . 0.0 110.917 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -43.17 -63.37 0.82 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.102 1.761 . . . . 0.0 112.423 -172.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -12.37 59.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.415 1.086 . . . . 0.0 113.885 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.03 -32.21 64.96 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.012 0.823 . . . . 0.0 109.953 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.8 41.25 0.72 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.619 0.768 . . . . 0.0 111.686 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -138.34 168.71 19.18 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.356 1.462 . . . . 0.0 108.509 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.47 39.47 1.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.792 0.837 . . . . 0.0 111.384 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 mp -97.74 141.69 23.39 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.89 153.1 58.43 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.664 2.243 . . . . 0.0 109.732 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -57.01 -25.34 58.39 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.335 1.054 . . . . 0.0 113.091 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.92 -45.82 71.3 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.604 1.162 . . . . 0.0 111.166 171.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.5 mt -80.87 -4.91 56.46 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.644 -0.694 . . . . 0.0 112.214 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.96 -28.03 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.075 0.852 . . . . 0.0 109.945 166.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -53.65 -44.46 69.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 166.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 9.1 ttt -62.07 -63.57 1.21 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.311 1.044 . . . . 0.0 110.265 168.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.22 79.35 0.98 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.047 0.939 . . . . 0.0 112.58 -174.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.68 -44.81 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.744 2.017 . . . . 0.0 107.738 174.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -85.83 48.74 1.65 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.525 1.53 . . . . 0.0 108.578 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.8 mm -127.86 135.33 63.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 C-N-CA 124.881 1.272 . . . . 0.0 109.471 -175.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HG2' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -154.12 82.24 4.46 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -176.02 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.946 ' HD2' HG11 ' A' ' 8' ' ' VAL . 21.6 Cg_exo -70.27 173.1 11.92 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.711 2.274 . . . . 0.0 112.879 -173.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.59 HD12 ' HG3' ' A' ' 39' ' ' GLU . 21.0 pt -107.46 137.8 36.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 167.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.6 t -118.45 104.04 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.59 ' HG3' HD12 ' A' ' 37' ' ' ILE . 25.7 mm-40 -112.94 98.61 7.28 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.004 2.122 . . . . 0.0 107.267 -166.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.7 mt -106.29 133.41 50.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 123.318 0.647 . . . . 0.0 110.026 -173.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -126.56 121.71 33.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.009 1.724 . . . . 0.0 107.821 172.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -108.7 145.09 35.6 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.344 0.592 . . . . 0.0 110.92 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.65 161.36 30.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 129.75 3.22 . . . . 0.0 106.408 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -14.44 -68.57 0.01 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 127.868 2.651 . . . . 0.0 114.378 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -129.97 12.14 5.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.583 1.553 . . . . 0.0 110.802 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.13 139.22 47.84 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 118.785 0.72 . . . . 0.0 109.866 -172.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -135.14 119.31 17.65 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.15 0.58 . . . . 0.0 109.583 -172.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.8 t -113.63 110.32 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -108.38 118.95 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m -106.86 106.84 17.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.86 1.664 . . . . 0.0 107.205 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 p -108.17 82.08 1.58 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.053 1.741 . . . . 0.0 107.799 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -104.03 127.54 51.6 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.086 0.954 . . . . 0.0 109.883 -166.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.3 p -113.84 157.33 42.12 Favored Pre-proline 0 CA--C 1.53 0.21 0 C-N-CA 125.819 1.648 . . . . 0.0 109.754 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.41 60.11 5.64 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.54 2.827 . . . . 0.0 109.423 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -175.65 -53.7 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.411 1.484 . . . . 0.0 110.497 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -126.92 154.46 44.46 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.682 1.193 . . . . 0.0 110.742 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.1 p -110.17 53.6 0.69 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.021 1.328 . . . . 0.0 110.05 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -72.21 138.12 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.5 m -148.36 137.96 22.17 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.243 1.017 . . . . 0.0 108.346 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -132.26 102.04 5.61 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.134 1.374 . . . . 0.0 108.483 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.5 p -110.6 141.03 44.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.702 1.201 . . . . 0.0 109.379 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -156.05 176.9 12.05 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.661 0.784 . . . . 0.0 110.313 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.0 m -137.36 149.38 46.95 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 172.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.12 -65.39 0.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.647 0.779 . . . . 0.0 110.043 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.94 62.39 4.38 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -162.46 159.04 24.56 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.516 0.726 . . . . 0.0 110.594 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.76 136.47 37.4 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.518 1.127 . . . . 0.0 109.528 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.46 144.85 10.97 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.698 1.199 . . . . 0.0 109.426 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -110.32 130.67 55.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.762 1.225 . . . . 0.0 108.468 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 42.6 mm -108.37 141.35 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.429 1.091 . . . . 0.0 109.113 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.5 p -108.82 164.54 12.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.313 1.445 . . . . 0.0 110.631 -173.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 t -128.71 160.1 33.55 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.745 1.218 . . . . 0.0 108.183 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -71.34 -67.18 0.54 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -140.62 103.02 4.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.865 0.866 . . . . 0.0 108.731 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.54 -109.28 0.24 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -157.36 163.55 38.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.954 0.902 . . . . 0.0 109.784 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -70.36 87.17 0.62 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.182 0.993 . . . . 0.0 110.06 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 tt -151.74 78.08 1.24 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -141.27 86.42 2.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.0 1.32 . . . . 0.0 108.427 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.1 p -107.47 86.51 2.31 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -150.23 53.64 0.91 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.158 0.983 . . . . 0.0 110.815 -170.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.3 m -133.85 50.82 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -154.25 170.96 20.03 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.513 -0.742 . . . . 0.0 109.659 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.74 133.32 35.92 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.202 1.801 . . . . 0.0 106.299 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.05 -52.95 2.93 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.276 0.631 . . . . 0.0 109.775 -176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.0 -52.75 0.29 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.517 1.127 . . . . 0.0 108.741 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.05 41.21 0.54 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -142.19 125.01 16.01 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.242 1.017 . . . . 0.0 109.193 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 tt -73.26 79.15 1.31 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.593 1.557 . . . . 0.0 108.434 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.7 143.33 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.493 1.117 . . . . 0.0 110.021 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 t -118.4 -37.43 3.33 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.206 1.402 . . . . 0.0 109.249 169.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -160.79 167.16 27.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.304 1.042 . . . . 0.0 109.071 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.2 t -144.92 136.0 24.91 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -129.45 -135.49 0.22 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.975 0.91 . . . . 0.0 108.964 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -63.31 -47.03 83.97 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.74 0.816 . . . . 0.0 109.604 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -83.71 62.16 6.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.021 1.728 . . . . 0.0 109.829 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.5 m -66.28 127.06 30.73 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -101.42 -41.13 6.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.829 1.252 . . . . 0.0 111.954 -172.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -166.05 166.63 17.1 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.327 0.512 . . . . 0.0 111.285 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -149.31 -61.2 0.22 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.203 1.401 . . . . 0.0 108.829 169.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -85.31 89.41 7.66 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.005 0.922 . . . . 0.0 110.962 -171.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.5 t -106.9 134.42 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 125.194 1.398 . . . . 0.0 107.283 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -124.95 153.15 43.18 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.929 0.892 . . . . 0.0 109.987 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -30.67 -53.98 0.24 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 127.635 2.54 . . . . 0.0 115.219 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -122.97 11.95 9.64 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.725 1.21 . . . . 0.0 112.557 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -148.49 105.89 3.65 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.888 0.875 . . . . 0.0 108.848 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.1 ttt -101.56 115.35 30.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 t -106.67 86.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -176.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.2 111.52 3.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.2 m -107.11 81.97 1.62 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -174.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 tp -104.35 116.17 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.712 0.805 . . . . 0.0 109.463 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -98.97 157.99 15.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.125 0.97 . . . . 0.0 110.125 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -161.12 166.01 28.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.049 1.74 . . . . 0.0 107.172 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 2.08 -82.17 0.0 OUTLIER Glycine 0 C--N 1.344 1.001 0 C-N-CA 128.617 3.008 . . . . 0.0 115.355 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -141.15 52.3 0.68 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.1 p -160.88 145.06 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.599 1.159 . . . . 0.0 108.542 -173.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t -150.4 135.94 18.13 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.848 0.459 . . . . 0.0 110.655 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.86 139.2 49.97 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.88 1.272 . . . . 0.0 108.762 -173.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.61 -11.06 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.232 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 5.79 80.74 0.01 OUTLIER 'General case' 0 C--N 1.349 0.549 0 C-N-CA 129.593 3.157 . . . . 0.0 113.005 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 30.4 ttt180 -104.22 121.92 44.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.891 1.276 . . . . 0.0 108.127 -170.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.4 p -122.15 152.28 40.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.084 1.754 . . . . 0.0 109.944 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -124.17 148.4 47.26 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.294 1.038 . . . . 0.0 108.918 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.9 73.22 4.46 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 123.823 0.702 . . . . 0.0 109.643 -177.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 C--O 1.25 1.116 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.048 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -84.34 69.11 10.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.174 0.59 . . . . 0.0 110.359 -170.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 t -169.27 72.39 0.08 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.358 1.463 . . . . 0.0 108.14 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.22 -163.59 31.78 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 t -105.1 135.02 47.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -134.93 106.4 6.83 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -80.65 -122.26 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -171.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.758 HG11 ' HD2' ' A' ' 36' ' ' PRO . 3.2 p 175.76 125.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -175.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -134.88 -24.41 1.48 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.8 -67.99 0.83 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.831 -1.08 . . . . 0.0 112.585 -168.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . 0.272 1.1 pt20 3.9 83.61 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.373 2.269 . . . . 0.0 114.045 -162.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -75.13 -71.85 0.33 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.043 0.937 . . . . 0.0 111.629 -169.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -82.91 53.81 2.53 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.921 0.889 . . . . 0.0 110.406 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -67.71 -42.24 82.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.198 0.599 . . . . 0.0 111.263 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -53.99 -52.12 61.74 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.829 1.252 . . . . 0.0 112.147 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -55.29 -50.86 68.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.911 0.484 . . . . 0.0 110.703 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.549 ' CG ' HD12 ' A' ' 118' ' ' LEU . 26.7 t80 -65.52 -48.47 72.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.248 1.419 . . . . 0.0 112.111 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.24 -50.96 63.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.371 0.668 . . . . 0.0 110.459 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.98 65.59 6.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.308 1.051 . . . . 0.0 109.512 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.13 -27.52 0.05 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.034 2.534 . . . . 0.0 109.487 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.2 mt -67.58 -120.56 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.485 1.514 . . . . 0.0 107.823 163.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.12 67.17 0.59 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.274 -0.891 . . . . 0.0 110.401 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HB2' HD11 ' A' ' 28' ' ' ILE . 5.1 mp -124.42 143.64 43.66 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.816 1.246 . . . . 0.0 108.281 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 141.42 24.44 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.351 3.367 . . . . 0.0 111.765 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -47.66 -44.61 27.32 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 125.294 1.438 . . . . 0.0 113.336 -171.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.01 -48.95 32.45 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.542 1.137 . . . . 0.0 111.3 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.0 mt -74.61 -23.1 58.66 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.929 0.892 . . . . 0.0 112.017 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.426 HD11 ' HB2' ' A' ' 23' ' ' LEU . 3.0 mp -73.34 -41.29 57.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 CA-C-N 119.562 1.074 . . . . 0.0 109.344 170.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -42.99 86.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 46.3 ttm -56.43 -56.28 23.12 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.416 1.086 . . . . 0.0 110.589 167.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.42 -37.9 57.82 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 113.208 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -59.13 -30.73 68.36 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.286 1.434 . . . . 0.0 111.683 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -77.21 -26.88 53.24 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.146 0.978 . . . . 0.0 111.491 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mt -70.59 116.84 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.842 0.857 . . . . 0.0 111.65 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.1 106.49 16.18 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 168.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.758 ' HD2' HG11 ' A' ' 8' ' ' VAL . 66.5 Cg_endo -68.13 177.8 4.12 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.061 1.841 . . . . 0.0 112.982 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.621 HD12 ' HG3' ' A' ' 39' ' ' GLU . 22.9 pt -129.37 153.31 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 165.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.5 t -131.68 111.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.621 ' HG3' HD12 ' A' ' 37' ' ' ILE . 59.4 mm-40 -121.68 97.6 5.57 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.816 2.046 . . . . 0.0 107.575 -162.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.4 mt -108.63 140.38 27.45 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 C-N-CA 122.784 0.434 . . . . 0.0 110.21 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -142.11 150.05 40.65 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.929 1.292 . . . . 0.0 108.093 171.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -121.75 167.52 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.151 0.981 . . . . 0.0 112.531 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -151.56 159.61 44.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.746 2.818 . . . . 0.0 107.77 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.31 -59.67 0.22 Allowed Glycine 0 C--N 1.341 0.858 0 C-N-CA 126.625 2.06 . . . . 0.0 113.937 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -130.93 33.45 4.19 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.816 1.246 . . . . 0.0 110.429 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -144.31 154.49 43.1 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.913 0.779 . . . . 0.0 111.866 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -149.7 127.29 11.62 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.689 0.796 . . . . 0.0 110.194 -173.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.2 t -108.27 122.73 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.51 96.17 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.774 1.629 . . . . 0.0 109.024 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 m -102.88 98.84 8.76 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.42 1.088 . . . . 0.0 108.515 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -105.68 117.75 34.81 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -137.06 138.48 40.45 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.629 0.772 . . . . 0.0 111.128 -167.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -124.49 153.89 69.48 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.641 1.577 . . . . 0.0 108.172 167.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.66 56.01 5.74 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.105 3.203 . . . . 0.0 109.854 172.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -175.0 -51.54 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.121 1.769 . . . . 0.0 109.543 -171.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -125.44 162.32 25.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.436 1.095 . . . . 0.0 109.823 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.3 m -138.3 118.28 13.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.889 0.876 . . . . 0.0 108.78 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.17 43.26 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.8 p -79.79 126.94 31.6 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.63 1.172 . . . . 0.0 108.414 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -140.13 168.91 18.71 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.195 0.998 . . . . 0.0 110.737 -172.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.1 m -153.16 153.44 32.76 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.812 1.245 . . . . 0.0 109.443 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -148.44 151.99 36.18 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.376 1.07 . . . . 0.0 110.318 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 m -86.66 -117.64 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.8 mt -151.07 -78.45 0.13 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 171.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.8 41.75 2.91 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.28 144.99 25.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.032 1.333 . . . . 0.0 107.962 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 151.61 20.91 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.093 1.357 . . . . 0.0 113.701 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.61 138.19 9.46 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.631 1.172 . . . . 0.0 109.804 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.08 91.13 3.6 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.478 1.111 . . . . 0.0 111.446 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.8 mm -94.1 127.88 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.729 1.612 . . . . 0.0 108.749 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -155.7 152.83 29.07 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.264 0.626 . . . . 0.0 111.018 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.7 p -89.77 147.72 23.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.325 1.45 . . . . 0.0 109.266 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.1 -64.98 1.07 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -106.94 80.26 1.41 Allowed 'General case' 0 C--N 1.343 0.299 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.04 -112.93 0.29 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -164.26 135.35 4.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.526 1.13 . . . . 0.0 108.728 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -68.22 103.59 1.61 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.67 1.188 . . . . 0.0 110.045 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.4 mt -125.38 60.2 1.24 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.482 1.113 . . . . 0.0 109.311 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -97.29 139.48 33.18 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.793 1.237 . . . . 0.0 107.827 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 91.2 m -128.91 -74.37 0.57 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.0 p -146.73 163.97 34.23 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.679 1.592 . . . . 0.0 107.898 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.12 88.82 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.742 0.817 . . . . 0.0 109.382 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -132.72 -173.84 3.29 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.024 1.73 . . . . 0.0 109.24 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.35 142.25 37.44 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.681 1.592 . . . . 0.0 108.986 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.18 -176.83 5.08 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.609 1.164 . . . . 0.0 110.286 174.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -76.41 73.06 3.17 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.48 1.112 . . . . 0.0 110.954 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.79 -82.8 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 106.251 -2.74 . . . . 0.0 106.251 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -160.47 -54.28 0.05 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.722 0.809 . . . . 0.0 109.076 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.97 144.94 43.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.451 1.1 . . . . 0.0 108.514 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.5 -47.4 77.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 122.39 0.276 . . . . 0.0 110.508 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -103.11 148.82 25.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.789 1.635 . . . . 0.0 109.214 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.86 163.1 28.38 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 169.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.2 p -54.16 -76.49 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.593 0.757 . . . . 0.0 110.229 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -140.26 146.04 38.09 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -58.35 -40.86 83.32 Favored 'General case' 0 CA--C 1.526 0.052 0 C-N-CA 123.53 0.732 . . . . 0.0 109.463 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -87.3 40.04 0.9 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.143 0.977 . . . . 0.0 110.113 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.4 m -149.09 -94.2 0.07 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 125.786 1.634 . . . . 0.0 108.217 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -114.82 140.61 48.8 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.885 0.874 . . . . 0.0 110.121 -171.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.58 -54.58 2.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.058 0.943 . . . . 0.0 109.715 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.9 154.19 21.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.415 0.686 . . . . 0.0 111.41 -166.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -68.57 172.89 5.59 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.265 1.026 . . . . 0.0 111.615 175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.7 m -107.05 178.89 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.668 1.587 . . . . 0.0 110.962 -168.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.73 160.75 17.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.243 1.417 . . . . 0.0 110.033 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -32.58 -64.47 0.26 Allowed Glycine 0 C--N 1.342 0.905 0 C-N-CA 127.356 2.408 . . . . 0.0 114.373 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -121.3 33.72 5.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.737 0.815 . . . . 0.0 110.491 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -151.15 98.58 2.58 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 122.635 0.374 . . . . 0.0 111.738 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.1 ttt -92.41 80.81 4.9 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 166.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.68 27.22 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.448 1.099 . . . . 0.0 110.547 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -73.51 143.56 46.51 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.1 p -101.7 144.01 30.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -174.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 tt -103.17 114.21 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -169.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.3 t -103.49 164.19 11.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.009 0.924 . . . . 0.0 112.035 -173.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -147.94 172.63 13.9 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 128.206 2.602 . . . . 0.0 106.395 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.55 -39.8 85.78 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.89 -42.61 16.12 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.609 1.1 . . . . 0.0 113.532 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.32 154.64 39.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 CA-C-N 117.887 0.843 . . . . 0.0 112.495 -162.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 p -112.48 109.67 19.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 163.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.549 HD12 ' CG ' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -100.33 114.68 28.37 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -167.52 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.7 mm -66.88 80.32 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.723 1.609 . . . . 0.0 108.344 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -110.76 145.88 37.33 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.476 1.511 . . . . 0.0 108.846 171.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -143.13 119.29 10.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.404 1.882 . . . . 0.0 106.466 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.6 p -109.29 115.76 30.6 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -106.17 151.54 24.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -74.48 146.43 42.77 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--O 1.252 1.218 0 CA-C-O 117.69 -1.148 . . . . 0.0 110.437 -178.232 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.31 78.66 1.83 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 p -171.06 68.16 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.739 0.816 . . . . 0.0 109.782 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.67 -160.02 25.56 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 p -103.35 119.5 38.99 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -124.59 146.04 49.27 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.618 0.767 . . . . 0.0 109.318 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -141.9 135.25 29.27 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.19 0.596 . . . . 0.0 109.877 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.796 HG11 ' HD2' ' A' ' 36' ' ' PRO . 1.4 p -77.87 140.92 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 124.814 1.245 . . . . 0.0 110.449 176.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -135.72 -13.91 1.92 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.129 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.0 135.98 15.51 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -167.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.35 145.4 21.65 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -90.6 -107.97 0.09 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.459 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -76.97 60.17 1.76 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.537 1.062 . . . . 0.0 110.338 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -75.15 -30.49 60.78 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.233 0.613 . . . . 0.0 111.517 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -56.61 -47.3 79.94 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.093 0.406 . . . . 0.0 110.122 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.03 -31.15 71.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.657 1.183 . . . . 0.0 111.459 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -58.56 -38.9 78.82 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.219 0.463 . . . . 0.0 110.079 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -72.24 -55.51 7.08 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.116 0.416 . . . . 0.0 109.944 169.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -76.05 73.71 2.92 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 124.979 1.311 . . . . 0.0 109.7 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.23 -32.35 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.197 2.599 . . . . 0.0 108.817 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.7 mt -72.73 -117.37 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.529 1.532 . . . . 0.0 108.28 169.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.21 31.93 0.48 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.157 0.983 . . . . 0.0 110.754 172.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.88 121.98 69.37 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.23 161.85 39.78 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.033 2.488 . . . . 0.0 112.166 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -53.21 -45.57 68.68 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.776 1.63 . . . . 0.0 112.413 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -52.44 -50.42 62.63 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.841 0.856 . . . . 0.0 110.454 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -42.47 95.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.664 0.786 . . . . 0.0 109.879 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.597 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 58.3 mt -55.06 -36.78 40.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-N 119.181 0.9 . . . . 0.0 111.545 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -45.13 -45.46 11.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.38 1.072 . . . . 0.0 111.33 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.6 mmt -80.25 -57.41 3.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.317 1.447 . . . . 0.0 109.851 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.597 ' HB3' ' HA ' ' A' ' 28' ' ' ILE . . . -43.39 -45.32 6.12 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 127.725 2.41 . . . . 0.0 113.978 -175.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -61.98 -39.9 93.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.058 0.543 . . . . 0.0 110.357 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -95.66 52.47 1.36 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.589 1.156 . . . . 0.0 109.693 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.0 mm -115.7 128.58 72.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.94 1.296 . . . . 0.0 107.864 170.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.37 91.11 49.99 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.796 ' HD2' HG11 ' A' ' 8' ' ' VAL . 11.2 Cg_exo -71.53 170.44 18.5 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 CA-C-N 120.758 1.306 . . . . 0.0 111.465 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.59 134.49 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 167.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.8 t -116.54 99.34 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.84 110.28 22.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.088 1.755 . . . . 0.0 107.695 -168.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.7 mt -121.46 134.19 65.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 C-N-CA 124.124 0.97 . . . . 0.0 110.553 -163.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -129.91 120.83 25.52 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -90.85 140.7 29.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.378 1.071 . . . . 0.0 109.877 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.69 157.45 33.86 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 128.582 2.753 . . . . 0.0 108.12 173.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -32.56 -59.76 0.4 Allowed Glycine 0 C--N 1.344 0.999 0 C-N-CA 126.822 2.153 . . . . 0.0 112.705 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' HA ' HD23 ' A' ' 64' ' ' LEU . 1.9 m-20 -136.1 71.23 1.42 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 165.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -165.53 155.81 13.21 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.129 0.972 . . . . 0.0 109.13 164.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -141.2 127.11 19.29 Favored 'General case' 0 C--O 1.228 -0.054 0 C-N-CA 123.935 0.894 . . . . 0.0 109.649 174.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.4 t -108.6 133.38 53.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 173.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 60' ' ' ASN . 12.5 p -134.32 117.44 24.64 Favored 'Isoleucine or valine' 0 C--N 1.341 0.21 0 C-N-CA 124.368 1.067 . . . . 0.0 108.914 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.8 m -108.35 107.2 17.67 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.383 1.473 . . . . 0.0 108.39 -173.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -103.72 93.49 4.93 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -107.95 122.62 47.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.359 1.463 . . . . 0.0 109.042 -170.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.2 p -108.63 156.63 38.48 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 123.818 0.847 . . . . 0.0 109.714 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.33 58.01 4.28 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.87 2.38 . . . . 0.0 108.979 166.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -167.64 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.055 1.342 . . . . 0.0 109.785 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -135.47 178.91 6.67 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.188 1.795 . . . . 0.0 109.284 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.0 m -138.26 137.41 37.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.254 1.022 . . . . 0.0 108.255 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.4 t -133.84 90.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.9 m -87.29 121.76 30.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HB2' HG13 ' A' ' 49' ' ' VAL . 82.9 m-20 -121.26 156.14 33.14 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.697 1.199 . . . . 0.0 110.115 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.1 p -149.02 141.02 23.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.388 1.075 . . . . 0.0 108.858 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.525 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -148.4 153.11 38.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.716 0.806 . . . . 0.0 109.879 174.714 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 45' ' ' ASP . 87.0 m -125.26 165.18 18.78 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.639 1.176 . . . . 0.0 108.685 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -82.88 -64.31 1.2 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.91 1.684 . . . . 0.0 109.634 -172.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.61 38.82 2.97 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.021 0.82 . . . . 0.0 111.893 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -162.49 138.41 7.37 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -55.47 163.7 1.19 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.614 1.566 . . . . 0.0 113.288 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 62' ' ' PHE . . . -150.45 86.83 1.42 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.543 0.737 . . . . 0.0 110.108 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -78.88 51.97 1.18 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.586 1.954 . . . . 0.0 111.882 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.04 128.37 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.039 0.935 . . . . 0.0 109.273 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.8 p -116.75 -172.93 2.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.118 1.767 . . . . 0.0 108.086 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.1 t -143.0 -174.05 4.08 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.934 0.493 . . . . 0.0 110.236 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 42.2 mtp -66.11 -63.24 1.12 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.166 1.386 . . . . 0.0 110.331 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -106.2 49.33 0.81 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.244 1.017 . . . . 0.0 108.326 -172.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.55 118.74 0.57 Allowed Glycine 0 C--N 1.344 0.975 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -104.7 -101.41 0.32 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.489 1.116 . . . . 0.0 108.936 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -98.84 82.64 2.81 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.049 1.295 . . . . 0.0 108.98 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tt -148.14 74.65 1.3 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -171.0 167.28 7.3 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.197 0.999 . . . . 0.0 110.112 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.63 -165.18 1.17 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.746 1.618 . . . . 0.0 108.064 170.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -106.69 135.13 48.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.52 1.128 . . . . 0.0 108.195 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.8 m -74.68 155.98 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.168 0.587 . . . . 0.0 110.617 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -162.46 159.82 25.5 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.46 0.704 . . . . 0.0 110.537 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.36 138.69 44.22 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.879 1.672 . . . . 0.0 108.168 -175.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.29 -61.65 1.45 Allowed 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.942 0.897 . . . . 0.0 108.824 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -145.97 -62.81 0.32 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.616 0.766 . . . . 0.0 110.107 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.62 -77.84 0.91 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.443 0.545 . . . . 0.0 112.001 -174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -135.89 -172.47 3.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.045 1.338 . . . . 0.0 109.869 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.2 134.41 39.07 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.245 1.418 . . . . 0.0 110.971 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.33 131.62 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.0 m -151.45 67.79 0.9 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -73.96 80.4 1.67 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.685 1.194 . . . . 0.0 109.904 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 55.9 p -166.86 -33.16 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.539 1.135 . . . . 0.0 111.569 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -75.97 71.26 2.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.199 1.4 . . . . 0.0 110.068 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -47.13 -62.95 1.18 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.261 1.824 . . . . 0.0 111.981 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -88.81 64.02 7.08 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.272 0.629 . . . . 0.0 109.803 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.8 t -153.13 -163.38 1.68 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.627 1.171 . . . . 0.0 108.986 174.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -78.38 135.47 37.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.471 0.708 . . . . 0.0 109.85 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -76.2 164.3 26.21 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -102.97 74.04 1.28 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.46 1.104 . . . . 0.0 108.601 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -125.14 132.2 53.12 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.054 1.742 . . . . 0.0 107.851 172.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -157.43 157.09 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.133 0.973 . . . . 0.0 109.462 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -126.72 147.55 49.95 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.253 1.021 . . . . 0.0 108.494 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -35.97 -51.3 1.18 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.425 1.964 . . . . 0.0 113.965 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -130.08 36.38 4.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.427 1.891 . . . . 0.0 111.064 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -161.76 125.11 3.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.748 0.819 . . . . 0.0 109.016 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 41.9 ttm -123.45 84.68 2.3 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.347 1.059 . . . . 0.0 109.281 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.8 t -105.13 82.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -80.49 154.48 27.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.702 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.5 p -108.14 116.4 31.9 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.065 1.746 . . . . 0.0 106.649 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 71.9 mt -103.72 96.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.7 m -75.57 125.4 28.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -142.65 166.57 24.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.923 1.289 . . . . 0.0 107.614 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -54.73 -40.22 70.46 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.326 0.489 . . . . 0.0 112.171 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.8 -38.5 6.5 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.597 1.094 . . . . 0.0 113.398 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.85 150.91 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 118.406 1.103 . . . . 0.0 111.887 -170.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.9 p -106.76 91.36 3.64 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 162.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.88 114.12 28.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.751 0.786 . . . . 0.0 112.249 -158.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.2 mm -68.13 118.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.297 1.839 . . . . 0.0 108.484 172.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -125.28 114.84 19.47 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -107.37 105.49 15.45 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.292 1.037 . . . . 0.0 109.519 -169.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.8 p -114.12 145.3 41.82 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.419 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -136.87 154.95 50.36 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.5 -171.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -73.23 74.67 1.31 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.862 1.665 . . . . 0.0 113.165 -165.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.271 -1.347 . . . . 0.0 109.822 175.197 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -84.12 -45.16 13.29 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 122.618 0.367 . . . . 0.0 110.982 -175.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.3 p -51.03 99.1 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.602 1.561 . . . . 0.0 111.886 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.71 -168.16 39.99 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.6 p -110.03 131.92 54.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -131.21 140.59 49.91 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.155 0.982 . . . . 0.0 110.775 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -119.19 106.51 12.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.744 1.217 . . . . 0.0 109.224 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.851 HG11 ' HD2' ' A' ' 36' ' ' PRO . 3.6 p -47.21 136.58 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 125.644 1.578 . . . . 0.0 109.638 165.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -147.81 -29.81 0.32 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.5 -7.78 46.4 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -154.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -54.61 104.78 0.12 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.869 1.213 . . . . 0.0 111.132 -173.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.19 -76.54 0.11 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.188 0.595 . . . . 0.0 110.058 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -83.09 58.31 4.36 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.052 0.941 . . . . 0.0 108.472 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -57.78 -30.54 65.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.151 -1.593 . . . . 0.0 111.364 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -36.25 76.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.552 0.741 . . . . 0.0 111.863 173.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -67.17 -40.58 86.63 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.624 ' HA ' HG21 ' A' ' 116' ' ' VAL . 1.7 t80 -55.48 -43.57 75.66 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.328 0.651 . . . . 0.0 111.682 -176.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -78.99 49.89 0.97 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.578 1.151 . . . . 0.0 111.474 -174.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 -40.99 1.31 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.049 0.94 . . . . 0.0 111.261 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.17 46.04 1.08 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.587 0.755 . . . . 0.0 110.32 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.3 mt -138.79 -128.85 0.12 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.231 2.212 . . . . 0.0 105.524 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.72 77.11 0.45 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.238 1.015 . . . . 0.0 109.4 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.48 139.51 35.75 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.851 0.86 . . . . 0.0 109.651 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.61 147.08 39.88 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.218 2.612 . . . . 0.0 109.771 175.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.26 -38.6 68.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.771 1.228 . . . . 0.0 113.304 -168.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.91 -44.03 14.27 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.419 1.488 . . . . 0.0 112.073 170.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -76.8 -33.04 58.01 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 117.898 -1.049 . . . . 0.0 111.13 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -64.48 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 CA-C-N 120.012 1.278 . . . . 0.0 109.77 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -44.8 -37.46 3.84 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.519 1.127 . . . . 0.0 112.083 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.2 mmt -90.39 -42.03 11.15 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.599 1.16 . . . . 0.0 111.218 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.66 -39.49 68.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.928 0.891 . . . . 0.0 112.872 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -69.23 7.06 0.82 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -172.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -131.78 12.2 4.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.275 0.943 . . . . 0.0 111.935 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.4 mm -87.19 105.97 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -105.31 105.32 51.69 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 123.836 0.854 . . . . 0.0 108.758 -175.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.851 ' HD2' HG11 ' A' ' 8' ' ' VAL . 11.3 Cg_endo -65.19 178.69 1.85 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.517 2.145 . . . . 0.0 115.14 -177.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.32 114.96 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 169.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.6 t -107.28 92.34 2.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 124.542 1.137 . . . . 0.0 108.494 -169.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -97.4 138.36 34.97 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.762 2.025 . . . . 0.0 108.476 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.7 mt -136.02 136.09 49.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 C-N-CA 123.49 0.716 . . . . 0.0 109.847 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -128.26 142.62 51.1 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.963 2.105 . . . . 0.0 108.345 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -125.42 158.57 34.05 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.64 1.176 . . . . 0.0 111.463 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.12 161.18 42.06 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 127.389 2.276 . . . . 0.0 109.017 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.72 -66.29 0.14 Allowed Glycine 0 C--N 1.344 0.975 0 C-N-CA 127.144 2.307 . . . . 0.0 113.822 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -124.73 33.06 5.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.885 1.274 . . . . 0.0 109.831 171.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.258 16.4 t70 -140.26 147.62 40.24 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.089 0.859 . . . . 0.0 112.541 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -146.17 134.52 21.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.752 0.821 . . . . 0.0 109.851 -174.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.3 t -133.1 127.91 55.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.46 153.25 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 124.027 0.931 . . . . 0.0 108.851 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.0 m -141.21 81.06 1.77 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.5 m -106.33 80.08 1.45 Allowed 'General case' 0 C--N 1.339 0.15 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -107.45 144.43 34.39 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.034 0.934 . . . . 0.0 111.098 -167.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.7 p -127.86 150.93 74.76 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 126.918 2.087 . . . . 0.0 106.457 171.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.61 59.79 4.96 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.596 2.198 . . . . 0.0 109.991 166.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.3 ttt-85 -168.31 -60.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.443 1.097 . . . . 0.0 110.89 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -120.04 173.45 7.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.736 2.014 . . . . 0.0 109.252 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.2 m -137.94 117.18 12.68 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.931 0.892 . . . . 0.0 111.017 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 t -128.31 80.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 170.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -109.27 65.99 0.63 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -69.29 153.4 43.68 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.178 0.591 . . . . 0.0 110.452 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.3 t -154.34 144.15 21.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.292 1.037 . . . . 0.0 108.616 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -161.65 152.48 17.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.948 0.404 . . . . 0.0 110.83 174.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.8 m -81.71 -106.5 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.7 mt -152.92 -75.97 0.13 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 171.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.61 48.48 0.93 Allowed Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.95 -80.33 0.44 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.447 1.099 . . . . 0.0 108.872 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -143.3 162.61 35.22 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.432 1.093 . . . . 0.0 110.329 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.85 123.13 7.73 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.702 0.801 . . . . 0.0 111.484 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -99.69 102.7 14.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.657 1.983 . . . . 0.0 108.079 174.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.5 mm -121.69 124.09 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 t -108.24 -179.14 3.8 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.514 0.725 . . . . 0.0 110.291 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 t -120.36 -177.38 3.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.077 1.351 . . . . 0.0 110.198 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 60.9 mmm -109.45 -91.21 0.45 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.476 1.51 . . . . 0.0 107.141 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -114.18 -35.59 4.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.434 1.494 . . . . 0.0 109.499 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.83 72.32 0.11 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.2 96.59 2.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.023 0.929 . . . . 0.0 109.579 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -115.12 147.54 40.11 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.217 1.007 . . . . 0.0 111.029 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.54 165.88 11.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.669 1.588 . . . . 0.0 109.703 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -155.58 78.12 0.99 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.5 p -159.38 169.62 23.58 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.567 1.147 . . . . 0.0 109.857 -174.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.8 m -115.75 92.11 3.81 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 m -60.07 146.03 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.341 1.056 . . . . 0.0 110.921 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -163.55 -164.22 0.9 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.788 0.835 . . . . 0.0 109.122 -169.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.4 160.4 31.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.641 1.976 . . . . 0.0 107.877 172.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.65 -64.51 1.18 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.249 1.02 . . . . 0.0 109.31 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -132.96 -66.37 0.67 Allowed 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.689 1.196 . . . . 0.0 108.149 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.28 29.1 0.79 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.217 0.913 . . . . 0.0 111.208 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -133.43 135.97 44.91 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.31 1.444 . . . . 0.0 107.212 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.5 mt -72.4 86.41 1.14 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.953 1.301 . . . . 0.0 110.072 -172.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.73 141.22 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 122.832 0.453 . . . . 0.0 111.266 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -131.71 154.3 49.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.798 1.639 . . . . 0.0 107.107 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -70.46 -164.18 0.08 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.005 0.922 . . . . 0.0 110.98 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 36.7 p -75.08 66.73 1.66 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.509 1.124 . . . . 0.0 112.641 -175.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -132.39 126.01 32.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.536 1.534 . . . . 0.0 108.053 172.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.79 52.56 2.06 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.872 0.869 . . . . 0.0 109.281 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.86 28.04 1.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.821 0.849 . . . . 0.0 111.965 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.9 p -170.84 -80.99 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.032 0.933 . . . . 0.0 109.084 -171.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -158.48 175.04 14.2 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.46 1.104 . . . . 0.0 108.35 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -84.71 -135.52 0.05 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -118.46 114.52 23.0 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -147.17 149.1 32.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.082 0.953 . . . . 0.0 108.943 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 p -168.62 165.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.423 1.089 . . . . 0.0 108.774 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.55 156.03 42.43 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.508 0.723 . . . . 0.0 110.148 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -31.34 -55.27 0.31 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 127.234 2.35 . . . . 0.0 114.676 -173.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -136.23 28.37 3.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.465 1.106 . . . . 0.0 110.759 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -145.93 149.71 34.72 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.81 1.244 . . . . 0.0 110.112 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 38.1 mtt -130.02 110.54 11.72 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 m -117.2 50.97 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.357 0.663 . . . . 0.0 110.875 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -86.38 116.55 24.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.835 0.854 . . . . 0.0 109.074 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.2 m -102.21 127.8 49.0 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.7 mt -103.99 88.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 123.519 0.728 . . . . 0.0 109.382 -160.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.5 t -80.35 100.32 8.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.501 1.52 . . . . 0.0 107.838 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -102.06 -136.84 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.914 1.286 . . . . 0.0 108.893 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.9 -72.72 0.9 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.827 0.727 . . . . 0.0 111.488 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -123.06 49.08 0.91 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 17' ' ' PHE . 1.1 t -150.81 147.86 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.833 1.653 . . . . 0.0 108.509 -170.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 t -150.63 97.78 2.55 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.58 126.19 51.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.163 0.985 . . . . 0.0 110.335 -163.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.8 mp -79.84 66.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -86.35 141.55 29.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -168.53 143.25 3.35 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.3 p -133.82 151.64 51.62 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.888 1.275 . . . . 0.0 109.083 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -117.46 141.94 47.74 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.192 0.997 . . . . 0.0 109.11 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.0 ttp85 -75.57 147.83 39.34 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.867 176.779 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.782 ' HB3' HD13 ' A' ' 40' ' ' ILE . 19.7 m-85 -81.6 -76.74 0.24 Allowed 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 p -25.48 90.89 0.01 OUTLIER 'General case' 0 C--N 1.342 0.252 0 C-N-CA 128.179 2.591 . . . . 0.0 114.197 -163.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' H ' HG23 ' A' ' 40' ' ' ILE . . . 178.08 -150.44 9.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.6 p -108.21 142.88 37.79 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.862 1.265 . . . . 0.0 107.891 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -145.7 133.62 21.31 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.838 0.855 . . . . 0.0 110.158 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -139.35 127.03 21.87 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.904 0.882 . . . . 0.0 109.106 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.485 HG11 ' HG2' ' A' ' 36' ' ' PRO . 1.9 m -72.76 135.89 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -125.5 -29.86 3.16 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.196 0.31 . . . . 0.0 111.746 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.3 112.77 7.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.495 0.718 . . . . 0.0 110.483 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -105.23 -160.81 0.77 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -135.8 -101.64 0.22 Allowed 'General case' 0 C--N 1.343 0.283 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.977 170.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -81.21 66.54 6.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.163 0.892 . . . . 0.0 110.66 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.99 -28.34 70.03 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.315 1.046 . . . . 0.0 110.681 -175.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -62.49 -55.59 26.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.212 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -59.67 -39.02 83.11 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.413 ' HA ' HG21 ' A' ' 116' ' ' VAL . 5.0 t80 -52.95 -52.97 56.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.145 176.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.12 -29.1 63.74 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.328 1.051 . . . . 0.0 112.696 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -37.76 75.59 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.994 0.816 . . . . 0.0 110.877 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.81 -33.9 76.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.482 0.713 . . . . 0.0 111.618 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.99 156.09 32.14 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.852 0.461 . . . . 0.0 110.485 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.78 35.49 0.84 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.281 1.033 . . . . 0.0 112.169 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 mp -88.58 139.29 29.71 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.61 157.83 54.98 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.587 2.192 . . . . 0.0 110.473 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -62.17 -36.86 83.16 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -166.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -61.16 -48.79 79.96 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.285 0.634 . . . . 0.0 110.206 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -20.18 64.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.701 1.2 . . . . 0.0 110.907 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.42 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 46.8 mt -78.22 -37.0 21.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.896 0.771 . . . . 0.0 110.845 171.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.56 -38.38 80.96 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.0 ttt -63.92 -51.98 61.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.915 1.286 . . . . 0.0 110.52 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 28' ' ' ILE . . . -52.71 -39.89 62.46 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.245 1.418 . . . . 0.0 112.479 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.17 -16.23 19.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.053 1.341 . . . . 0.0 112.306 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -121.14 18.05 11.59 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 mm -79.37 123.52 36.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.09 101.48 30.48 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 168.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.485 ' HG2' HG11 ' A' ' 8' ' ' VAL . 92.8 Cg_endo -74.52 179.9 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.402 1.401 . . . . 0.0 111.302 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -131.02 158.63 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 168.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.6 t -132.39 121.8 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 165.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -125.48 95.57 4.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.265 2.226 . . . . 0.0 105.086 -170.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.782 HD13 ' HB3' ' A' ' 2' ' ' PHE . 13.8 tt -118.5 140.5 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.669 1.188 . . . . 0.0 111.227 -165.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -139.59 143.93 37.52 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.517 1.127 . . . . 0.0 109.742 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.48 147.36 31.79 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.908 1.283 . . . . 0.0 111.117 -175.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -135.49 163.47 30.01 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 129.05 2.94 . . . . 0.0 107.456 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -20.5 -72.24 0.01 OUTLIER Glycine 0 C--N 1.344 0.982 0 C-N-CA 127.618 2.533 . . . . 0.0 114.338 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -127.19 30.87 5.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.526 1.531 . . . . 0.0 109.32 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -131.43 152.32 50.77 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.523 0.601 . . . . 0.0 112.107 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -138.03 130.58 29.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.022 0.929 . . . . 0.0 109.837 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.14 127.46 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.2 t -127.8 109.37 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.243 1.417 . . . . 0.0 109.491 -173.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -107.43 102.15 11.45 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.496 1.118 . . . . 0.0 108.096 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 t -105.7 111.34 23.98 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -108.25 129.05 55.22 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.331 0.653 . . . . 0.0 109.909 -171.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 p -134.55 150.0 72.5 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 126.161 1.784 . . . . 0.0 107.957 171.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.52 73.93 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.768 2.979 . . . . 0.0 109.56 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -167.63 -52.16 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.786 1.634 . . . . 0.0 108.137 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.14 150.41 11.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.632 1.173 . . . . 0.0 107.878 176.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.4 p -80.1 94.84 6.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.6 72.57 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.5 m -97.65 128.76 44.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.29 1.436 . . . . 0.0 108.489 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -145.35 162.62 36.81 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.746 1.218 . . . . 0.0 107.997 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.3 m -150.68 141.53 22.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.36 137.44 27.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.917 0.487 . . . . 0.0 110.618 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.0 m -98.47 141.59 31.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.757 1.223 . . . . 0.0 107.856 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.6 mt -68.09 -57.71 5.66 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.804 0.842 . . . . 0.0 110.634 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.34 57.9 4.66 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -169.58 138.58 1.93 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.736 1.614 . . . . 0.0 107.172 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -58.5 129.08 40.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.047 0.539 . . . . 0.0 109.71 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.22 157.0 47.37 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.659 1.183 . . . . 0.0 110.628 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -144.99 158.98 43.64 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.222 1.409 . . . . 0.0 108.845 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.1 mm -105.95 148.9 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 125.457 1.503 . . . . 0.0 109.694 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.8 m -105.54 153.85 21.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.851 1.66 . . . . 0.0 109.891 -171.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 m -44.67 142.73 1.59 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.764 2.026 . . . . 0.0 112.727 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.16 176.82 8.14 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.835 1.254 . . . . 0.0 110.242 -172.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.64 -73.34 0.68 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.492 1.517 . . . . 0.0 107.78 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.01 95.59 0.16 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -157.99 -54.66 0.07 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -132.54 178.68 6.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.539 1.536 . . . . 0.0 109.907 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tp -150.01 149.08 29.84 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.713 1.205 . . . . 0.0 108.956 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -70.65 101.97 2.18 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.0 p -144.05 -170.47 3.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.351 1.46 . . . . 0.0 109.531 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.6 m -107.36 110.49 22.5 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.308 1.043 . . . . 0.0 108.805 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.4 m -78.34 136.78 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.287 0.635 . . . . 0.0 110.658 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -165.66 118.47 1.14 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.323 1.049 . . . . 0.0 109.257 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -109.32 131.42 55.09 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 172.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.96 -67.58 0.9 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.11 62.79 0.23 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.29 -87.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -128.94 159.27 36.37 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.259 1.423 . . . . 0.0 108.895 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 tt -74.16 81.79 1.79 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.112 0.965 . . . . 0.0 108.77 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.7 p -74.51 142.76 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.518 0.727 . . . . 0.0 110.235 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.0 t -165.36 174.23 10.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.322 1.449 . . . . 0.0 108.218 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -148.32 152.73 37.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.838 0.855 . . . . 0.0 110.658 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 99.4 p -164.24 -144.58 0.08 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.975 1.31 . . . . 0.0 108.625 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -82.52 -151.53 0.1 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.945 1.298 . . . . 0.0 110.153 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -77.75 65.47 3.22 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.031 1.332 . . . . 0.0 110.523 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -147.38 149.98 33.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.361 1.464 . . . . 0.0 108.746 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.0 t -152.93 103.32 2.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -59.65 -38.34 81.16 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.408 1.083 . . . . 0.0 110.913 173.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -155.66 150.48 26.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.588 1.155 . . . . 0.0 108.631 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -115.85 -55.14 2.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.369 1.068 . . . . 0.0 108.921 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.43 153.72 42.21 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.638 0.775 . . . . 0.0 111.094 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.7 t -139.86 142.18 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.897 1.679 . . . . 0.0 107.02 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -105.83 154.21 20.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -41.34 -38.33 1.95 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.554 1.549 . . . . 0.0 115.018 -172.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.28 40.15 1.92 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.91 0.884 . . . . 0.0 110.681 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -167.15 116.18 0.84 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.608 0.763 . . . . 0.0 110.496 173.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -99.69 127.05 45.81 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 169.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.11 173.58 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.871 0.869 . . . . 0.0 112.765 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -43.13 88.06 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.803 2.841 . . . . 0.0 115.826 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.8 t -165.43 131.0 2.57 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 tp -172.54 121.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.546 1.938 . . . . 0.0 106.802 167.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 m -112.0 125.81 54.47 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -129.35 161.96 29.08 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.936 1.294 . . . . 0.0 109.766 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -2.94 -74.93 0.01 OUTLIER Glycine 0 C--N 1.346 1.129 0 C-N-CA 129.249 3.309 . . . . 0.0 115.693 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -144.11 47.79 0.76 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' A' ' 17' ' ' PHE . 2.0 p -165.69 131.69 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -127.32 135.8 51.05 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.06 158.17 28.43 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.97 1.308 . . . . 0.0 110.46 -169.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 mp -97.71 113.97 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 172.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 tpt85 -123.26 114.02 19.68 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.235 1.414 . . . . 0.0 109.431 -174.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -111.11 110.95 21.71 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.902 0.881 . . . . 0.0 109.452 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.4 p -114.63 130.3 56.78 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 122.1 0.953 . . . . 0.0 109.504 169.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -113.91 143.82 44.07 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -173.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.25 165.67 11.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.162 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.033 -1.936 . . . . 0.0 108.352 178.813 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.44 113.83 26.2 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.87 0.468 . . . . 0.0 110.761 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 t -138.57 40.99 2.21 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.445 1.098 . . . . 0.0 108.753 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.98 172.55 53.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.257 0.932 . . . . 0.0 113.74 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 m -148.85 109.44 4.21 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -143.21 157.72 44.25 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.141 1.376 . . . . 0.0 111.121 -166.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -139.95 134.43 31.54 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 124.066 0.947 . . . . 0.0 111.073 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.59 HG11 ' HD2' ' A' ' 36' ' ' PRO . 8.1 p -62.5 150.81 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 127.029 2.132 . . . . 0.0 112.103 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -146.3 -6.85 0.55 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 163.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . . . -152.64 76.65 1.15 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.776 0.43 . . . . 0.0 110.142 -164.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.75 103.2 15.1 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -77.89 0.06 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.54 1.136 . . . . 0.0 113.043 -171.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -85.48 51.1 2.1 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.866 0.866 . . . . 0.0 111.122 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -43.5 77.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.54 1.136 . . . . 0.0 111.777 -168.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.9 -38.8 92.41 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.874 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -61.88 -48.21 81.53 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.507 0.594 . . . . 0.0 110.783 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.612 ' HA ' HG21 ' A' ' 116' ' ' VAL . 30.5 t80 -55.92 -47.16 78.01 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.141 1.376 . . . . 0.0 111.406 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.25 -43.08 74.7 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.143 0.577 . . . . 0.0 112.301 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -78.92 67.99 4.76 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.111 0.964 . . . . 0.0 109.963 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.05 -44.88 0.06 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.176 1.79 . . . . 0.0 108.614 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -83.07 147.69 27.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.579 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.67 52.32 2.36 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.755 1.222 . . . . 0.0 112.674 -162.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mt -92.01 147.16 34.24 Favored Pre-proline 0 N--CA 1.453 -0.275 0 C-N-CA 124.518 1.127 . . . . 0.0 108.758 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.46 151.8 48.2 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.323 2.015 . . . . 0.0 109.559 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -62.24 -28.77 69.93 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -170.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -63.11 -44.97 94.18 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.345 0.52 . . . . 0.0 110.548 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.81 -41.78 99.44 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.24 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.53 -34.47 61.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 118.525 0.602 . . . . 0.0 111.377 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.91 -44.08 73.88 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.765 0.711 . . . . 0.0 110.469 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.56 -47.09 57.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.827 0.851 . . . . 0.0 110.643 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.41 -46.2 73.11 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 111.823 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -65.59 -30.56 71.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.186 2.194 . . . . 0.0 110.818 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -108.17 50.71 0.77 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.363 1.465 . . . . 0.0 108.984 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.39 150.91 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.068 1.347 . . . . 0.0 109.118 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -128.2 99.91 24.09 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.099 1.359 . . . . 0.0 109.756 -170.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.59 ' HD2' HG11 ' A' ' 8' ' ' VAL . 83.8 Cg_endo -70.86 160.13 50.37 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.062 2.508 . . . . 0.0 113.78 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.494 HD12 ' HG3' ' A' ' 39' ' ' GLU . 8.3 pt -105.6 170.97 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 168.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.1 t -141.25 103.73 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HG3' HD12 ' A' ' 37' ' ' ILE . 67.0 mm-40 -123.69 101.21 7.17 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.204 2.602 . . . . 0.0 106.053 -167.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.6 mt -108.87 150.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.526 0.731 . . . . 0.0 110.031 -171.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -134.25 119.74 19.12 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.051 1.34 . . . . 0.0 108.716 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -83.9 153.28 24.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.72 1.608 . . . . 0.0 109.425 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.34 152.99 10.99 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.984 1.714 . . . . 0.0 108.235 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -20.6 -69.77 0.01 OUTLIER Glycine 0 C--N 1.344 0.99 0 C-N-CA 127.733 2.587 . . . . 0.0 113.969 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -125.94 20.71 7.64 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.786 1.235 . . . . 0.0 110.568 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.35 134.26 55.03 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.409 1.004 . . . . 0.0 109.887 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -134.42 101.31 4.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.5 t -107.98 116.18 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -174.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 p -111.91 125.06 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.522 1.129 . . . . 0.0 109.72 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 m -107.52 95.11 5.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 t -107.82 63.15 0.62 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -102.14 162.55 12.83 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.343 0.657 . . . . 0.0 110.314 -170.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.54 162.36 55.26 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.476 1.111 . . . . 0.0 108.341 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.04 51.37 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.461 2.774 . . . . 0.0 111.433 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 178.57 -58.6 0.01 OUTLIER 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.19 1.796 . . . . 0.0 109.013 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -95.66 155.83 16.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.137 1.375 . . . . 0.0 109.571 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.6 p -132.44 109.61 9.94 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.819 0.848 . . . . 0.0 110.672 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -129.76 87.86 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.6 m -110.26 136.73 49.01 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 171.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -137.02 150.81 48.33 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.2 p -144.05 94.25 2.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.9 0.88 . . . . 0.0 108.781 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.426 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -105.76 104.32 14.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.07 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.1 m -76.68 126.77 31.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 164.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.7 mt -57.46 -56.43 21.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.774 0.829 . . . . 0.0 111.376 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.51 53.66 4.85 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -167.16 148.44 5.77 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.885 0.874 . . . . 0.0 109.387 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 67' ' ' GLU . 3.1 mp0 -53.67 107.08 0.22 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.345 1.458 . . . . 0.0 108.896 170.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.426 ' CB ' ' HB3' ' A' ' 62' ' ' PHE . . . -112.53 58.98 0.64 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.237 0.615 . . . . 0.0 110.951 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -100.3 101.12 12.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 171.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.52 143.22 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 125.227 1.411 . . . . 0.0 107.801 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.4 t -158.8 152.2 22.83 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.124 0.97 . . . . 0.0 109.322 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 t -167.84 -47.06 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.098 1.359 . . . . 0.0 108.988 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -75.6 165.44 25.07 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.382 1.073 . . . . 0.0 108.851 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.28 74.24 1.73 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.706 0.802 . . . . 0.0 109.025 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.21 58.54 0.1 OUTLIER Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.051 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.48 91.75 1.93 Allowed 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -124.93 58.2 1.26 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.353 1.061 . . . . 0.0 109.58 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.76 173.01 17.21 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.349 1.06 . . . . 0.0 110.369 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -116.72 143.06 46.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.323 1.449 . . . . 0.0 108.321 172.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.3 p -163.17 164.48 25.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.331 1.052 . . . . 0.0 109.314 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 88.2 m -135.37 108.01 7.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.2 137.5 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.83 169.87 21.19 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.734 0.413 . . . . 0.0 110.556 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -137.12 136.39 38.25 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.451 1.5 . . . . 0.0 107.609 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.57 -60.3 1.59 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.566 1.146 . . . . 0.0 108.972 -176.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -161.79 -57.42 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.602 0.761 . . . . 0.0 109.629 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.51 -59.47 8.76 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.896 0.76 . . . . 0.0 112.167 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -158.85 172.98 17.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.55 1.14 . . . . 0.0 109.068 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.84 162.35 20.59 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.999 0.52 . . . . 0.0 112.276 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.98 144.21 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.324 1.449 . . . . 0.0 108.901 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.7 m -114.45 -66.45 1.09 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.593 1.557 . . . . 0.0 109.224 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -165.59 159.43 16.58 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.22 1.408 . . . . 0.0 107.673 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.5 p -62.69 170.25 2.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.643 1.177 . . . . 0.0 112.751 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -50.84 106.42 0.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.373 1.469 . . . . 0.0 112.091 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.7 mttm 179.11 -55.9 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 126.62 1.968 . . . . 0.0 106.99 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -77.39 -55.09 5.69 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.942 1.297 . . . . 0.0 110.888 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.2 m -157.71 -37.63 0.07 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.274 -0.87 . . . . 0.0 113.229 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 9.16 80.63 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.294 2.237 . . . . 0.0 113.574 -159.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -128.05 93.97 3.81 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.721 2.008 . . . . 0.0 107.031 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -151.26 74.84 1.16 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.742 0.817 . . . . 0.0 111.472 -172.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -176.66 129.86 0.19 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.044 1.338 . . . . 0.0 109.023 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.53 155.81 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.9 0.88 . . . . 0.0 108.694 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -114.13 160.18 19.23 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.921 1.288 . . . . 0.0 109.282 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -31.05 -56.07 0.28 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 127.533 2.492 . . . . 0.0 115.056 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -128.58 29.56 5.27 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.976 0.911 . . . . 0.0 111.772 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.55 107.07 3.78 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.14 0.427 . . . . 0.0 110.598 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 40.1 ttm -84.46 86.79 7.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.6 m -123.78 122.96 65.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.122 1.369 . . . . 0.0 109.294 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.44 175.59 3.53 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.318 1.047 . . . . 0.0 109.029 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.2 p -106.43 152.68 23.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.361 1.065 . . . . 0.0 110.304 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.5 mt -104.2 106.9 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 m -89.81 99.71 12.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -123.86 -179.86 4.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.539 1.536 . . . . 0.0 109.552 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -46.96 117.25 2.94 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 125.063 1.316 . . . . 0.0 110.77 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 8.11 59.26 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 128.361 2.886 . . . . 0.0 114.875 -156.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.612 HG21 ' HA ' ' A' ' 17' ' ' PHE . 2.0 t -140.85 144.75 26.41 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 126.008 1.723 . . . . 0.0 108.759 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.0 m -136.31 101.55 4.71 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.02 102.85 12.32 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.97 98.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.243 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 168.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -98.96 105.32 17.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.561 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 45.7 ttt85 -108.26 111.7 23.8 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 -173.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.3 t -124.6 149.92 46.54 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.201 1.8 . . . . 0.0 108.716 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -125.23 146.16 49.65 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.825 1.25 . . . . 0.0 109.693 -170.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.75 148.57 42.46 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.061 0.944 . . . . 0.0 111.004 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--O 1.25 1.087 0 CA-C-O 117.46 -1.257 . . . . 0.0 110.501 175.313 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 111.077 0.028 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -49.49 53.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.043 0.537 . . . . 0.0 110.942 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.1 p -38.01 108.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.654 1.982 . . . . 0.0 113.367 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.01 -179.17 46.47 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.3 t -107.57 134.42 50.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.019 1.328 . . . . 0.0 107.639 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -133.66 118.76 18.54 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.432 0.693 . . . . 0.0 110.209 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -102.75 93.43 5.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.971 1.308 . . . . 0.0 109.539 -172.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.463 ' CG1' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -53.95 129.37 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.069 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -145.62 10.06 1.21 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.37 0.419 . . . . 0.0 111.784 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . . . -161.33 105.76 1.31 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 122.7 0.4 . . . . 0.0 110.238 -161.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.66 -167.16 1.48 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.18 1.392 . . . . 0.0 108.591 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.536 ' HB2' HG22 ' A' ' 119' ' ' ILE . 31.0 tt0 -135.52 -104.24 0.22 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.966 0.803 . . . . 0.0 111.141 -174.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -75.46 67.62 2.02 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.219 1.008 . . . . 0.0 109.356 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -81.52 -45.31 16.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.166 0.586 . . . . 0.0 112.412 -169.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.0 -43.38 91.5 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.383 0.538 . . . . 0.0 110.468 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -61.0 -50.93 71.37 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.527 1.131 . . . . 0.0 110.44 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.412 ' CD2' HD21 ' A' ' 118' ' ' LEU . 10.2 t80 -56.64 -49.06 76.11 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.097 0.959 . . . . 0.0 110.134 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -58.75 -46.38 87.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.269 1.028 . . . . 0.0 111.667 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -65.79 -24.42 66.92 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.287 0.635 . . . . 0.0 111.83 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.35 -23.99 60.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.613 0.765 . . . . 0.0 111.03 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.0 mt -84.14 -162.12 0.62 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.97 41.57 2.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.045 0.938 . . . . 0.0 111.381 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.0 127.8 31.16 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.3 164.86 33.17 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.582 2.854 . . . . 0.0 113.615 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -59.48 -44.95 92.92 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.11 1.764 . . . . 0.0 112.514 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -54.58 -46.63 73.76 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.486 0.714 . . . . 0.0 110.577 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.29 -43.43 86.34 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.501 -0.762 . . . . 0.0 109.986 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.35 -41.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 CA-C-N 118.747 0.703 . . . . 0.0 111.618 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -42.96 -43.35 4.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.129 1.372 . . . . 0.0 111.44 173.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 19.7 mmt -102.11 -1.88 30.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.938 1.695 . . . . 0.0 112.536 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.56 -51.04 6.13 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.766 1.226 . . . . 0.0 110.704 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -56.83 -39.83 74.94 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.402 0.681 . . . . 0.0 111.471 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.65 -37.28 79.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.11 1.364 . . . . 0.0 111.55 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -51.14 142.62 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.503 1.121 . . . . 0.0 111.74 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -119.08 98.39 50.85 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 125.43 1.492 . . . . 0.0 107.209 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.463 ' HD2' ' CG1' ' A' ' 8' ' ' VAL . 17.0 Cg_exo -63.57 176.09 2.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.803 2.335 . . . . 0.0 112.396 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.67 131.36 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 169.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.2 t -113.08 96.58 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -103.88 101.31 11.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.869 2.067 . . . . 0.0 107.778 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.46 138.36 32.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -173.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -141.42 131.5 24.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.455 1.102 . . . . 0.0 108.994 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -104.15 150.66 24.15 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.441 1.497 . . . . 0.0 110.053 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -152.38 155.4 37.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.394 1.878 . . . . 0.0 108.863 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -21.1 -68.18 0.01 OUTLIER Glycine 0 C--N 1.345 1.035 0 C-N-CA 127.563 2.506 . . . . 0.0 114.115 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -123.81 12.96 9.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.946 1.298 . . . . 0.0 110.893 172.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -114.38 143.53 44.76 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.334 0.97 . . . . 0.0 110.09 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -141.55 110.17 6.06 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.0 t -108.25 122.21 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.883 1.273 . . . . 0.0 108.599 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.15 104.52 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.01 1.324 . . . . 0.0 107.786 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.8 m -101.3 82.8 2.38 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.8 p -102.93 98.96 8.85 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -137.37 140.02 41.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.314 -162.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 p -130.38 157.02 78.62 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 126.277 1.831 . . . . 0.0 106.873 167.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.26 60.67 6.41 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.167 2.578 . . . . 0.0 108.707 168.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -169.84 -67.57 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.639 1.176 . . . . 0.0 109.66 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -106.83 156.31 18.81 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.864 1.266 . . . . 0.0 110.07 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -123.15 70.17 1.02 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.219 1.408 . . . . 0.0 108.731 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.3 t -71.95 -46.75 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -6.48 106.11 0.01 OUTLIER 'General case' 0 C--N 1.345 0.408 0 C-N-CA 129.386 3.074 . . . . 0.0 114.244 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -104.81 156.74 17.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.728 1.211 . . . . 0.0 109.693 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.1 t -158.94 95.18 1.27 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.45 163.7 22.07 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.639 0.776 . . . . 0.0 111.297 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.8 m -133.46 150.77 51.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.89 1.676 . . . . 0.0 107.191 -176.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.3 mt -65.46 -60.15 3.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.474 0.31 . . . . 0.0 111.479 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.3 47.75 1.01 Allowed Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.317 0.96 . . . . 0.0 111.122 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -164.99 144.09 6.73 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -57.13 165.14 1.42 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.843 1.257 . . . . 0.0 112.591 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.22 98.79 2.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.504 0.721 . . . . 0.0 109.46 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -89.47 83.34 6.35 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.413 1.085 . . . . 0.0 109.899 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.93 167.02 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 125.345 1.458 . . . . 0.0 109.695 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.2 t -162.2 176.01 11.08 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.013 0.925 . . . . 0.0 110.053 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 t -113.49 121.28 43.78 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.241 1.416 . . . . 0.0 108.223 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.45 85.23 7.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -169.71 -70.03 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.099 0.959 . . . . 0.0 111.514 174.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.39 -119.19 3.24 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 124.748 1.166 . . . . 0.0 111.094 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -108.46 171.79 7.22 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.787 1.235 . . . . 0.0 109.158 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -154.69 131.07 10.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.924 0.89 . . . . 0.0 108.834 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.19 136.28 48.14 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.859 1.263 . . . . 0.0 109.399 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -147.81 124.32 11.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.2 t -106.98 -65.78 1.07 Allowed 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -150.7 127.61 11.06 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.1 m -104.26 49.75 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.275 1.43 . . . . 0.0 110.06 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -91.45 -179.28 5.34 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.399 1.079 . . . . 0.0 111.349 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -154.85 139.96 17.46 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.741 2.017 . . . . 0.0 106.796 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.45 -72.11 0.73 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.821 0.848 . . . . 0.0 110.093 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -95.39 -67.84 0.83 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.877 0.871 . . . . 0.0 110.248 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.64 48.49 0.22 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -158.96 128.92 5.74 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.379 1.072 . . . . 0.0 109.337 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.04 135.64 51.24 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.976 1.31 . . . . 0.0 109.872 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.5 p -158.7 154.56 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.05 1.34 . . . . 0.0 108.545 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.5 m -135.37 127.58 30.05 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.516 1.126 . . . . 0.0 108.253 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.6 88.63 2.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.922 0.889 . . . . 0.0 110.36 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.2 m -130.46 83.76 2.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.944 1.298 . . . . 0.0 109.235 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.04 76.67 2.9 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.0 -52.97 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 126.822 2.049 . . . . 0.0 106.897 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -98.95 91.81 5.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.546 1.539 . . . . 0.0 107.504 171.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -99.8 118.72 36.88 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.992 0.917 . . . . 0.0 109.441 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -126.21 103.76 7.86 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.394 1.077 . . . . 0.0 109.001 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -69.89 134.39 48.38 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -108.61 49.2 0.82 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.463 1.105 . . . . 0.0 110.767 -171.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -81.3 83.66 6.82 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.4 p -108.27 128.55 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.346 1.458 . . . . 0.0 108.971 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -122.06 156.5 33.41 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.11 1.364 . . . . 0.0 109.075 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -26.13 -60.39 0.08 OUTLIER Glycine 0 CA--C 1.53 1.013 0 C-N-CA 127.562 2.505 . . . . 0.0 115.487 -173.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -131.51 28.24 4.65 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.848 0.859 . . . . 0.0 111.571 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -155.35 119.5 4.61 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 41.8 ttm -106.12 115.22 29.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.03 61.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.844 1.258 . . . . 0.0 108.69 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -73.08 165.37 25.15 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.06 0.944 . . . . 0.0 110.952 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m -131.44 96.88 4.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 173.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 pp -106.65 134.91 46.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 94.2 m -129.83 137.76 50.63 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.039 1.336 . . . . 0.0 111.046 -167.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -108.34 179.45 4.2 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.199 2.2 . . . . 0.0 107.594 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -18.95 -56.55 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 128.139 2.78 . . . . 0.0 115.334 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -155.05 36.01 0.66 Allowed Glycine 0 CA--C 1.532 1.116 0 CA-C-O 118.689 -1.062 . . . . 0.0 114.072 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -146.26 151.61 14.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.32 0 CA-C-N 118.778 1.289 . . . . 0.0 109.037 170.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 87.3 m -128.53 142.95 50.91 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.423 1.489 . . . . 0.0 110.254 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.412 HD21 ' CD2' ' A' ' 17' ' ' PHE . 1.6 mm? -108.43 146.88 32.43 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.536 HG22 ' HB2' ' A' ' 12' ' ' GLU . 8.8 tp -80.17 63.35 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 170.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -52.23 97.3 0.02 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 126.19 1.796 . . . . 0.0 111.56 -170.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.461 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 64.3 ttt180 -125.32 113.68 17.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.919 0.887 . . . . 0.0 110.124 -169.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 56.4 p -126.36 144.68 50.73 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.505 1.522 . . . . 0.0 109.692 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -114.39 142.34 46.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.398 1.479 . . . . 0.0 108.952 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.66 98.59 6.26 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.7 t . . . . . 0 C--O 1.252 1.199 0 CA-C-O 116.494 -1.717 . . . . 0.0 107.144 175.394 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 111.213 0.079 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -77.24 -37.22 53.65 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.017 0.527 . . . . 0.0 110.376 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 p -50.32 95.5 0.01 OUTLIER 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.303 1.841 . . . . 0.0 112.198 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.73 -171.38 44.45 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -106.83 142.38 36.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 168.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -142.41 124.47 15.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.178 0.991 . . . . 0.0 109.387 -169.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -119.78 112.11 18.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.096 0.958 . . . . 0.0 109.239 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.811 HG11 ' HD2' ' A' ' 36' ' ' PRO . 1.4 p -63.94 121.46 12.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 C-N-CA 124.109 0.964 . . . . 0.0 109.853 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -113.65 -24.22 9.32 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.538 0.735 . . . . 0.0 110.981 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.63 143.87 28.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.272 1.429 . . . . 0.0 108.113 -169.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.99 162.89 34.33 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.48 -100.93 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.283 0.633 . . . . 0.0 110.869 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -106.97 65.05 0.65 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.546 1.138 . . . . 0.0 110.532 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.0 -41.5 99.6 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.013 0.525 . . . . 0.0 111.16 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -58.35 -24.55 60.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 119.026 -0.511 . . . . 0.0 112.017 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -88.45 -38.78 14.75 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 123.093 0.557 . . . . 0.0 111.89 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.489 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 67.1 t80 -46.14 -41.53 12.63 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.073 0.949 . . . . 0.0 110.49 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.762 HD13 HG23 ' A' ' 28' ' ' ILE . 7.6 mt -78.61 40.16 0.37 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.107 1.763 . . . . 0.0 112.77 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.4 -33.31 1.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.188 0.904 . . . . 0.0 111.852 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.7 98.38 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.239 0.616 . . . . 0.0 110.579 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.419 HD22 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -74.53 168.26 20.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.126 0.97 . . . . 0.0 110.713 175.148 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.74 60.28 0.64 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.698 1.199 . . . . 0.0 111.183 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.419 HD13 HD22 ' A' ' 21' ' ' LEU . 9.4 mp -103.23 148.47 35.72 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.685 1.194 . . . . 0.0 108.583 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.88 158.01 59.23 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.385 2.723 . . . . 0.0 111.52 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . 13.1 pt-20 -57.08 -35.21 69.1 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.53 -35.52 80.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.368 0.667 . . . . 0.0 111.677 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -24.55 64.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.562 0.745 . . . . 0.0 112.219 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.762 HG23 HD13 ' A' ' 18' ' ' LEU . 3.9 mp -70.54 -39.49 76.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -55.65 -52.33 64.18 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 16.4 mmt -83.77 47.18 1.26 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.331 1.052 . . . . 0.0 110.571 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 18' ' ' LEU . . . -151.52 -58.67 0.16 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.757 1.623 . . . . 0.0 109.42 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.1 ptt85 -69.79 -37.31 76.27 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 122.244 -0.285 . . . . 0.0 111.31 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -83.79 37.27 0.58 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.767 0.827 . . . . 0.0 110.424 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.5 mm -130.62 117.31 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.1 96.7 39.84 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.818 1.247 . . . . 0.0 107.764 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.811 ' HD2' HG11 ' A' ' 8' ' ' VAL . 8.3 Cg_exo -72.52 164.85 34.39 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.743 2.295 . . . . 0.0 112.698 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.13 117.18 53.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 166.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.95 140.23 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -148.64 100.32 3.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.065 0.946 . . . . 0.0 109.161 -165.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 mt -108.87 135.7 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.593 0.757 . . . . 0.0 109.624 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -125.05 133.28 53.0 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.15 1.38 . . . . 0.0 108.286 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.1 150.66 21.8 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.448 1.099 . . . . 0.0 110.465 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -140.19 154.13 46.83 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 127.735 2.414 . . . . 0.0 106.729 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.93 -55.28 2.31 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.21 1.386 . . . . 0.0 112.499 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -129.84 61.57 1.57 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.739 1.615 . . . . 0.0 109.194 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.4 155.42 17.66 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.246 0.546 . . . . 0.0 110.789 163.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -139.54 111.85 7.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.841 1.656 . . . . 0.0 106.986 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 80.9 t -106.17 127.72 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -127.42 119.79 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.436 1.094 . . . . 0.0 109.207 -171.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.1 m -107.93 141.08 40.09 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.607 1.563 . . . . 0.0 107.522 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.4 t -148.54 87.43 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.146 1.378 . . . . 0.0 107.353 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 120.21 41.33 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.925 0.89 . . . . 0.0 108.844 -170.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 p -101.19 153.8 37.57 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 124.519 1.127 . . . . 0.0 110.041 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.85 51.29 3.33 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.232 2.621 . . . . 0.0 110.418 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -167.09 -48.41 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.694 1.197 . . . . 0.0 110.441 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -130.59 -166.16 1.65 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.647 1.579 . . . . 0.0 108.903 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.8 m -155.27 130.59 9.63 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.48 1.112 . . . . 0.0 108.222 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -133.12 136.03 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.1 m -152.93 141.87 21.21 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.779 1.232 . . . . 0.0 107.894 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -145.84 166.42 26.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.247 1.419 . . . . 0.0 109.473 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.0 p -157.13 141.87 16.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.845 0.858 . . . . 0.0 109.436 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -169.44 167.32 9.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.533 1.133 . . . . 0.0 108.826 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 m -133.02 164.76 26.28 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.842 0.857 . . . . 0.0 110.294 -167.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.48 -58.85 5.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.286 1.035 . . . . 0.0 110.62 175.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.46 36.18 4.39 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.84 1.21 . . . . 0.0 113.564 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -130.24 128.61 41.99 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.862 1.331 . . . . 0.0 109.236 167.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -66.77 133.17 49.61 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.41 0.684 . . . . 0.0 109.463 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -161.15 107.78 1.43 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.097 0.959 . . . . 0.0 109.575 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.86 150.03 44.64 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.22 0.464 . . . . 0.0 110.027 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.7 mm -108.37 111.59 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.277 1.031 . . . . 0.0 108.483 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.9 t -107.39 155.04 20.45 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.491 1.116 . . . . 0.0 111.032 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.6 p -138.12 137.25 37.51 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.8 1.24 . . . . 0.0 109.023 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.7 ptp -88.44 82.36 7.0 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.371 1.068 . . . . 0.0 110.412 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -155.51 -93.56 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.152 0.581 . . . . 0.0 110.934 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.34 -31.5 0.1 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.465 1.507 . . . . 0.0 111.904 -174.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.06 124.79 7.15 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.953 1.376 . . . . 0.0 111.406 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -94.55 131.38 40.34 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.27 0.628 . . . . 0.0 109.323 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.1 tt -157.51 73.42 0.71 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 171.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -141.9 149.77 40.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.688 1.195 . . . . 0.0 108.513 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -136.89 119.84 16.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.4 m -146.37 71.31 1.24 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 83' ' ' HIS . 9.6 m -131.08 -65.24 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.141 0.576 . . . . 0.0 111.315 -175.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.42 ' N ' HG23 ' A' ' 82' ' ' VAL . 46.3 t-80 -99.51 130.72 45.79 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.189 1.396 . . . . 0.0 110.817 -169.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -125.75 119.04 26.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.773 1.629 . . . . 0.0 107.481 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.98 -53.63 0.48 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.015 0.926 . . . . 0.0 109.901 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -66.86 -60.09 2.97 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.249 0.619 . . . . 0.0 110.58 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.2 -48.69 0.1 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.03 110.46 22.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.5 119.51 7.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.431 1.092 . . . . 0.0 111.216 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.0 p -160.11 162.14 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.875 0.87 . . . . 0.0 109.861 -173.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 m -145.86 -38.5 0.24 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.544 1.138 . . . . 0.0 110.028 173.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -139.68 141.19 37.0 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 125.745 1.618 . . . . 0.0 107.787 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.5 t -168.28 67.56 0.07 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.514 1.126 . . . . 0.0 108.463 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -89.35 -99.49 0.09 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.77 0.828 . . . . 0.0 111.085 -173.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -73.57 -48.97 28.8 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -76.43 74.74 3.19 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.0 m -72.93 93.88 1.78 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -90.43 -16.36 29.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.848 1.259 . . . . 0.0 111.672 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.72 136.84 58.15 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.232 0.613 . . . . 0.0 109.883 -172.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.87 169.07 18.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.149 0.98 . . . . 0.0 110.548 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -123.16 146.38 47.82 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.814 1.646 . . . . 0.0 107.915 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.6 t -139.25 124.94 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -121.51 -173.95 2.75 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.664 1.186 . . . . 0.0 109.506 -169.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -39.3 116.49 0.62 Allowed Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.845 1.688 . . . . 0.0 111.593 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 p30 8.19 56.77 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.835 2.854 . . . . 0.0 115.195 -163.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -158.6 133.74 8.49 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.47 0.708 . . . . 0.0 110.372 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.8 ttt -129.41 129.65 44.97 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.903 2.081 . . . . 0.0 106.032 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.55 -72.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -53.48 142.18 22.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.716 0.806 . . . . 0.0 109.635 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.5 m -139.05 -88.72 0.21 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.869 -175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.75 149.21 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.276 0.944 . . . . 0.0 110.353 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 t -123.02 142.54 50.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.133 0.973 . . . . 0.0 109.485 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -109.26 -164.98 0.98 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.848 1.659 . . . . 0.0 108.383 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.71 -58.93 12.0 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 123.87 0.748 . . . . 0.0 113.255 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -131.55 42.29 1.41 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 123.876 0.75 . . . . 0.0 112.014 -175.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.8 p -169.31 157.86 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 125.481 1.512 . . . . 0.0 107.461 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.9 t -151.5 152.28 32.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.489 ' HG ' ' HB2' ' A' ' 17' ' ' PHE . 1.2 tm? -149.07 79.65 1.41 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.294 0.569 . . . . 0.0 112.158 -168.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.22 126.47 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 161.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -112.16 124.83 53.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -102.32 98.69 8.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 82.9 p -106.93 135.59 48.23 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.64 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -108.12 138.59 44.13 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -98.7 131.9 44.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.11 1.364 . . . . 0.0 108.971 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 C--O 1.25 1.094 0 C-N-CA 125.145 1.378 . . . . 0.0 107.914 -176.7 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 119.278 -0.391 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.7 p -60.07 92.36 0.02 OUTLIER 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.797 1.239 . . . . 0.0 110.946 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.98 -170.27 42.46 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.4 t -106.5 144.53 33.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.288 1.035 . . . . 0.0 108.221 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -141.58 126.84 18.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.691 0.796 . . . . 0.0 110.917 -171.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -126.45 115.89 20.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.701 0.8 . . . . 0.0 109.189 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.484 HG11 ' HD2' ' A' ' 36' ' ' PRO . 8.3 p -50.93 143.82 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.89 1.676 . . . . 0.0 110.4 170.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -146.1 -5.52 0.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 121' ' ' ARG . . . -166.21 91.24 0.45 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -164.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.64 94.73 4.82 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.988 1.315 . . . . 0.0 107.639 174.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -55.52 -76.66 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.286 1.434 . . . . 0.0 112.133 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -85.2 59.39 5.6 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.066 0.946 . . . . 0.0 111.152 -172.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -67.14 0.43 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.541 0.737 . . . . 0.0 111.905 -173.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -53.01 -41.2 64.43 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.051 0.94 . . . . 0.0 112.541 -169.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -60.55 -53.72 54.08 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.308 0.643 . . . . 0.0 110.958 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -46.12 80.47 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.06 0.944 . . . . 0.0 109.883 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.608 HD21 HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -56.6 -46.26 80.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.785 1.234 . . . . 0.0 110.835 176.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -27.77 69.43 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.308 0.643 . . . . 0.0 111.838 -171.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.21 -31.6 71.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.005 0.522 . . . . 0.0 111.627 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.45 163.93 23.42 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.654 0.781 . . . . 0.0 109.793 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.4 52.04 1.36 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 111.998 -172.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.17 137.54 22.14 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.68 162.73 29.81 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.276 2.65 . . . . 0.0 111.97 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.88 -42.69 72.4 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.246 1.418 . . . . 0.0 113.511 -172.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -61.43 -44.61 96.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.37 0.668 . . . . 0.0 110.622 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.78 -35.15 79.67 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.646 -0.692 . . . . 0.0 110.482 171.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.608 HG12 HD21 ' A' ' 18' ' ' LEU . 78.5 mt -63.71 -31.25 52.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 119.245 0.93 . . . . 0.0 112.688 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.57 -48.7 10.31 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 168.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.4 mmt -75.71 -48.68 20.89 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.543 0.737 . . . . 0.0 111.048 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB3' ' HA ' ' A' ' 28' ' ' ILE . . . -66.42 78.9 0.1 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 125.793 1.637 . . . . 0.0 111.355 -173.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 179.03 -42.14 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.301 2.24 . . . . 0.0 107.11 -171.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -107.14 -0.38 22.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.187 1.795 . . . . 0.0 112.118 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.7 mt -62.99 117.21 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 118.99 0.813 . . . . 0.0 109.554 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -108.53 98.59 28.97 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.761 1.225 . . . . 0.0 108.943 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.484 ' HD2' HG11 ' A' ' 8' ' ' VAL . 91.8 Cg_endo -72.26 140.38 33.79 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.603 2.202 . . . . 0.0 113.83 175.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.75 137.66 37.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 166.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.24 145.65 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.743 1.217 . . . . 0.0 108.035 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 105.24 3.67 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.906 0.882 . . . . 0.0 109.214 -168.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.7 mt -107.71 131.06 58.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.742 1.217 . . . . 0.0 108.368 -173.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? -129.04 134.43 48.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.738 1.215 . . . . 0.0 108.715 -176.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -106.21 150.15 26.16 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.2 160.23 40.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 128.206 2.602 . . . . 0.0 107.755 173.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -19.67 -72.23 0.01 OUTLIER Glycine 0 C--N 1.343 0.963 0 C-N-CA 127.719 2.581 . . . . 0.0 114.231 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -123.19 18.81 9.92 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.99 1.316 . . . . 0.0 110.74 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -124.43 144.68 49.93 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.068 0.849 . . . . 0.0 109.404 -172.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -143.68 127.79 17.57 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 122.447 0.299 . . . . 0.0 110.811 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.91 138.82 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.946 1.298 . . . . 0.0 107.94 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.89 117.27 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.966 1.306 . . . . 0.0 107.895 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.5 m -107.61 143.3 36.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.625 1.57 . . . . 0.0 107.506 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -146.04 143.82 29.67 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.488 1.115 . . . . 0.0 108.222 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -138.07 120.66 16.17 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.3 p -136.11 159.5 70.71 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.02 1.728 . . . . 0.0 108.601 172.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.49 67.98 6.23 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.788 2.992 . . . . 0.0 108.899 168.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -157.88 -60.85 0.08 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.633 1.573 . . . . 0.0 107.994 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -171.04 162.94 7.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.555 1.942 . . . . 0.0 107.758 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.8 p -84.57 99.0 10.47 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.72 65.49 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.5 m -90.79 123.98 34.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.804 1.242 . . . . 0.0 108.121 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -142.45 178.86 7.3 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.224 1.41 . . . . 0.0 108.964 -176.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -167.7 166.79 13.67 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 121.918 -0.489 . . . . 0.0 110.721 -177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -152.88 155.61 37.39 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.715 0.806 . . . . 0.0 110.419 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.6 m -119.45 136.42 54.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 169.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.8 mt -57.21 -64.11 0.99 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.968 0.507 . . . . 0.0 109.931 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.43 49.91 1.86 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.358 -0.69 . . . . 0.0 112.043 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -155.12 -95.67 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.049 0.925 . . . . 0.0 110.515 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -142.81 169.36 17.72 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.296 1.039 . . . . 0.0 110.502 -174.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.25 147.19 20.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.905 1.282 . . . . 0.0 109.61 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -153.83 100.46 2.37 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.4 mm -120.08 104.79 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.069 1.348 . . . . 0.0 107.521 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -109.48 173.46 6.31 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.441 0.696 . . . . 0.0 112.45 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.2 p -138.89 170.83 15.27 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.293 2.237 . . . . 0.0 108.333 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -154.78 73.78 0.9 Allowed 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.86 -61.55 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.204 1.002 . . . . 0.0 109.817 -176.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.8 -125.45 5.64 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -116.4 161.36 19.18 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.714 1.606 . . . . 0.0 110.061 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -61.16 143.12 56.09 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.906 0.883 . . . . 0.0 111.96 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.9 mt -132.88 102.83 5.79 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.665 1.586 . . . . 0.0 107.318 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.75 139.37 8.83 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.353 0.661 . . . . 0.0 110.161 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 41.2 t -145.37 -63.91 0.33 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.583 1.553 . . . . 0.0 107.349 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.0 t -161.11 159.11 28.68 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.11 0.964 . . . . 0.0 109.513 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.7 139.69 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 125.35 1.46 . . . . 0.0 107.468 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -164.06 -157.07 0.37 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.68 121.9 38.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.008 1.323 . . . . 0.0 107.589 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.11 -52.6 2.59 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.89 1.676 . . . . 0.0 110.43 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -149.92 -80.26 0.12 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.272 0.629 . . . . 0.0 109.575 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.97 -69.13 1.41 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 173.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -145.7 -115.68 0.08 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.228 1.411 . . . . 0.0 107.379 163.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.06 163.41 27.16 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.353 1.061 . . . . 0.0 112.529 -174.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.85 141.62 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.798 1.639 . . . . 0.0 106.708 172.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -166.64 139.65 3.8 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.415 0.552 . . . . 0.0 110.594 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -81.55 74.51 8.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.856 0.862 . . . . 0.0 108.952 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.4 p -82.46 -171.23 3.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.864 1.266 . . . . 0.0 109.577 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -58.49 -59.35 5.5 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.035 0.534 . . . . 0.0 110.679 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.61 -48.11 0.07 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.184 0.593 . . . . 0.0 110.971 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.0 t80 67.55 -75.5 0.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.895 1.678 . . . . 0.0 111.729 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.9 m -158.55 -53.88 0.07 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 127.065 2.146 . . . . 0.0 106.689 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -165.17 -126.4 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.558 2.343 . . . . 0.0 105.832 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -124.03 -71.28 0.72 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.671 1.188 . . . . 0.0 108.547 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -154.27 97.73 2.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -145.88 92.14 2.17 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.486 1.114 . . . . 0.0 108.945 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.6 t -139.59 138.42 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.011 1.324 . . . . 0.0 107.712 176.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -106.72 159.15 16.44 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.512 1.125 . . . . 0.0 108.498 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -25.23 -63.05 0.06 OUTLIER Glycine 0 C--N 1.342 0.881 0 C-N-CA 127.401 2.429 . . . . 0.0 114.254 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -130.71 34.55 4.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.012 0.925 . . . . 0.0 111.239 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -144.02 112.97 6.73 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.642 0.777 . . . . 0.0 109.44 173.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.2 ttm -100.18 82.29 2.51 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.38 71.1 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.618 1.167 . . . . 0.0 108.735 -173.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.4 84.14 0.8 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -105.59 26.0 10.06 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.936 1.294 . . . . 0.0 111.212 -168.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 mm -108.7 -124.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 117.9 -1.048 . . . . 0.0 108.184 -173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 t -132.86 125.32 29.7 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 120.198 1.363 . . . . 0.0 112.954 -165.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -41.28 78.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.75 -65.99 0.08 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.99 -43.81 4.95 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.513 1.054 . . . . 0.0 112.189 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.3 t -107.54 154.04 8.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 124.208 1.003 . . . . 0.0 109.541 -172.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.3 p -103.72 107.58 18.51 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.52 120.85 43.02 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.1 mp -76.19 75.3 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 171.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -93.88 106.16 18.14 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.675 1.19 . . . . 0.0 108.466 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 6.0 mtt-85 -107.91 119.23 38.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.615 1.566 . . . . 0.0 109.907 -175.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.0 p -125.07 121.52 34.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 170.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -107.35 155.55 19.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.347 1.459 . . . . 0.0 109.049 -173.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -74.82 148.21 40.5 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.413 177.311 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.4 p -51.77 118.67 3.55 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.556 1.142 . . . . 0.0 110.84 -172.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.27 172.05 42.26 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -170.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.4 p -114.9 102.43 9.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.887 1.275 . . . . 0.0 108.249 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -115.57 147.37 40.82 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.325 1.05 . . . . 0.0 110.007 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -95.53 -131.7 0.17 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.625 0.77 . . . . 0.0 109.094 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.625 HG11 ' CD ' ' A' ' 36' ' ' PRO . 1.4 p 176.75 133.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 127.584 2.354 . . . . 0.0 105.099 -178.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -146.17 -8.91 0.52 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -158.06 110.99 2.4 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -165.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.7 140.2 52.9 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 172.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -90.32 -77.96 0.39 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.413 0.551 . . . . 0.0 112.189 -170.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -83.31 57.42 3.98 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.158 0.983 . . . . 0.0 110.208 -176.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -69.13 -61.59 1.73 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -54.56 -43.31 71.94 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-O 118.983 -0.532 . . . . 0.0 111.801 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.52 -50.66 72.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.796 0.438 . . . . 0.0 110.709 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -58.22 -50.11 74.7 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.755 0.822 . . . . 0.0 110.675 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -16.94 62.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.398 0.679 . . . . 0.0 111.678 -175.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -95.74 -15.11 22.83 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.013 0.925 . . . . 0.0 111.811 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.07 -38.3 87.96 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 166.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.98 144.77 57.07 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.03 43.99 1.04 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.28 0.632 . . . . 0.0 111.941 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.19 145.06 29.58 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.95 1.3 . . . . 0.0 107.99 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.8 135.61 26.11 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.566 2.844 . . . . 0.0 111.869 -171.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -46.34 -41.53 13.53 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.56 1.544 . . . . 0.0 113.061 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -40.46 -56.04 2.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 126.977 2.111 . . . . 0.0 111.858 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.47 -41.66 84.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.888 0.875 . . . . 0.0 110.504 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.3 mp -60.79 -37.82 77.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 118.594 0.634 . . . . 0.0 110.4 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -53.06 -34.22 55.55 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.423 0.689 . . . . 0.0 111.065 177.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 81.2 mmm -108.14 19.71 19.6 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.961 1.704 . . . . 0.0 112.202 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.79 -36.06 4.96 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.554 1.542 . . . . 0.0 110.358 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -56.11 -28.66 58.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.141 0.977 . . . . 0.0 113.476 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.85 -17.46 40.84 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.087 0.955 . . . . 0.0 113.039 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.58 143.6 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.636 0.774 . . . . 0.0 110.09 -176.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -117.36 107.95 44.35 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.084 1.354 . . . . 0.0 109.005 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.625 ' CD ' HG11 ' A' ' 8' ' ' VAL . 16.3 Cg_exo -57.43 -174.47 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.455 3.437 . . . . 0.0 115.187 173.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.5 tt -118.8 146.21 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 157.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.74 78.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.3 143.81 30.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.56 1.944 . . . . 0.0 107.687 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 tt -145.74 142.1 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 118.426 0.557 . . . . 0.0 109.721 169.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -133.75 155.12 50.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.291 1.836 . . . . 0.0 109.254 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -127.16 161.67 27.95 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.837 1.255 . . . . 0.0 112.364 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -149.31 163.4 37.81 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.301 2.641 . . . . 0.0 107.824 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -23.28 -66.8 0.03 OUTLIER Glycine 0 C--N 1.344 1.002 0 C-N-CA 127.453 2.454 . . . . 0.0 114.114 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -129.16 21.8 5.71 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.079 1.752 . . . . 0.0 110.137 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -126.58 150.28 48.95 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.601 0.76 . . . . 0.0 111.584 -171.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -139.14 140.31 37.86 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.173 0.989 . . . . 0.0 110.555 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.2 t -135.44 112.54 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -105.54 149.79 8.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.3 m -143.5 82.58 1.74 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.131 1.372 . . . . 0.0 108.129 -172.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.9 m -114.83 47.17 1.3 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.669 1.187 . . . . 0.0 109.812 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.73 168.47 9.16 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -166.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.2 p -124.94 158.06 64.33 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 126.025 1.73 . . . . 0.0 107.298 171.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.6 65.12 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.145 2.563 . . . . 0.0 108.381 168.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -174.84 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.691 1.596 . . . . 0.0 108.862 -172.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -128.18 122.91 33.02 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.869 1.267 . . . . 0.0 109.171 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.3 m -95.5 82.08 3.62 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.143 1.377 . . . . 0.0 110.303 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -91.29 96.18 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.5 m -139.28 74.76 1.48 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.341 1.057 . . . . 0.0 109.415 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.51 138.44 58.07 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 m -155.55 142.81 19.33 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -167.56 148.4 5.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -99.69 142.66 30.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 162.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 mp -56.03 -72.07 0.08 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.027 0.931 . . . . 0.0 110.093 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.14 72.62 2.46 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -167.79 174.3 7.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.565 0.746 . . . . 0.0 110.901 -173.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -81.63 166.09 20.48 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.513 0.725 . . . . 0.0 109.24 162.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.87 85.65 0.54 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.24 73.53 3.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.076 0.55 . . . . 0.0 110.479 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.2 mt -77.13 125.97 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.0 p -107.75 -163.48 0.9 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.013 1.325 . . . . 0.0 109.465 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -161.86 171.15 18.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.579 0.752 . . . . 0.0 110.238 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.38 -61.18 1.74 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.097 1.359 . . . . 0.0 110.209 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -135.33 21.02 3.4 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.785 1.234 . . . . 0.0 111.153 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.91 -121.21 1.62 Allowed Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -141.55 -77.06 0.28 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.154 1.382 . . . . 0.0 109.389 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.4 134.03 2.72 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.42 114.61 28.17 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.176 0.99 . . . . 0.0 110.602 -171.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.28 52.08 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.41 1.084 . . . . 0.0 108.335 174.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 79.7 m -115.23 -57.77 2.21 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.559 1.144 . . . . 0.0 110.348 -170.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.5 p -104.17 84.29 2.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 -170.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.2 m -123.62 -130.81 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.048 1.339 . . . . 0.0 109.039 -171.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -24.0 127.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.715 2.406 . . . . 0.0 114.014 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.3 tt -114.76 95.69 5.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.18 -61.86 1.46 Allowed 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 123.657 0.783 . . . . 0.0 108.923 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -67.92 -56.87 7.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.252 0.621 . . . . 0.0 111.233 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.27 -38.89 0.08 OUTLIER Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -110.88 171.44 7.46 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.286 1.434 . . . . 0.0 107.89 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.04 159.44 33.82 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.13 -86.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -76.99 87.65 3.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.612 1.165 . . . . 0.0 110.349 -171.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -104.13 41.45 1.3 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.508 1.123 . . . . 0.0 108.704 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.5 p -151.03 57.4 0.91 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.459 0.703 . . . . 0.0 110.106 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -156.4 -167.78 2.52 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -64.1 133.17 52.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.182 0.593 . . . . 0.0 109.625 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.8 t80 69.02 51.93 0.52 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.758 1.223 . . . . 0.0 110.944 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 73.9 m -112.45 134.61 53.88 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.234 1.014 . . . . 0.0 109.647 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -78.0 170.28 16.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.62 0.768 . . . . 0.0 110.231 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -57.29 -73.2 0.07 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.846 1.258 . . . . 0.0 112.316 -171.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -161.06 -55.28 0.05 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.495 1.118 . . . . 0.0 108.892 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -167.41 178.82 5.28 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.524 0.73 . . . . 0.0 112.152 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 63.7 t -108.69 145.94 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 126.818 2.047 . . . . 0.0 108.633 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -108.01 151.75 25.41 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.8 0.84 . . . . 0.0 109.734 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -13.34 -72.2 0.01 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 128.777 3.084 . . . . 0.0 115.81 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -128.56 28.4 5.42 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.502 1.121 . . . . 0.0 110.972 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -151.45 113.66 4.54 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.7 ttt -98.9 97.68 8.84 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.864 1.266 . . . . 0.0 107.751 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.3 t -105.79 102.81 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -115.68 129.36 56.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.665 0.786 . . . . 0.0 109.474 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.6 t -110.91 116.41 31.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 164.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.34 110.37 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -168.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.0 p -73.59 104.06 4.41 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.877 1.271 . . . . 0.0 110.311 -172.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -92.08 174.19 7.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.905 1.282 . . . . 0.0 110.226 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -41.87 -52.48 4.77 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.066 1.793 . . . . 0.0 113.836 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -136.36 19.86 3.58 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.279 -0.734 . . . . 0.0 114.469 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.7 t -149.43 162.98 4.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 171.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.0 t -118.3 125.37 49.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 159.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 28.2 tp -101.77 99.86 10.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.1 mt -55.55 128.6 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.335 166.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -146.57 124.03 11.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.315 1.446 . . . . 0.0 108.496 176.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -107.81 116.29 31.68 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.7 p -110.98 127.55 55.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.143 1.377 . . . . 0.0 107.839 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -105.87 145.77 30.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.517 1.127 . . . . 0.0 108.894 -170.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.5 tpt85 -69.8 121.99 18.34 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.616 0.766 . . . . 0.0 110.711 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.271 -1.347 . . . . 0.0 109.289 173.889 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 . . . . . 0 C--O 1.224 -0.246 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 p -57.56 100.2 0.05 OUTLIER 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.188 0.995 . . . . 0.0 111.768 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.84 -174.71 47.07 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.9 p -105.91 128.14 53.59 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -130.26 153.44 48.62 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.207 0.603 . . . . 0.0 111.548 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -142.22 119.72 11.69 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.39 1.076 . . . . 0.0 109.908 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.946 HG11 ' HD2' ' A' ' 36' ' ' PRO . 1.2 p -49.77 138.01 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.729 1.212 . . . . 0.0 109.293 163.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -138.77 -16.67 1.12 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 172.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . . . -136.3 85.94 2.19 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.308 1.043 . . . . 0.0 110.709 -163.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -95.52 145.67 25.02 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 167.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -79.82 -106.67 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -85.99 75.41 9.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -46.23 75.84 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.948 0.899 . . . . 0.0 110.97 -176.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -62.6 -16.71 57.84 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -72.2 -54.06 10.77 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.378 0.99 . . . . 0.0 110.917 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -43.17 -63.37 0.82 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.102 1.761 . . . . 0.0 112.423 -172.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -12.37 59.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.415 1.086 . . . . 0.0 113.885 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.03 -32.21 64.96 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.012 0.823 . . . . 0.0 109.953 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.8 41.25 0.72 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.619 0.768 . . . . 0.0 111.686 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -138.34 168.71 19.18 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.356 1.462 . . . . 0.0 108.509 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.47 39.47 1.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.792 0.837 . . . . 0.0 111.384 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 mp -97.74 141.69 23.39 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.89 153.1 58.43 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.664 2.243 . . . . 0.0 109.732 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -57.01 -25.34 58.39 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.335 1.054 . . . . 0.0 113.091 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.92 -45.82 71.3 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.604 1.162 . . . . 0.0 111.166 171.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.5 mt -80.87 -4.91 56.46 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.644 -0.694 . . . . 0.0 112.214 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.96 -28.03 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.075 0.852 . . . . 0.0 109.945 166.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -53.65 -44.46 69.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 166.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 9.1 ttt -62.07 -63.57 1.21 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.311 1.044 . . . . 0.0 110.265 168.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.22 79.35 0.98 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.047 0.939 . . . . 0.0 112.58 -174.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.68 -44.81 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.744 2.017 . . . . 0.0 107.738 174.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -85.83 48.74 1.65 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.525 1.53 . . . . 0.0 108.578 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.8 mm -127.86 135.33 63.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 C-N-CA 124.881 1.272 . . . . 0.0 109.471 -175.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HG2' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -154.12 82.24 4.46 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -176.02 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.946 ' HD2' HG11 ' A' ' 8' ' ' VAL . 21.6 Cg_exo -70.27 173.1 11.92 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.711 2.274 . . . . 0.0 112.879 -173.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.59 HD12 ' HG3' ' A' ' 39' ' ' GLU . 21.0 pt -107.46 137.8 36.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 167.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.6 t -118.45 104.04 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.59 ' HG3' HD12 ' A' ' 37' ' ' ILE . 25.7 mm-40 -112.94 98.61 7.28 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.004 2.122 . . . . 0.0 107.267 -166.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.7 mt -106.29 133.41 50.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 123.318 0.647 . . . . 0.0 110.026 -173.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -126.56 121.71 33.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.009 1.724 . . . . 0.0 107.821 172.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -108.7 145.09 35.6 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.344 0.592 . . . . 0.0 110.92 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.65 161.36 30.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 129.75 3.22 . . . . 0.0 106.408 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -14.44 -68.57 0.01 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 127.868 2.651 . . . . 0.0 114.378 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -129.97 12.14 5.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.583 1.553 . . . . 0.0 110.802 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.13 139.22 47.84 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 118.785 0.72 . . . . 0.0 109.866 -172.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -135.14 119.31 17.65 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.15 0.58 . . . . 0.0 109.583 -172.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.8 t -113.63 110.32 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -108.38 118.95 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m -106.86 106.84 17.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.86 1.664 . . . . 0.0 107.205 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 p -108.17 82.08 1.58 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.053 1.741 . . . . 0.0 107.799 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -104.03 127.54 51.6 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.086 0.954 . . . . 0.0 109.883 -166.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.3 p -113.84 157.33 42.12 Favored Pre-proline 0 CA--C 1.53 0.21 0 C-N-CA 125.819 1.648 . . . . 0.0 109.754 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.41 60.11 5.64 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.54 2.827 . . . . 0.0 109.423 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -175.65 -53.7 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.411 1.484 . . . . 0.0 110.497 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -126.92 154.46 44.46 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.682 1.193 . . . . 0.0 110.742 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.1 p -110.17 53.6 0.69 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.021 1.328 . . . . 0.0 110.05 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -72.21 138.12 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.5 m -148.36 137.96 22.17 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.243 1.017 . . . . 0.0 108.346 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -132.26 102.04 5.61 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.134 1.374 . . . . 0.0 108.483 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.5 p -110.6 141.03 44.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.702 1.201 . . . . 0.0 109.379 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -156.05 176.9 12.05 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.661 0.784 . . . . 0.0 110.313 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.0 m -137.36 149.38 46.95 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 172.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.12 -65.39 0.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.647 0.779 . . . . 0.0 110.043 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.94 62.39 4.38 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -162.46 159.04 24.56 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.516 0.726 . . . . 0.0 110.594 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.76 136.47 37.4 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.518 1.127 . . . . 0.0 109.528 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.46 144.85 10.97 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.698 1.199 . . . . 0.0 109.426 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -110.32 130.67 55.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.762 1.225 . . . . 0.0 108.468 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 42.6 mm -108.37 141.35 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.429 1.091 . . . . 0.0 109.113 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.5 p -108.82 164.54 12.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.313 1.445 . . . . 0.0 110.631 -173.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 t -128.71 160.1 33.55 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.745 1.218 . . . . 0.0 108.183 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -71.34 -67.18 0.54 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -140.62 103.02 4.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.865 0.866 . . . . 0.0 108.731 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.54 -109.28 0.24 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -157.36 163.55 38.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.954 0.902 . . . . 0.0 109.784 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -70.36 87.17 0.62 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.182 0.993 . . . . 0.0 110.06 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 tt -151.74 78.08 1.24 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -141.27 86.42 2.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.0 1.32 . . . . 0.0 108.427 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.1 p -107.47 86.51 2.31 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -150.23 53.64 0.91 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.158 0.983 . . . . 0.0 110.815 -170.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.3 m -133.85 50.82 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -154.25 170.96 20.03 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.513 -0.742 . . . . 0.0 109.659 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.74 133.32 35.92 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.202 1.801 . . . . 0.0 106.299 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.05 -52.95 2.93 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.276 0.631 . . . . 0.0 109.775 -176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.0 -52.75 0.29 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.517 1.127 . . . . 0.0 108.741 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.05 41.21 0.54 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -142.19 125.01 16.01 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.242 1.017 . . . . 0.0 109.193 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 tt -73.26 79.15 1.31 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.593 1.557 . . . . 0.0 108.434 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.7 143.33 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.493 1.117 . . . . 0.0 110.021 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 t -118.4 -37.43 3.33 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.206 1.402 . . . . 0.0 109.249 169.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -160.79 167.16 27.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.304 1.042 . . . . 0.0 109.071 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.2 t -144.92 136.0 24.91 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -129.45 -135.49 0.22 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.975 0.91 . . . . 0.0 108.964 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -63.31 -47.03 83.97 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.74 0.816 . . . . 0.0 109.604 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -83.71 62.16 6.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.021 1.728 . . . . 0.0 109.829 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.5 m -66.28 127.06 30.73 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -101.42 -41.13 6.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.829 1.252 . . . . 0.0 111.954 -172.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -166.05 166.63 17.1 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.327 0.512 . . . . 0.0 111.285 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -149.31 -61.2 0.22 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.203 1.401 . . . . 0.0 108.829 169.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -85.31 89.41 7.66 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.005 0.922 . . . . 0.0 110.962 -171.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.5 t -106.9 134.42 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 125.194 1.398 . . . . 0.0 107.283 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -124.95 153.15 43.18 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.929 0.892 . . . . 0.0 109.987 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -30.67 -53.98 0.24 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 127.635 2.54 . . . . 0.0 115.219 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -122.97 11.95 9.64 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.725 1.21 . . . . 0.0 112.557 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -148.49 105.89 3.65 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.888 0.875 . . . . 0.0 108.848 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.1 ttt -101.56 115.35 30.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 t -106.67 86.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -176.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.2 111.52 3.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.2 m -107.11 81.97 1.62 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -174.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 tp -104.35 116.17 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.712 0.805 . . . . 0.0 109.463 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -98.97 157.99 15.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.125 0.97 . . . . 0.0 110.125 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -161.12 166.01 28.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.049 1.74 . . . . 0.0 107.172 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 2.08 -82.17 0.0 OUTLIER Glycine 0 C--N 1.344 1.001 0 C-N-CA 128.617 3.008 . . . . 0.0 115.355 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -141.15 52.3 0.68 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.1 p -160.88 145.06 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.599 1.159 . . . . 0.0 108.542 -173.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t -150.4 135.94 18.13 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.848 0.459 . . . . 0.0 110.655 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.86 139.2 49.97 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.88 1.272 . . . . 0.0 108.762 -173.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.61 -11.06 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.232 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 5.79 80.74 0.01 OUTLIER 'General case' 0 C--N 1.349 0.549 0 C-N-CA 129.593 3.157 . . . . 0.0 113.005 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 30.4 ttt180 -104.22 121.92 44.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.891 1.276 . . . . 0.0 108.127 -170.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.4 p -122.15 152.28 40.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.084 1.754 . . . . 0.0 109.944 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -124.17 148.4 47.26 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.294 1.038 . . . . 0.0 108.918 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.9 73.22 4.46 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 123.823 0.702 . . . . 0.0 109.643 -177.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 C--O 1.25 1.116 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.048 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 . . . . . 0 CA--C 1.532 0.288 0 CA-C-O 120.688 0.28 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 t -169.27 72.39 0.08 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.358 1.463 . . . . 0.0 108.14 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.22 -163.59 31.78 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 t -105.1 135.02 47.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -134.93 106.4 6.83 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -80.65 -122.26 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -171.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.758 HG11 ' HD2' ' A' ' 36' ' ' PRO . 3.2 p 175.76 125.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -175.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -134.88 -24.41 1.48 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.8 -67.99 0.83 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.831 -1.08 . . . . 0.0 112.585 -168.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . 0.272 1.1 pt20 3.9 83.61 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.373 2.269 . . . . 0.0 114.045 -162.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -75.13 -71.85 0.33 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.043 0.937 . . . . 0.0 111.629 -169.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -82.91 53.81 2.53 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.921 0.889 . . . . 0.0 110.406 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -67.71 -42.24 82.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.198 0.599 . . . . 0.0 111.263 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -53.99 -52.12 61.74 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.829 1.252 . . . . 0.0 112.147 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -55.29 -50.86 68.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.911 0.484 . . . . 0.0 110.703 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.549 ' CG ' HD12 ' A' ' 118' ' ' LEU . 26.7 t80 -65.52 -48.47 72.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.248 1.419 . . . . 0.0 112.111 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.24 -50.96 63.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.371 0.668 . . . . 0.0 110.459 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.98 65.59 6.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.308 1.051 . . . . 0.0 109.512 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.13 -27.52 0.05 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.034 2.534 . . . . 0.0 109.487 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.2 mt -67.58 -120.56 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.485 1.514 . . . . 0.0 107.823 163.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.12 67.17 0.59 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.274 -0.891 . . . . 0.0 110.401 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HB2' HD11 ' A' ' 28' ' ' ILE . 5.1 mp -124.42 143.64 43.66 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.816 1.246 . . . . 0.0 108.281 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 141.42 24.44 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.351 3.367 . . . . 0.0 111.765 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -47.66 -44.61 27.32 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 125.294 1.438 . . . . 0.0 113.336 -171.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.01 -48.95 32.45 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.542 1.137 . . . . 0.0 111.3 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.0 mt -74.61 -23.1 58.66 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.929 0.892 . . . . 0.0 112.017 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.426 HD11 ' HB2' ' A' ' 23' ' ' LEU . 3.0 mp -73.34 -41.29 57.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 CA-C-N 119.562 1.074 . . . . 0.0 109.344 170.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -42.99 86.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 46.3 ttm -56.43 -56.28 23.12 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.416 1.086 . . . . 0.0 110.589 167.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.42 -37.9 57.82 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 113.208 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -59.13 -30.73 68.36 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.286 1.434 . . . . 0.0 111.683 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -77.21 -26.88 53.24 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.146 0.978 . . . . 0.0 111.491 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mt -70.59 116.84 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.842 0.857 . . . . 0.0 111.65 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.1 106.49 16.18 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 168.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.758 ' HD2' HG11 ' A' ' 8' ' ' VAL . 66.5 Cg_endo -68.13 177.8 4.12 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.061 1.841 . . . . 0.0 112.982 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.621 HD12 ' HG3' ' A' ' 39' ' ' GLU . 22.9 pt -129.37 153.31 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 165.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.5 t -131.68 111.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.621 ' HG3' HD12 ' A' ' 37' ' ' ILE . 59.4 mm-40 -121.68 97.6 5.57 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.816 2.046 . . . . 0.0 107.575 -162.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.4 mt -108.63 140.38 27.45 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 C-N-CA 122.784 0.434 . . . . 0.0 110.21 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -142.11 150.05 40.65 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.929 1.292 . . . . 0.0 108.093 171.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -121.75 167.52 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.151 0.981 . . . . 0.0 112.531 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -151.56 159.61 44.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.746 2.818 . . . . 0.0 107.77 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.31 -59.67 0.22 Allowed Glycine 0 C--N 1.341 0.858 0 C-N-CA 126.625 2.06 . . . . 0.0 113.937 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -130.93 33.45 4.19 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.816 1.246 . . . . 0.0 110.429 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -144.31 154.49 43.1 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.913 0.779 . . . . 0.0 111.866 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -149.7 127.29 11.62 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.689 0.796 . . . . 0.0 110.194 -173.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.2 t -108.27 122.73 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.51 96.17 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.774 1.629 . . . . 0.0 109.024 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 m -102.88 98.84 8.76 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.42 1.088 . . . . 0.0 108.515 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -105.68 117.75 34.81 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -137.06 138.48 40.45 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.629 0.772 . . . . 0.0 111.128 -167.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -124.49 153.89 69.48 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.641 1.577 . . . . 0.0 108.172 167.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.66 56.01 5.74 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.105 3.203 . . . . 0.0 109.854 172.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -175.0 -51.54 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.121 1.769 . . . . 0.0 109.543 -171.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -125.44 162.32 25.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.436 1.095 . . . . 0.0 109.823 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.3 m -138.3 118.28 13.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.889 0.876 . . . . 0.0 108.78 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.17 43.26 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.8 p -79.79 126.94 31.6 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.63 1.172 . . . . 0.0 108.414 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -140.13 168.91 18.71 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.195 0.998 . . . . 0.0 110.737 -172.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.1 m -153.16 153.44 32.76 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.812 1.245 . . . . 0.0 109.443 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -148.44 151.99 36.18 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.376 1.07 . . . . 0.0 110.318 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 m -86.66 -117.64 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.8 mt -151.07 -78.45 0.13 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 171.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.8 41.75 2.91 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.28 144.99 25.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.032 1.333 . . . . 0.0 107.962 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 151.61 20.91 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.093 1.357 . . . . 0.0 113.701 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.61 138.19 9.46 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.631 1.172 . . . . 0.0 109.804 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.08 91.13 3.6 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.478 1.111 . . . . 0.0 111.446 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.8 mm -94.1 127.88 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.729 1.612 . . . . 0.0 108.749 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -155.7 152.83 29.07 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.264 0.626 . . . . 0.0 111.018 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.7 p -89.77 147.72 23.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.325 1.45 . . . . 0.0 109.266 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.1 -64.98 1.07 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -106.94 80.26 1.41 Allowed 'General case' 0 C--N 1.343 0.299 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.04 -112.93 0.29 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -164.26 135.35 4.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.526 1.13 . . . . 0.0 108.728 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -68.22 103.59 1.61 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.67 1.188 . . . . 0.0 110.045 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.4 mt -125.38 60.2 1.24 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.482 1.113 . . . . 0.0 109.311 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -97.29 139.48 33.18 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.793 1.237 . . . . 0.0 107.827 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 91.2 m -128.91 -74.37 0.57 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.0 p -146.73 163.97 34.23 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.679 1.592 . . . . 0.0 107.898 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.12 88.82 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.742 0.817 . . . . 0.0 109.382 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -132.72 -173.84 3.29 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.024 1.73 . . . . 0.0 109.24 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.35 142.25 37.44 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.681 1.592 . . . . 0.0 108.986 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.18 -176.83 5.08 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.609 1.164 . . . . 0.0 110.286 174.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -76.41 73.06 3.17 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.48 1.112 . . . . 0.0 110.954 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.79 -82.8 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 106.251 -2.74 . . . . 0.0 106.251 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -160.47 -54.28 0.05 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.722 0.809 . . . . 0.0 109.076 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.97 144.94 43.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.451 1.1 . . . . 0.0 108.514 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.5 -47.4 77.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 122.39 0.276 . . . . 0.0 110.508 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -103.11 148.82 25.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.789 1.635 . . . . 0.0 109.214 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.86 163.1 28.38 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 169.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.2 p -54.16 -76.49 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.593 0.757 . . . . 0.0 110.229 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -140.26 146.04 38.09 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -58.35 -40.86 83.32 Favored 'General case' 0 CA--C 1.526 0.052 0 C-N-CA 123.53 0.732 . . . . 0.0 109.463 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -87.3 40.04 0.9 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.143 0.977 . . . . 0.0 110.113 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.4 m -149.09 -94.2 0.07 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 125.786 1.634 . . . . 0.0 108.217 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -114.82 140.61 48.8 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.885 0.874 . . . . 0.0 110.121 -171.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.58 -54.58 2.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.058 0.943 . . . . 0.0 109.715 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.9 154.19 21.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.415 0.686 . . . . 0.0 111.41 -166.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -68.57 172.89 5.59 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.265 1.026 . . . . 0.0 111.615 175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.7 m -107.05 178.89 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.668 1.587 . . . . 0.0 110.962 -168.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.73 160.75 17.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.243 1.417 . . . . 0.0 110.033 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -32.58 -64.47 0.26 Allowed Glycine 0 C--N 1.342 0.905 0 C-N-CA 127.356 2.408 . . . . 0.0 114.373 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -121.3 33.72 5.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.737 0.815 . . . . 0.0 110.491 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -151.15 98.58 2.58 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 122.635 0.374 . . . . 0.0 111.738 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.1 ttt -92.41 80.81 4.9 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 166.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.68 27.22 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.448 1.099 . . . . 0.0 110.547 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -73.51 143.56 46.51 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.1 p -101.7 144.01 30.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -174.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 tt -103.17 114.21 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -169.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.3 t -103.49 164.19 11.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.009 0.924 . . . . 0.0 112.035 -173.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -147.94 172.63 13.9 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 128.206 2.602 . . . . 0.0 106.395 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.55 -39.8 85.78 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.89 -42.61 16.12 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.609 1.1 . . . . 0.0 113.532 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.32 154.64 39.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 CA-C-N 117.887 0.843 . . . . 0.0 112.495 -162.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 p -112.48 109.67 19.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 163.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.549 HD12 ' CG ' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -100.33 114.68 28.37 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -167.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.7 mm -66.88 80.32 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.723 1.609 . . . . 0.0 108.344 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -110.76 145.88 37.33 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.476 1.511 . . . . 0.0 108.846 171.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -143.13 119.29 10.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.404 1.882 . . . . 0.0 106.466 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.6 p -109.29 115.76 30.6 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -106.17 151.54 24.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -74.48 146.43 42.77 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--O 1.252 1.218 0 CA-C-O 117.69 -1.148 . . . . 0.0 110.437 -178.232 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.308 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 p -171.06 68.16 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.739 0.816 . . . . 0.0 109.782 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.67 -160.02 25.56 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 p -103.35 119.5 38.99 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -124.59 146.04 49.27 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.618 0.767 . . . . 0.0 109.318 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -141.9 135.25 29.27 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.19 0.596 . . . . 0.0 109.877 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.796 HG11 ' HD2' ' A' ' 36' ' ' PRO . 1.4 p -77.87 140.92 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 124.814 1.245 . . . . 0.0 110.449 176.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -135.72 -13.91 1.92 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.129 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.0 135.98 15.51 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -167.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.35 145.4 21.65 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -90.6 -107.97 0.09 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.459 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -76.97 60.17 1.76 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.537 1.062 . . . . 0.0 110.338 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -75.15 -30.49 60.78 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.233 0.613 . . . . 0.0 111.517 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -56.61 -47.3 79.94 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.093 0.406 . . . . 0.0 110.122 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.03 -31.15 71.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.657 1.183 . . . . 0.0 111.459 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -58.56 -38.9 78.82 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.219 0.463 . . . . 0.0 110.079 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -72.24 -55.51 7.08 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.116 0.416 . . . . 0.0 109.944 169.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -76.05 73.71 2.92 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 124.979 1.311 . . . . 0.0 109.7 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.23 -32.35 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.197 2.599 . . . . 0.0 108.817 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.7 mt -72.73 -117.37 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.529 1.532 . . . . 0.0 108.28 169.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.21 31.93 0.48 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.157 0.983 . . . . 0.0 110.754 172.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.88 121.98 69.37 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.23 161.85 39.78 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.033 2.488 . . . . 0.0 112.166 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -53.21 -45.57 68.68 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.776 1.63 . . . . 0.0 112.413 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -52.44 -50.42 62.63 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.841 0.856 . . . . 0.0 110.454 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -42.47 95.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.664 0.786 . . . . 0.0 109.879 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.597 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 58.3 mt -55.06 -36.78 40.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-N 119.181 0.9 . . . . 0.0 111.545 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -45.13 -45.46 11.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.38 1.072 . . . . 0.0 111.33 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.6 mmt -80.25 -57.41 3.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.317 1.447 . . . . 0.0 109.851 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.597 ' HB3' ' HA ' ' A' ' 28' ' ' ILE . . . -43.39 -45.32 6.12 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 127.725 2.41 . . . . 0.0 113.978 -175.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -61.98 -39.9 93.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.058 0.543 . . . . 0.0 110.357 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -95.66 52.47 1.36 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.589 1.156 . . . . 0.0 109.693 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.0 mm -115.7 128.58 72.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.94 1.296 . . . . 0.0 107.864 170.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.37 91.11 49.99 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.796 ' HD2' HG11 ' A' ' 8' ' ' VAL . 11.2 Cg_exo -71.53 170.44 18.5 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 CA-C-N 120.758 1.306 . . . . 0.0 111.465 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.59 134.49 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 167.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.8 t -116.54 99.34 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.84 110.28 22.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.088 1.755 . . . . 0.0 107.695 -168.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.7 mt -121.46 134.19 65.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 C-N-CA 124.124 0.97 . . . . 0.0 110.553 -163.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -129.91 120.83 25.52 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -90.85 140.7 29.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.378 1.071 . . . . 0.0 109.877 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.69 157.45 33.86 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 128.582 2.753 . . . . 0.0 108.12 173.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -32.56 -59.76 0.4 Allowed Glycine 0 C--N 1.344 0.999 0 C-N-CA 126.822 2.153 . . . . 0.0 112.705 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' HA ' HD23 ' A' ' 64' ' ' LEU . 1.9 m-20 -136.1 71.23 1.42 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 165.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -165.53 155.81 13.21 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.129 0.972 . . . . 0.0 109.13 164.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -141.2 127.11 19.29 Favored 'General case' 0 C--O 1.228 -0.054 0 C-N-CA 123.935 0.894 . . . . 0.0 109.649 174.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.4 t -108.6 133.38 53.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 173.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 60' ' ' ASN . 12.5 p -134.32 117.44 24.64 Favored 'Isoleucine or valine' 0 C--N 1.341 0.21 0 C-N-CA 124.368 1.067 . . . . 0.0 108.914 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.8 m -108.35 107.2 17.67 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.383 1.473 . . . . 0.0 108.39 -173.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -103.72 93.49 4.93 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -107.95 122.62 47.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.359 1.463 . . . . 0.0 109.042 -170.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.2 p -108.63 156.63 38.48 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 123.818 0.847 . . . . 0.0 109.714 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.33 58.01 4.28 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.87 2.38 . . . . 0.0 108.979 166.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -167.64 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.055 1.342 . . . . 0.0 109.785 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -135.47 178.91 6.67 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.188 1.795 . . . . 0.0 109.284 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.0 m -138.26 137.41 37.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.254 1.022 . . . . 0.0 108.255 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.4 t -133.84 90.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.9 m -87.29 121.76 30.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HB2' HG13 ' A' ' 49' ' ' VAL . 82.9 m-20 -121.26 156.14 33.14 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.697 1.199 . . . . 0.0 110.115 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.1 p -149.02 141.02 23.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.388 1.075 . . . . 0.0 108.858 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.525 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -148.4 153.11 38.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.716 0.806 . . . . 0.0 109.879 174.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 45' ' ' ASP . 87.0 m -125.26 165.18 18.78 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.639 1.176 . . . . 0.0 108.685 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -82.88 -64.31 1.2 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.91 1.684 . . . . 0.0 109.634 -172.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.61 38.82 2.97 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.021 0.82 . . . . 0.0 111.893 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -162.49 138.41 7.37 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -55.47 163.7 1.19 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.614 1.566 . . . . 0.0 113.288 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 62' ' ' PHE . . . -150.45 86.83 1.42 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.543 0.737 . . . . 0.0 110.108 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -78.88 51.97 1.18 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.586 1.954 . . . . 0.0 111.882 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.04 128.37 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.039 0.935 . . . . 0.0 109.273 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.8 p -116.75 -172.93 2.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.118 1.767 . . . . 0.0 108.086 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.1 t -143.0 -174.05 4.08 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.934 0.493 . . . . 0.0 110.236 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 42.2 mtp -66.11 -63.24 1.12 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.166 1.386 . . . . 0.0 110.331 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -106.2 49.33 0.81 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.244 1.017 . . . . 0.0 108.326 -172.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.55 118.74 0.57 Allowed Glycine 0 C--N 1.344 0.975 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -104.7 -101.41 0.32 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.489 1.116 . . . . 0.0 108.936 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -98.84 82.64 2.81 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.049 1.295 . . . . 0.0 108.98 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tt -148.14 74.65 1.3 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -171.0 167.28 7.3 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.197 0.999 . . . . 0.0 110.112 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.63 -165.18 1.17 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.746 1.618 . . . . 0.0 108.064 170.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -106.69 135.13 48.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.52 1.128 . . . . 0.0 108.195 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.8 m -74.68 155.98 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.168 0.587 . . . . 0.0 110.617 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -162.46 159.82 25.5 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.46 0.704 . . . . 0.0 110.537 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.36 138.69 44.22 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.879 1.672 . . . . 0.0 108.168 -175.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.29 -61.65 1.45 Allowed 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.942 0.897 . . . . 0.0 108.824 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -145.97 -62.81 0.32 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.616 0.766 . . . . 0.0 110.107 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.62 -77.84 0.91 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.443 0.545 . . . . 0.0 112.001 -174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -135.89 -172.47 3.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.045 1.338 . . . . 0.0 109.869 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.2 134.41 39.07 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.245 1.418 . . . . 0.0 110.971 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.33 131.62 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.0 m -151.45 67.79 0.9 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -73.96 80.4 1.67 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.685 1.194 . . . . 0.0 109.904 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 55.9 p -166.86 -33.16 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.539 1.135 . . . . 0.0 111.569 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -75.97 71.26 2.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.199 1.4 . . . . 0.0 110.068 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -47.13 -62.95 1.18 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.261 1.824 . . . . 0.0 111.981 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -88.81 64.02 7.08 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.272 0.629 . . . . 0.0 109.803 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.8 t -153.13 -163.38 1.68 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.627 1.171 . . . . 0.0 108.986 174.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -78.38 135.47 37.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.471 0.708 . . . . 0.0 109.85 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -76.2 164.3 26.21 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -102.97 74.04 1.28 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.46 1.104 . . . . 0.0 108.601 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -125.14 132.2 53.12 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.054 1.742 . . . . 0.0 107.851 172.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -157.43 157.09 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.133 0.973 . . . . 0.0 109.462 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -126.72 147.55 49.95 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.253 1.021 . . . . 0.0 108.494 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -35.97 -51.3 1.18 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.425 1.964 . . . . 0.0 113.965 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -130.08 36.38 4.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.427 1.891 . . . . 0.0 111.064 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -161.76 125.11 3.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.748 0.819 . . . . 0.0 109.016 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 41.9 ttm -123.45 84.68 2.3 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.347 1.059 . . . . 0.0 109.281 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.8 t -105.13 82.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -80.49 154.48 27.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.702 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.5 p -108.14 116.4 31.9 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.065 1.746 . . . . 0.0 106.649 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 71.9 mt -103.72 96.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.7 m -75.57 125.4 28.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -142.65 166.57 24.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.923 1.289 . . . . 0.0 107.614 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -54.73 -40.22 70.46 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.326 0.489 . . . . 0.0 112.171 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.8 -38.5 6.5 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.597 1.094 . . . . 0.0 113.398 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.85 150.91 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 118.406 1.103 . . . . 0.0 111.887 -170.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.9 p -106.76 91.36 3.64 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 162.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.88 114.12 28.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.751 0.786 . . . . 0.0 112.249 -158.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.2 mm -68.13 118.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.297 1.839 . . . . 0.0 108.484 172.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -125.28 114.84 19.47 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -107.37 105.49 15.45 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.292 1.037 . . . . 0.0 109.519 -169.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.8 p -114.12 145.3 41.82 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.419 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -136.87 154.95 50.36 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.5 -171.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -73.23 74.67 1.31 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.862 1.665 . . . . 0.0 113.165 -165.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.271 -1.347 . . . . 0.0 109.822 175.197 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 . . . . . 0 C--O 1.226 -0.18 0 CA-C-O 119.878 -0.106 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.3 p -51.03 99.1 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.602 1.561 . . . . 0.0 111.886 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.71 -168.16 39.99 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.6 p -110.03 131.92 54.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -131.21 140.59 49.91 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.155 0.982 . . . . 0.0 110.775 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -119.19 106.51 12.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.744 1.217 . . . . 0.0 109.224 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.851 HG11 ' HD2' ' A' ' 36' ' ' PRO . 3.6 p -47.21 136.58 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 125.644 1.578 . . . . 0.0 109.638 165.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -147.81 -29.81 0.32 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.5 -7.78 46.4 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -154.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -54.61 104.78 0.12 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.869 1.213 . . . . 0.0 111.132 -173.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.19 -76.54 0.11 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.188 0.595 . . . . 0.0 110.058 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -83.09 58.31 4.36 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.052 0.941 . . . . 0.0 108.472 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -57.78 -30.54 65.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.151 -1.593 . . . . 0.0 111.364 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -36.25 76.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.552 0.741 . . . . 0.0 111.863 173.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -67.17 -40.58 86.63 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.624 ' HA ' HG21 ' A' ' 116' ' ' VAL . 1.7 t80 -55.48 -43.57 75.66 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.328 0.651 . . . . 0.0 111.682 -176.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -78.99 49.89 0.97 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.578 1.151 . . . . 0.0 111.474 -174.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 -40.99 1.31 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.049 0.94 . . . . 0.0 111.261 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.17 46.04 1.08 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.587 0.755 . . . . 0.0 110.32 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.3 mt -138.79 -128.85 0.12 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.231 2.212 . . . . 0.0 105.524 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.72 77.11 0.45 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.238 1.015 . . . . 0.0 109.4 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.48 139.51 35.75 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.851 0.86 . . . . 0.0 109.651 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.61 147.08 39.88 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.218 2.612 . . . . 0.0 109.771 175.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.26 -38.6 68.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.771 1.228 . . . . 0.0 113.304 -168.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.91 -44.03 14.27 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.419 1.488 . . . . 0.0 112.073 170.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -76.8 -33.04 58.01 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 117.898 -1.049 . . . . 0.0 111.13 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -64.48 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 CA-C-N 120.012 1.278 . . . . 0.0 109.77 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -44.8 -37.46 3.84 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.519 1.127 . . . . 0.0 112.083 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.2 mmt -90.39 -42.03 11.15 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.599 1.16 . . . . 0.0 111.218 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.66 -39.49 68.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.928 0.891 . . . . 0.0 112.872 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -69.23 7.06 0.82 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -172.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -131.78 12.2 4.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.275 0.943 . . . . 0.0 111.935 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.4 mm -87.19 105.97 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -105.31 105.32 51.69 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 123.836 0.854 . . . . 0.0 108.758 -175.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.851 ' HD2' HG11 ' A' ' 8' ' ' VAL . 11.3 Cg_endo -65.19 178.69 1.85 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.517 2.145 . . . . 0.0 115.14 -177.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.32 114.96 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 169.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.6 t -107.28 92.34 2.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 124.542 1.137 . . . . 0.0 108.494 -169.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -97.4 138.36 34.97 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.762 2.025 . . . . 0.0 108.476 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.7 mt -136.02 136.09 49.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 C-N-CA 123.49 0.716 . . . . 0.0 109.847 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -128.26 142.62 51.1 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.963 2.105 . . . . 0.0 108.345 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -125.42 158.57 34.05 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.64 1.176 . . . . 0.0 111.463 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.12 161.18 42.06 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 127.389 2.276 . . . . 0.0 109.017 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.72 -66.29 0.14 Allowed Glycine 0 C--N 1.344 0.975 0 C-N-CA 127.144 2.307 . . . . 0.0 113.822 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -124.73 33.06 5.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.885 1.274 . . . . 0.0 109.831 171.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.258 16.4 t70 -140.26 147.62 40.24 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.089 0.859 . . . . 0.0 112.541 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -146.17 134.52 21.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.752 0.821 . . . . 0.0 109.851 -174.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.3 t -133.1 127.91 55.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.46 153.25 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 124.027 0.931 . . . . 0.0 108.851 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.0 m -141.21 81.06 1.77 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.5 m -106.33 80.08 1.45 Allowed 'General case' 0 C--N 1.339 0.15 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -107.45 144.43 34.39 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.034 0.934 . . . . 0.0 111.098 -167.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.7 p -127.86 150.93 74.76 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 126.918 2.087 . . . . 0.0 106.457 171.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.61 59.79 4.96 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.596 2.198 . . . . 0.0 109.991 166.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.3 ttt-85 -168.31 -60.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.443 1.097 . . . . 0.0 110.89 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -120.04 173.45 7.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.736 2.014 . . . . 0.0 109.252 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.2 m -137.94 117.18 12.68 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.931 0.892 . . . . 0.0 111.017 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 t -128.31 80.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 170.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -109.27 65.99 0.63 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -69.29 153.4 43.68 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.178 0.591 . . . . 0.0 110.452 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.3 t -154.34 144.15 21.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.292 1.037 . . . . 0.0 108.616 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -161.65 152.48 17.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.948 0.404 . . . . 0.0 110.83 174.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.8 m -81.71 -106.5 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.7 mt -152.92 -75.97 0.13 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 171.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.61 48.48 0.93 Allowed Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.95 -80.33 0.44 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.447 1.099 . . . . 0.0 108.872 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -143.3 162.61 35.22 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.432 1.093 . . . . 0.0 110.329 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.85 123.13 7.73 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.702 0.801 . . . . 0.0 111.484 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -99.69 102.7 14.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.657 1.983 . . . . 0.0 108.079 174.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.5 mm -121.69 124.09 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 t -108.24 -179.14 3.8 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.514 0.725 . . . . 0.0 110.291 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 t -120.36 -177.38 3.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.077 1.351 . . . . 0.0 110.198 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 60.9 mmm -109.45 -91.21 0.45 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.476 1.51 . . . . 0.0 107.141 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -114.18 -35.59 4.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.434 1.494 . . . . 0.0 109.499 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.83 72.32 0.11 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.2 96.59 2.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.023 0.929 . . . . 0.0 109.579 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -115.12 147.54 40.11 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.217 1.007 . . . . 0.0 111.029 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.54 165.88 11.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.669 1.588 . . . . 0.0 109.703 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -155.58 78.12 0.99 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.5 p -159.38 169.62 23.58 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.567 1.147 . . . . 0.0 109.857 -174.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.8 m -115.75 92.11 3.81 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 m -60.07 146.03 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.341 1.056 . . . . 0.0 110.921 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -163.55 -164.22 0.9 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.788 0.835 . . . . 0.0 109.122 -169.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.4 160.4 31.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.641 1.976 . . . . 0.0 107.877 172.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.65 -64.51 1.18 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.249 1.02 . . . . 0.0 109.31 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -132.96 -66.37 0.67 Allowed 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.689 1.196 . . . . 0.0 108.149 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.28 29.1 0.79 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.217 0.913 . . . . 0.0 111.208 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -133.43 135.97 44.91 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.31 1.444 . . . . 0.0 107.212 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.5 mt -72.4 86.41 1.14 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.953 1.301 . . . . 0.0 110.072 -172.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.73 141.22 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 122.832 0.453 . . . . 0.0 111.266 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -131.71 154.3 49.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.798 1.639 . . . . 0.0 107.107 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -70.46 -164.18 0.08 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.005 0.922 . . . . 0.0 110.98 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 36.7 p -75.08 66.73 1.66 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.509 1.124 . . . . 0.0 112.641 -175.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -132.39 126.01 32.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.536 1.534 . . . . 0.0 108.053 172.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.79 52.56 2.06 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.872 0.869 . . . . 0.0 109.281 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.86 28.04 1.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.821 0.849 . . . . 0.0 111.965 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.9 p -170.84 -80.99 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.032 0.933 . . . . 0.0 109.084 -171.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -158.48 175.04 14.2 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.46 1.104 . . . . 0.0 108.35 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -84.71 -135.52 0.05 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -118.46 114.52 23.0 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -147.17 149.1 32.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.082 0.953 . . . . 0.0 108.943 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 p -168.62 165.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.423 1.089 . . . . 0.0 108.774 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.55 156.03 42.43 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.508 0.723 . . . . 0.0 110.148 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -31.34 -55.27 0.31 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 127.234 2.35 . . . . 0.0 114.676 -173.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -136.23 28.37 3.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.465 1.106 . . . . 0.0 110.759 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -145.93 149.71 34.72 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.81 1.244 . . . . 0.0 110.112 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 38.1 mtt -130.02 110.54 11.72 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 m -117.2 50.97 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.357 0.663 . . . . 0.0 110.875 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -86.38 116.55 24.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.835 0.854 . . . . 0.0 109.074 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.2 m -102.21 127.8 49.0 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.7 mt -103.99 88.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 123.519 0.728 . . . . 0.0 109.382 -160.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.5 t -80.35 100.32 8.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.501 1.52 . . . . 0.0 107.838 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -102.06 -136.84 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.914 1.286 . . . . 0.0 108.893 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.9 -72.72 0.9 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.827 0.727 . . . . 0.0 111.488 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -123.06 49.08 0.91 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 17' ' ' PHE . 1.1 t -150.81 147.86 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.833 1.653 . . . . 0.0 108.509 -170.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 t -150.63 97.78 2.55 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.58 126.19 51.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.163 0.985 . . . . 0.0 110.335 -163.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.8 mp -79.84 66.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -86.35 141.55 29.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -168.53 143.25 3.35 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.3 p -133.82 151.64 51.62 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.888 1.275 . . . . 0.0 109.083 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -117.46 141.94 47.74 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.192 0.997 . . . . 0.0 109.11 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.0 ttp85 -75.57 147.83 39.34 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.867 176.779 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.782 ' HB3' HD13 ' A' ' 40' ' ' ILE . 19.7 m-85 . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 p -25.48 90.89 0.01 OUTLIER 'General case' 0 C--N 1.342 0.252 0 C-N-CA 128.179 2.591 . . . . 0.0 114.197 -163.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.4 ' H ' HG23 ' A' ' 40' ' ' ILE . . . 178.08 -150.44 9.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.6 p -108.21 142.88 37.79 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.862 1.265 . . . . 0.0 107.891 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -145.7 133.62 21.31 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.838 0.855 . . . . 0.0 110.158 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -139.35 127.03 21.87 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.904 0.882 . . . . 0.0 109.106 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.485 HG11 ' HG2' ' A' ' 36' ' ' PRO . 1.9 m -72.76 135.89 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -125.5 -29.86 3.16 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.196 0.31 . . . . 0.0 111.746 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.3 112.77 7.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.495 0.718 . . . . 0.0 110.483 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.23 -160.81 0.77 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -135.8 -101.64 0.22 Allowed 'General case' 0 C--N 1.343 0.283 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.977 170.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -81.21 66.54 6.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.163 0.892 . . . . 0.0 110.66 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.99 -28.34 70.03 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.315 1.046 . . . . 0.0 110.681 -175.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -62.49 -55.59 26.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.212 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -59.67 -39.02 83.11 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.413 ' HA ' HG21 ' A' ' 116' ' ' VAL . 5.0 t80 -52.95 -52.97 56.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.145 176.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.12 -29.1 63.74 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.328 1.051 . . . . 0.0 112.696 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -37.76 75.59 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.994 0.816 . . . . 0.0 110.877 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.81 -33.9 76.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.482 0.713 . . . . 0.0 111.618 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.99 156.09 32.14 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.852 0.461 . . . . 0.0 110.485 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.78 35.49 0.84 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.281 1.033 . . . . 0.0 112.169 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 mp -88.58 139.29 29.71 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.61 157.83 54.98 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.587 2.192 . . . . 0.0 110.473 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -62.17 -36.86 83.16 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -166.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -61.16 -48.79 79.96 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.285 0.634 . . . . 0.0 110.206 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -20.18 64.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.701 1.2 . . . . 0.0 110.907 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.42 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 46.8 mt -78.22 -37.0 21.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.896 0.771 . . . . 0.0 110.845 171.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.56 -38.38 80.96 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.0 ttt -63.92 -51.98 61.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.915 1.286 . . . . 0.0 110.52 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 28' ' ' ILE . . . -52.71 -39.89 62.46 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.245 1.418 . . . . 0.0 112.479 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.17 -16.23 19.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.053 1.341 . . . . 0.0 112.306 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -121.14 18.05 11.59 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 mm -79.37 123.52 36.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.09 101.48 30.48 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 168.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.485 ' HG2' HG11 ' A' ' 8' ' ' VAL . 92.8 Cg_endo -74.52 179.9 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.402 1.401 . . . . 0.0 111.302 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -131.02 158.63 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 168.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.6 t -132.39 121.8 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 165.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -125.48 95.57 4.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.265 2.226 . . . . 0.0 105.086 -170.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.782 HD13 ' HB3' ' A' ' 2' ' ' PHE . 13.8 tt -118.5 140.5 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.669 1.188 . . . . 0.0 111.227 -165.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -139.59 143.93 37.52 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.517 1.127 . . . . 0.0 109.742 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.48 147.36 31.79 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.908 1.283 . . . . 0.0 111.117 -175.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -135.49 163.47 30.01 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 129.05 2.94 . . . . 0.0 107.456 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -20.5 -72.24 0.01 OUTLIER Glycine 0 C--N 1.344 0.982 0 C-N-CA 127.618 2.533 . . . . 0.0 114.338 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -127.19 30.87 5.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.526 1.531 . . . . 0.0 109.32 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -131.43 152.32 50.77 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.523 0.601 . . . . 0.0 112.107 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -138.03 130.58 29.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.022 0.929 . . . . 0.0 109.837 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.14 127.46 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.2 t -127.8 109.37 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.243 1.417 . . . . 0.0 109.491 -173.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -107.43 102.15 11.45 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.496 1.118 . . . . 0.0 108.096 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 t -105.7 111.34 23.98 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -108.25 129.05 55.22 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.331 0.653 . . . . 0.0 109.909 -171.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 p -134.55 150.0 72.5 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 126.161 1.784 . . . . 0.0 107.957 171.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.52 73.93 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.768 2.979 . . . . 0.0 109.56 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -167.63 -52.16 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.786 1.634 . . . . 0.0 108.137 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.14 150.41 11.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.632 1.173 . . . . 0.0 107.878 176.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.4 p -80.1 94.84 6.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.6 72.57 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.5 m -97.65 128.76 44.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.29 1.436 . . . . 0.0 108.489 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -145.35 162.62 36.81 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.746 1.218 . . . . 0.0 107.997 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.3 m -150.68 141.53 22.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.36 137.44 27.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.917 0.487 . . . . 0.0 110.618 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.0 m -98.47 141.59 31.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.757 1.223 . . . . 0.0 107.856 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.6 mt -68.09 -57.71 5.66 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.804 0.842 . . . . 0.0 110.634 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.34 57.9 4.66 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -169.58 138.58 1.93 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.736 1.614 . . . . 0.0 107.172 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -58.5 129.08 40.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.047 0.539 . . . . 0.0 109.71 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.22 157.0 47.37 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.659 1.183 . . . . 0.0 110.628 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -144.99 158.98 43.64 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.222 1.409 . . . . 0.0 108.845 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.1 mm -105.95 148.9 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 125.457 1.503 . . . . 0.0 109.694 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.8 m -105.54 153.85 21.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.851 1.66 . . . . 0.0 109.891 -171.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 m -44.67 142.73 1.59 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.764 2.026 . . . . 0.0 112.727 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.16 176.82 8.14 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.835 1.254 . . . . 0.0 110.242 -172.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.64 -73.34 0.68 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.492 1.517 . . . . 0.0 107.78 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.01 95.59 0.16 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -157.99 -54.66 0.07 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -132.54 178.68 6.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.539 1.536 . . . . 0.0 109.907 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tp -150.01 149.08 29.84 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.713 1.205 . . . . 0.0 108.956 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -70.65 101.97 2.18 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.0 p -144.05 -170.47 3.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.351 1.46 . . . . 0.0 109.531 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.6 m -107.36 110.49 22.5 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.308 1.043 . . . . 0.0 108.805 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.4 m -78.34 136.78 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.287 0.635 . . . . 0.0 110.658 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -165.66 118.47 1.14 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.323 1.049 . . . . 0.0 109.257 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -109.32 131.42 55.09 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 172.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.96 -67.58 0.9 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.11 62.79 0.23 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.29 -87.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -128.94 159.27 36.37 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.259 1.423 . . . . 0.0 108.895 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 tt -74.16 81.79 1.79 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.112 0.965 . . . . 0.0 108.77 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.7 p -74.51 142.76 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.518 0.727 . . . . 0.0 110.235 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.0 t -165.36 174.23 10.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.322 1.449 . . . . 0.0 108.218 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -148.32 152.73 37.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.838 0.855 . . . . 0.0 110.658 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 99.4 p -164.24 -144.58 0.08 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.975 1.31 . . . . 0.0 108.625 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -82.52 -151.53 0.1 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.945 1.298 . . . . 0.0 110.153 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -77.75 65.47 3.22 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.031 1.332 . . . . 0.0 110.523 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -147.38 149.98 33.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.361 1.464 . . . . 0.0 108.746 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.0 t -152.93 103.32 2.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -59.65 -38.34 81.16 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.408 1.083 . . . . 0.0 110.913 173.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -155.66 150.48 26.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.588 1.155 . . . . 0.0 108.631 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -115.85 -55.14 2.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.369 1.068 . . . . 0.0 108.921 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.43 153.72 42.21 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.638 0.775 . . . . 0.0 111.094 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.7 t -139.86 142.18 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.897 1.679 . . . . 0.0 107.02 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -105.83 154.21 20.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -41.34 -38.33 1.95 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.554 1.549 . . . . 0.0 115.018 -172.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.28 40.15 1.92 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.91 0.884 . . . . 0.0 110.681 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -167.15 116.18 0.84 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.608 0.763 . . . . 0.0 110.496 173.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -99.69 127.05 45.81 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 169.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.11 173.58 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.871 0.869 . . . . 0.0 112.765 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -43.13 88.06 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.803 2.841 . . . . 0.0 115.826 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.8 t -165.43 131.0 2.57 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 tp -172.54 121.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.546 1.938 . . . . 0.0 106.802 167.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 m -112.0 125.81 54.47 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -129.35 161.96 29.08 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.936 1.294 . . . . 0.0 109.766 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -2.94 -74.93 0.01 OUTLIER Glycine 0 C--N 1.346 1.129 0 C-N-CA 129.249 3.309 . . . . 0.0 115.693 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -144.11 47.79 0.76 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' A' ' 17' ' ' PHE . 2.0 p -165.69 131.69 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -127.32 135.8 51.05 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.06 158.17 28.43 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.97 1.308 . . . . 0.0 110.46 -169.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 mp -97.71 113.97 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 172.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 tpt85 -123.26 114.02 19.68 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.235 1.414 . . . . 0.0 109.431 -174.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -111.11 110.95 21.71 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.902 0.881 . . . . 0.0 109.452 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.4 p -114.63 130.3 56.78 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 122.1 0.953 . . . . 0.0 109.504 169.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -113.91 143.82 44.07 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -173.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.25 165.67 11.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.162 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.033 -1.936 . . . . 0.0 108.352 178.813 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.457 -0.117 0 N-CA-C 110.761 -0.088 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 t -138.57 40.99 2.21 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.445 1.098 . . . . 0.0 108.753 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.98 172.55 53.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.257 0.932 . . . . 0.0 113.74 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 m -148.85 109.44 4.21 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -143.21 157.72 44.25 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.141 1.376 . . . . 0.0 111.121 -166.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -139.95 134.43 31.54 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 124.066 0.947 . . . . 0.0 111.073 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.59 HG11 ' HD2' ' A' ' 36' ' ' PRO . 8.1 p -62.5 150.81 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 127.029 2.132 . . . . 0.0 112.103 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -146.3 -6.85 0.55 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 163.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . . . -152.64 76.65 1.15 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.776 0.43 . . . . 0.0 110.142 -164.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.75 103.2 15.1 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -77.89 0.06 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.54 1.136 . . . . 0.0 113.043 -171.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -85.48 51.1 2.1 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.866 0.866 . . . . 0.0 111.122 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -43.5 77.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.54 1.136 . . . . 0.0 111.777 -168.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.9 -38.8 92.41 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.874 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -61.88 -48.21 81.53 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.507 0.594 . . . . 0.0 110.783 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.612 ' HA ' HG21 ' A' ' 116' ' ' VAL . 30.5 t80 -55.92 -47.16 78.01 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.141 1.376 . . . . 0.0 111.406 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.25 -43.08 74.7 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.143 0.577 . . . . 0.0 112.301 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -78.92 67.99 4.76 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.111 0.964 . . . . 0.0 109.963 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.05 -44.88 0.06 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.176 1.79 . . . . 0.0 108.614 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -83.07 147.69 27.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.67 52.32 2.36 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.755 1.222 . . . . 0.0 112.674 -162.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mt -92.01 147.16 34.24 Favored Pre-proline 0 N--CA 1.453 -0.275 0 C-N-CA 124.518 1.127 . . . . 0.0 108.758 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.46 151.8 48.2 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.323 2.015 . . . . 0.0 109.559 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -62.24 -28.77 69.93 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -170.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -63.11 -44.97 94.18 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.345 0.52 . . . . 0.0 110.548 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.81 -41.78 99.44 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.24 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.53 -34.47 61.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 118.525 0.602 . . . . 0.0 111.377 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.91 -44.08 73.88 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.765 0.711 . . . . 0.0 110.469 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.56 -47.09 57.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.827 0.851 . . . . 0.0 110.643 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.41 -46.2 73.11 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 111.823 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -65.59 -30.56 71.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.186 2.194 . . . . 0.0 110.818 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -108.17 50.71 0.77 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.363 1.465 . . . . 0.0 108.984 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.39 150.91 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.068 1.347 . . . . 0.0 109.118 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -128.2 99.91 24.09 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.099 1.359 . . . . 0.0 109.756 -170.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.59 ' HD2' HG11 ' A' ' 8' ' ' VAL . 83.8 Cg_endo -70.86 160.13 50.37 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.062 2.508 . . . . 0.0 113.78 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.494 HD12 ' HG3' ' A' ' 39' ' ' GLU . 8.3 pt -105.6 170.97 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 168.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.1 t -141.25 103.73 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HG3' HD12 ' A' ' 37' ' ' ILE . 67.0 mm-40 -123.69 101.21 7.17 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.204 2.602 . . . . 0.0 106.053 -167.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.6 mt -108.87 150.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.526 0.731 . . . . 0.0 110.031 -171.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -134.25 119.74 19.12 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.051 1.34 . . . . 0.0 108.716 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -83.9 153.28 24.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.72 1.608 . . . . 0.0 109.425 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.34 152.99 10.99 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.984 1.714 . . . . 0.0 108.235 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -20.6 -69.77 0.01 OUTLIER Glycine 0 C--N 1.344 0.99 0 C-N-CA 127.733 2.587 . . . . 0.0 113.969 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -125.94 20.71 7.64 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.786 1.235 . . . . 0.0 110.568 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.35 134.26 55.03 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.409 1.004 . . . . 0.0 109.887 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -134.42 101.31 4.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.5 t -107.98 116.18 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -174.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 p -111.91 125.06 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.522 1.129 . . . . 0.0 109.72 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 m -107.52 95.11 5.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 t -107.82 63.15 0.62 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -102.14 162.55 12.83 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.343 0.657 . . . . 0.0 110.314 -170.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.54 162.36 55.26 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.476 1.111 . . . . 0.0 108.341 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.04 51.37 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.461 2.774 . . . . 0.0 111.433 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 178.57 -58.6 0.01 OUTLIER 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.19 1.796 . . . . 0.0 109.013 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -95.66 155.83 16.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.137 1.375 . . . . 0.0 109.571 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.6 p -132.44 109.61 9.94 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.819 0.848 . . . . 0.0 110.672 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -129.76 87.86 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.6 m -110.26 136.73 49.01 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 171.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -137.02 150.81 48.33 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.2 p -144.05 94.25 2.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.9 0.88 . . . . 0.0 108.781 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.426 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -105.76 104.32 14.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.07 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.1 m -76.68 126.77 31.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 164.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.7 mt -57.46 -56.43 21.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.774 0.829 . . . . 0.0 111.376 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.51 53.66 4.85 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -167.16 148.44 5.77 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.885 0.874 . . . . 0.0 109.387 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 67' ' ' GLU . 3.1 mp0 -53.67 107.08 0.22 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.345 1.458 . . . . 0.0 108.896 170.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.426 ' CB ' ' HB3' ' A' ' 62' ' ' PHE . . . -112.53 58.98 0.64 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.237 0.615 . . . . 0.0 110.951 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -100.3 101.12 12.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 171.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.52 143.22 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 125.227 1.411 . . . . 0.0 107.801 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.4 t -158.8 152.2 22.83 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.124 0.97 . . . . 0.0 109.322 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 t -167.84 -47.06 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.098 1.359 . . . . 0.0 108.988 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -75.6 165.44 25.07 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.382 1.073 . . . . 0.0 108.851 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.28 74.24 1.73 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.706 0.802 . . . . 0.0 109.025 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.21 58.54 0.1 OUTLIER Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.051 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.48 91.75 1.93 Allowed 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -124.93 58.2 1.26 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.353 1.061 . . . . 0.0 109.58 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.76 173.01 17.21 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.349 1.06 . . . . 0.0 110.369 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -116.72 143.06 46.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.323 1.449 . . . . 0.0 108.321 172.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.3 p -163.17 164.48 25.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.331 1.052 . . . . 0.0 109.314 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 88.2 m -135.37 108.01 7.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.2 137.5 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.83 169.87 21.19 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.734 0.413 . . . . 0.0 110.556 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -137.12 136.39 38.25 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.451 1.5 . . . . 0.0 107.609 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.57 -60.3 1.59 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.566 1.146 . . . . 0.0 108.972 -176.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -161.79 -57.42 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.602 0.761 . . . . 0.0 109.629 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.51 -59.47 8.76 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.896 0.76 . . . . 0.0 112.167 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -158.85 172.98 17.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.55 1.14 . . . . 0.0 109.068 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.84 162.35 20.59 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.999 0.52 . . . . 0.0 112.276 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.98 144.21 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.324 1.449 . . . . 0.0 108.901 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.7 m -114.45 -66.45 1.09 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.593 1.557 . . . . 0.0 109.224 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -165.59 159.43 16.58 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.22 1.408 . . . . 0.0 107.673 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.5 p -62.69 170.25 2.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.643 1.177 . . . . 0.0 112.751 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -50.84 106.42 0.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.373 1.469 . . . . 0.0 112.091 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.7 mttm 179.11 -55.9 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 126.62 1.968 . . . . 0.0 106.99 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -77.39 -55.09 5.69 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.942 1.297 . . . . 0.0 110.888 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.2 m -157.71 -37.63 0.07 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.274 -0.87 . . . . 0.0 113.229 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 9.16 80.63 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.294 2.237 . . . . 0.0 113.574 -159.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -128.05 93.97 3.81 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.721 2.008 . . . . 0.0 107.031 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -151.26 74.84 1.16 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.742 0.817 . . . . 0.0 111.472 -172.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -176.66 129.86 0.19 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.044 1.338 . . . . 0.0 109.023 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.53 155.81 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.9 0.88 . . . . 0.0 108.694 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -114.13 160.18 19.23 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.921 1.288 . . . . 0.0 109.282 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -31.05 -56.07 0.28 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 127.533 2.492 . . . . 0.0 115.056 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -128.58 29.56 5.27 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.976 0.911 . . . . 0.0 111.772 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.55 107.07 3.78 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.14 0.427 . . . . 0.0 110.598 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 40.1 ttm -84.46 86.79 7.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.6 m -123.78 122.96 65.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.122 1.369 . . . . 0.0 109.294 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.44 175.59 3.53 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.318 1.047 . . . . 0.0 109.029 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.2 p -106.43 152.68 23.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.361 1.065 . . . . 0.0 110.304 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.5 mt -104.2 106.9 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 m -89.81 99.71 12.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -123.86 -179.86 4.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.539 1.536 . . . . 0.0 109.552 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -46.96 117.25 2.94 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 125.063 1.316 . . . . 0.0 110.77 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 8.11 59.26 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 128.361 2.886 . . . . 0.0 114.875 -156.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.612 HG21 ' HA ' ' A' ' 17' ' ' PHE . 2.0 t -140.85 144.75 26.41 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 126.008 1.723 . . . . 0.0 108.759 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.0 m -136.31 101.55 4.71 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.02 102.85 12.32 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.97 98.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.243 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 168.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -98.96 105.32 17.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.561 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 45.7 ttt85 -108.26 111.7 23.8 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 -173.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.3 t -124.6 149.92 46.54 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.201 1.8 . . . . 0.0 108.716 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -125.23 146.16 49.65 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.825 1.25 . . . . 0.0 109.693 -170.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.75 148.57 42.46 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.061 0.944 . . . . 0.0 111.004 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--O 1.25 1.087 0 CA-C-O 117.46 -1.257 . . . . 0.0 110.501 175.313 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 119.531 -0.271 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.1 p -38.01 108.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.654 1.982 . . . . 0.0 113.367 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.01 -179.17 46.47 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.3 t -107.57 134.42 50.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.019 1.328 . . . . 0.0 107.639 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -133.66 118.76 18.54 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.432 0.693 . . . . 0.0 110.209 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -102.75 93.43 5.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.971 1.308 . . . . 0.0 109.539 -172.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.463 ' CG1' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -53.95 129.37 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -145.62 10.06 1.21 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.37 0.419 . . . . 0.0 111.784 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . . . -161.33 105.76 1.31 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 122.7 0.4 . . . . 0.0 110.238 -161.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.66 -167.16 1.48 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.18 1.392 . . . . 0.0 108.591 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.536 ' HB2' HG22 ' A' ' 119' ' ' ILE . 31.0 tt0 -135.52 -104.24 0.22 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.966 0.803 . . . . 0.0 111.141 -174.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -75.46 67.62 2.02 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.219 1.008 . . . . 0.0 109.356 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -81.52 -45.31 16.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.166 0.586 . . . . 0.0 112.412 -169.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.0 -43.38 91.5 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.383 0.538 . . . . 0.0 110.468 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -61.0 -50.93 71.37 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.527 1.131 . . . . 0.0 110.44 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.412 ' CD2' HD21 ' A' ' 118' ' ' LEU . 10.2 t80 -56.64 -49.06 76.11 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.097 0.959 . . . . 0.0 110.134 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -58.75 -46.38 87.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.269 1.028 . . . . 0.0 111.667 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -65.79 -24.42 66.92 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.287 0.635 . . . . 0.0 111.83 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.35 -23.99 60.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.613 0.765 . . . . 0.0 111.03 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.0 mt -84.14 -162.12 0.62 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.97 41.57 2.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.045 0.938 . . . . 0.0 111.381 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.0 127.8 31.16 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.3 164.86 33.17 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.582 2.854 . . . . 0.0 113.615 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -59.48 -44.95 92.92 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.11 1.764 . . . . 0.0 112.514 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -54.58 -46.63 73.76 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.486 0.714 . . . . 0.0 110.577 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.29 -43.43 86.34 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.501 -0.762 . . . . 0.0 109.986 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.35 -41.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 CA-C-N 118.747 0.703 . . . . 0.0 111.618 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -42.96 -43.35 4.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.129 1.372 . . . . 0.0 111.44 173.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 19.7 mmt -102.11 -1.88 30.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.938 1.695 . . . . 0.0 112.536 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.56 -51.04 6.13 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.766 1.226 . . . . 0.0 110.704 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -56.83 -39.83 74.94 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.402 0.681 . . . . 0.0 111.471 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.65 -37.28 79.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.11 1.364 . . . . 0.0 111.55 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -51.14 142.62 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.503 1.121 . . . . 0.0 111.74 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -119.08 98.39 50.85 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 125.43 1.492 . . . . 0.0 107.209 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.463 ' HD2' ' CG1' ' A' ' 8' ' ' VAL . 17.0 Cg_exo -63.57 176.09 2.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.803 2.335 . . . . 0.0 112.396 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.67 131.36 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 169.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.2 t -113.08 96.58 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -103.88 101.31 11.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.869 2.067 . . . . 0.0 107.778 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.46 138.36 32.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -173.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -141.42 131.5 24.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.455 1.102 . . . . 0.0 108.994 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -104.15 150.66 24.15 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.441 1.497 . . . . 0.0 110.053 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -152.38 155.4 37.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.394 1.878 . . . . 0.0 108.863 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -21.1 -68.18 0.01 OUTLIER Glycine 0 C--N 1.345 1.035 0 C-N-CA 127.563 2.506 . . . . 0.0 114.115 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -123.81 12.96 9.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.946 1.298 . . . . 0.0 110.893 172.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -114.38 143.53 44.76 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.334 0.97 . . . . 0.0 110.09 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -141.55 110.17 6.06 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.0 t -108.25 122.21 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.883 1.273 . . . . 0.0 108.599 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.15 104.52 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.01 1.324 . . . . 0.0 107.786 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.8 m -101.3 82.8 2.38 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.8 p -102.93 98.96 8.85 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -137.37 140.02 41.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.314 -162.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 p -130.38 157.02 78.62 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 126.277 1.831 . . . . 0.0 106.873 167.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.26 60.67 6.41 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.167 2.578 . . . . 0.0 108.707 168.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -169.84 -67.57 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.639 1.176 . . . . 0.0 109.66 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -106.83 156.31 18.81 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.864 1.266 . . . . 0.0 110.07 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -123.15 70.17 1.02 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.219 1.408 . . . . 0.0 108.731 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.3 t -71.95 -46.75 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -6.48 106.11 0.01 OUTLIER 'General case' 0 C--N 1.345 0.408 0 C-N-CA 129.386 3.074 . . . . 0.0 114.244 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -104.81 156.74 17.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.728 1.211 . . . . 0.0 109.693 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.1 t -158.94 95.18 1.27 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.45 163.7 22.07 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.639 0.776 . . . . 0.0 111.297 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.8 m -133.46 150.77 51.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.89 1.676 . . . . 0.0 107.191 -176.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.3 mt -65.46 -60.15 3.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.474 0.31 . . . . 0.0 111.479 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.3 47.75 1.01 Allowed Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.317 0.96 . . . . 0.0 111.122 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -164.99 144.09 6.73 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -57.13 165.14 1.42 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.843 1.257 . . . . 0.0 112.591 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.22 98.79 2.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.504 0.721 . . . . 0.0 109.46 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -89.47 83.34 6.35 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.413 1.085 . . . . 0.0 109.899 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.93 167.02 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 125.345 1.458 . . . . 0.0 109.695 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.2 t -162.2 176.01 11.08 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.013 0.925 . . . . 0.0 110.053 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 t -113.49 121.28 43.78 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.241 1.416 . . . . 0.0 108.223 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.45 85.23 7.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -169.71 -70.03 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.099 0.959 . . . . 0.0 111.514 174.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.39 -119.19 3.24 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 124.748 1.166 . . . . 0.0 111.094 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -108.46 171.79 7.22 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.787 1.235 . . . . 0.0 109.158 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -154.69 131.07 10.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.924 0.89 . . . . 0.0 108.834 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.19 136.28 48.14 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.859 1.263 . . . . 0.0 109.399 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -147.81 124.32 11.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.2 t -106.98 -65.78 1.07 Allowed 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -150.7 127.61 11.06 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.1 m -104.26 49.75 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.275 1.43 . . . . 0.0 110.06 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -91.45 -179.28 5.34 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.399 1.079 . . . . 0.0 111.349 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -154.85 139.96 17.46 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.741 2.017 . . . . 0.0 106.796 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.45 -72.11 0.73 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.821 0.848 . . . . 0.0 110.093 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -95.39 -67.84 0.83 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.877 0.871 . . . . 0.0 110.248 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.64 48.49 0.22 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -158.96 128.92 5.74 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.379 1.072 . . . . 0.0 109.337 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.04 135.64 51.24 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.976 1.31 . . . . 0.0 109.872 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.5 p -158.7 154.56 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.05 1.34 . . . . 0.0 108.545 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.5 m -135.37 127.58 30.05 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.516 1.126 . . . . 0.0 108.253 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.6 88.63 2.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.922 0.889 . . . . 0.0 110.36 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.2 m -130.46 83.76 2.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.944 1.298 . . . . 0.0 109.235 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.04 76.67 2.9 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.0 -52.97 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 126.822 2.049 . . . . 0.0 106.897 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -98.95 91.81 5.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.546 1.539 . . . . 0.0 107.504 171.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -99.8 118.72 36.88 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.992 0.917 . . . . 0.0 109.441 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -126.21 103.76 7.86 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.394 1.077 . . . . 0.0 109.001 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -69.89 134.39 48.38 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -108.61 49.2 0.82 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.463 1.105 . . . . 0.0 110.767 -171.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -81.3 83.66 6.82 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.4 p -108.27 128.55 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.346 1.458 . . . . 0.0 108.971 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -122.06 156.5 33.41 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.11 1.364 . . . . 0.0 109.075 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -26.13 -60.39 0.08 OUTLIER Glycine 0 CA--C 1.53 1.013 0 C-N-CA 127.562 2.505 . . . . 0.0 115.487 -173.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -131.51 28.24 4.65 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.848 0.859 . . . . 0.0 111.571 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -155.35 119.5 4.61 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 41.8 ttm -106.12 115.22 29.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.03 61.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.844 1.258 . . . . 0.0 108.69 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -73.08 165.37 25.15 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.06 0.944 . . . . 0.0 110.952 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m -131.44 96.88 4.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 173.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 pp -106.65 134.91 46.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 94.2 m -129.83 137.76 50.63 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.039 1.336 . . . . 0.0 111.046 -167.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -108.34 179.45 4.2 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.199 2.2 . . . . 0.0 107.594 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -18.95 -56.55 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 128.139 2.78 . . . . 0.0 115.334 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -155.05 36.01 0.66 Allowed Glycine 0 CA--C 1.532 1.116 0 CA-C-O 118.689 -1.062 . . . . 0.0 114.072 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -146.26 151.61 14.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.32 0 CA-C-N 118.778 1.289 . . . . 0.0 109.037 170.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 87.3 m -128.53 142.95 50.91 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.423 1.489 . . . . 0.0 110.254 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.412 HD21 ' CD2' ' A' ' 17' ' ' PHE . 1.6 mm? -108.43 146.88 32.43 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.536 HG22 ' HB2' ' A' ' 12' ' ' GLU . 8.8 tp -80.17 63.35 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 170.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -52.23 97.3 0.02 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 126.19 1.796 . . . . 0.0 111.56 -170.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.461 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 64.3 ttt180 -125.32 113.68 17.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.919 0.887 . . . . 0.0 110.124 -169.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 56.4 p -126.36 144.68 50.73 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.505 1.522 . . . . 0.0 109.692 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -114.39 142.34 46.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.398 1.479 . . . . 0.0 108.952 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.66 98.59 6.26 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.7 t . . . . . 0 C--O 1.252 1.199 0 CA-C-O 116.494 -1.717 . . . . 0.0 107.144 175.394 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 . . . . . 0 CA--C 1.53 0.178 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 p -50.32 95.5 0.01 OUTLIER 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.303 1.841 . . . . 0.0 112.198 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.73 -171.38 44.45 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -106.83 142.38 36.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 168.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -142.41 124.47 15.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.178 0.991 . . . . 0.0 109.387 -169.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -119.78 112.11 18.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.096 0.958 . . . . 0.0 109.239 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.811 HG11 ' HD2' ' A' ' 36' ' ' PRO . 1.4 p -63.94 121.46 12.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 C-N-CA 124.109 0.964 . . . . 0.0 109.853 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -113.65 -24.22 9.32 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.538 0.735 . . . . 0.0 110.981 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.63 143.87 28.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.272 1.429 . . . . 0.0 108.113 -169.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.99 162.89 34.33 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.48 -100.93 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.283 0.633 . . . . 0.0 110.869 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -106.97 65.05 0.65 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.546 1.138 . . . . 0.0 110.532 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.0 -41.5 99.6 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.013 0.525 . . . . 0.0 111.16 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -58.35 -24.55 60.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 119.026 -0.511 . . . . 0.0 112.017 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -88.45 -38.78 14.75 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 123.093 0.557 . . . . 0.0 111.89 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.489 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 67.1 t80 -46.14 -41.53 12.63 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.073 0.949 . . . . 0.0 110.49 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.762 HD13 HG23 ' A' ' 28' ' ' ILE . 7.6 mt -78.61 40.16 0.37 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.107 1.763 . . . . 0.0 112.77 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.4 -33.31 1.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.188 0.904 . . . . 0.0 111.852 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.7 98.38 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.239 0.616 . . . . 0.0 110.579 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.419 HD22 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -74.53 168.26 20.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.126 0.97 . . . . 0.0 110.713 175.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.74 60.28 0.64 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.698 1.199 . . . . 0.0 111.183 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.419 HD13 HD22 ' A' ' 21' ' ' LEU . 9.4 mp -103.23 148.47 35.72 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.685 1.194 . . . . 0.0 108.583 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.88 158.01 59.23 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.385 2.723 . . . . 0.0 111.52 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . 13.1 pt-20 -57.08 -35.21 69.1 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.53 -35.52 80.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.368 0.667 . . . . 0.0 111.677 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -24.55 64.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.562 0.745 . . . . 0.0 112.219 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.762 HG23 HD13 ' A' ' 18' ' ' LEU . 3.9 mp -70.54 -39.49 76.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -55.65 -52.33 64.18 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 16.4 mmt -83.77 47.18 1.26 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.331 1.052 . . . . 0.0 110.571 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 18' ' ' LEU . . . -151.52 -58.67 0.16 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.757 1.623 . . . . 0.0 109.42 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.1 ptt85 -69.79 -37.31 76.27 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 122.244 -0.285 . . . . 0.0 111.31 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -83.79 37.27 0.58 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.767 0.827 . . . . 0.0 110.424 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.5 mm -130.62 117.31 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.1 96.7 39.84 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.818 1.247 . . . . 0.0 107.764 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.811 ' HD2' HG11 ' A' ' 8' ' ' VAL . 8.3 Cg_exo -72.52 164.85 34.39 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.743 2.295 . . . . 0.0 112.698 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.13 117.18 53.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 166.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.95 140.23 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -148.64 100.32 3.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.065 0.946 . . . . 0.0 109.161 -165.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 mt -108.87 135.7 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.593 0.757 . . . . 0.0 109.624 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -125.05 133.28 53.0 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.15 1.38 . . . . 0.0 108.286 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.1 150.66 21.8 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.448 1.099 . . . . 0.0 110.465 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -140.19 154.13 46.83 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 127.735 2.414 . . . . 0.0 106.729 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.93 -55.28 2.31 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.21 1.386 . . . . 0.0 112.499 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -129.84 61.57 1.57 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.739 1.615 . . . . 0.0 109.194 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.4 155.42 17.66 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.246 0.546 . . . . 0.0 110.789 163.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -139.54 111.85 7.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.841 1.656 . . . . 0.0 106.986 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 80.9 t -106.17 127.72 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -127.42 119.79 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.436 1.094 . . . . 0.0 109.207 -171.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.1 m -107.93 141.08 40.09 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.607 1.563 . . . . 0.0 107.522 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.4 t -148.54 87.43 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.146 1.378 . . . . 0.0 107.353 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 120.21 41.33 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.925 0.89 . . . . 0.0 108.844 -170.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 p -101.19 153.8 37.57 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 124.519 1.127 . . . . 0.0 110.041 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.85 51.29 3.33 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.232 2.621 . . . . 0.0 110.418 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -167.09 -48.41 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.694 1.197 . . . . 0.0 110.441 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -130.59 -166.16 1.65 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.647 1.579 . . . . 0.0 108.903 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.8 m -155.27 130.59 9.63 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.48 1.112 . . . . 0.0 108.222 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -133.12 136.03 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.1 m -152.93 141.87 21.21 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.779 1.232 . . . . 0.0 107.894 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -145.84 166.42 26.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.247 1.419 . . . . 0.0 109.473 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.0 p -157.13 141.87 16.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.845 0.858 . . . . 0.0 109.436 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -169.44 167.32 9.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.533 1.133 . . . . 0.0 108.826 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 m -133.02 164.76 26.28 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.842 0.857 . . . . 0.0 110.294 -167.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.48 -58.85 5.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.286 1.035 . . . . 0.0 110.62 175.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.46 36.18 4.39 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.84 1.21 . . . . 0.0 113.564 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -130.24 128.61 41.99 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.862 1.331 . . . . 0.0 109.236 167.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -66.77 133.17 49.61 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.41 0.684 . . . . 0.0 109.463 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -161.15 107.78 1.43 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.097 0.959 . . . . 0.0 109.575 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.86 150.03 44.64 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.22 0.464 . . . . 0.0 110.027 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.7 mm -108.37 111.59 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.277 1.031 . . . . 0.0 108.483 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.9 t -107.39 155.04 20.45 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.491 1.116 . . . . 0.0 111.032 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.6 p -138.12 137.25 37.51 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.8 1.24 . . . . 0.0 109.023 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.7 ptp -88.44 82.36 7.0 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.371 1.068 . . . . 0.0 110.412 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -155.51 -93.56 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.152 0.581 . . . . 0.0 110.934 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.34 -31.5 0.1 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.465 1.507 . . . . 0.0 111.904 -174.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.06 124.79 7.15 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.953 1.376 . . . . 0.0 111.406 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -94.55 131.38 40.34 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.27 0.628 . . . . 0.0 109.323 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.1 tt -157.51 73.42 0.71 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 171.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -141.9 149.77 40.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.688 1.195 . . . . 0.0 108.513 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -136.89 119.84 16.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.4 m -146.37 71.31 1.24 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 83' ' ' HIS . 9.6 m -131.08 -65.24 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.141 0.576 . . . . 0.0 111.315 -175.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.42 ' N ' HG23 ' A' ' 82' ' ' VAL . 46.3 t-80 -99.51 130.72 45.79 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.189 1.396 . . . . 0.0 110.817 -169.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -125.75 119.04 26.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.773 1.629 . . . . 0.0 107.481 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.98 -53.63 0.48 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.015 0.926 . . . . 0.0 109.901 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -66.86 -60.09 2.97 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.249 0.619 . . . . 0.0 110.58 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.2 -48.69 0.1 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.03 110.46 22.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.5 119.51 7.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.431 1.092 . . . . 0.0 111.216 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.0 p -160.11 162.14 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.875 0.87 . . . . 0.0 109.861 -173.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 m -145.86 -38.5 0.24 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.544 1.138 . . . . 0.0 110.028 173.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -139.68 141.19 37.0 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 125.745 1.618 . . . . 0.0 107.787 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.5 t -168.28 67.56 0.07 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.514 1.126 . . . . 0.0 108.463 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -89.35 -99.49 0.09 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.77 0.828 . . . . 0.0 111.085 -173.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -73.57 -48.97 28.8 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -76.43 74.74 3.19 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.0 m -72.93 93.88 1.78 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -90.43 -16.36 29.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.848 1.259 . . . . 0.0 111.672 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.72 136.84 58.15 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.232 0.613 . . . . 0.0 109.883 -172.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.87 169.07 18.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.149 0.98 . . . . 0.0 110.548 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -123.16 146.38 47.82 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.814 1.646 . . . . 0.0 107.915 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.6 t -139.25 124.94 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -121.51 -173.95 2.75 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.664 1.186 . . . . 0.0 109.506 -169.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -39.3 116.49 0.62 Allowed Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.845 1.688 . . . . 0.0 111.593 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 p30 8.19 56.77 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.835 2.854 . . . . 0.0 115.195 -163.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -158.6 133.74 8.49 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.47 0.708 . . . . 0.0 110.372 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.8 ttt -129.41 129.65 44.97 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.903 2.081 . . . . 0.0 106.032 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.55 -72.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -53.48 142.18 22.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.716 0.806 . . . . 0.0 109.635 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.5 m -139.05 -88.72 0.21 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.869 -175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.75 149.21 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.276 0.944 . . . . 0.0 110.353 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 t -123.02 142.54 50.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.133 0.973 . . . . 0.0 109.485 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -109.26 -164.98 0.98 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.848 1.659 . . . . 0.0 108.383 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.71 -58.93 12.0 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 123.87 0.748 . . . . 0.0 113.255 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -131.55 42.29 1.41 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 123.876 0.75 . . . . 0.0 112.014 -175.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.8 p -169.31 157.86 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 125.481 1.512 . . . . 0.0 107.461 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.9 t -151.5 152.28 32.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.489 ' HG ' ' HB2' ' A' ' 17' ' ' PHE . 1.2 tm? -149.07 79.65 1.41 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.294 0.569 . . . . 0.0 112.158 -168.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.22 126.47 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 161.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -112.16 124.83 53.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -102.32 98.69 8.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 82.9 p -106.93 135.59 48.23 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.64 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -108.12 138.59 44.13 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -98.7 131.9 44.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.11 1.364 . . . . 0.0 108.971 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 C--O 1.25 1.094 0 C-N-CA 125.145 1.378 . . . . 0.0 107.914 -176.7 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -43.85 -54.6 5.12 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 124.629 1.172 . . . . 0.0 111.291 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.7 p -60.07 92.36 0.02 OUTLIER 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.797 1.239 . . . . 0.0 110.946 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.98 -170.27 42.46 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.4 t -106.5 144.53 33.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.288 1.035 . . . . 0.0 108.221 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -141.58 126.84 18.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.691 0.796 . . . . 0.0 110.917 -171.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -126.45 115.89 20.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.701 0.8 . . . . 0.0 109.189 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.484 HG11 ' HD2' ' A' ' 36' ' ' PRO . 8.3 p -50.93 143.82 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.89 1.676 . . . . 0.0 110.4 170.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -146.1 -5.52 0.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 121' ' ' ARG . . . -166.21 91.24 0.45 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -164.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.64 94.73 4.82 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.988 1.315 . . . . 0.0 107.639 174.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -55.52 -76.66 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.286 1.434 . . . . 0.0 112.133 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -85.2 59.39 5.6 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.066 0.946 . . . . 0.0 111.152 -172.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -67.14 0.43 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.541 0.737 . . . . 0.0 111.905 -173.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -53.01 -41.2 64.43 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.051 0.94 . . . . 0.0 112.541 -169.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -60.55 -53.72 54.08 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.308 0.643 . . . . 0.0 110.958 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -46.12 80.47 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.06 0.944 . . . . 0.0 109.883 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.608 HD21 HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -56.6 -46.26 80.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.785 1.234 . . . . 0.0 110.835 176.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -27.77 69.43 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.308 0.643 . . . . 0.0 111.838 -171.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.21 -31.6 71.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.005 0.522 . . . . 0.0 111.627 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.45 163.93 23.42 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.654 0.781 . . . . 0.0 109.793 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.4 52.04 1.36 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 111.998 -172.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.17 137.54 22.14 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.68 162.73 29.81 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.276 2.65 . . . . 0.0 111.97 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.88 -42.69 72.4 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.246 1.418 . . . . 0.0 113.511 -172.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -61.43 -44.61 96.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.37 0.668 . . . . 0.0 110.622 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.78 -35.15 79.67 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.646 -0.692 . . . . 0.0 110.482 171.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.608 HG12 HD21 ' A' ' 18' ' ' LEU . 78.5 mt -63.71 -31.25 52.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 119.245 0.93 . . . . 0.0 112.688 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.57 -48.7 10.31 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 168.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.4 mmt -75.71 -48.68 20.89 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.543 0.737 . . . . 0.0 111.048 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB3' ' HA ' ' A' ' 28' ' ' ILE . . . -66.42 78.9 0.1 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 125.793 1.637 . . . . 0.0 111.355 -173.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 179.03 -42.14 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.301 2.24 . . . . 0.0 107.11 -171.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -107.14 -0.38 22.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.187 1.795 . . . . 0.0 112.118 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.7 mt -62.99 117.21 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 118.99 0.813 . . . . 0.0 109.554 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -108.53 98.59 28.97 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.761 1.225 . . . . 0.0 108.943 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.484 ' HD2' HG11 ' A' ' 8' ' ' VAL . 91.8 Cg_endo -72.26 140.38 33.79 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.603 2.202 . . . . 0.0 113.83 175.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.75 137.66 37.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 166.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.24 145.65 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.743 1.217 . . . . 0.0 108.035 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 105.24 3.67 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.906 0.882 . . . . 0.0 109.214 -168.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.7 mt -107.71 131.06 58.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.742 1.217 . . . . 0.0 108.368 -173.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? -129.04 134.43 48.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.738 1.215 . . . . 0.0 108.715 -176.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -106.21 150.15 26.16 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.2 160.23 40.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 128.206 2.602 . . . . 0.0 107.755 173.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -19.67 -72.23 0.01 OUTLIER Glycine 0 C--N 1.343 0.963 0 C-N-CA 127.719 2.581 . . . . 0.0 114.231 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -123.19 18.81 9.92 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.99 1.316 . . . . 0.0 110.74 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -124.43 144.68 49.93 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.068 0.849 . . . . 0.0 109.404 -172.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -143.68 127.79 17.57 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 122.447 0.299 . . . . 0.0 110.811 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.91 138.82 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.946 1.298 . . . . 0.0 107.94 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.89 117.27 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.966 1.306 . . . . 0.0 107.895 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.5 m -107.61 143.3 36.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.625 1.57 . . . . 0.0 107.506 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 m -146.04 143.82 29.67 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.488 1.115 . . . . 0.0 108.222 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -138.07 120.66 16.17 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.3 p -136.11 159.5 70.71 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.02 1.728 . . . . 0.0 108.601 172.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.49 67.98 6.23 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.788 2.992 . . . . 0.0 108.899 168.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -157.88 -60.85 0.08 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.633 1.573 . . . . 0.0 107.994 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -171.04 162.94 7.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.555 1.942 . . . . 0.0 107.758 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.8 p -84.57 99.0 10.47 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.72 65.49 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.5 m -90.79 123.98 34.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.804 1.242 . . . . 0.0 108.121 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -142.45 178.86 7.3 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.224 1.41 . . . . 0.0 108.964 -176.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -167.7 166.79 13.67 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 121.918 -0.489 . . . . 0.0 110.721 -177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -152.88 155.61 37.39 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.715 0.806 . . . . 0.0 110.419 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.6 m -119.45 136.42 54.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 169.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.8 mt -57.21 -64.11 0.99 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.968 0.507 . . . . 0.0 109.931 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.43 49.91 1.86 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.358 -0.69 . . . . 0.0 112.043 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -155.12 -95.67 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.049 0.925 . . . . 0.0 110.515 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -142.81 169.36 17.72 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.296 1.039 . . . . 0.0 110.502 -174.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.25 147.19 20.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.905 1.282 . . . . 0.0 109.61 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -153.83 100.46 2.37 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.4 mm -120.08 104.79 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.069 1.348 . . . . 0.0 107.521 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -109.48 173.46 6.31 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.441 0.696 . . . . 0.0 112.45 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.2 p -138.89 170.83 15.27 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.293 2.237 . . . . 0.0 108.333 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -154.78 73.78 0.9 Allowed 'General case' 0 C--N 1.342 0.264 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.86 -61.55 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.204 1.002 . . . . 0.0 109.817 -176.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.8 -125.45 5.64 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -116.4 161.36 19.18 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.714 1.606 . . . . 0.0 110.061 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -61.16 143.12 56.09 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.906 0.883 . . . . 0.0 111.96 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.9 mt -132.88 102.83 5.79 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.665 1.586 . . . . 0.0 107.318 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.75 139.37 8.83 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.353 0.661 . . . . 0.0 110.161 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 41.2 t -145.37 -63.91 0.33 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.583 1.553 . . . . 0.0 107.349 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.0 t -161.11 159.11 28.68 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.11 0.964 . . . . 0.0 109.513 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.7 139.69 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 125.35 1.46 . . . . 0.0 107.468 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -164.06 -157.07 0.37 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.68 121.9 38.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.008 1.323 . . . . 0.0 107.589 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.11 -52.6 2.59 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.89 1.676 . . . . 0.0 110.43 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -149.92 -80.26 0.12 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.272 0.629 . . . . 0.0 109.575 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.97 -69.13 1.41 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 173.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -145.7 -115.68 0.08 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.228 1.411 . . . . 0.0 107.379 163.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.06 163.41 27.16 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.353 1.061 . . . . 0.0 112.529 -174.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.85 141.62 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.798 1.639 . . . . 0.0 106.708 172.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -166.64 139.65 3.8 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.415 0.552 . . . . 0.0 110.594 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -81.55 74.51 8.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.856 0.862 . . . . 0.0 108.952 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.4 p -82.46 -171.23 3.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.864 1.266 . . . . 0.0 109.577 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -58.49 -59.35 5.5 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.035 0.534 . . . . 0.0 110.679 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.61 -48.11 0.07 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.184 0.593 . . . . 0.0 110.971 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.0 t80 67.55 -75.5 0.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.895 1.678 . . . . 0.0 111.729 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.9 m -158.55 -53.88 0.07 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 127.065 2.146 . . . . 0.0 106.689 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -165.17 -126.4 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.558 2.343 . . . . 0.0 105.832 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -124.03 -71.28 0.72 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.671 1.188 . . . . 0.0 108.547 171.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -154.27 97.73 2.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -145.88 92.14 2.17 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.486 1.114 . . . . 0.0 108.945 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.6 t -139.59 138.42 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 125.011 1.324 . . . . 0.0 107.712 176.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -106.72 159.15 16.44 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.512 1.125 . . . . 0.0 108.498 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -25.23 -63.05 0.06 OUTLIER Glycine 0 C--N 1.342 0.881 0 C-N-CA 127.401 2.429 . . . . 0.0 114.254 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -130.71 34.55 4.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.012 0.925 . . . . 0.0 111.239 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -144.02 112.97 6.73 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.642 0.777 . . . . 0.0 109.44 173.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.2 ttm -100.18 82.29 2.51 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.38 71.1 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.618 1.167 . . . . 0.0 108.735 -173.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.4 84.14 0.8 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -105.59 26.0 10.06 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.936 1.294 . . . . 0.0 111.212 -168.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 mm -108.7 -124.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 117.9 -1.048 . . . . 0.0 108.184 -173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.5 t -132.86 125.32 29.7 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 120.198 1.363 . . . . 0.0 112.954 -165.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -41.28 78.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.75 -65.99 0.08 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.99 -43.81 4.95 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.513 1.054 . . . . 0.0 112.189 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.3 t -107.54 154.04 8.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 124.208 1.003 . . . . 0.0 109.541 -172.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.3 p -103.72 107.58 18.51 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.52 120.85 43.02 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.1 mp -76.19 75.3 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 171.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -93.88 106.16 18.14 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.675 1.19 . . . . 0.0 108.466 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 6.0 mtt-85 -107.91 119.23 38.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.615 1.566 . . . . 0.0 109.907 -175.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.0 p -125.07 121.52 34.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 170.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -107.35 155.55 19.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.347 1.459 . . . . 0.0 109.049 -173.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -74.82 148.21 40.5 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.413 177.311 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 119.46 -0.305 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -95.25 14.57 21.83 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.609 171.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.4 p -51.77 118.67 3.55 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.556 1.142 . . . . 0.0 110.84 -172.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.27 172.05 42.26 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -170.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.4 p -114.9 102.43 9.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.887 1.275 . . . . 0.0 108.249 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -115.57 147.37 40.82 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.325 1.05 . . . . 0.0 110.007 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -95.53 -131.7 0.17 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.625 0.77 . . . . 0.0 109.094 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.625 HG11 ' CD ' ' A' ' 36' ' ' PRO . 1.4 p 176.75 133.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 127.584 2.354 . . . . 0.0 105.099 -178.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -146.17 -8.91 0.52 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -158.06 110.99 2.4 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -165.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.7 140.2 52.9 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 172.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -90.32 -77.96 0.39 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.413 0.551 . . . . 0.0 112.189 -170.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -83.31 57.42 3.98 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.158 0.983 . . . . 0.0 110.208 -176.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -69.13 -61.59 1.73 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -54.56 -43.31 71.94 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-O 118.983 -0.532 . . . . 0.0 111.801 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.52 -50.66 72.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.796 0.438 . . . . 0.0 110.709 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -58.22 -50.11 74.7 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.755 0.822 . . . . 0.0 110.675 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -16.94 62.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.398 0.679 . . . . 0.0 111.678 -175.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -95.74 -15.11 22.83 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.013 0.925 . . . . 0.0 111.811 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.07 -38.3 87.96 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 166.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.98 144.77 57.07 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 163.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.03 43.99 1.04 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.28 0.632 . . . . 0.0 111.941 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.19 145.06 29.58 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.95 1.3 . . . . 0.0 107.99 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.8 135.61 26.11 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.566 2.844 . . . . 0.0 111.869 -171.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -46.34 -41.53 13.53 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.56 1.544 . . . . 0.0 113.061 -175.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -40.46 -56.04 2.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 126.977 2.111 . . . . 0.0 111.858 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.47 -41.66 84.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.888 0.875 . . . . 0.0 110.504 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.3 mp -60.79 -37.82 77.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 118.594 0.634 . . . . 0.0 110.4 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -53.06 -34.22 55.55 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.423 0.689 . . . . 0.0 111.065 177.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 81.2 mmm -108.14 19.71 19.6 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.961 1.704 . . . . 0.0 112.202 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.79 -36.06 4.96 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.554 1.542 . . . . 0.0 110.358 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -56.11 -28.66 58.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.141 0.977 . . . . 0.0 113.476 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.85 -17.46 40.84 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.087 0.955 . . . . 0.0 113.039 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.58 143.6 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.636 0.774 . . . . 0.0 110.09 -176.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -117.36 107.95 44.35 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.084 1.354 . . . . 0.0 109.005 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.625 ' CD ' HG11 ' A' ' 8' ' ' VAL . 16.3 Cg_exo -57.43 -174.47 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.455 3.437 . . . . 0.0 115.187 173.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.5 tt -118.8 146.21 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 157.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.74 78.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.3 143.81 30.06 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.56 1.944 . . . . 0.0 107.687 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 tt -145.74 142.1 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 118.426 0.557 . . . . 0.0 109.721 169.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -133.75 155.12 50.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.291 1.836 . . . . 0.0 109.254 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -127.16 161.67 27.95 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.837 1.255 . . . . 0.0 112.364 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -149.31 163.4 37.81 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.301 2.641 . . . . 0.0 107.824 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -23.28 -66.8 0.03 OUTLIER Glycine 0 C--N 1.344 1.002 0 C-N-CA 127.453 2.454 . . . . 0.0 114.114 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -129.16 21.8 5.71 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.079 1.752 . . . . 0.0 110.137 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -126.58 150.28 48.95 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.601 0.76 . . . . 0.0 111.584 -171.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -139.14 140.31 37.86 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.173 0.989 . . . . 0.0 110.555 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.2 t -135.44 112.54 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -105.54 149.79 8.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.3 m -143.5 82.58 1.74 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.131 1.372 . . . . 0.0 108.129 -172.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.9 m -114.83 47.17 1.3 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.669 1.187 . . . . 0.0 109.812 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.73 168.47 9.16 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -166.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.2 p -124.94 158.06 64.33 Favored Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 126.025 1.73 . . . . 0.0 107.298 171.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.6 65.12 5.69 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.145 2.563 . . . . 0.0 108.381 168.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -174.84 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.691 1.596 . . . . 0.0 108.862 -172.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -128.18 122.91 33.02 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.869 1.267 . . . . 0.0 109.171 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.3 m -95.5 82.08 3.62 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.143 1.377 . . . . 0.0 110.303 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -91.29 96.18 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.5 m -139.28 74.76 1.48 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.341 1.057 . . . . 0.0 109.415 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.51 138.44 58.07 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 m -155.55 142.81 19.33 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -167.56 148.4 5.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -99.69 142.66 30.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 162.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 mp -56.03 -72.07 0.08 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.027 0.931 . . . . 0.0 110.093 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.14 72.62 2.46 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -167.79 174.3 7.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.565 0.746 . . . . 0.0 110.901 -173.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -81.63 166.09 20.48 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.513 0.725 . . . . 0.0 109.24 162.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.87 85.65 0.54 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.24 73.53 3.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.076 0.55 . . . . 0.0 110.479 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.2 mt -77.13 125.97 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.0 p -107.75 -163.48 0.9 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.013 1.325 . . . . 0.0 109.465 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -161.86 171.15 18.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.579 0.752 . . . . 0.0 110.238 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.38 -61.18 1.74 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.097 1.359 . . . . 0.0 110.209 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -135.33 21.02 3.4 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.785 1.234 . . . . 0.0 111.153 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.91 -121.21 1.62 Allowed Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -141.55 -77.06 0.28 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.154 1.382 . . . . 0.0 109.389 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.4 134.03 2.72 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.42 114.61 28.17 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.176 0.99 . . . . 0.0 110.602 -171.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.28 52.08 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.41 1.084 . . . . 0.0 108.335 174.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 79.7 m -115.23 -57.77 2.21 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.559 1.144 . . . . 0.0 110.348 -170.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.5 p -104.17 84.29 2.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 -170.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.2 m -123.62 -130.81 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.048 1.339 . . . . 0.0 109.039 -171.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -24.0 127.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.715 2.406 . . . . 0.0 114.014 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.3 tt -114.76 95.69 5.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.18 -61.86 1.46 Allowed 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 123.657 0.783 . . . . 0.0 108.923 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -67.92 -56.87 7.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.252 0.621 . . . . 0.0 111.233 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.27 -38.89 0.08 OUTLIER Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -110.88 171.44 7.46 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.286 1.434 . . . . 0.0 107.89 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.04 159.44 33.82 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.13 -86.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.6 m -76.99 87.65 3.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.612 1.165 . . . . 0.0 110.349 -171.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -104.13 41.45 1.3 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.508 1.123 . . . . 0.0 108.704 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.5 p -151.03 57.4 0.91 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.459 0.703 . . . . 0.0 110.106 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -156.4 -167.78 2.52 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -64.1 133.17 52.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.182 0.593 . . . . 0.0 109.625 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.8 t80 69.02 51.93 0.52 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.758 1.223 . . . . 0.0 110.944 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 73.9 m -112.45 134.61 53.88 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.234 1.014 . . . . 0.0 109.647 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -78.0 170.28 16.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.62 0.768 . . . . 0.0 110.231 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -57.29 -73.2 0.07 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.846 1.258 . . . . 0.0 112.316 -171.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -161.06 -55.28 0.05 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.495 1.118 . . . . 0.0 108.892 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -167.41 178.82 5.28 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.524 0.73 . . . . 0.0 112.152 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 63.7 t -108.69 145.94 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 126.818 2.047 . . . . 0.0 108.633 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -108.01 151.75 25.41 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.8 0.84 . . . . 0.0 109.734 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -13.34 -72.2 0.01 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 128.777 3.084 . . . . 0.0 115.81 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -128.56 28.4 5.42 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.502 1.121 . . . . 0.0 110.972 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -151.45 113.66 4.54 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.7 ttt -98.9 97.68 8.84 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.864 1.266 . . . . 0.0 107.751 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.3 t -105.79 102.81 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -115.68 129.36 56.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.665 0.786 . . . . 0.0 109.474 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.6 t -110.91 116.41 31.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 164.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.34 110.37 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -168.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.0 p -73.59 104.06 4.41 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.877 1.271 . . . . 0.0 110.311 -172.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -92.08 174.19 7.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.905 1.282 . . . . 0.0 110.226 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -41.87 -52.48 4.77 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.066 1.793 . . . . 0.0 113.836 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -136.36 19.86 3.58 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.279 -0.734 . . . . 0.0 114.469 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.7 t -149.43 162.98 4.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 171.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.0 t -118.3 125.37 49.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 159.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 28.2 tp -101.77 99.86 10.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.1 mt -55.55 128.6 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.335 166.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -146.57 124.03 11.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.315 1.446 . . . . 0.0 108.496 176.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -107.81 116.29 31.68 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.7 p -110.98 127.55 55.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.143 1.377 . . . . 0.0 107.839 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -105.87 145.77 30.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.517 1.127 . . . . 0.0 108.894 -170.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.5 tpt85 -69.8 121.99 18.34 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.616 0.766 . . . . 0.0 110.711 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.271 -1.347 . . . . 0.0 109.289 173.889 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 119.362 -0.352 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -132.21 -59.12 0.94 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 123.695 0.798 . . . . 0.0 110.163 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 p -57.56 100.2 0.05 OUTLIER 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.188 0.995 . . . . 0.0 111.768 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.84 -174.71 47.07 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.9 p -105.91 128.14 53.59 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -130.26 153.44 48.62 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.207 0.603 . . . . 0.0 111.548 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -142.22 119.72 11.69 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.39 1.076 . . . . 0.0 109.908 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.946 HG11 ' HD2' ' A' ' 36' ' ' PRO . 1.2 p -49.77 138.01 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.729 1.212 . . . . 0.0 109.293 163.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -138.77 -16.67 1.12 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 172.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . . . -136.3 85.94 2.19 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.308 1.043 . . . . 0.0 110.709 -163.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -95.52 145.67 25.02 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 167.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -79.82 -106.67 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -85.99 75.41 9.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -46.23 75.84 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.948 0.899 . . . . 0.0 110.97 -176.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -62.6 -16.71 57.84 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -72.2 -54.06 10.77 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.378 0.99 . . . . 0.0 110.917 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -43.17 -63.37 0.82 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.102 1.761 . . . . 0.0 112.423 -172.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -12.37 59.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.415 1.086 . . . . 0.0 113.885 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.03 -32.21 64.96 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.012 0.823 . . . . 0.0 109.953 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.8 41.25 0.72 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.619 0.768 . . . . 0.0 111.686 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -138.34 168.71 19.18 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.356 1.462 . . . . 0.0 108.509 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.47 39.47 1.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.792 0.837 . . . . 0.0 111.384 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 mp -97.74 141.69 23.39 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.89 153.1 58.43 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.664 2.243 . . . . 0.0 109.732 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -57.01 -25.34 58.39 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.335 1.054 . . . . 0.0 113.091 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.92 -45.82 71.3 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.604 1.162 . . . . 0.0 111.166 171.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.5 mt -80.87 -4.91 56.46 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.644 -0.694 . . . . 0.0 112.214 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.96 -28.03 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.075 0.852 . . . . 0.0 109.945 166.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -53.65 -44.46 69.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 166.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 9.1 ttt -62.07 -63.57 1.21 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.311 1.044 . . . . 0.0 110.265 168.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.22 79.35 0.98 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.047 0.939 . . . . 0.0 112.58 -174.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.68 -44.81 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.744 2.017 . . . . 0.0 107.738 174.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -85.83 48.74 1.65 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.525 1.53 . . . . 0.0 108.578 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.8 mm -127.86 135.33 63.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 C-N-CA 124.881 1.272 . . . . 0.0 109.471 -175.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HG2' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -154.12 82.24 4.46 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -176.02 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.946 ' HD2' HG11 ' A' ' 8' ' ' VAL . 21.6 Cg_exo -70.27 173.1 11.92 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.711 2.274 . . . . 0.0 112.879 -173.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.59 HD12 ' HG3' ' A' ' 39' ' ' GLU . 21.0 pt -107.46 137.8 36.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 167.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.6 t -118.45 104.04 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.59 ' HG3' HD12 ' A' ' 37' ' ' ILE . 25.7 mm-40 -112.94 98.61 7.28 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.004 2.122 . . . . 0.0 107.267 -166.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.7 mt -106.29 133.41 50.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 123.318 0.647 . . . . 0.0 110.026 -173.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -126.56 121.71 33.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.009 1.724 . . . . 0.0 107.821 172.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -108.7 145.09 35.6 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.344 0.592 . . . . 0.0 110.92 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.65 161.36 30.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 129.75 3.22 . . . . 0.0 106.408 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -14.44 -68.57 0.01 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 127.868 2.651 . . . . 0.0 114.378 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -129.97 12.14 5.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.583 1.553 . . . . 0.0 110.802 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.13 139.22 47.84 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 118.785 0.72 . . . . 0.0 109.866 -172.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -135.14 119.31 17.65 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.15 0.58 . . . . 0.0 109.583 -172.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.8 t -113.63 110.32 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -108.38 118.95 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m -106.86 106.84 17.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.86 1.664 . . . . 0.0 107.205 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 p -108.17 82.08 1.58 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.053 1.741 . . . . 0.0 107.799 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -104.03 127.54 51.6 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.086 0.954 . . . . 0.0 109.883 -166.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.3 p -113.84 157.33 42.12 Favored Pre-proline 0 CA--C 1.53 0.21 0 C-N-CA 125.819 1.648 . . . . 0.0 109.754 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.41 60.11 5.64 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.54 2.827 . . . . 0.0 109.423 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -175.65 -53.7 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.411 1.484 . . . . 0.0 110.497 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -126.92 154.46 44.46 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.682 1.193 . . . . 0.0 110.742 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.1 p -110.17 53.6 0.69 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.021 1.328 . . . . 0.0 110.05 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -72.21 138.12 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.5 m -148.36 137.96 22.17 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.243 1.017 . . . . 0.0 108.346 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -132.26 102.04 5.61 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.134 1.374 . . . . 0.0 108.483 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.5 p -110.6 141.03 44.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.702 1.201 . . . . 0.0 109.379 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -156.05 176.9 12.05 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.661 0.784 . . . . 0.0 110.313 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.0 m -137.36 149.38 46.95 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 172.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.12 -65.39 0.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.647 0.779 . . . . 0.0 110.043 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.94 62.39 4.38 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -162.46 159.04 24.56 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.516 0.726 . . . . 0.0 110.594 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.76 136.47 37.4 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.518 1.127 . . . . 0.0 109.528 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.46 144.85 10.97 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.698 1.199 . . . . 0.0 109.426 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -110.32 130.67 55.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.762 1.225 . . . . 0.0 108.468 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 42.6 mm -108.37 141.35 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.429 1.091 . . . . 0.0 109.113 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.5 p -108.82 164.54 12.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.313 1.445 . . . . 0.0 110.631 -173.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 t -128.71 160.1 33.55 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.745 1.218 . . . . 0.0 108.183 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -71.34 -67.18 0.54 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -140.62 103.02 4.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.865 0.866 . . . . 0.0 108.731 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.54 -109.28 0.24 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -157.36 163.55 38.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.954 0.902 . . . . 0.0 109.784 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -70.36 87.17 0.62 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.182 0.993 . . . . 0.0 110.06 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 tt -151.74 78.08 1.24 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -141.27 86.42 2.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.0 1.32 . . . . 0.0 108.427 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.1 p -107.47 86.51 2.31 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -150.23 53.64 0.91 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.158 0.983 . . . . 0.0 110.815 -170.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.3 m -133.85 50.82 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -154.25 170.96 20.03 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.513 -0.742 . . . . 0.0 109.659 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.74 133.32 35.92 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.202 1.801 . . . . 0.0 106.299 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.05 -52.95 2.93 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.276 0.631 . . . . 0.0 109.775 -176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.0 -52.75 0.29 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.517 1.127 . . . . 0.0 108.741 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.05 41.21 0.54 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -142.19 125.01 16.01 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.242 1.017 . . . . 0.0 109.193 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 tt -73.26 79.15 1.31 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.593 1.557 . . . . 0.0 108.434 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.7 143.33 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.493 1.117 . . . . 0.0 110.021 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 t -118.4 -37.43 3.33 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.206 1.402 . . . . 0.0 109.249 169.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -160.79 167.16 27.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.304 1.042 . . . . 0.0 109.071 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.2 t -144.92 136.0 24.91 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -129.45 -135.49 0.22 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.975 0.91 . . . . 0.0 108.964 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -63.31 -47.03 83.97 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.74 0.816 . . . . 0.0 109.604 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -83.71 62.16 6.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.021 1.728 . . . . 0.0 109.829 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.5 m -66.28 127.06 30.73 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -101.42 -41.13 6.76 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.829 1.252 . . . . 0.0 111.954 -172.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -166.05 166.63 17.1 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.327 0.512 . . . . 0.0 111.285 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -149.31 -61.2 0.22 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.203 1.401 . . . . 0.0 108.829 169.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -85.31 89.41 7.66 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.005 0.922 . . . . 0.0 110.962 -171.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.5 t -106.9 134.42 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 125.194 1.398 . . . . 0.0 107.283 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -124.95 153.15 43.18 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.929 0.892 . . . . 0.0 109.987 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -30.67 -53.98 0.24 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 127.635 2.54 . . . . 0.0 115.219 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -122.97 11.95 9.64 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.725 1.21 . . . . 0.0 112.557 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -148.49 105.89 3.65 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.888 0.875 . . . . 0.0 108.848 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.1 ttt -101.56 115.35 30.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 t -106.67 86.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -176.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.2 111.52 3.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.2 m -107.11 81.97 1.62 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -174.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 tp -104.35 116.17 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.712 0.805 . . . . 0.0 109.463 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -98.97 157.99 15.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.125 0.97 . . . . 0.0 110.125 175.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -161.12 166.01 28.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.049 1.74 . . . . 0.0 107.172 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 2.08 -82.17 0.0 OUTLIER Glycine 0 C--N 1.344 1.001 0 C-N-CA 128.617 3.008 . . . . 0.0 115.355 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -141.15 52.3 0.68 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.1 p -160.88 145.06 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.599 1.159 . . . . 0.0 108.542 -173.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t -150.4 135.94 18.13 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.848 0.459 . . . . 0.0 110.655 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.86 139.2 49.97 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.88 1.272 . . . . 0.0 108.762 -173.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.3 tp -72.61 -11.06 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.232 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 5.79 80.74 0.01 OUTLIER 'General case' 0 C--N 1.349 0.549 0 C-N-CA 129.593 3.157 . . . . 0.0 113.005 -174.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 30.4 ttt180 -104.22 121.92 44.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.891 1.276 . . . . 0.0 108.127 -170.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 95.4 p -122.15 152.28 40.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.084 1.754 . . . . 0.0 109.944 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -124.17 148.4 47.26 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.294 1.038 . . . . 0.0 108.918 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.9 73.22 4.46 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 123.823 0.702 . . . . 0.0 109.643 -177.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 C--O 1.25 1.116 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.048 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -84.34 69.11 10.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.174 0.59 . . . . 0.0 110.359 -170.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 t -169.27 72.39 0.08 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.358 1.463 . . . . 0.0 108.14 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.22 -163.59 31.78 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 t -105.1 135.02 47.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -134.93 106.4 6.83 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -80.65 -122.26 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -171.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.758 HG11 ' HD2' ' A' ' 36' ' ' PRO . 3.2 p 175.76 125.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -175.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -134.88 -24.41 1.48 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.8 -67.99 0.83 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.831 -1.08 . . . . 0.0 112.585 -168.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . 0.272 1.1 pt20 3.9 83.61 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.373 2.269 . . . . 0.0 114.045 -162.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -75.13 -71.85 0.33 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.043 0.937 . . . . 0.0 111.629 -169.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -82.91 53.81 2.53 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.921 0.889 . . . . 0.0 110.406 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -67.71 -42.24 82.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.198 0.599 . . . . 0.0 111.263 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -53.99 -52.12 61.74 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.829 1.252 . . . . 0.0 112.147 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -55.29 -50.86 68.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.911 0.484 . . . . 0.0 110.703 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.549 ' CG ' HD12 ' A' ' 118' ' ' LEU . 26.7 t80 -65.52 -48.47 72.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.248 1.419 . . . . 0.0 112.111 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.24 -50.96 63.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.371 0.668 . . . . 0.0 110.459 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.98 65.59 6.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.308 1.051 . . . . 0.0 109.512 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.13 -27.52 0.05 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.034 2.534 . . . . 0.0 109.487 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.2 mt -67.58 -120.56 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.485 1.514 . . . . 0.0 107.823 163.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.12 67.17 0.59 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.274 -0.891 . . . . 0.0 110.401 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HB2' HD11 ' A' ' 28' ' ' ILE . 5.1 mp -124.42 143.64 43.66 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.816 1.246 . . . . 0.0 108.281 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 141.42 24.44 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.351 3.367 . . . . 0.0 111.765 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -47.66 -44.61 27.32 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 125.294 1.438 . . . . 0.0 113.336 -171.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.01 -48.95 32.45 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.542 1.137 . . . . 0.0 111.3 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.0 mt -74.61 -23.1 58.66 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.929 0.892 . . . . 0.0 112.017 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.426 HD11 ' HB2' ' A' ' 23' ' ' LEU . 3.0 mp -73.34 -41.29 57.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 CA-C-N 119.562 1.074 . . . . 0.0 109.344 170.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -42.99 86.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 46.3 ttm -56.43 -56.28 23.12 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.416 1.086 . . . . 0.0 110.589 167.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.42 -37.9 57.82 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 113.208 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -59.13 -30.73 68.36 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.286 1.434 . . . . 0.0 111.683 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -77.21 -26.88 53.24 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.146 0.978 . . . . 0.0 111.491 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mt -70.59 116.84 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.842 0.857 . . . . 0.0 111.65 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.1 106.49 16.18 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 168.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.758 ' HD2' HG11 ' A' ' 8' ' ' VAL . 66.5 Cg_endo -68.13 177.8 4.12 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.061 1.841 . . . . 0.0 112.982 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.621 HD12 ' HG3' ' A' ' 39' ' ' GLU . 22.9 pt -129.37 153.31 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 165.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.5 t -131.68 111.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.621 ' HG3' HD12 ' A' ' 37' ' ' ILE . 59.4 mm-40 -121.68 97.6 5.57 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.816 2.046 . . . . 0.0 107.575 -162.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.4 mt -108.63 140.38 27.45 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 C-N-CA 122.784 0.434 . . . . 0.0 110.21 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -142.11 150.05 40.65 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.929 1.292 . . . . 0.0 108.093 171.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -121.75 167.52 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.151 0.981 . . . . 0.0 112.531 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -151.56 159.61 44.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.746 2.818 . . . . 0.0 107.77 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.31 -59.67 0.22 Allowed Glycine 0 C--N 1.341 0.858 0 C-N-CA 126.625 2.06 . . . . 0.0 113.937 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -130.93 33.45 4.19 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.816 1.246 . . . . 0.0 110.429 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -144.31 154.49 43.1 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.913 0.779 . . . . 0.0 111.866 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -149.7 127.29 11.62 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.689 0.796 . . . . 0.0 110.194 -173.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.2 t -108.27 122.73 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.51 96.17 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.774 1.629 . . . . 0.0 109.024 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.4 m -102.88 98.84 8.76 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.42 1.088 . . . . 0.0 108.515 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.6 p -105.68 117.75 34.81 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -137.06 138.48 40.45 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.629 0.772 . . . . 0.0 111.128 -167.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.6 p -124.49 153.89 69.48 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.641 1.577 . . . . 0.0 108.172 167.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.66 56.01 5.74 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.105 3.203 . . . . 0.0 109.854 172.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -175.0 -51.54 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.121 1.769 . . . . 0.0 109.543 -171.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -125.44 162.32 25.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.436 1.095 . . . . 0.0 109.823 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.3 m -138.3 118.28 13.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.889 0.876 . . . . 0.0 108.78 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.17 43.26 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.8 p -79.79 126.94 31.6 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.63 1.172 . . . . 0.0 108.414 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -140.13 168.91 18.71 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.195 0.998 . . . . 0.0 110.737 -172.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.1 m -153.16 153.44 32.76 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.812 1.245 . . . . 0.0 109.443 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -148.44 151.99 36.18 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.376 1.07 . . . . 0.0 110.318 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 m -86.66 -117.64 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.8 mt -151.07 -78.45 0.13 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 171.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.8 41.75 2.91 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.28 144.99 25.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.032 1.333 . . . . 0.0 107.962 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 151.61 20.91 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.093 1.357 . . . . 0.0 113.701 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.61 138.19 9.46 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.631 1.172 . . . . 0.0 109.804 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.08 91.13 3.6 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.478 1.111 . . . . 0.0 111.446 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.8 mm -94.1 127.88 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.729 1.612 . . . . 0.0 108.749 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -155.7 152.83 29.07 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.264 0.626 . . . . 0.0 111.018 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.7 p -89.77 147.72 23.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.325 1.45 . . . . 0.0 109.266 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.1 -64.98 1.07 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -106.94 80.26 1.41 Allowed 'General case' 0 C--N 1.343 0.299 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.04 -112.93 0.29 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -164.26 135.35 4.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.526 1.13 . . . . 0.0 108.728 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -68.22 103.59 1.61 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.67 1.188 . . . . 0.0 110.045 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.4 mt -125.38 60.2 1.24 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.482 1.113 . . . . 0.0 109.311 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -97.29 139.48 33.18 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.793 1.237 . . . . 0.0 107.827 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 91.2 m -128.91 -74.37 0.57 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.0 p -146.73 163.97 34.23 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.679 1.592 . . . . 0.0 107.898 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.12 88.82 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.742 0.817 . . . . 0.0 109.382 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -132.72 -173.84 3.29 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.024 1.73 . . . . 0.0 109.24 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.35 142.25 37.44 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.681 1.592 . . . . 0.0 108.986 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.18 -176.83 5.08 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.609 1.164 . . . . 0.0 110.286 174.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -76.41 73.06 3.17 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.48 1.112 . . . . 0.0 110.954 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.79 -82.8 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 106.251 -2.74 . . . . 0.0 106.251 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -160.47 -54.28 0.05 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.722 0.809 . . . . 0.0 109.076 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.97 144.94 43.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.451 1.1 . . . . 0.0 108.514 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.5 -47.4 77.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 122.39 0.276 . . . . 0.0 110.508 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -103.11 148.82 25.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.789 1.635 . . . . 0.0 109.214 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.86 163.1 28.38 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 169.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.2 p -54.16 -76.49 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.593 0.757 . . . . 0.0 110.229 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -140.26 146.04 38.09 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -58.35 -40.86 83.32 Favored 'General case' 0 CA--C 1.526 0.052 0 C-N-CA 123.53 0.732 . . . . 0.0 109.463 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -87.3 40.04 0.9 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.143 0.977 . . . . 0.0 110.113 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.4 m -149.09 -94.2 0.07 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 125.786 1.634 . . . . 0.0 108.217 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -114.82 140.61 48.8 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.885 0.874 . . . . 0.0 110.121 -171.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.58 -54.58 2.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.058 0.943 . . . . 0.0 109.715 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.9 154.19 21.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.415 0.686 . . . . 0.0 111.41 -166.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -68.57 172.89 5.59 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.265 1.026 . . . . 0.0 111.615 175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.7 m -107.05 178.89 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.668 1.587 . . . . 0.0 110.962 -168.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.73 160.75 17.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.243 1.417 . . . . 0.0 110.033 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -32.58 -64.47 0.26 Allowed Glycine 0 C--N 1.342 0.905 0 C-N-CA 127.356 2.408 . . . . 0.0 114.373 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -121.3 33.72 5.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.737 0.815 . . . . 0.0 110.491 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -151.15 98.58 2.58 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 122.635 0.374 . . . . 0.0 111.738 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.1 ttt -92.41 80.81 4.9 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 166.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.68 27.22 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.448 1.099 . . . . 0.0 110.547 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -73.51 143.56 46.51 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.1 p -101.7 144.01 30.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -174.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 tt -103.17 114.21 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -169.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.3 t -103.49 164.19 11.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.009 0.924 . . . . 0.0 112.035 -173.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -147.94 172.63 13.9 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 128.206 2.602 . . . . 0.0 106.395 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.55 -39.8 85.78 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.89 -42.61 16.12 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.609 1.1 . . . . 0.0 113.532 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.32 154.64 39.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 CA-C-N 117.887 0.843 . . . . 0.0 112.495 -162.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 p -112.48 109.67 19.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 163.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.549 HD12 ' CG ' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -100.33 114.68 28.37 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -167.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.7 mm -66.88 80.32 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.723 1.609 . . . . 0.0 108.344 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -110.76 145.88 37.33 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.476 1.511 . . . . 0.0 108.846 171.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -143.13 119.29 10.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.404 1.882 . . . . 0.0 106.466 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.6 p -109.29 115.76 30.6 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -106.17 151.54 24.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -74.48 146.43 42.77 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--O 1.252 1.218 0 CA-C-O 117.69 -1.148 . . . . 0.0 110.437 -178.232 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.31 78.66 1.83 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 p -171.06 68.16 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.739 0.816 . . . . 0.0 109.782 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.67 -160.02 25.56 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 p -103.35 119.5 38.99 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -124.59 146.04 49.27 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.618 0.767 . . . . 0.0 109.318 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -141.9 135.25 29.27 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.19 0.596 . . . . 0.0 109.877 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.796 HG11 ' HD2' ' A' ' 36' ' ' PRO . 1.4 p -77.87 140.92 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 124.814 1.245 . . . . 0.0 110.449 176.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -135.72 -13.91 1.92 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.129 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.0 135.98 15.51 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -167.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.35 145.4 21.65 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -90.6 -107.97 0.09 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.459 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -76.97 60.17 1.76 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.537 1.062 . . . . 0.0 110.338 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -75.15 -30.49 60.78 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.233 0.613 . . . . 0.0 111.517 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -56.61 -47.3 79.94 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.093 0.406 . . . . 0.0 110.122 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.03 -31.15 71.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.657 1.183 . . . . 0.0 111.459 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -58.56 -38.9 78.82 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.219 0.463 . . . . 0.0 110.079 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -72.24 -55.51 7.08 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.116 0.416 . . . . 0.0 109.944 169.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -76.05 73.71 2.92 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 124.979 1.311 . . . . 0.0 109.7 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.23 -32.35 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.197 2.599 . . . . 0.0 108.817 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.7 mt -72.73 -117.37 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.529 1.532 . . . . 0.0 108.28 169.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.21 31.93 0.48 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.157 0.983 . . . . 0.0 110.754 172.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.88 121.98 69.37 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.23 161.85 39.78 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.033 2.488 . . . . 0.0 112.166 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -53.21 -45.57 68.68 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.776 1.63 . . . . 0.0 112.413 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -52.44 -50.42 62.63 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.841 0.856 . . . . 0.0 110.454 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -42.47 95.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.664 0.786 . . . . 0.0 109.879 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.597 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 58.3 mt -55.06 -36.78 40.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-N 119.181 0.9 . . . . 0.0 111.545 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -45.13 -45.46 11.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.38 1.072 . . . . 0.0 111.33 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.6 mmt -80.25 -57.41 3.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.317 1.447 . . . . 0.0 109.851 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.597 ' HB3' ' HA ' ' A' ' 28' ' ' ILE . . . -43.39 -45.32 6.12 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 127.725 2.41 . . . . 0.0 113.978 -175.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -61.98 -39.9 93.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.058 0.543 . . . . 0.0 110.357 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -95.66 52.47 1.36 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.589 1.156 . . . . 0.0 109.693 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.0 mm -115.7 128.58 72.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.94 1.296 . . . . 0.0 107.864 170.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.37 91.11 49.99 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.796 ' HD2' HG11 ' A' ' 8' ' ' VAL . 11.2 Cg_exo -71.53 170.44 18.5 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 CA-C-N 120.758 1.306 . . . . 0.0 111.465 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.59 134.49 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 167.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.8 t -116.54 99.34 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.84 110.28 22.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.088 1.755 . . . . 0.0 107.695 -168.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.7 mt -121.46 134.19 65.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 C-N-CA 124.124 0.97 . . . . 0.0 110.553 -163.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -129.91 120.83 25.52 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -90.85 140.7 29.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.378 1.071 . . . . 0.0 109.877 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.69 157.45 33.86 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 128.582 2.753 . . . . 0.0 108.12 173.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -32.56 -59.76 0.4 Allowed Glycine 0 C--N 1.344 0.999 0 C-N-CA 126.822 2.153 . . . . 0.0 112.705 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' HA ' HD23 ' A' ' 64' ' ' LEU . 1.9 m-20 -136.1 71.23 1.42 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 165.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -165.53 155.81 13.21 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.129 0.972 . . . . 0.0 109.13 164.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -141.2 127.11 19.29 Favored 'General case' 0 C--O 1.228 -0.054 0 C-N-CA 123.935 0.894 . . . . 0.0 109.649 174.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.4 t -108.6 133.38 53.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 173.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 60' ' ' ASN . 12.5 p -134.32 117.44 24.64 Favored 'Isoleucine or valine' 0 C--N 1.341 0.21 0 C-N-CA 124.368 1.067 . . . . 0.0 108.914 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.8 m -108.35 107.2 17.67 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.383 1.473 . . . . 0.0 108.39 -173.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 m -103.72 93.49 4.93 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -107.95 122.62 47.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.359 1.463 . . . . 0.0 109.042 -170.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.2 p -108.63 156.63 38.48 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 123.818 0.847 . . . . 0.0 109.714 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.33 58.01 4.28 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.87 2.38 . . . . 0.0 108.979 166.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -167.64 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.055 1.342 . . . . 0.0 109.785 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -135.47 178.91 6.67 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.188 1.795 . . . . 0.0 109.284 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.0 m -138.26 137.41 37.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.254 1.022 . . . . 0.0 108.255 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.4 t -133.84 90.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.9 m -87.29 121.76 30.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HB2' HG13 ' A' ' 49' ' ' VAL . 82.9 m-20 -121.26 156.14 33.14 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.697 1.199 . . . . 0.0 110.115 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.1 p -149.02 141.02 23.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.388 1.075 . . . . 0.0 108.858 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.525 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -148.4 153.11 38.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.716 0.806 . . . . 0.0 109.879 174.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 45' ' ' ASP . 87.0 m -125.26 165.18 18.78 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.639 1.176 . . . . 0.0 108.685 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -82.88 -64.31 1.2 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.91 1.684 . . . . 0.0 109.634 -172.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.61 38.82 2.97 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.021 0.82 . . . . 0.0 111.893 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -162.49 138.41 7.37 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -55.47 163.7 1.19 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.614 1.566 . . . . 0.0 113.288 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 62' ' ' PHE . . . -150.45 86.83 1.42 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.543 0.737 . . . . 0.0 110.108 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -78.88 51.97 1.18 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.586 1.954 . . . . 0.0 111.882 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.04 128.37 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.039 0.935 . . . . 0.0 109.273 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.8 p -116.75 -172.93 2.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.118 1.767 . . . . 0.0 108.086 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.1 t -143.0 -174.05 4.08 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.934 0.493 . . . . 0.0 110.236 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 42.2 mtp -66.11 -63.24 1.12 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.166 1.386 . . . . 0.0 110.331 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -106.2 49.33 0.81 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.244 1.017 . . . . 0.0 108.326 -172.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.55 118.74 0.57 Allowed Glycine 0 C--N 1.344 0.975 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -104.7 -101.41 0.32 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.489 1.116 . . . . 0.0 108.936 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -98.84 82.64 2.81 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.049 1.295 . . . . 0.0 108.98 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tt -148.14 74.65 1.3 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -171.0 167.28 7.3 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.197 0.999 . . . . 0.0 110.112 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.63 -165.18 1.17 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.746 1.618 . . . . 0.0 108.064 170.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -106.69 135.13 48.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.52 1.128 . . . . 0.0 108.195 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.8 m -74.68 155.98 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.168 0.587 . . . . 0.0 110.617 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -162.46 159.82 25.5 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.46 0.704 . . . . 0.0 110.537 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.36 138.69 44.22 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.879 1.672 . . . . 0.0 108.168 -175.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.29 -61.65 1.45 Allowed 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.942 0.897 . . . . 0.0 108.824 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -145.97 -62.81 0.32 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.616 0.766 . . . . 0.0 110.107 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.62 -77.84 0.91 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.443 0.545 . . . . 0.0 112.001 -174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -135.89 -172.47 3.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.045 1.338 . . . . 0.0 109.869 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.2 134.41 39.07 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.245 1.418 . . . . 0.0 110.971 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.33 131.62 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.0 m -151.45 67.79 0.9 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -73.96 80.4 1.67 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.685 1.194 . . . . 0.0 109.904 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 55.9 p -166.86 -33.16 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.539 1.135 . . . . 0.0 111.569 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -75.97 71.26 2.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.199 1.4 . . . . 0.0 110.068 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -47.13 -62.95 1.18 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.261 1.824 . . . . 0.0 111.981 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -88.81 64.02 7.08 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.272 0.629 . . . . 0.0 109.803 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.8 t -153.13 -163.38 1.68 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.627 1.171 . . . . 0.0 108.986 174.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -78.38 135.47 37.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.471 0.708 . . . . 0.0 109.85 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -76.2 164.3 26.21 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -102.97 74.04 1.28 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.46 1.104 . . . . 0.0 108.601 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -125.14 132.2 53.12 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.054 1.742 . . . . 0.0 107.851 172.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -157.43 157.09 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.133 0.973 . . . . 0.0 109.462 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -126.72 147.55 49.95 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.253 1.021 . . . . 0.0 108.494 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -35.97 -51.3 1.18 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.425 1.964 . . . . 0.0 113.965 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -130.08 36.38 4.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.427 1.891 . . . . 0.0 111.064 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -161.76 125.11 3.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.748 0.819 . . . . 0.0 109.016 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 41.9 ttm -123.45 84.68 2.3 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.347 1.059 . . . . 0.0 109.281 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.8 t -105.13 82.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -80.49 154.48 27.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.702 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.5 p -108.14 116.4 31.9 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.065 1.746 . . . . 0.0 106.649 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 71.9 mt -103.72 96.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.7 m -75.57 125.4 28.96 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -142.65 166.57 24.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.923 1.289 . . . . 0.0 107.614 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -54.73 -40.22 70.46 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.326 0.489 . . . . 0.0 112.171 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.8 -38.5 6.5 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.597 1.094 . . . . 0.0 113.398 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.85 150.91 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 118.406 1.103 . . . . 0.0 111.887 -170.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.9 p -106.76 91.36 3.64 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 162.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.88 114.12 28.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.751 0.786 . . . . 0.0 112.249 -158.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.2 mm -68.13 118.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.297 1.839 . . . . 0.0 108.484 172.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -125.28 114.84 19.47 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -107.37 105.49 15.45 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.292 1.037 . . . . 0.0 109.519 -169.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.8 p -114.12 145.3 41.82 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.419 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -136.87 154.95 50.36 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.5 -171.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -73.23 74.67 1.31 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.862 1.665 . . . . 0.0 113.165 -165.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.271 -1.347 . . . . 0.0 109.822 175.197 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -84.12 -45.16 13.29 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 122.618 0.367 . . . . 0.0 110.982 -175.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.3 p -51.03 99.1 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.602 1.561 . . . . 0.0 111.886 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.71 -168.16 39.99 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.6 p -110.03 131.92 54.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -131.21 140.59 49.91 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.155 0.982 . . . . 0.0 110.775 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -119.19 106.51 12.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.744 1.217 . . . . 0.0 109.224 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.851 HG11 ' HD2' ' A' ' 36' ' ' PRO . 3.6 p -47.21 136.58 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 125.644 1.578 . . . . 0.0 109.638 165.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -147.81 -29.81 0.32 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.5 -7.78 46.4 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -154.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -54.61 104.78 0.12 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.869 1.213 . . . . 0.0 111.132 -173.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.19 -76.54 0.11 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.188 0.595 . . . . 0.0 110.058 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -83.09 58.31 4.36 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.052 0.941 . . . . 0.0 108.472 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -57.78 -30.54 65.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.151 -1.593 . . . . 0.0 111.364 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -36.25 76.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.552 0.741 . . . . 0.0 111.863 173.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -67.17 -40.58 86.63 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.624 ' HA ' HG21 ' A' ' 116' ' ' VAL . 1.7 t80 -55.48 -43.57 75.66 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.328 0.651 . . . . 0.0 111.682 -176.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -78.99 49.89 0.97 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.578 1.151 . . . . 0.0 111.474 -174.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 -40.99 1.31 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.049 0.94 . . . . 0.0 111.261 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.17 46.04 1.08 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.587 0.755 . . . . 0.0 110.32 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.3 mt -138.79 -128.85 0.12 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.231 2.212 . . . . 0.0 105.524 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.72 77.11 0.45 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.238 1.015 . . . . 0.0 109.4 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.48 139.51 35.75 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.851 0.86 . . . . 0.0 109.651 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.61 147.08 39.88 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.218 2.612 . . . . 0.0 109.771 175.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.26 -38.6 68.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.771 1.228 . . . . 0.0 113.304 -168.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.91 -44.03 14.27 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.419 1.488 . . . . 0.0 112.073 170.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -76.8 -33.04 58.01 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 117.898 -1.049 . . . . 0.0 111.13 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -64.48 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 CA-C-N 120.012 1.278 . . . . 0.0 109.77 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -44.8 -37.46 3.84 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.519 1.127 . . . . 0.0 112.083 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.2 mmt -90.39 -42.03 11.15 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.599 1.16 . . . . 0.0 111.218 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.66 -39.49 68.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.928 0.891 . . . . 0.0 112.872 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -69.23 7.06 0.82 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -172.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -131.78 12.2 4.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.275 0.943 . . . . 0.0 111.935 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.4 mm -87.19 105.97 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -105.31 105.32 51.69 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 123.836 0.854 . . . . 0.0 108.758 -175.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.851 ' HD2' HG11 ' A' ' 8' ' ' VAL . 11.3 Cg_endo -65.19 178.69 1.85 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.517 2.145 . . . . 0.0 115.14 -177.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.32 114.96 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 169.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.6 t -107.28 92.34 2.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 124.542 1.137 . . . . 0.0 108.494 -169.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -97.4 138.36 34.97 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.762 2.025 . . . . 0.0 108.476 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.7 mt -136.02 136.09 49.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 C-N-CA 123.49 0.716 . . . . 0.0 109.847 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -128.26 142.62 51.1 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.963 2.105 . . . . 0.0 108.345 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -125.42 158.57 34.05 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.64 1.176 . . . . 0.0 111.463 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.12 161.18 42.06 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 127.389 2.276 . . . . 0.0 109.017 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.72 -66.29 0.14 Allowed Glycine 0 C--N 1.344 0.975 0 C-N-CA 127.144 2.307 . . . . 0.0 113.822 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -124.73 33.06 5.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.885 1.274 . . . . 0.0 109.831 171.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . 0.258 16.4 t70 -140.26 147.62 40.24 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.089 0.859 . . . . 0.0 112.541 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -146.17 134.52 21.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.752 0.821 . . . . 0.0 109.851 -174.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.3 t -133.1 127.91 55.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.46 153.25 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 124.027 0.931 . . . . 0.0 108.851 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.0 m -141.21 81.06 1.77 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.5 m -106.33 80.08 1.45 Allowed 'General case' 0 C--N 1.339 0.15 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -107.45 144.43 34.39 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.034 0.934 . . . . 0.0 111.098 -167.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.7 p -127.86 150.93 74.76 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 126.918 2.087 . . . . 0.0 106.457 171.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.61 59.79 4.96 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.596 2.198 . . . . 0.0 109.991 166.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.3 ttt-85 -168.31 -60.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.443 1.097 . . . . 0.0 110.89 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -120.04 173.45 7.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.736 2.014 . . . . 0.0 109.252 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.2 m -137.94 117.18 12.68 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.931 0.892 . . . . 0.0 111.017 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 t -128.31 80.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 170.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -109.27 65.99 0.63 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -69.29 153.4 43.68 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.178 0.591 . . . . 0.0 110.452 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.3 t -154.34 144.15 21.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.292 1.037 . . . . 0.0 108.616 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -161.65 152.48 17.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.948 0.404 . . . . 0.0 110.83 174.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.8 m -81.71 -106.5 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.7 mt -152.92 -75.97 0.13 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 171.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.61 48.48 0.93 Allowed Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.95 -80.33 0.44 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.447 1.099 . . . . 0.0 108.872 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -143.3 162.61 35.22 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.432 1.093 . . . . 0.0 110.329 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.85 123.13 7.73 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.702 0.801 . . . . 0.0 111.484 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -99.69 102.7 14.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.657 1.983 . . . . 0.0 108.079 174.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.5 mm -121.69 124.09 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 t -108.24 -179.14 3.8 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.514 0.725 . . . . 0.0 110.291 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 t -120.36 -177.38 3.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.077 1.351 . . . . 0.0 110.198 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 60.9 mmm -109.45 -91.21 0.45 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.476 1.51 . . . . 0.0 107.141 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -114.18 -35.59 4.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.434 1.494 . . . . 0.0 109.499 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.83 72.32 0.11 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.2 96.59 2.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.023 0.929 . . . . 0.0 109.579 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -115.12 147.54 40.11 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.217 1.007 . . . . 0.0 111.029 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.54 165.88 11.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.669 1.588 . . . . 0.0 109.703 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -155.58 78.12 0.99 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.5 p -159.38 169.62 23.58 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.567 1.147 . . . . 0.0 109.857 -174.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.8 m -115.75 92.11 3.81 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 m -60.07 146.03 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.341 1.056 . . . . 0.0 110.921 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -163.55 -164.22 0.9 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.788 0.835 . . . . 0.0 109.122 -169.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.4 160.4 31.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.641 1.976 . . . . 0.0 107.877 172.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.65 -64.51 1.18 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.249 1.02 . . . . 0.0 109.31 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -132.96 -66.37 0.67 Allowed 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.689 1.196 . . . . 0.0 108.149 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.28 29.1 0.79 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.217 0.913 . . . . 0.0 111.208 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -133.43 135.97 44.91 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.31 1.444 . . . . 0.0 107.212 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.5 mt -72.4 86.41 1.14 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.953 1.301 . . . . 0.0 110.072 -172.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.73 141.22 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 122.832 0.453 . . . . 0.0 111.266 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -131.71 154.3 49.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.798 1.639 . . . . 0.0 107.107 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -70.46 -164.18 0.08 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.005 0.922 . . . . 0.0 110.98 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 36.7 p -75.08 66.73 1.66 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.509 1.124 . . . . 0.0 112.641 -175.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -132.39 126.01 32.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.536 1.534 . . . . 0.0 108.053 172.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.79 52.56 2.06 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.872 0.869 . . . . 0.0 109.281 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.86 28.04 1.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.821 0.849 . . . . 0.0 111.965 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.9 p -170.84 -80.99 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.032 0.933 . . . . 0.0 109.084 -171.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -158.48 175.04 14.2 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.46 1.104 . . . . 0.0 108.35 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -84.71 -135.52 0.05 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -118.46 114.52 23.0 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -147.17 149.1 32.3 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.082 0.953 . . . . 0.0 108.943 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 p -168.62 165.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.423 1.089 . . . . 0.0 108.774 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.55 156.03 42.43 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.508 0.723 . . . . 0.0 110.148 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -31.34 -55.27 0.31 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 127.234 2.35 . . . . 0.0 114.676 -173.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -136.23 28.37 3.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.465 1.106 . . . . 0.0 110.759 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -145.93 149.71 34.72 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.81 1.244 . . . . 0.0 110.112 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 38.1 mtt -130.02 110.54 11.72 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 m -117.2 50.97 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.357 0.663 . . . . 0.0 110.875 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -86.38 116.55 24.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.835 0.854 . . . . 0.0 109.074 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.2 m -102.21 127.8 49.0 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.7 mt -103.99 88.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 123.519 0.728 . . . . 0.0 109.382 -160.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.5 t -80.35 100.32 8.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.501 1.52 . . . . 0.0 107.838 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -102.06 -136.84 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.914 1.286 . . . . 0.0 108.893 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.9 -72.72 0.9 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.827 0.727 . . . . 0.0 111.488 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -123.06 49.08 0.91 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 17' ' ' PHE . 1.1 t -150.81 147.86 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.833 1.653 . . . . 0.0 108.509 -170.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 t -150.63 97.78 2.55 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.58 126.19 51.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.163 0.985 . . . . 0.0 110.335 -163.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.8 mp -79.84 66.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -86.35 141.55 29.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -168.53 143.25 3.35 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.3 p -133.82 151.64 51.62 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.888 1.275 . . . . 0.0 109.083 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -117.46 141.94 47.74 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.192 0.997 . . . . 0.0 109.11 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.0 ttp85 -75.57 147.83 39.34 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.867 176.779 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.782 ' HB3' HD13 ' A' ' 40' ' ' ILE . 19.7 m-85 -81.6 -76.74 0.24 Allowed 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 p -25.48 90.89 0.01 OUTLIER 'General case' 0 C--N 1.342 0.252 0 C-N-CA 128.179 2.591 . . . . 0.0 114.197 -163.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' H ' HG23 ' A' ' 40' ' ' ILE . . . 178.08 -150.44 9.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.6 p -108.21 142.88 37.79 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.862 1.265 . . . . 0.0 107.891 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -145.7 133.62 21.31 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.838 0.855 . . . . 0.0 110.158 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -139.35 127.03 21.87 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.904 0.882 . . . . 0.0 109.106 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.485 HG11 ' HG2' ' A' ' 36' ' ' PRO . 1.9 m -72.76 135.89 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -125.5 -29.86 3.16 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.196 0.31 . . . . 0.0 111.746 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.3 112.77 7.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.495 0.718 . . . . 0.0 110.483 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.23 -160.81 0.77 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -135.8 -101.64 0.22 Allowed 'General case' 0 C--N 1.343 0.283 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.977 170.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -81.21 66.54 6.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.163 0.892 . . . . 0.0 110.66 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.99 -28.34 70.03 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.315 1.046 . . . . 0.0 110.681 -175.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -62.49 -55.59 26.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.212 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -59.67 -39.02 83.11 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.413 ' HA ' HG21 ' A' ' 116' ' ' VAL . 5.0 t80 -52.95 -52.97 56.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.145 176.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.12 -29.1 63.74 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.328 1.051 . . . . 0.0 112.696 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -37.76 75.59 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.994 0.816 . . . . 0.0 110.877 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.81 -33.9 76.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.482 0.713 . . . . 0.0 111.618 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.99 156.09 32.14 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.852 0.461 . . . . 0.0 110.485 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.78 35.49 0.84 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.281 1.033 . . . . 0.0 112.169 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 mp -88.58 139.29 29.71 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.61 157.83 54.98 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.587 2.192 . . . . 0.0 110.473 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -62.17 -36.86 83.16 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -166.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -61.16 -48.79 79.96 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.285 0.634 . . . . 0.0 110.206 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -20.18 64.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.701 1.2 . . . . 0.0 110.907 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.42 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 46.8 mt -78.22 -37.0 21.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.896 0.771 . . . . 0.0 110.845 171.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.56 -38.38 80.96 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.0 ttt -63.92 -51.98 61.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.915 1.286 . . . . 0.0 110.52 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 28' ' ' ILE . . . -52.71 -39.89 62.46 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.245 1.418 . . . . 0.0 112.479 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.17 -16.23 19.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.053 1.341 . . . . 0.0 112.306 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -121.14 18.05 11.59 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 mm -79.37 123.52 36.4 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.09 101.48 30.48 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 168.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.485 ' HG2' HG11 ' A' ' 8' ' ' VAL . 92.8 Cg_endo -74.52 179.9 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.402 1.401 . . . . 0.0 111.302 177.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -131.02 158.63 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 168.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.6 t -132.39 121.8 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 165.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -125.48 95.57 4.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.265 2.226 . . . . 0.0 105.086 -170.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.782 HD13 ' HB3' ' A' ' 2' ' ' PHE . 13.8 tt -118.5 140.5 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.669 1.188 . . . . 0.0 111.227 -165.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -139.59 143.93 37.52 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.517 1.127 . . . . 0.0 109.742 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.48 147.36 31.79 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.908 1.283 . . . . 0.0 111.117 -175.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -135.49 163.47 30.01 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 129.05 2.94 . . . . 0.0 107.456 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -20.5 -72.24 0.01 OUTLIER Glycine 0 C--N 1.344 0.982 0 C-N-CA 127.618 2.533 . . . . 0.0 114.338 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -127.19 30.87 5.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.526 1.531 . . . . 0.0 109.32 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -131.43 152.32 50.77 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.523 0.601 . . . . 0.0 112.107 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -138.03 130.58 29.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.022 0.929 . . . . 0.0 109.837 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.14 127.46 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.2 t -127.8 109.37 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.243 1.417 . . . . 0.0 109.491 -173.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -107.43 102.15 11.45 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.496 1.118 . . . . 0.0 108.096 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 t -105.7 111.34 23.98 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -108.25 129.05 55.22 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.331 0.653 . . . . 0.0 109.909 -171.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 p -134.55 150.0 72.5 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 126.161 1.784 . . . . 0.0 107.957 171.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.52 73.93 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.768 2.979 . . . . 0.0 109.56 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -167.63 -52.16 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.786 1.634 . . . . 0.0 108.137 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.14 150.41 11.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.632 1.173 . . . . 0.0 107.878 176.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.4 p -80.1 94.84 6.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.6 72.57 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.5 m -97.65 128.76 44.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.29 1.436 . . . . 0.0 108.489 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -145.35 162.62 36.81 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.746 1.218 . . . . 0.0 107.997 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.3 m -150.68 141.53 22.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.36 137.44 27.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.917 0.487 . . . . 0.0 110.618 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.0 m -98.47 141.59 31.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.757 1.223 . . . . 0.0 107.856 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.6 mt -68.09 -57.71 5.66 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.804 0.842 . . . . 0.0 110.634 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.34 57.9 4.66 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -169.58 138.58 1.93 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.736 1.614 . . . . 0.0 107.172 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -58.5 129.08 40.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.047 0.539 . . . . 0.0 109.71 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.22 157.0 47.37 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.659 1.183 . . . . 0.0 110.628 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -144.99 158.98 43.64 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.222 1.409 . . . . 0.0 108.845 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.1 mm -105.95 148.9 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 125.457 1.503 . . . . 0.0 109.694 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.8 m -105.54 153.85 21.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.851 1.66 . . . . 0.0 109.891 -171.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 m -44.67 142.73 1.59 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.764 2.026 . . . . 0.0 112.727 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.16 176.82 8.14 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.835 1.254 . . . . 0.0 110.242 -172.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.64 -73.34 0.68 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.492 1.517 . . . . 0.0 107.78 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.01 95.59 0.16 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -157.99 -54.66 0.07 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -132.54 178.68 6.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.539 1.536 . . . . 0.0 109.907 -176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tp -150.01 149.08 29.84 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.713 1.205 . . . . 0.0 108.956 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -70.65 101.97 2.18 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.0 p -144.05 -170.47 3.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.351 1.46 . . . . 0.0 109.531 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.6 m -107.36 110.49 22.5 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.308 1.043 . . . . 0.0 108.805 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.4 m -78.34 136.78 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.287 0.635 . . . . 0.0 110.658 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -165.66 118.47 1.14 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.323 1.049 . . . . 0.0 109.257 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -109.32 131.42 55.09 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 172.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.96 -67.58 0.9 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.11 62.79 0.23 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.29 -87.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -128.94 159.27 36.37 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.259 1.423 . . . . 0.0 108.895 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 tt -74.16 81.79 1.79 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.112 0.965 . . . . 0.0 108.77 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.7 p -74.51 142.76 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.518 0.727 . . . . 0.0 110.235 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.0 t -165.36 174.23 10.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.322 1.449 . . . . 0.0 108.218 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -148.32 152.73 37.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.838 0.855 . . . . 0.0 110.658 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 99.4 p -164.24 -144.58 0.08 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.975 1.31 . . . . 0.0 108.625 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -82.52 -151.53 0.1 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.945 1.298 . . . . 0.0 110.153 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -77.75 65.47 3.22 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.031 1.332 . . . . 0.0 110.523 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -147.38 149.98 33.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.361 1.464 . . . . 0.0 108.746 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.0 t -152.93 103.32 2.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -59.65 -38.34 81.16 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.408 1.083 . . . . 0.0 110.913 173.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -155.66 150.48 26.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.588 1.155 . . . . 0.0 108.631 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -115.85 -55.14 2.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.369 1.068 . . . . 0.0 108.921 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.43 153.72 42.21 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.638 0.775 . . . . 0.0 111.094 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.7 t -139.86 142.18 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.897 1.679 . . . . 0.0 107.02 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -105.83 154.21 20.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -41.34 -38.33 1.95 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.554 1.549 . . . . 0.0 115.018 -172.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.28 40.15 1.92 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.91 0.884 . . . . 0.0 110.681 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -167.15 116.18 0.84 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.608 0.763 . . . . 0.0 110.496 173.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -99.69 127.05 45.81 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 169.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.11 173.58 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.871 0.869 . . . . 0.0 112.765 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -43.13 88.06 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.803 2.841 . . . . 0.0 115.826 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.8 t -165.43 131.0 2.57 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 tp -172.54 121.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.546 1.938 . . . . 0.0 106.802 167.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 m -112.0 125.81 54.47 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -129.35 161.96 29.08 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.936 1.294 . . . . 0.0 109.766 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -2.94 -74.93 0.01 OUTLIER Glycine 0 C--N 1.346 1.129 0 C-N-CA 129.249 3.309 . . . . 0.0 115.693 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -144.11 47.79 0.76 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' A' ' 17' ' ' PHE . 2.0 p -165.69 131.69 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -127.32 135.8 51.05 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.06 158.17 28.43 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.97 1.308 . . . . 0.0 110.46 -169.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 mp -97.71 113.97 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 172.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 tpt85 -123.26 114.02 19.68 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.235 1.414 . . . . 0.0 109.431 -174.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -111.11 110.95 21.71 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.902 0.881 . . . . 0.0 109.452 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.4 p -114.63 130.3 56.78 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 122.1 0.953 . . . . 0.0 109.504 169.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -113.91 143.82 44.07 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -173.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.25 165.67 11.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.162 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.033 -1.936 . . . . 0.0 108.352 178.813 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.44 113.83 26.2 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.87 0.468 . . . . 0.0 110.761 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 t -138.57 40.99 2.21 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.445 1.098 . . . . 0.0 108.753 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.98 172.55 53.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.257 0.932 . . . . 0.0 113.74 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 m -148.85 109.44 4.21 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -143.21 157.72 44.25 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.141 1.376 . . . . 0.0 111.121 -166.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -139.95 134.43 31.54 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 124.066 0.947 . . . . 0.0 111.073 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.59 HG11 ' HD2' ' A' ' 36' ' ' PRO . 8.1 p -62.5 150.81 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 127.029 2.132 . . . . 0.0 112.103 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -146.3 -6.85 0.55 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 163.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . . . -152.64 76.65 1.15 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 122.776 0.43 . . . . 0.0 110.142 -164.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.75 103.2 15.1 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -77.89 0.06 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.54 1.136 . . . . 0.0 113.043 -171.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -85.48 51.1 2.1 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.866 0.866 . . . . 0.0 111.122 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -43.5 77.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.54 1.136 . . . . 0.0 111.777 -168.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -63.9 -38.8 92.41 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.874 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -61.88 -48.21 81.53 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.507 0.594 . . . . 0.0 110.783 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.612 ' HA ' HG21 ' A' ' 116' ' ' VAL . 30.5 t80 -55.92 -47.16 78.01 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.141 1.376 . . . . 0.0 111.406 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.25 -43.08 74.7 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.143 0.577 . . . . 0.0 112.301 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -78.92 67.99 4.76 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.111 0.964 . . . . 0.0 109.963 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.05 -44.88 0.06 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.176 1.79 . . . . 0.0 108.614 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -83.07 147.69 27.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.67 52.32 2.36 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.755 1.222 . . . . 0.0 112.674 -162.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mt -92.01 147.16 34.24 Favored Pre-proline 0 N--CA 1.453 -0.275 0 C-N-CA 124.518 1.127 . . . . 0.0 108.758 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.46 151.8 48.2 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.323 2.015 . . . . 0.0 109.559 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -62.24 -28.77 69.93 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -170.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -63.11 -44.97 94.18 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.345 0.52 . . . . 0.0 110.548 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.81 -41.78 99.44 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.24 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.53 -34.47 61.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 118.525 0.602 . . . . 0.0 111.377 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.91 -44.08 73.88 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.765 0.711 . . . . 0.0 110.469 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.56 -47.09 57.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.827 0.851 . . . . 0.0 110.643 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.41 -46.2 73.11 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 111.823 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -65.59 -30.56 71.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.186 2.194 . . . . 0.0 110.818 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -108.17 50.71 0.77 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.363 1.465 . . . . 0.0 108.984 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.39 150.91 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.068 1.347 . . . . 0.0 109.118 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -128.2 99.91 24.09 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.099 1.359 . . . . 0.0 109.756 -170.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.59 ' HD2' HG11 ' A' ' 8' ' ' VAL . 83.8 Cg_endo -70.86 160.13 50.37 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.062 2.508 . . . . 0.0 113.78 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.494 HD12 ' HG3' ' A' ' 39' ' ' GLU . 8.3 pt -105.6 170.97 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 168.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.1 t -141.25 103.73 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HG3' HD12 ' A' ' 37' ' ' ILE . 67.0 mm-40 -123.69 101.21 7.17 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.204 2.602 . . . . 0.0 106.053 -167.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.6 mt -108.87 150.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.526 0.731 . . . . 0.0 110.031 -171.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -134.25 119.74 19.12 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.051 1.34 . . . . 0.0 108.716 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -83.9 153.28 24.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.72 1.608 . . . . 0.0 109.425 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.34 152.99 10.99 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.984 1.714 . . . . 0.0 108.235 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -20.6 -69.77 0.01 OUTLIER Glycine 0 C--N 1.344 0.99 0 C-N-CA 127.733 2.587 . . . . 0.0 113.969 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -125.94 20.71 7.64 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.786 1.235 . . . . 0.0 110.568 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.35 134.26 55.03 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.409 1.004 . . . . 0.0 109.887 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -134.42 101.31 4.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.5 t -107.98 116.18 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -174.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 p -111.91 125.06 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.522 1.129 . . . . 0.0 109.72 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.2 m -107.52 95.11 5.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 t -107.82 63.15 0.62 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -102.14 162.55 12.83 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.343 0.657 . . . . 0.0 110.314 -170.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.54 162.36 55.26 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.476 1.111 . . . . 0.0 108.341 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.04 51.37 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.461 2.774 . . . . 0.0 111.433 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.4 mtt-85 178.57 -58.6 0.01 OUTLIER 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.19 1.796 . . . . 0.0 109.013 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -95.66 155.83 16.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.137 1.375 . . . . 0.0 109.571 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.6 p -132.44 109.61 9.94 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.819 0.848 . . . . 0.0 110.672 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -129.76 87.86 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.6 m -110.26 136.73 49.01 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 171.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -137.02 150.81 48.33 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.2 p -144.05 94.25 2.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.9 0.88 . . . . 0.0 108.781 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.426 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -105.76 104.32 14.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.07 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.1 m -76.68 126.77 31.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 164.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.7 mt -57.46 -56.43 21.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.774 0.829 . . . . 0.0 111.376 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.51 53.66 4.85 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -167.16 148.44 5.77 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.885 0.874 . . . . 0.0 109.387 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 67' ' ' GLU . 3.1 mp0 -53.67 107.08 0.22 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.345 1.458 . . . . 0.0 108.896 170.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.426 ' CB ' ' HB3' ' A' ' 62' ' ' PHE . . . -112.53 58.98 0.64 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.237 0.615 . . . . 0.0 110.951 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -100.3 101.12 12.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 171.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.52 143.22 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 125.227 1.411 . . . . 0.0 107.801 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.4 t -158.8 152.2 22.83 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.124 0.97 . . . . 0.0 109.322 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 t -167.84 -47.06 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.098 1.359 . . . . 0.0 108.988 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -75.6 165.44 25.07 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.382 1.073 . . . . 0.0 108.851 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.28 74.24 1.73 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.706 0.802 . . . . 0.0 109.025 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.21 58.54 0.1 OUTLIER Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.051 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.48 91.75 1.93 Allowed 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -124.93 58.2 1.26 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.353 1.061 . . . . 0.0 109.58 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.76 173.01 17.21 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.349 1.06 . . . . 0.0 110.369 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -116.72 143.06 46.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.323 1.449 . . . . 0.0 108.321 172.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.3 p -163.17 164.48 25.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.331 1.052 . . . . 0.0 109.314 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 88.2 m -135.37 108.01 7.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.2 137.5 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.83 169.87 21.19 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.734 0.413 . . . . 0.0 110.556 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -137.12 136.39 38.25 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.451 1.5 . . . . 0.0 107.609 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.57 -60.3 1.59 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.566 1.146 . . . . 0.0 108.972 -176.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -161.79 -57.42 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.602 0.761 . . . . 0.0 109.629 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.51 -59.47 8.76 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.896 0.76 . . . . 0.0 112.167 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -158.85 172.98 17.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.55 1.14 . . . . 0.0 109.068 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.84 162.35 20.59 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.999 0.52 . . . . 0.0 112.276 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.98 144.21 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.324 1.449 . . . . 0.0 108.901 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.7 m -114.45 -66.45 1.09 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.593 1.557 . . . . 0.0 109.224 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -165.59 159.43 16.58 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.22 1.408 . . . . 0.0 107.673 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.5 p -62.69 170.25 2.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.643 1.177 . . . . 0.0 112.751 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -50.84 106.42 0.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.373 1.469 . . . . 0.0 112.091 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.7 mttm 179.11 -55.9 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 126.62 1.968 . . . . 0.0 106.99 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -77.39 -55.09 5.69 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.942 1.297 . . . . 0.0 110.888 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.2 m -157.71 -37.63 0.07 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.274 -0.87 . . . . 0.0 113.229 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 9.16 80.63 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.294 2.237 . . . . 0.0 113.574 -159.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -128.05 93.97 3.81 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.721 2.008 . . . . 0.0 107.031 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -151.26 74.84 1.16 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.742 0.817 . . . . 0.0 111.472 -172.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -176.66 129.86 0.19 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.044 1.338 . . . . 0.0 109.023 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.53 155.81 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.9 0.88 . . . . 0.0 108.694 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -114.13 160.18 19.23 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.921 1.288 . . . . 0.0 109.282 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -31.05 -56.07 0.28 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 127.533 2.492 . . . . 0.0 115.056 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -128.58 29.56 5.27 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.976 0.911 . . . . 0.0 111.772 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.55 107.07 3.78 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.14 0.427 . . . . 0.0 110.598 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 40.1 ttm -84.46 86.79 7.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.6 m -123.78 122.96 65.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.122 1.369 . . . . 0.0 109.294 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.44 175.59 3.53 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.318 1.047 . . . . 0.0 109.029 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.2 p -106.43 152.68 23.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.361 1.065 . . . . 0.0 110.304 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.5 mt -104.2 106.9 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 m -89.81 99.71 12.66 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -123.86 -179.86 4.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.539 1.536 . . . . 0.0 109.552 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -46.96 117.25 2.94 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 125.063 1.316 . . . . 0.0 110.77 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 8.11 59.26 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 128.361 2.886 . . . . 0.0 114.875 -156.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.612 HG21 ' HA ' ' A' ' 17' ' ' PHE . 2.0 t -140.85 144.75 26.41 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 126.008 1.723 . . . . 0.0 108.759 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.0 m -136.31 101.55 4.71 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.02 102.85 12.32 Favored 'General case' 0 C--N 1.338 0.091 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.97 98.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.243 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 168.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -98.96 105.32 17.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.561 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 45.7 ttt85 -108.26 111.7 23.8 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 -173.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 45.3 t -124.6 149.92 46.54 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.201 1.8 . . . . 0.0 108.716 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -125.23 146.16 49.65 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.825 1.25 . . . . 0.0 109.693 -170.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.75 148.57 42.46 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.061 0.944 . . . . 0.0 111.004 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--O 1.25 1.087 0 CA-C-O 117.46 -1.257 . . . . 0.0 110.501 175.313 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 111.077 0.028 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -49.49 53.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.043 0.537 . . . . 0.0 110.942 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.1 p -38.01 108.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.654 1.982 . . . . 0.0 113.367 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.01 -179.17 46.47 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.3 t -107.57 134.42 50.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.019 1.328 . . . . 0.0 107.639 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -133.66 118.76 18.54 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.432 0.693 . . . . 0.0 110.209 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -102.75 93.43 5.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.971 1.308 . . . . 0.0 109.539 -172.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.463 ' CG1' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -53.95 129.37 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 170.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -145.62 10.06 1.21 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.37 0.419 . . . . 0.0 111.784 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . . . -161.33 105.76 1.31 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 122.7 0.4 . . . . 0.0 110.238 -161.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.66 -167.16 1.48 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.18 1.392 . . . . 0.0 108.591 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.536 ' HB2' HG22 ' A' ' 119' ' ' ILE . 31.0 tt0 -135.52 -104.24 0.22 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.966 0.803 . . . . 0.0 111.141 -174.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -75.46 67.62 2.02 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.219 1.008 . . . . 0.0 109.356 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -81.52 -45.31 16.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.166 0.586 . . . . 0.0 112.412 -169.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.0 -43.38 91.5 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.383 0.538 . . . . 0.0 110.468 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -61.0 -50.93 71.37 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.527 1.131 . . . . 0.0 110.44 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.412 ' CD2' HD21 ' A' ' 118' ' ' LEU . 10.2 t80 -56.64 -49.06 76.11 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.097 0.959 . . . . 0.0 110.134 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -58.75 -46.38 87.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.269 1.028 . . . . 0.0 111.667 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -65.79 -24.42 66.92 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.287 0.635 . . . . 0.0 111.83 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.35 -23.99 60.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.613 0.765 . . . . 0.0 111.03 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.0 mt -84.14 -162.12 0.62 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.97 41.57 2.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.045 0.938 . . . . 0.0 111.381 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.0 127.8 31.16 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.3 164.86 33.17 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.582 2.854 . . . . 0.0 113.615 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -59.48 -44.95 92.92 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.11 1.764 . . . . 0.0 112.514 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -54.58 -46.63 73.76 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.486 0.714 . . . . 0.0 110.577 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.29 -43.43 86.34 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.501 -0.762 . . . . 0.0 109.986 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.35 -41.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 CA-C-N 118.747 0.703 . . . . 0.0 111.618 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -42.96 -43.35 4.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.129 1.372 . . . . 0.0 111.44 173.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 19.7 mmt -102.11 -1.88 30.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.938 1.695 . . . . 0.0 112.536 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.56 -51.04 6.13 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.766 1.226 . . . . 0.0 110.704 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -56.83 -39.83 74.94 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.402 0.681 . . . . 0.0 111.471 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.65 -37.28 79.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.11 1.364 . . . . 0.0 111.55 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -51.14 142.62 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.503 1.121 . . . . 0.0 111.74 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -119.08 98.39 50.85 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 125.43 1.492 . . . . 0.0 107.209 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.463 ' HD2' ' CG1' ' A' ' 8' ' ' VAL . 17.0 Cg_exo -63.57 176.09 2.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.803 2.335 . . . . 0.0 112.396 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.67 131.36 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 169.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.2 t -113.08 96.58 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -103.88 101.31 11.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.869 2.067 . . . . 0.0 107.778 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.46 138.36 32.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -173.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -141.42 131.5 24.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.455 1.102 . . . . 0.0 108.994 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -104.15 150.66 24.15 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.441 1.497 . . . . 0.0 110.053 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -152.38 155.4 37.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.394 1.878 . . . . 0.0 108.863 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -21.1 -68.18 0.01 OUTLIER Glycine 0 C--N 1.345 1.035 0 C-N-CA 127.563 2.506 . . . . 0.0 114.115 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -123.81 12.96 9.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.946 1.298 . . . . 0.0 110.893 172.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -114.38 143.53 44.76 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.334 0.97 . . . . 0.0 110.09 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -141.55 110.17 6.06 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.0 t -108.25 122.21 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.883 1.273 . . . . 0.0 108.599 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.15 104.52 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.01 1.324 . . . . 0.0 107.786 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.8 m -101.3 82.8 2.38 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.8 p -102.93 98.96 8.85 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -137.37 140.02 41.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.314 -162.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 p -130.38 157.02 78.62 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 126.277 1.831 . . . . 0.0 106.873 167.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.26 60.67 6.41 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.167 2.578 . . . . 0.0 108.707 168.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -169.84 -67.57 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.639 1.176 . . . . 0.0 109.66 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -106.83 156.31 18.81 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.864 1.266 . . . . 0.0 110.07 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -123.15 70.17 1.02 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.219 1.408 . . . . 0.0 108.731 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.3 t -71.95 -46.75 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -6.48 106.11 0.01 OUTLIER 'General case' 0 C--N 1.345 0.408 0 C-N-CA 129.386 3.074 . . . . 0.0 114.244 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -104.81 156.74 17.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.728 1.211 . . . . 0.0 109.693 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.1 t -158.94 95.18 1.27 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.45 163.7 22.07 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.639 0.776 . . . . 0.0 111.297 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.8 m -133.46 150.77 51.74 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.89 1.676 . . . . 0.0 107.191 -176.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.3 mt -65.46 -60.15 3.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.474 0.31 . . . . 0.0 111.479 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.3 47.75 1.01 Allowed Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.317 0.96 . . . . 0.0 111.122 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -164.99 144.09 6.73 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -57.13 165.14 1.42 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.843 1.257 . . . . 0.0 112.591 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.22 98.79 2.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.504 0.721 . . . . 0.0 109.46 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -89.47 83.34 6.35 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.413 1.085 . . . . 0.0 109.899 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.93 167.02 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 125.345 1.458 . . . . 0.0 109.695 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.2 t -162.2 176.01 11.08 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.013 0.925 . . . . 0.0 110.053 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 t -113.49 121.28 43.78 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.241 1.416 . . . . 0.0 108.223 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.45 85.23 7.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -169.71 -70.03 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.099 0.959 . . . . 0.0 111.514 174.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.39 -119.19 3.24 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 124.748 1.166 . . . . 0.0 111.094 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -108.46 171.79 7.22 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.787 1.235 . . . . 0.0 109.158 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -154.69 131.07 10.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.924 0.89 . . . . 0.0 108.834 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.19 136.28 48.14 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.859 1.263 . . . . 0.0 109.399 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -147.81 124.32 11.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.2 t -106.98 -65.78 1.07 Allowed 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -150.7 127.61 11.06 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.1 m -104.26 49.75 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.275 1.43 . . . . 0.0 110.06 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -91.45 -179.28 5.34 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.399 1.079 . . . . 0.0 111.349 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -154.85 139.96 17.46 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.741 2.017 . . . . 0.0 106.796 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.45 -72.11 0.73 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.821 0.848 . . . . 0.0 110.093 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -95.39 -67.84 0.83 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.877 0.871 . . . . 0.0 110.248 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.64 48.49 0.22 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -158.96 128.92 5.74 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.379 1.072 . . . . 0.0 109.337 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.04 135.64 51.24 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.976 1.31 . . . . 0.0 109.872 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.5 p -158.7 154.56 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.05 1.34 . . . . 0.0 108.545 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.5 m -135.37 127.58 30.05 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.516 1.126 . . . . 0.0 108.253 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.6 88.63 2.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.922 0.889 . . . . 0.0 110.36 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.2 m -130.46 83.76 2.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.944 1.298 . . . . 0.0 109.235 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.04 76.67 2.9 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.0 -52.97 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 126.822 2.049 . . . . 0.0 106.897 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -98.95 91.81 5.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.546 1.539 . . . . 0.0 107.504 171.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -99.8 118.72 36.88 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.992 0.917 . . . . 0.0 109.441 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -126.21 103.76 7.86 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.394 1.077 . . . . 0.0 109.001 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -69.89 134.39 48.38 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -108.61 49.2 0.82 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.463 1.105 . . . . 0.0 110.767 -171.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -81.3 83.66 6.82 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.4 p -108.27 128.55 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.346 1.458 . . . . 0.0 108.971 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -122.06 156.5 33.41 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.11 1.364 . . . . 0.0 109.075 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -26.13 -60.39 0.08 OUTLIER Glycine 0 CA--C 1.53 1.013 0 C-N-CA 127.562 2.505 . . . . 0.0 115.487 -173.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -131.51 28.24 4.65 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.848 0.859 . . . . 0.0 111.571 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -155.35 119.5 4.61 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 41.8 ttm -106.12 115.22 29.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.03 61.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.844 1.258 . . . . 0.0 108.69 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -73.08 165.37 25.15 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.06 0.944 . . . . 0.0 110.952 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m -131.44 96.88 4.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 173.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 pp -106.65 134.91 46.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 94.2 m -129.83 137.76 50.63 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.039 1.336 . . . . 0.0 111.046 -167.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -108.34 179.45 4.2 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.199 2.2 . . . . 0.0 107.594 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -18.95 -56.55 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 C-N-CA 128.139 2.78 . . . . 0.0 115.334 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -155.05 36.01 0.66 Allowed Glycine 0 CA--C 1.532 1.116 0 CA-C-O 118.689 -1.062 . . . . 0.0 114.072 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 t -146.26 151.61 14.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.32 0 CA-C-N 118.778 1.289 . . . . 0.0 109.037 170.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 87.3 m -128.53 142.95 50.91 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.423 1.489 . . . . 0.0 110.254 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.412 HD21 ' CD2' ' A' ' 17' ' ' PHE . 1.6 mm? -108.43 146.88 32.43 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.536 HG22 ' HB2' ' A' ' 12' ' ' GLU . 8.8 tp -80.17 63.35 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 170.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -52.23 97.3 0.02 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 126.19 1.796 . . . . 0.0 111.56 -170.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.461 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 64.3 ttt180 -125.32 113.68 17.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.919 0.887 . . . . 0.0 110.124 -169.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 56.4 p -126.36 144.68 50.73 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.505 1.522 . . . . 0.0 109.692 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -114.39 142.34 46.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.398 1.479 . . . . 0.0 108.952 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.66 98.59 6.26 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.7 t . . . . . 0 C--O 1.252 1.199 0 CA-C-O 116.494 -1.717 . . . . 0.0 107.144 175.394 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 111.213 0.079 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -77.24 -37.22 53.65 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.017 0.527 . . . . 0.0 110.376 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 p -50.32 95.5 0.01 OUTLIER 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.303 1.841 . . . . 0.0 112.198 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.73 -171.38 44.45 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -106.83 142.38 36.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 168.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -142.41 124.47 15.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.178 0.991 . . . . 0.0 109.387 -169.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -119.78 112.11 18.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.096 0.958 . . . . 0.0 109.239 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.811 HG11 ' HD2' ' A' ' 36' ' ' PRO . 1.4 p -63.94 121.46 12.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 C-N-CA 124.109 0.964 . . . . 0.0 109.853 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -113.65 -24.22 9.32 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.538 0.735 . . . . 0.0 110.981 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -147.63 143.87 28.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.272 1.429 . . . . 0.0 108.113 -169.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.99 162.89 34.33 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.48 -100.93 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.283 0.633 . . . . 0.0 110.869 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -106.97 65.05 0.65 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.546 1.138 . . . . 0.0 110.532 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.0 -41.5 99.6 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.013 0.525 . . . . 0.0 111.16 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -58.35 -24.55 60.14 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 119.026 -0.511 . . . . 0.0 112.017 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -88.45 -38.78 14.75 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 123.093 0.557 . . . . 0.0 111.89 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.489 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 67.1 t80 -46.14 -41.53 12.63 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.073 0.949 . . . . 0.0 110.49 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.762 HD13 HG23 ' A' ' 28' ' ' ILE . 7.6 mt -78.61 40.16 0.37 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.107 1.763 . . . . 0.0 112.77 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.4 -33.31 1.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.188 0.904 . . . . 0.0 111.852 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.7 98.38 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.239 0.616 . . . . 0.0 110.579 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.419 HD22 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -74.53 168.26 20.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.126 0.97 . . . . 0.0 110.713 175.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.74 60.28 0.64 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.698 1.199 . . . . 0.0 111.183 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.419 HD13 HD22 ' A' ' 21' ' ' LEU . 9.4 mp -103.23 148.47 35.72 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.685 1.194 . . . . 0.0 108.583 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.88 158.01 59.23 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.385 2.723 . . . . 0.0 111.52 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . 13.1 pt-20 -57.08 -35.21 69.1 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.53 -35.52 80.44 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.368 0.667 . . . . 0.0 111.677 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -24.55 64.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.562 0.745 . . . . 0.0 112.219 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.762 HG23 HD13 ' A' ' 18' ' ' LEU . 3.9 mp -70.54 -39.49 76.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -55.65 -52.33 64.18 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 16.4 mmt -83.77 47.18 1.26 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.331 1.052 . . . . 0.0 110.571 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 18' ' ' LEU . . . -151.52 -58.67 0.16 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.757 1.623 . . . . 0.0 109.42 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.1 ptt85 -69.79 -37.31 76.27 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 122.244 -0.285 . . . . 0.0 111.31 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -83.79 37.27 0.58 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.767 0.827 . . . . 0.0 110.424 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.5 mm -130.62 117.31 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.1 96.7 39.84 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.818 1.247 . . . . 0.0 107.764 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.811 ' HD2' HG11 ' A' ' 8' ' ' VAL . 8.3 Cg_exo -72.52 164.85 34.39 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.743 2.295 . . . . 0.0 112.698 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.13 117.18 53.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 166.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.95 140.23 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -148.64 100.32 3.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.065 0.946 . . . . 0.0 109.161 -165.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 mt -108.87 135.7 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.593 0.757 . . . . 0.0 109.624 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -125.05 133.28 53.0 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.15 1.38 . . . . 0.0 108.286 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.1 150.66 21.8 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.448 1.099 . . . . 0.0 110.465 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -140.19 154.13 46.83 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 127.735 2.414 . . . . 0.0 106.729 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.93 -55.28 2.31 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.21 1.386 . . . . 0.0 112.499 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -129.84 61.57 1.57 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.739 1.615 . . . . 0.0 109.194 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.4 155.42 17.66 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.246 0.546 . . . . 0.0 110.789 163.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -139.54 111.85 7.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.841 1.656 . . . . 0.0 106.986 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 80.9 t -106.17 127.72 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -127.42 119.79 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.436 1.094 . . . . 0.0 109.207 -171.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.1 m -107.93 141.08 40.09 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.607 1.563 . . . . 0.0 107.522 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.4 t -148.54 87.43 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.146 1.378 . . . . 0.0 107.353 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 120.21 41.33 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.925 0.89 . . . . 0.0 108.844 -170.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 p -101.19 153.8 37.57 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 124.519 1.127 . . . . 0.0 110.041 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.85 51.29 3.33 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.232 2.621 . . . . 0.0 110.418 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -167.09 -48.41 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.694 1.197 . . . . 0.0 110.441 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -130.59 -166.16 1.65 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.647 1.579 . . . . 0.0 108.903 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.8 m -155.27 130.59 9.63 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.48 1.112 . . . . 0.0 108.222 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -133.12 136.03 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.1 m -152.93 141.87 21.21 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.779 1.232 . . . . 0.0 107.894 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -145.84 166.42 26.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.247 1.419 . . . . 0.0 109.473 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.0 p -157.13 141.87 16.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.845 0.858 . . . . 0.0 109.436 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -169.44 167.32 9.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.533 1.133 . . . . 0.0 108.826 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 m -133.02 164.76 26.28 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.842 0.857 . . . . 0.0 110.294 -167.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.48 -58.85 5.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.286 1.035 . . . . 0.0 110.62 175.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.46 36.18 4.39 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.84 1.21 . . . . 0.0 113.564 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -130.24 128.61 41.99 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.862 1.331 . . . . 0.0 109.236 167.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -66.77 133.17 49.61 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.41 0.684 . . . . 0.0 109.463 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -161.15 107.78 1.43 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.097 0.959 . . . . 0.0 109.575 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.86 150.03 44.64 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.22 0.464 . . . . 0.0 110.027 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.7 mm -108.37 111.59 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.277 1.031 . . . . 0.0 108.483 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.9 t -107.39 155.04 20.45 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.491 1.116 . . . . 0.0 111.032 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.6 p -138.12 137.25 37.51 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.8 1.24 . . . . 0.0 109.023 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.7 ptp -88.44 82.36 7.0 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.371 1.068 . . . . 0.0 110.412 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -155.51 -93.56 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.152 0.581 . . . . 0.0 110.934 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.34 -31.5 0.1 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.465 1.507 . . . . 0.0 111.904 -174.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.06 124.79 7.15 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.953 1.376 . . . . 0.0 111.406 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -94.55 131.38 40.34 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.27 0.628 . . . . 0.0 109.323 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.1 tt -157.51 73.42 0.71 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 171.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -141.9 149.77 40.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.688 1.195 . . . . 0.0 108.513 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -136.89 119.84 16.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.4 m -146.37 71.31 1.24 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 83' ' ' HIS . 9.6 m -131.08 -65.24 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.141 0.576 . . . . 0.0 111.315 -175.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.42 ' N ' HG23 ' A' ' 82' ' ' VAL . 46.3 t-80 -99.51 130.72 45.79 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.189 1.396 . . . . 0.0 110.817 -169.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -125.75 119.04 26.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.773 1.629 . . . . 0.0 107.481 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.98 -53.63 0.48 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.015 0.926 . . . . 0.0 109.901 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -66.86 -60.09 2.97 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.249 0.619 . . . . 0.0 110.58 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.2 -48.69 0.1 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.03 110.46 22.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.5 119.51 7.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.431 1.092 . . . . 0.0 111.216 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.0 p -160.11 162.14 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.875 0.87 . . . . 0.0 109.861 -173.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 m -145.86 -38.5 0.24 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.544 1.138 . . . . 0.0 110.028 173.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -139.68 141.19 37.0 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 125.745 1.618 . . . . 0.0 107.787 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.5 t -168.28 67.56 0.07 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.514 1.126 . . . . 0.0 108.463 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -89.35 -99.49 0.09 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.77 0.828 . . . . 0.0 111.085 -173.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -73.57 -48.97 28.8 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -76.43 74.74 3.19 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.0 m -72.93 93.88 1.78 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -90.43 -16.36 29.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.848 1.259 . . . . 0.0 111.672 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.72 136.84 58.15 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.232 0.613 . . . . 0.0 109.883 -172.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.87 169.07 18.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.149 0.98 . . . . 0.0 110.548 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -123.16 146.38 47.82 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.814 1.646 . . . . 0.0 107.915 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.6 t -139.25 124.94 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -121.51 -173.95 2.75 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.664 1.186 . . . . 0.0 109.506 -169.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -39.3 116.49 0.62 Allowed Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.845 1.688 . . . . 0.0 111.593 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 p30 8.19 56.77 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.835 2.854 . . . . 0.0 115.195 -163.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -158.6 133.74 8.49 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.47 0.708 . . . . 0.0 110.372 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.8 ttt -129.41 129.65 44.97 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.903 2.081 . . . . 0.0 106.032 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.55 -72.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.173 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -53.48 142.18 22.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.716 0.806 . . . . 0.0 109.635 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.5 m -139.05 -88.72 0.21 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.869 -175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.75 149.21 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.276 0.944 . . . . 0.0 110.353 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 t -123.02 142.54 50.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.133 0.973 . . . . 0.0 109.485 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -109.26 -164.98 0.98 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.848 1.659 . . . . 0.0 108.383 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.71 -58.93 12.0 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 123.87 0.748 . . . . 0.0 113.255 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -131.55 42.29 1.41 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 123.876 0.75 . . . . 0.0 112.014 -175.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.8 p -169.31 157.86 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 125.481 1.512 . . . . 0.0 107.461 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.9 t -151.5 152.28 32.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.489 ' HG ' ' HB2' ' A' ' 17' ' ' PHE . 1.2 tm? -149.07 79.65 1.41 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.294 0.569 . . . . 0.0 112.158 -168.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.22 126.47 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 161.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -112.16 124.83 53.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -102.32 98.69 8.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 82.9 p -106.93 135.59 48.23 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.64 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -108.12 138.59 44.13 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -98.7 131.9 44.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.11 1.364 . . . . 0.0 108.971 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 C--O 1.25 1.094 0 C-N-CA 125.145 1.378 . . . . 0.0 107.914 -176.7 . . . . . . . . 0 0 . 1 stop_ save_